Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ABCA9	EST640918	ENSG00000154258	"ATP binding cassette subfamily A member 9"	Q8IUA7	17	68974488-69061064	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 42.5"	"Cell type enhanced"	"Detected in many"	22	"Ito cells: 26.4;Leydig cells: 89.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"ASC diff: 14.5;ASC TERT1: 31.1;HSkMC: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052113, HPA054823"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA052113: AB_2732573, HPA054823: AB_2682615"	"unprognostic (3.88e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.46e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.51e-4)"	"unprognostic (1.83e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.51e-1)"	"unprognostic (7.77e-6)"	"unprognostic (5.32e-4)"	"unprognostic (7.22e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.96e-3)"	42.5	4.2	1.2	5.5	2.8	1.7	14.1	2.7	2.6	13.4	17.4	2.6	6.8	1.7	15.5	11.8	25.5	8.8	7.2	15.0	2.1	1.9	2.5	7.6	5.6	2.1	7.8	2.0	25.2	2.3	1.7	2.8	1.1	4.4	13.9	3.8	4.1	5.7	4.7	12.4	5.4	3.7	11.9	3.8	1.6	4.8	10.9	2.1	1.0	7.6	9.9	2.5	20.4	18.7	1.8	0.9	2.9	0.8	1.2	1.3	0.0	0.2	0.4	0.5	0.6	14.5	31.1	0.5	0.3	0.3	0.0	0.2	0.4	0.4	0.4	0.1	0.5	0.3	0.4	0.3	0.5	0.2	0.2	0.4	0.5	1.3	0.4	1.6	0.6	0.9	11.1	0.4	2.3	0.2	0.6	3.1	0.4	0.5	1.1	0.2	0.2	0.2	1.4	0.3	0.1	0.3	1.5	0.1	0.2	0.1	1.3	0.6	0.5	0.4	0.3	0.3	0.4	0.3	0.5	1.3	0.9	0.4	1.7	0.3	1.0	0.3	0.3	0.3	0.3	1.5	1.7	0.8	1.4	1.3	0.6	1.3	1.1	0.8	0.5	0.9	1.8	1.3	1.3	2.9	1.2	0.5	0.7	0.4	0.0	1.2	2.8	2.7	2.6	2.1	1.9	7.8	2.0	4.4	2.1	0.0	1.0	0.0	0.2	1.5	5.4	2.4	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.9	0.4	0.0	0.0	0.0	10.6	0.1	0.0	9.9	0.2	0.0	0.0	26.4	1.8	2.1	89.2	0.6	0.0	0.0	0.0	12.1	0.3	0.0	14.5	0.0	6.1	12.9	1.4	1.2	0.6	1.4	0.0	0.0	0.0	0.1
AC068631.2		ENSG00000283149			3	186581995-186597103	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 17.4"	"Not detected"	"Not detected"											"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA010814	Uncertain		Uncertain	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA010814: AB_1078691"																		1.9	1.3		3.1		6.3	2.7		1.2	0.0	4.7			2.9	1.3	8.3	0.7	0.1	1.9	0.4			1.3	5.3	0.5	1.5			0.2	2.8	0.0		1.6		0.0	2.3		0.6	0.5	0.0	0.0	1.5	0.3		2.1	1.7	0.2			2.9		1.2	0.0		9.0	17.4	9.7	8.7	10.7	11.9	6.6	12.7	10.1	12.9	16.1	10.9	5.1	4.2	24.0	6.7	9.9	6.8	35.5	6.2	8.0	29.8	16.1	15.7	9.5	13.0	9.1	13.0	6.5	0.2	8.0	18.2	37.2	13.0	15.6	5.5	5.7	5.5	11.6	20.7	8.0	6.3	3.9	4.5	31.8	4.4	28.0	8.0	5.3	4.0	32.0	0.0	5.3	12.9	11.3	10.3	23.0	1.0	1.9	10.7	22.9	7.3	15.2	15.6	20.2	3.4	6.7	8.0	5.9	22.5	13.5	27.2	22.8	10.1	12.5	13.9	7.6	6.7	9.7	11.9	8.7	8.5	9.0	7.5	10.1	10.5	5.5	4.9	9.5	1.8	10.7	7.2	17.4	8.8	6.6											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC135050.2		ENSG00000255439			16	31083439-31094956	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"liver: 47.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA042720	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA042720: AB_10961864"	"unprognostic (2.74e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.68e-3)"	"unprognostic (2.45e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.79e-2)"	"unprognostic (4.48e-3)"	"unprognostic (8.49e-2)"	"unprognostic (2.84e-8)"	"unprognostic (4.96e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.29e-4)"	4.5	2.6	1.6	4.8	1.7	3.0	6.4	1.9	2.6	5.4	3.9	3.3	3.2	3.3	5.1	5.9	3.7	4.0	4.9	3.7	1.8	1.8	6.9	47.1	3.6	3.7	2.4	1.1	5.6	14.1	4.6	3.1	4.8	2.3	4.8	2.2	4.4	8.3	3.8	2.0	7.8	6.0	6.3	1.8	4.3	3.5	3.6	1.5	3.0	5.7	2.4	2.6	6.5	3.9	2.3	2.6	2.9	2.7	1.4	3.8	2.0	1.2	1.2	0.0	1.2	2.7	3.6	0.3	3.7	0.9	0.0	0.5	0.6	0.7	0.7	1.9	0.3	0.0	0.5	0.0	0.4	0.0	0.4	1.7	1.5	1.2	0.5	0.0	0.0	1.5	1.0	0.6	0.6	0.0	0.6	0.0	1.1	0.0	1.5	0.3	1.2	1.0	3.1	0.3	0.1	1.6	2.9	0.2	1.1	0.0	0.8	1.0	0.9	1.8	1.0	1.9	0.0	0.0	0.4	0.0	1.2	0.0	3.2	0.9	3.6	0.8	0.0	2.9	0.9	0.4	0.8	1.6	2.9	2.7	1.6	3.5	2.3	3.4	3.8	2.3	1.8	2.1	2.8	1.5	1.4	2.7	2.6	3.4	2.0	1.6	1.7	1.9	2.6	1.8	1.8	2.4	1.1	2.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC138811.2		ENSG00000260342			16	18788063-18801519	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"blood: 51.6;testis: 43.2"	"Cell type enhanced"	"Detected in some"	24	"Alveolar cells type 2: 3.5;Ciliated cells: 9.4;Club cells: 4.5;granulocytes: 2.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 28.6;HDLM-2: 34.8"									HPA045307	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA045307: AB_10961042"	"unprognostic (1.03e-2)"	"unprognostic (8.89e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.59e-3)"	"unprognostic (2.28e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.18e-4)"	"unprognostic (2.92e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.95e-2)"	5.0	5.8	7.8	7.0	12.6	4.6	4.4	9.4	17.0	3.8	13.5	6.3	2.3	1.9	4.2	3.1	5.6	3.5	3.8	4.8	6.9	4.8	6.4	12.1	4.3	4.0	6.6	10.6	4.1	9.3	10.8	3.6	4.0	17.1	3.6	4.1	9.6	4.1	4.1	12.0	4.0	5.9	5.5	7.0	6.0	14.6	43.2	4.0	7.5	4.5	1.6	4.1	4.7	3.9	29.2	51.6	29.0	25.8	37.2	49.0	48.3	11.6	2.3	2.0	12.2	0.7	0.3	0.4	12.6	0.7	1.2	1.6	8.3	14.9	3.1	28.6	2.9	3.1	13.9	4.4	1.8	3.6	34.8	1.3	3.3	5.3	2.2	0.0	15.8	8.2	0.7	0.4	4.2	0.0	1.2	0.7	1.5	6.7	12.1	1.3	0.0	5.5	0.2	1.1	0.7	0.3	21.1	4.5	1.6	0.8	7.0	6.4	0.7	16.3	4.3	1.1	1.1	7.8	0.3	13.1	5.7	8.9	5.6	13.0	3.3	16.5	7.2	8.1	1.9	13.2	29.0	25.8	15.0	43.5	18.0	34.2	29.0	34.9	41.5	24.5	29.2	29.8	32.9	20.1	37.2	22.9	51.6	49.0	48.3	7.8	12.6	9.4	17.0	6.9	4.8	6.6	10.6	17.1	4.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	9.4	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AGR2	"AG2, HAG-2, PDIA17, XAG-2"	ENSG00000106541	"Anterior gradient 2, protein disulphide isomerase family member"	O95994	7	16791811-16833433	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 160.2;gallbladder: 147.0;seminal vesicle: 159.4"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 1045.3;Mucus-secreting cells: 2788.2;Paneth cells: 1013.4;Undifferentiated cells: 1404.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"OE19: 672.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007912	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		22000	"Endoplasmic reticulum"		"HPA007912: AB_1844879"	"unprognostic (6.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (8.79e-5)"	"unprognostic (6.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.22e-3)"	0.9	0.9	0.9	23.0	0.9	0.0	5.3	0.9	0.9	52.8	58.8	1.3	160.2	36.5	4.8	51.9	4.0	23.7	147.0	0.9	0.9	0.9	3.3	0.9	19.0	0.0	0.8	0.0	4.0	59.2	0.0	11.3	1.6	0.1	18.8	97.7	0.0	70.0	159.4	0.9	1.1	62.2	3.3	0.8	0.9	107.6	0.9	0.0	0.1	1.1	20.0	97.7	13.2	3.7	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.3	0.0	0.0	0.0	0.2	0.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	672.3	5.3	0.0	0.0	0.1	21.3	12.6	0.0	0.0	0.0	3.4	0.0	0.0	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.9	0.9	0.9	0.9	0.9	0.8	0.0	0.1	0.0	47.6	221.9	2.2	104.9	2.5	0.0	0.0	351.6	1045.3	577.8	76.8	0.0	4.6	0.0	37.7	2.8	0.1	824.5	0.0	764.4	3.5	4.2	606.7	44.8	0.6	180.1	0.0	501.7	0.0	0.6	0.0	0.3	2.7	3.3	1.8	2788.2	0.0	180.9	1013.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	2.7	0.7	1404.9	754.7
AL035078.4		ENSG00000285283	"Reticulocalbin-1 "	Q15293	11	31812391-32104665	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.2"	"Cell type enriched"	"Detected in single"	4	"Ciliated cells: 1.4"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 63.7;RH-30: 39.5;RT4: 43.1"									HPA038474	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA		2300000	"Endoplasmic reticulum"		"HPA038474: AB_10672595"																		4.7	0.9	1.6	7.5	2.4	0.0	0.3	16.2	3.2	0.3	5.9	1.7	0.3	0.9	3.8	0.3	1.7	4.3	0.3	0.3	3.1		0.4	2.8	1.4	0.3	2.2	1.9	6.1	0.3	0.0	1.8	1.6	3.0	0.3	0.8	6.9	0.3	0.3	3.3	0.0	2.4	4.6	3.6	0.5	2.2	0.3	1.0	0.3	0.5	0.3	0.7	1.9	0.3	0.6	5.3	0.4	3.5	3.2	2.1	1.7	7.4	12.4	12.0	11.5	3.4	2.1	6.7	63.7	21.2	11.2	10.4	6.0	9.6	0.0	21.0	24.0	16.2	6.5	9.0	7.2	12.3	5.0	1.5	3.6	9.0	0.7	0.0	3.1	1.5	10.6	1.4	12.3	8.1	3.9	15.8	2.0	1.2	3.9	0.1	2.6	4.9	0.0	5.1	0.0	0.1	2.7	39.5	1.6	0.0	43.1	5.0	1.9	12.4	0.8	7.6	3.1	9.1	0.1	37.7	28.7	12.1	17.3	24.3	0.0	0.0	0.1	30.4	1.2	13.1	0.0	3.5	0.0	2.1	3.4	1.9	0.6	0.2	1.8	5.3	0.1	0.3	0.9	0.4	3.2	2.0	0.6	0.0	1.7											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALG10	"ALG10A, DIE2, FLJ14751"	ENSG00000139133	"ALG10, alpha-1,2-glucosyltransferase"	Q5BKT4	12	34022281-34029694	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043329, HPA063387"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA043329: AB_2678432, HPA063387: AB_2685000"	"unprognostic (1.71e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.80e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.88e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.29e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (6.45e-2)"	6.2	7.0	2.7	5.4	5.9	6.9	6.9	4.0	5.5	5.3	4.6	3.8	3.6	3.4	10.3	5.5	6.0	6.2	3.7	4.6	2.6	2.9	4.6	5.7	5.4	6.7	4.1	1.7	7.1	7.8	7.5	6.1	7.2	3.5	5.8	4.1	8.7	9.0	4.4	4.6	5.1	5.0	4.0	3.5	6.1	5.1	8.0	3.6	17.2	6.2	3.0	9.8	5.8	4.8	2.7	1.8	4.5	2.7	2.1	3.8	1.6	4.5	5.4	3.5	5.8	4.2	3.3	12.4	4.4	4.1	4.8	8.6	7.9	11.0	6.9	6.5	2.2	7.1	6.9	6.6	5.6	6.5	11.0	6.3	6.4	5.7	3.1	1.7	9.2	6.7	3.6	3.3	10.1	7.7	2.3	3.2	6.2	9.6	11.7	3.9	6.2	5.9	5.1	13.1	2.7	6.8	5.3	12.7	7.0	2.6	6.8	3.1	2.5	7.7	3.3	5.5	10.5	7.9	2.5	6.8	6.6	9.8	8.8	5.5	6.4	11.5	13.3	4.6	3.7	5.2	0.0	2.7	4.5	1.9	1.2	3.0	2.5	2.6	1.1	1.8	2.7	3.1	3.8	0.4	2.1	1.2	1.8	3.0	1.6	2.7	5.9	4.0	5.5	2.6	2.9	4.1	1.7	3.5	3.6	6.0	0.3	3.0	2.5	1.3	3.5	0.8	2.5	4.0	3.4	5.2	3.9	6.4	1.7	1.9	0.6	2.1	1.0	0.0	3.3	4.7	2.1	0.6	1.1	2.4	2.9	1.6	1.2	0.6	2.7	0.0	1.4	2.1	0.0	4.6	1.9	3.7	2.6	0.0	1.1	1.1	4.1	0.0	1.0	7.5	3.0	2.4	2.6	4.3	1.7	1.4
ALG10B	KCR1	ENSG00000175548	"ALG10B, alpha-1,2-glucosyltransferase"	Q5I7T1	12	38316578-38329728	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA043329, HPA063387"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA043329: AB_2678432, HPA063387: AB_2685000"	"unprognostic (4.55e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.43e-2)"	"unprognostic (8.58e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.30e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.28e-1)"	8.2	8.5	4.3	4.9	7.0	6.6	9.1	5.3	7.2	6.1	4.4	5.4	9.5	4.2	8.5	6.7	6.9	6.4	6.0	5.8	5.0	2.7	5.9	6.6	6.5	7.3	6.6	4.8	8.7	9.6	8.7	7.8	11.6	4.3	6.1	4.5	10.5	9.3	9.7	5.8	7.7	6.5	4.6	4.5	7.5	6.4	8.9	5.0	10.5	7.4	5.6	6.6	7.7	6.8	3.6	2.6	2.0	2.0	1.4	4.1	1.2	5.0	4.7	6.2	6.2	3.1	5.8	6.4	4.0	2.1	5.4	4.8	1.7	15.3	7.7	7.0	2.0	4.0	5.3	5.4	4.4	7.8	5.1	6.9	8.1	8.1	3.4	3.4	10.8	5.7	3.2	5.8	7.6	5.6	4.8	3.9	9.8	9.1	4.7	4.5	3.8	7.2	8.6	7.8	0.5	4.7	2.4	13.3	6.1	4.6	6.3	1.8	6.4	7.0	2.4	4.8	6.9	10.7	4.4	3.3	5.7	6.6	5.0	5.0	3.7	9.5	12.3	4.8	7.6	7.1	1.2	1.5	2.0	1.1	2.0	2.2	1.8	1.1	1.8	1.1	3.6	2.2	2.7	0.6	1.4	1.4	2.6	4.1	1.2	4.3	7.0	5.3	7.2	5.0	2.7	6.6	4.8	4.3	5.0	6.0	11.5	0.5	3.5	1.8	12.9	3.0	0.0	6.7	9.1	3.5	31.4	15.2	6.6	3.6	0.2	4.9	1.2	0.0	5.0	8.2	3.5	2.4	1.1	5.9	4.2	9.5	0.0	6.2	1.5	1.5	3.7	1.9	1.7	0.0	2.5	8.9	3.5	2.0	5.3	2.2	12.4	6.5	1.4	8.3	3.4	1.6	6.8	1.3	2.5	2.3
ALG12	"CDG1G, ECM39"	ENSG00000182858	"ALG12, alpha-1,6-mannosyltransferase"	Q9BV10	22	49900229-49918458	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003076, HPA051665"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA003076: AB_2666777, HPA051665: AB_2681566"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.39e-3)"	"prognostic favorable (6.09e-4)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.27e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (3.60e-5)"	"unprognostic (1.62e-2)"	"unprognostic (3.00e-2)"	"unprognostic (9.89e-3)"	"unprognostic (6.32e-2)"	9.8	13.3	9.6	11.3	11.2	8.5	9.9	16.0	12.7	10.9	11.7	16.2	15.7	18.0	13.2	11.5	12.1	11.4	11.0	12.0	10.0	5.8	14.1	22.8	10.8	9.2	11.6	7.9	11.8	17.5	14.7	10.6	11.3	10.9	13.5	7.1	12.2	19.4	10.2	8.7	11.5	14.8	7.7	8.9	11.5	14.5	6.5	14.9	12.6	24.5	10.5	12.8	12.1	10.3	7.6	7.8	17.7	9.4	16.1	12.7	7.9	7.0	7.1	7.5	12.5	14.5	6.8	8.4	7.4	6.7	8.8	7.1	11.6	10.2	3.8	6.8	6.6	9.6	12.9	9.2	8.8	4.4	6.0	13.5	3.5	11.9	11.7	16.4	8.7	7.7	10.2	9.1	8.6	12.4	9.7	8.4	8.7	4.3	9.6	4.6	16.1	8.4	7.1	7.2	9.4	6.6	14.2	9.5	10.0	9.2	8.1	5.1	8.4	11.8	22.5	9.2	10.6	9.2	7.8	6.5	9.8	7.5	6.8	5.6	8.5	3.9	5.0	10.9	6.7	9.3	17.7	8.8	7.4	12.4	8.2	12.7	5.3	9.8	12.2	7.7	7.6	8.3	9.3	6.9	16.1	9.4	7.8	12.3	7.9	9.6	11.2	16.0	12.7	10.0	5.8	11.6	7.9	10.9	14.9	8.9	1.9	8.1	9.0	3.7	5.4	1.2	2.5	5.3	7.9	17.4	2.0	17.2	3.3	14.4	4.7	6.9	15.5	0.0	11.7	19.0	7.8	8.8	8.1	11.9	15.8	3.2	6.4	7.4	8.6	3.0	8.1	6.1	10.1	10.8	11.2	3.4	10.1	7.0	7.8	5.5	5.1	0.0	3.3	8.6	9.4	5.3	22.0	12.9	13.7	8.1
ALG6		ENSG00000088035	"ALG6, alpha-1,3-glucosyltransferase"	Q9Y672	1	63367590-63438562	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062536, HPA076130"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA062536: AB_2684792, HPA076130: "	"unprognostic (1.21e-1)"	"unprognostic (5.60e-3)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (2.07e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (2.63e-6)"	"unprognostic (1.84e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.41e-1)"	9.7	13.7	9.3	13.5	13.5	8.8	11.6	12.2	12.6	9.9	11.8	10.1	9.0	12.1	11.0	14.3	16.7	9.6	9.1	9.9	11.2	7.1	10.3	14.6	10.0	13.4	8.2	11.1	10.8	11.5	10.6	10.0	14.1	11.6	8.9	14.0	10.2	12.9	11.9	8.0	13.7	13.5	7.5	10.5	14.5	10.0	6.9	8.7	25.9	9.7	8.5	21.7	10.0	11.6	7.5	7.9	24.2	7.4	7.4	10.6	5.6	5.3	4.8	8.5	7.7	10.2	8.8	11.2	6.3	2.2	3.3	3.8	5.6	5.4	13.9	15.2	5.2	14.6	10.3	12.4	10.1	6.0	15.6	9.8	10.7	5.5	4.6	5.0	12.7	9.3	7.3	6.1	8.1	3.0	6.1	12.5	14.2	11.3	11.2	7.7	7.0	12.2	10.7	26.0	14.6	7.2	12.5	12.0	16.4	9.5	7.4	7.9	4.3	16.8	17.5	16.5	16.3	9.7	7.2	6.8	5.5	5.5	11.6	8.1	9.5	13.3	11.5	5.3	12.7	18.4	24.2	7.4	13.6	8.8	6.6	10.6	7.5	7.2	8.5	7.9	5.6	8.7	9.1	4.3	7.4	6.4	6.5	9.4	5.6	9.3	13.5	12.2	12.6	11.2	7.1	8.2	11.1	11.6	8.7	8.9	3.7	7.5	8.0	9.7	5.6	2.8	10.2	4.0	7.9	3.5	3.9	39.5	1.7	10.5	1.9	5.8	5.8	0.0	7.8	23.6	8.2	5.4	9.2	9.2	13.7	6.4	4.1	8.0	5.9	1.7	6.4	7.5	15.1	0.0	7.8	4.9	6.5	0.0	4.6	5.9	5.1	6.5	5.1	12.1	15.9	9.7	22.4	13.8	9.3	6.4
ALG9	DIBD1	ENSG00000086848	"ALG9, alpha-1,2-mannosyltransferase"	Q9H6U8	11	111782195-111871581	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA038575	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA038575: AB_10672718"	"unprognostic (1.48e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.34e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.07e-3)"	"unprognostic (5.11e-2)"	"unprognostic (8.75e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (9.15e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.10e-2)"	19.9	13.5	11.8	11.4	17.9	9.0	16.8	19.3	19.3	16.9	13.7	15.6	15.7	16.2	19.1	15.7	13.8	12.5	14.0	14.3	11.6	13.7	13.7	17.7	12.3	13.5	12.2	11.2	19.2	29.9	21.0	16.5	20.3	14.6	14.7	14.9	17.5	34.3	20.1	11.7	17.3	13.2	15.8	13.2	13.0	14.1	25.0	9.8	15.3	17.4	10.9	15.2	13.8	14.2	7.8	9.5	7.0	7.9	7.1	12.2	6.5	9.9	10.1	19.8	19.4	12.3	11.8	15.0	13.0	10.6	10.8	11.7	17.2	17.0	16.1	18.5	14.6	13.6	18.7	10.3	15.7	15.2	12.4	8.1	12.2	5.9	12.6	14.3	13.7	8.5	10.2	10.6	11.2	11.1	15.5	10.3	12.5	12.2	25.2	17.6	7.3	13.7	12.2	6.5	13.9	11.2	12.6	17.6	31.3	11.8	8.9	9.7	16.7	11.4	17.5	7.0	14.4	18.9	5.6	10.2	22.7	16.0	11.0	14.0	8.2	6.1	15.1	9.4	17.1	15.3	6.7	5.8	7.0	8.5	7.9	9.4	7.8	8.0	8.8	9.5	6.6	12.2	7.3	2.3	7.1	6.9	9.4	7.7	6.5	11.8	17.9	19.3	19.3	11.6	13.7	12.2	11.2	14.6	9.8	0.0	4.1	2.9	1.2	1.8	9.4	5.0	2.5	1.4	4.5	7.0	7.9	3.0	3.3	6.3	4.3	2.1	3.2	0.0	6.1	11.4	2.8	1.2	0.0	5.8	2.7	14.3	4.1	2.5	1.2	3.5	4.4	2.3	0.0	3.6	3.4	5.4	5.9	3.5	3.5	2.2	10.3	6.5	4.1	3.7	5.5	1.4	7.6	2.5	3.9	0.6
ANKRD16	DKFZP434N1511	ENSG00000134461	"Ankyrin repeat domain 16"	Q6P6B7	10	5861617-5889906	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037920, HPA037921"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA037920: AB_10671381, HPA037921: AB_2675740"	"unprognostic (1.90e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.94e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.96e-3)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (1.98e-4)"	"unprognostic (5.85e-2)"	"prognostic unfavorable (4.31e-7)"	"unprognostic (1.06e-2)"	"unprognostic (7.64e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.93e-2)"	6.2	7.2	9.8	7.1	13.9	3.9	8.4	12.9	16.6	10.9	7.3	10.0	7.9	7.3	12.7	11.6	6.3	13.6	10.8	5.7	8.6	7.7	6.2	7.3	4.9	6.5	7.8	7.8	14.7	12.6	10.0	7.2	4.0	8.0	8.4	6.0	9.3	8.3	7.7	6.6	14.8	5.3	9.3	6.3	6.3	10.0	13.6	11.2	7.3	7.1	5.4	7.2	7.7	7.7	2.6	2.7	1.4	1.1	2.1	2.2	0.8	7.5	9.1	4.2	8.7	4.5	3.3	6.3	2.3	1.8	4.2	3.7	11.1	4.0	8.1	3.3	3.9	1.6	7.9	5.2	6.0	1.9	2.8	8.0	5.0	4.2	10.1	5.7	3.1	3.6	5.1	4.6	3.8	3.0	3.4	4.6	8.5	6.7	2.5	2.9	10.4	11.4	5.3	3.5	10.2	6.5	8.7	2.8	16.3	4.7	4.9	2.6	5.7	4.8	6.0	5.3	3.6	8.4	6.3	2.9	2.5	3.2	5.5	3.2	13.9	6.3	5.3	5.2	3.0	2.7	1.4	1.1	0.3	0.9	0.5	0.8	2.0	0.7	1.3	1.3	2.6	2.2	0.9	1.1	2.1	0.8	2.7	1.2	0.8	9.8	13.9	12.9	16.6	8.6	7.7	7.8	7.8	8.0	11.2	3.0	2.2	0.8	6.0	4.1	13.2	2.0	10.2	0.0	2.3	3.5	5.9	3.9	11.6	1.8	6.8	2.7	4.0	0.0	1.9	2.6	5.1	4.5	0.0	3.4	2.8	25.4	4.1	2.5	0.6	11.0	5.2	1.6	3.3	4.6	2.0	7.0	0.8	0.0	3.5	6.7	13.5	0.0	3.1	8.9	8.0	5.0	1.3	1.5	5.4	3.2
AP001781.2		ENSG00000258529			11	111786286-111879425	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 6.0;HeLa: 4.7;U-698: 4.5"									HPA038575	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA038575: AB_10672718"																		2.2	0.2	1.7	2.8	2.2	2.9	2.5	0.4	2.7	0.4	3.6	1.9	1.0	2.9	2.0	2.1	0.9	0.9	2.0	0.9	3.0		1.2	0.7	2.6	4.1	1.3	1.1	1.5	1.2	1.7	0.4	0.4	2.2	1.2	2.5	1.5	2.8	0.2	1.2	4.1	0.6	1.3	2.2	3.6	2.1	5.6	1.5	5.7	1.3	0.7	3.7	0.2	0.0	1.6	2.0	1.3	1.6	1.7	3.6	2.9	0.3	0.1	1.3	1.3	0.0	1.8	0.4	1.8	0.1	0.3	0.0	6.0	0.0	0.2	0.9	0.0	1.6	2.3	0.0	0.0	1.3	0.5	0.0	3.4	4.7	0.4	0.0	0.0	0.8	2.5	2.2	1.7	3.4	1.0	0.0	2.0	0.3	2.2	0.0	0.0	1.3	2.6	0.5	0.0	0.0	0.0	0.0	1.7	1.0	1.9	0.0	0.0	1.7	0.0	0.0	0.0	1.2	1.3	0.2	2.4	0.7	1.2	0.0	1.7	1.3	4.5	0.7	3.1	0.4	1.0	1.0	1.3	3.3	1.6	2.2	1.4	2.6	2.1	1.6	1.6	3.6	1.5	0.1	1.7	1.3	2.0	0.9	2.9											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARL6IP1	"AIP1, ARL6IP, ARMER, KIAA0069, SPG61"	ENSG00000170540	"ADP ribosylation factor like GTPase 6 interacting protein 1"	Q15041	16	18791667-18801678	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA045307	Uncertain		Approved	"Endoplasmic reticulum"		NA	Yes			"Endoplasmic reticulum"		"HPA045307: AB_10961042"	"unprognostic (2.42e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.09e-2)"	"unprognostic (4.60e-2)"	"unprognostic (6.32e-3)"	"unprognostic (5.36e-3)"	29.6	40.9	75.9	16.5	62.0	40.2	26.2	76.5	93.0	19.5	31.5	28.6	13.8	31.4	16.7	29.7	19.8	20.5	30.2	8.8	65.7	70.1	35.1	80.7	18.0	27.0	65.2	44.6	24.7	18.6	45.1	13.4	20.3	68.6	18.1	29.0	40.9	18.6	17.4	8.3	14.8	27.5	16.0	43.0	20.4	27.8	28.1	20.4	33.1	26.2	11.3	24.9	27.8	14.2	41.2	57.2	40.1	32.4	44.1	67.7	63.0	48.3	44.2	58.8	45.9	21.1	13.6	52.6	28.3	27.3	44.0	35.2	27.1	117.2	42.3	51.9	27.1	29.6	53.1	42.1	19.9	51.2	54.1	19.0	30.0	27.3	73.7	16.8	42.4	32.1	11.3	19.4	30.4	31.9	32.6	43.9	25.0	32.7	44.1	84.6	43.8	29.8	32.1	72.2	42.4	15.1	50.8	73.8	35.9	47.2	27.3	35.8	40.7	62.2	39.0	27.9	41.4	80.0	42.9	24.2	28.9	27.2	20.5	50.5	15.0	26.6	51.0	25.8	29.0	55.8	40.1	32.4	20.9	48.7	30.0	44.7	41.2	43.2	52.4	32.0	38.3	38.5	45.8	27.7	44.1	30.9	57.2	67.7	63.0	75.9	62.0	76.5	93.0	65.7	70.1	65.2	44.6	68.6	20.4	62.5	47.7	99.8	227.5	331.0	171.8	27.4	341.4	91.0	61.4	272.2	123.7	218.9	147.6	292.3	62.1	144.0	214.0	677.5	180.9	329.7	163.0	191.1	134.8	383.9	223.1	84.2	140.0	177.4	230.1	29.6	78.6	248.9	190.6	385.9	155.5	189.5	210.1	217.5	104.3	161.1	161.3	90.5	101.1	73.5	56.8	285.4	273.1	186.2	246.9	307.2
ARL6IP5	"DERP11, GTRAP3-18, HSPC127, JWA, PRAF3, Yip6b"	ENSG00000144746	"ADP ribosylation factor like GTPase 6 interacting protein 5"	O75915	3	69084944-69106066	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA015540, CAB019321"	Supported		Approved	"Endoplasmic reticulum"		NA	NA		19000000	"Endoplasmic reticulum"		"CAB019321: , HPA015540: AB_1852061"	"unprognostic (8.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.31e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.60e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.31e-2)"	53.2	53.2	44.0	37.4	48.5	21.3	51.5	32.9	62.1	48.1	31.9	41.5	16.8	21.1	33.8	40.0	38.5	34.5	37.3	76.0	42.9	51.0	43.3	28.4	44.9	43.7	53.1	30.7	28.9	23.3	18.3	36.3	50.6	81.7	49.2	31.8	32.1	54.9	35.6	69.3	18.5	30.3	37.0	51.6	40.7	27.9	21.4	46.1	32.5	39.9	32.7	45.2	46.9	30.2	57.3	40.4	91.5	57.5	41.4	74.8	114.8	15.2	10.6	13.1	9.6	68.3	64.0	16.6	15.8	35.8	12.3	14.5	5.3	37.4	3.0	5.3	27.1	23.1	12.2	10.7	18.2	10.6	59.8	10.0	10.5	18.0	8.1	17.6	8.9	52.1	46.0	32.9	11.3	14.4	43.7	37.6	10.1	4.6	28.7	29.8	8.8	9.7	11.8	3.4	35.6	10.0	8.6	12.0	28.0	60.7	25.7	3.3	8.7	15.7	17.1	20.6	13.5	11.3	14.3	36.7	8.2	6.5	20.7	17.1	25.8	36.1	5.6	27.2	22.4	13.2	81.4	57.5	91.5	52.3	51.4	40.1	57.3	73.9	66.5	40.4	43.9	63.1	66.2	24.0	41.4	43.0	25.6	74.8	114.8	44.0	48.5	32.9	62.1	42.9	51.0	53.1	30.7	81.7	46.1	163.8	103.0	121.2	73.7	64.7	192.5	338.6	84.1	117.8	116.0	89.0	176.7	275.4	21.6	231.6	8.1	130.0	85.8	70.0	188.9	320.0	170.5	132.5	322.8	62.5	267.8	116.0	40.4	118.4	223.5	12.7	191.8	306.3	258.1	527.6	54.0	207.9	194.4	84.2	246.1	66.8	224.8	187.5	100.4	8.1	2.5	64.5	149.2	256.0	66.9	73.3
ASPH	"BAH, CASQ2BP1, HAAH, JCTN"	ENSG00000198363	"Aspartate beta-hydroxylase"	Q12797	8	61500556-61714640	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 462.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 102.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055161, HPA059303"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA		900000	"Endoplasmic reticulum"		"HPA055161: AB_2682721, HPA059303: AB_2683973"	"unprognostic (8.07e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (6.39e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (8.96e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (2.74e-2)"	104.6	60.4	27.3	15.0	29.5	4.8	84.3	35.2	31.3	22.3	23.8	10.6	18.3	14.0	16.8	17.8	22.4	16.5	19.1	33.9	26.1	22.4	19.0	23.0	22.5	10.9	21.1	22.2	20.5	13.8	12.5	15.7	14.7	20.5	17.3	26.8	23.6	28.8	23.4	103.1	12.0	13.9	26.1	16.7	12.8	30.5	6.4	19.6	2.9	31.7	36.0	13.7	30.0	25.4	3.3	21.0	15.9	5.2	4.9	3.4	2.3	49.9	72.6	10.2	6.2	45.7	43.5	3.5	89.7	83.3	38.4	40.3	12.4	66.6	3.8	6.2	52.5	30.9	18.7	6.3	31.3	65.7	1.4	6.4	8.9	44.1	33.9	29.3	1.3	1.4	35.7	7.0	21.3	27.3	75.4	16.2	2.0	2.4	3.6	33.8	10.6	0.3	1.8	5.8	48.4	42.8	2.4	11.0	0.8	23.4	41.4	10.6	3.6	27.8	13.1	11.1	5.8	5.3	2.4	50.8	38.9	20.0	35.5	31.6	2.3	2.9	0.1	102.4	0.8	26.0	1.1	5.2	0.1	1.6	1.9	3.1	3.3	2.3	1.6	6.1	3.3	3.4	1.6	15.9	4.9	1.0	21.0	2.3	2.3	27.3	29.5	35.2	31.3	26.1	22.4	21.1	22.2	20.5	19.6	181.7	183.4	8.3	108.3	41.8	126.7	192.2	22.9	57.6	137.6	82.0	276.9	97.4	13.3	97.2	1.6	71.6	39.8	0.0	158.3	85.9	64.5	113.1	8.1	51.6	62.4	120.8	111.8	38.6	25.4	0.5	65.6	43.4	40.5	13.6	178.8	462.0	186.9	24.6	54.1	31.9	150.0	45.3	73.9	2.6	16.8	44.0	40.2	10.0	58.7	212.3
ASTE1	HT001	ENSG00000034533	"Asteroid homolog 1"	Q2TB18	3	131013875-131027649	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037010, HPA037011"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA037010: AB_10673629, HPA037011: AB_10696929"	"unprognostic (7.42e-2)"	"prognostic favorable (3.09e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.03e-5)"	"unprognostic (2.27e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.64e-2)"	10.1	9.2	6.8	11.7	9.5	10.2	10.3	9.3	9.4	11.9	14.3	13.1	7.1	10.4	12.4	11.4	7.7	9.3	9.4	6.1	8.5	7.1	7.2	10.9	7.4	11.9	11.3	9.7	11.1	12.9	10.7	14.0	8.0	8.8	7.9	10.8	8.2	7.2	8.2	4.9	7.4	16.6	8.9	9.7	12.0	8.7	12.1	8.0	17.7	12.9	6.9	13.8	8.3	7.8	9.8	9.1	25.1	12.1	17.6	19.9	7.0	10.2	7.4	4.9	5.0	8.8	9.3	2.2	5.8	5.1	7.1	7.3	12.2	4.3	11.3	8.9	5.6	6.0	11.4	9.7	4.8	10.7	6.1	5.8	6.7	4.0	5.6	8.9	10.4	4.0	6.1	6.6	5.7	5.4	6.1	5.9	9.5	5.8	5.8	7.3	7.0	9.0	5.3	4.5	12.2	7.5	9.8	6.9	9.9	5.8	6.4	8.4	7.7	10.9	2.6	7.9	5.0	6.7	7.2	4.1	8.0	5.4	13.3	4.6	7.4	6.5	15.2	6.2	9.0	4.0	25.1	8.4	16.9	13.8	9.5	14.5	9.6	15.2	12.0	9.1	9.8	19.9	14.5	6.1	17.6	12.1	6.6	16.7	7.0	6.8	9.5	9.3	9.4	8.5	7.1	11.3	9.7	8.8	8.0	11.9	4.3	4.2	3.5	2.9	9.1	1.7	2.5	1.4	7.9	3.5	13.7	5.1	5.0	4.4	25.5	5.8	9.3	0.0	5.1	4.2	3.7	2.4	8.1	4.4	4.2	3.2	6.4	5.5	2.2	9.3	6.6	5.9	1.7	2.8	4.7	6.9	2.8	5.8	4.6	3.7	12.7	0.0	5.1	1.8	5.1	1.3	3.3	11.5	6.6	2.5
ATL2	ARL6IP2	ENSG00000119787	"Atlastin GTPase 2"	Q8NHH9	2	38294880-38377285	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029108, HPA075302"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029108: AB_10670557, HPA075302: AB_2732289"	"unprognostic (5.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (3.64e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.27e-3)"	"unprognostic (8.22e-2)"	"unprognostic (6.86e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.84e-1)"	11.9	19.1	14.2	15.2	28.0	15.7	23.4	29.4	17.1	18.2	31.0	7.2	12.3	19.0	21.8	12.3	25.8	18.3	15.5	11.5	12.9	7.9	16.6	25.0	15.0	9.9	10.2	15.9	24.2	14.3	8.8	15.6	10.1	9.8	19.6	15.5	14.0	29.2	19.5	32.8	29.7	23.7	35.3	8.3	13.8	22.9	9.9	12.1	17.9	32.2	24.8	19.0	28.5	20.7	5.4	3.8	13.0	3.8	3.5	6.0	3.5	34.0	17.4	20.6	15.1	19.0	12.2	26.3	12.6	11.1	15.4	15.3	19.7	26.5	28.9	14.2	8.0	18.5	40.9	25.5	12.6	23.7	29.2	22.2	16.9	12.3	27.1	10.7	20.8	15.5	8.6	30.2	13.6	19.4	9.1	14.1	9.5	28.3	15.1	11.9	12.5	21.9	19.3	29.2	36.5	11.9	19.5	23.9	17.6	11.8	18.7	10.7	18.7	15.4	16.6	15.3	17.2	8.8	12.1	8.8	15.2	21.3	14.4	23.9	20.7	18.3	32.3	9.7	20.6	18.3	1.3	3.3	13.0	3.3	2.9	4.7	4.1	4.3	3.5	3.8	5.4	6.0	4.9	4.4	3.5	3.8	2.8	4.6	3.5	14.2	28.0	29.4	17.1	12.9	7.9	10.2	15.9	9.8	12.1	11.9	23.0	18.6	28.2	32.6	19.7	6.7	12.7	14.7	34.2	7.0	13.7	13.6	6.6	8.9	19.2	15.5	11.8	0.0	4.3	12.2	12.2	21.6	4.6	28.0	9.3	20.6	6.3	12.9	7.0	16.1	13.3	7.4	11.8	5.4	11.5	9.5	4.6	10.5	15.6	10.2	18.8	32.3	14.4	17.0	19.0	40.9	12.2	10.0	12.7	29.4
ATL3	DKFZP564J0863	ENSG00000184743	"Atlastin GTPase 3"	Q6DD88	11	63624087-63671921	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 242.0;Late spermatids: 574.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065702, HPA076616"			Enhanced	"Endoplasmic reticulum"		NA	NA		1600000	"Endoplasmic reticulum"		"HPA065702: AB_2685536, HPA076616: AB_2732318"	"unprognostic (4.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.09e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (4.52e-2)"	"unprognostic (1.11e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.67e-3)"	40.3	17.7	7.9	11.8	10.4	8.2	28.3	5.6	7.4	20.9	15.0	12.4	14.0	6.7	22.5	15.7	23.4	14.5	15.1	9.7	7.0	5.0	15.0	23.6	15.9	24.7	10.9	5.4	22.3	18.4	12.9	8.8	11.8	9.8	17.9	11.7	14.0	17.5	15.4	7.6	20.3	11.0	35.6	12.8	12.0	14.1	43.3	10.7	11.0	18.9	14.2	13.0	32.2	22.3	6.2	9.6	6.6	13.7	7.4	11.8	8.1	13.3	12.9	3.6	8.9	19.3	26.3	0.0	15.9	18.9	16.0	11.0	10.3	21.0	7.8	16.5	27.4	12.3	8.6	6.8	10.7	23.1	11.6	1.8	7.9	14.5	0.0	12.7	15.6	12.0	16.7	18.0	20.5	13.4	10.7	17.2	9.1	8.8	21.9	18.5	14.5	5.7	9.8	4.6	4.4	10.2	12.3	9.1	11.7	13.3	9.6	2.0	5.5	47.6	11.4	15.3	5.0	21.0	6.0	23.7	33.7	16.1	32.9	11.1	6.2	8.5	15.8	18.1	10.5	20.4	6.6	9.1	4.0	10.8	12.4	11.8	6.2	9.0	8.7	9.6	5.2	7.5	10.1	3.9	7.4	13.7	4.8	9.9	8.1	7.9	10.4	5.6	7.4	7.0	5.0	10.9	5.4	9.8	10.7	41.7	22.7	18.0	39.1	38.8	4.3	7.8	30.6	13.4	21.6	31.4	0.0	5.8	1.7	37.0	242.0	45.4	28.8	23.3	43.5	16.5	29.6	47.3	16.2	46.1	35.2	4.8	10.3	47.9	54.0	574.9	50.3	34.8	40.5	40.5	18.4	12.4	59.3	22.9	63.3	18.2	7.0	71.1	60.4	25.8	27.3	35.5	3.3	23.5	15.9	44.8
ATP2A1	"ATP2A, SERCA1"	ENSG00000196296	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1"	O14983	16	28878405-28904509	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"skeletal muscle: 456.3;tongue: 209.0"	"Cell type enhanced"	"Detected in some"	20	"Cone photoreceptor cells: 13.7;Late spermatids: 2.9;Rod photoreceptor cells: 4.6;Spermatogonia: 3.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 19.8"	"Region enriched"	"Detected in single"	8	"thalamus: 14.3"	"Not detected"	"Not detected"			"CAB002310, CAB032706"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB002310: AB_564139, CAB032706: AB_2061286"	"unprognostic (2.37e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.23e-5)"	"unprognostic (5.35e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-2)"	7.6	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.1	1.1	5.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.6	0.1	12.6	7.0	0.3	456.3	0.2	0.2	0.1	0.1	0.1	0.1	0.9	0.0	0.0	4.2	209.0	6.5	0.2	0.1	1.6	3.1	0.7	0.2	4.7	1.5	0.6	4.8	5.2	9.6	5.8	0.4	1.6	8.9	2.3	1.3	0.4	0.4	2.9	4.4	7.6	2.7	0.4	3.2	5.1	2.4	0.1	0.7	3.8	19.8	2.7	11.8	9.0	0.2	1.1	2.6	4.1	1.1	0.6	0.5	4.9	0.2	14.3	5.2	6.5	0.3	9.7	10.9	6.1	9.7	1.8	7.4	16.9	6.8	5.7	0.0	0.6	6.2	4.9	3.3	4.5	3.4	3.7	3.4	2.7	2.0	3.0	6.3	5.6	2.8	9.5	5.8	7.4	5.9	15.0	2.9	0.0	0.1	0.7	1.0	0.0	1.3	1.6	1.1	1.0	0.0	0.8	1.4	1.3	0.0	4.7	0.2	3.1	1.5	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.3	0.0	0.0	0.0	0.0	13.7	0.3	0.0	0.1	1.0	0.0	0.5	0.0	0.2	0.1	0.2	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.3	2.9	0.3	0.0	0.0	0.0	0.1	0.5	0.2	0.3	0.0	0.0	4.6	0.0	0.0	1.8	3.0	0.1	0.6	0.0	0.6	0.0
AVL9	KIAA0241	ENSG00000105778	"AVL9 cell migration associated"	Q8NBF6	7	32495426-32588721	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050957	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA050957: AB_2681289"	"unprognostic (2.33e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.72e-3)"	"unprognostic (5.14e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.21e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.68e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.05e-1)"	12.0	15.8	17.4	16.7	22.9	12.2	15.6	24.1	25.7	14.2	22.5	12.9	14.0	18.8	13.1	18.6	12.4	12.9	11.6	8.8	16.6	20.0	15.6	11.9	12.0	14.1	14.5	15.1	13.8	15.9	12.7	15.9	16.3	17.3	14.4	26.2	15.4	15.2	12.8	12.6	11.6	19.9	12.2	11.5	14.3	17.4	10.0	10.3	21.3	19.3	6.6	15.8	12.9	11.0	12.5	9.9	27.4	10.7	5.1	10.9	9.4	9.4	8.3	8.7	11.7	5.3	7.6	6.1	8.5	11.3	8.4	11.3	6.5	12.7	11.9	0.1	7.4	32.5	7.8	8.3	8.4	14.3	5.1	5.1	8.9	5.7	7.0	19.4	15.1	11.7	8.2	8.3	10.7	12.3	9.3	12.4	9.6	21.7	11.0	26.3	9.7	6.1	12.7	9.8	13.1	7.4	5.9	9.7	9.0	8.9	16.0	18.8	12.0	7.1	17.7	7.6	12.2	12.6	13.9	9.4	8.8	10.4	6.9	7.4	25.5	22.1	19.0	17.3	14.4	19.1	12.8	10.7	15.5	10.6	8.4	9.1	9.9	8.8	9.9	8.2	12.5	10.9	9.5	27.4	5.1	7.9	9.9	8.0	9.4	17.4	22.9	24.1	25.7	16.6	20.0	14.5	15.1	17.3	10.3	6.0	9.4	15.9	9.1	10.2	32.8	6.1	12.7	14.7	11.4	12.2	58.9	13.5	3.3	11.2	4.6	9.5	26.2	0.0	15.0	11.6	9.3	16.4	17.3	11.1	13.1	30.2	21.5	11.6	28.6	1.8	9.5	14.6	11.8	5.4	28.5	13.8	20.1	28.1	8.9	13.1	38.6	6.5	10.0	8.1	7.5	9.3	14.6	16.2	24.7	20.1
BAZ1A	"ACF1, hACF1, WALp1, WCRF180"	ENSG00000198604	"Bromodomain adjacent to zinc finger domain 1A"	Q9NRL2	14	34752731-34875647	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 380.8;Early spermatids: 560.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 22.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 22.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA002730	Supported		Uncertain	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA002730: AB_1078269"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.99e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.24e-3)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.31e-7)"	"unprognostic (2.44e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.37e-2)"	15.2	5.3	3.8	23.8	4.6	39.3	9.8	1.6	3.1	9.3	14.0	3.0	9.9	6.0	6.8	5.8	14.8	7.6	8.3	9.4	3.7	2.6	7.5	11.7	23.7	21.9	8.2	1.1	11.7	6.7	6.2	6.6	13.4	5.1	10.1	8.0	3.3	10.7	8.2	9.0	14.4	17.6	7.0	6.6	34.7	7.6	17.4	5.3	33.2	8.4	15.1	19.4	14.7	18.6	3.6	3.0	22.0	4.7	2.0	2.9	1.0	16.6	8.9	14.9	11.4	6.5	7.6	18.5	13.5	7.4	12.7	12.8	8.7	12.1	33.4	10.7	9.6	7.0	17.4	25.4	8.8	22.2	12.0	10.9	21.7	8.1	24.2	7.7	35.8	26.3	7.0	9.1	13.7	18.4	5.1	18.4	15.2	20.0	8.6	10.6	19.0	34.0	11.2	7.2	13.2	12.5	26.1	15.5	9.3	7.9	16.2	19.0	15.6	18.4	25.3	7.3	5.3	12.9	24.9	16.1	11.8	8.7	12.6	13.6	4.8	4.7	28.6	3.8	16.8	13.4	3.9	4.3	5.1	2.6	4.5	1.9	3.3	2.7	2.9	2.4	3.6	2.7	2.2	22.0	2.0	4.7	3.0	2.8	1.0	3.8	4.6	1.6	3.1	3.7	2.6	8.2	1.1	5.1	5.3	56.6	74.6	62.4	190.4	380.8	2.3	11.6	25.5	73.6	58.0	15.7	2.0	59.9	0.0	79.3	560.7	61.8	66.5	23.3	65.2	94.9	81.7	165.1	101.3	28.0	79.6	0.0	29.2	25.8	88.6	290.9	37.4	126.2	69.2	144.3	45.8	2.8	92.7	70.2	12.7	10.3	2.0	6.5	117.4	223.9	39.1	340.5	164.7	97.6	50.3	278.3
BCAP31	"6C6-Ag, BAP31, CDM, DXS1357E"	ENSG00000185825	"B cell receptor associated protein 31"	P51572	X	153700492-153724746	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Protein transport, Transport"		"Deafness, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003906, CAB015350, CAB015424"	Supported	Approved	Enhanced	"Endoplasmic reticulum"		NA	NA		6800000	"Endoplasmic reticulum"		"CAB015350: AB_2243544, CAB015424: AB_781567, HPA003906: AB_1078270"	"unprognostic (1.02e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (9.87e-4)"	"unprognostic (3.25e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	60.7	43.4	38.3	20.3	38.8	27.4	71.3	22.2	48.1	28.7	31.8	27.1	27.5	28.8	30.2	48.6	42.4	31.0	26.8	26.7	34.1	36.5	41.6	52.4	42.2	50.0	38.1	26.0	29.1	67.6	36.0	27.4	43.6	44.5	34.3	36.6	30.7	44.5	37.7	15.6	37.3	37.8	32.4	33.6	36.7	24.8	31.6	21.1	25.4	53.1	27.2	37.1	38.1	30.8	72.7	109.7	104.4	97.5	68.2	89.8	150.4	55.1	52.0	14.4	72.3	64.2	19.5	33.5	26.8	30.8	31.9	41.1	41.9	40.5	32.3	122.4	43.4	42.5	55.9	36.0	56.3	26.7	15.9	53.7	20.4	41.2	36.0	31.5	33.1	44.2	26.0	48.9	31.1	36.6	33.6	39.0	19.1	27.6	58.9	35.7	57.7	21.2	45.1	16.5	74.8	53.8	23.2	16.1	72.4	50.0	60.5	18.9	26.8	12.0	59.6	40.2	23.7	21.8	37.4	40.7	28.1	27.7	38.0	53.7	60.5	116.6	42.9	54.8	44.9	24.6	80.3	80.6	77.5	89.0	86.1	79.5	71.2	89.8	88.1	69.9	72.7	79.4	86.4	104.4	68.2	97.5	109.7	72.4	150.4	38.3	38.8	22.2	48.1	34.1	36.5	38.1	26.0	44.5	21.1	104.2	111.8	94.7	188.6	125.9	40.7	56.9	135.0	112.4	95.5	122.1	43.2	414.9	31.5	221.9	4.3	139.7	190.7	23.3	182.9	352.4	105.7	160.9	92.5	177.7	341.5	30.2	99.2	204.4	127.2	16.4	97.5	153.8	151.8	150.5	117.5	122.3	207.2	171.9	93.0	136.1	33.7	155.2	85.4	143.9	179.9	114.0	450.0	97.8	147.8	228.6
BNIP1	"Nip1, SEC20"	ENSG00000113734	"BCL2 interacting protein 1"	Q12981	5	173144442-173164387	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008009, HPA008149"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA008009: AB_1078291, HPA008149: AB_2667993"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.89e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.38e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.40e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.07e-2)"	12.0	14.5	13.3	9.5	14.5	34.0	13.7	10.1	16.9	10.5	11.1	13.4	9.0	10.2	10.2	15.0	11.4	10.8	9.4	13.0	12.2	14.9	14.5	14.1	10.1	10.9	13.7	12.0	11.3	22.5	13.6	14.7	13.1	17.5	10.6	13.4	10.8	12.4	9.6	20.9	9.0	9.8	10.8	11.8	11.8	11.5	28.1	9.3	14.4	13.1	9.3	12.4	9.9	10.1	9.9	12.7	3.4	9.3	9.6	14.6	8.5	10.8	9.7	11.6	14.3	7.2	16.8	12.9	9.2	14.5	19.6	19.8	16.7	15.0	11.6	10.9	13.6	20.6	8.6	15.0	26.0	20.1	19.0	12.1	10.4	6.4	8.7	19.0	16.6	13.1	9.4	13.2	18.1	22.9	9.3	14.9	17.0	10.0	14.1	15.9	25.2	18.4	14.7	5.1	13.2	11.6	12.2	9.4	14.2	11.2	6.6	14.7	9.1	8.1	10.4	19.7	8.5	17.5	13.4	11.8	17.0	12.7	14.5	18.5	10.8	12.6	17.8	15.7	17.1	10.9	0.0	8.5	3.4	14.6	9.3	12.4	9.0	12.8	10.5	10.3	9.9	11.0	10.8	0.3	9.6	7.2	12.7	11.1	8.5	13.3	14.5	10.1	16.9	12.2	14.9	13.7	12.0	17.5	9.3	3.0	10.7	5.6	9.0	10.3	13.2	4.5	7.6	10.7	6.8	5.2	3.9	18.5	23.2	12.5	2.2	6.5	7.4	0.0	10.8	15.9	8.2	11.0	1.1	5.7	13.4	9.5	6.9	5.5	6.9	4.8	8.1	9.1	3.3	11.8	10.8	9.8	8.4	7.8	11.0	13.0	9.6	0.0	6.1	19.2	12.5	9.5	25.2	10.4	10.1	7.8
C16orf95		ENSG00000260456	"Chromosome 16 open reading frame 95"	Q9H693	16	87083562-87317420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 47.2"	"Group enriched"	"Detected in many"	9	"Early spermatids: 56.7;Erythroid cells: 23.3;Late spermatids: 77.4;Sertoli cells: 25.8;Spermatocytes: 52.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA040850, HPA067924"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA040850: AB_10794882, HPA067924: AB_2685924"	"unprognostic (3.51e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.77e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.92e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.23e-1)"	1.5	1.7	1.7	1.0	2.6	2.2	0.8	1.5	2.0	0.5	1.0	1.5	1.2	1.2	0.7	1.2	0.5	0.8	1.2	1.0	1.7	1.4	1.1	2.6	0.7	0.9	1.9	0.9	0.7	2.1	1.0	0.9	0.5	1.8	0.6	0.6	0.9	1.1	1.2	3.0	0.5	1.2	1.2	1.3	0.7	1.1	47.2	1.1	1.2	0.7	0.6	0.9	0.7	0.4	3.4	6.0	1.1	6.0	1.5	5.7	3.2	3.2	9.1	3.2	3.8	3.7	2.2	5.4	3.0	1.2	3.0	2.3	4.4	5.2	8.1	8.6	0.6	3.3	2.7	2.9	2.0	1.4	3.9	5.3	7.6	3.2	5.9	3.2	0.8	1.5	3.8	0.7	3.4	1.1	1.5	2.8	6.0	6.7	4.1	3.6	8.4	2.8	6.9	2.9	2.0	5.5	6.4	1.4	4.6	1.7	1.3	4.0	3.3	7.4	0.4	2.5	1.2	4.5	3.6	3.3	5.5	2.4	3.2	2.8	12.6	10.2	15.4	7.4	7.6	3.7	0.0	4.9	1.1	4.9	4.8	3.6	3.4	4.3	4.5	4.5	2.9	3.5	5.7	0.8	1.5	6.0	6.0	5.1	3.2	1.7	2.6	1.5	2.0	1.7	1.4	1.9	0.9	1.8	1.1	0.0	1.0	2.2	0.4	1.4	2.3	2.0	2.5	1.4	0.0	0.0	2.0	1.9	1.7	2.8	56.7	0.6	4.9	23.3	3.0	2.7	1.1	0.4	0.0	4.2	2.5	1.6	0.0	2.5	1.5	77.4	3.1	1.6	0.0	3.6	2.5	2.4	3.6	2.9	4.9	2.4	2.0	25.8	0.5	52.2	4.3	0.5	0.9	1.5	5.3	0.3
C22orf39	MGC74441	ENSG00000242259	"Chromosome 22 open reading frame 39"	Q6P5X5	22	19351368-19448232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073701			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA073701: AB_2686627"	"unprognostic (4.97e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.87e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.27e-2)"	"unprognostic (6.53e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.95e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.45e-3)"	"unprognostic (5.34e-3)"	"prognostic favorable (1.44e-4)"	"unprognostic (6.51e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.32e-2)"	18.2	19.5	27.0	11.9	22.6	11.4	20.1	21.9	24.4	13.1	19.6	14.0	13.9	11.3	13.8	13.9	14.4	13.6	13.1	29.9	23.7	19.6	15.6	10.3	12.5	14.1	23.5	18.3	16.4	27.3	17.4	16.5	12.6	16.2	19.6	13.5	13.7	15.4	18.5	69.5	14.6	12.0	21.3	19.2	13.6	13.1	11.7	14.1	12.9	22.1	18.4	14.7	13.7	13.7	23.5	27.6	48.8	22.4	21.3	23.7	19.9	10.6	7.1	12.3	8.7	14.9	10.4	7.8	3.8	4.0	11.0	12.3	10.4	3.4	11.3	5.1	4.3	7.3	10.5	14.8	8.0	11.3	12.4	35.5	13.2	14.1	18.1	12.8	18.5	15.3	9.9	12.8	6.7	15.0	10.1	11.0	23.5	44.8	17.2	6.9	8.3	15.3	15.3	4.5	26.1	10.4	18.9	16.8	6.9	12.4	8.8	15.9	7.0	8.5	5.8	12.6	12.1	9.7	11.6	8.0	8.4	16.3	4.3	6.2	17.4	7.5	16.1	7.1	9.5	7.8	24.3	21.6	48.8	19.3	22.4	17.7	23.5	20.9	15.6	18.5	23.2	22.3	18.4	29.4	21.3	18.9	27.6	23.7	19.9	27.0	22.6	21.9	24.4	23.7	19.6	23.5	18.3	16.2	14.1	20.8	30.2	29.0	23.3	21.6	27.3	86.7	25.5	45.5	42.1	34.9	15.7	47.2	91.2	36.1	13.9	32.2	49.1	23.3	67.6	38.3	31.6	33.0	26.5	27.0	56.0	17.5	43.4	28.3	31.9	10.2	32.5	31.1	37.1	60.5	40.1	27.8	49.4	34.5	31.8	43.3	16.4	45.3	42.2	56.4	60.9	28.4	42.1	39.5	51.9	24.7
C2orf76	"AIM29, LOC130355, MGC104437"	ENSG00000186132	"Chromosome 2 open reading frame 76"	Q3KRA6	2	119302225-119366828	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 66.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044977, HPA055362"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044977: AB_10961918, HPA055362: AB_2682794"	"unprognostic (4.29e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.47e-3)"	"unprognostic (5.51e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (2.16e-8)"	"unprognostic (3.42e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.55e-2)"	"unprognostic (9.19e-2)"	13.7	14.9	17.6	6.8	17.4	6.2	16.9	10.1	17.6	10.0	9.5	11.9	17.0	4.6	12.7	33.1	11.8	15.2	9.1	11.3	15.9	13.8	14.3	9.9	19.5	9.7	19.5	13.0	13.5	20.6	10.6	14.7	7.8	23.0	11.9	8.6	9.6	10.8	11.9	7.4	14.5	6.2	14.0	20.3	8.7	9.5	18.3	15.3	7.9	15.1	10.2	9.4	10.0	9.3	14.8	15.7	27.7	16.3	23.4	15.8	9.3	9.4	9.0	13.0	8.3	18.8	23.2	7.5	13.4	9.6	8.8	9.6	5.7	6.4	11.4	23.9	14.0	10.2	4.4	5.7	8.5	8.6	9.8	19.4	22.0	6.9	7.4	13.1	8.2	14.3	12.0	14.5	12.3	8.2	11.3	12.6	8.9	6.9	11.3	12.9	14.3	8.6	15.6	7.1	7.5	7.2	5.3	2.7	16.1	19.2	10.3	8.5	9.7	9.7	14.0	18.0	12.9	7.6	29.5	11.6	10.2	7.9	8.5	7.1	7.5	12.2	12.3	10.3	6.2	11.4	17.4	16.3	15.4	15.8	14.5	14.1	14.8	12.4	14.4	15.7	11.2	11.3	15.6	27.7	23.4	8.9	14.7	12.1	9.3	17.6	17.4	10.1	17.6	15.9	13.8	19.5	13.0	23.0	15.3	6.0	10.7	8.0	14.8	22.1	2.7	14.9	12.7	38.8	13.6	14.0	0.0	22.7	66.3	12.0	4.8	18.6	8.4	23.3	15.4	27.7	18.3	10.6	21.9	10.5	23.6	1.6	10.5	16.5	20.3	3.4	17.8	14.4	42.2	17.2	10.6	8.6	15.0	7.0	15.9	35.2	3.8	6.5	18.6	18.0	20.4	31.1	17.3	16.7	10.3	10.3
C4orf3	HCVFTP1	ENSG00000164096	"Chromosome 4 open reading frame 3"	Q8WVX3	4	119296419-119304445	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Proximal tubular cells: 865.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA026907	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA026907: AB_10600760"	"unprognostic (2.97e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.85e-3)"	"unprognostic (9.30e-2)"	"unprognostic (7.15e-3)"	"unprognostic (2.04e-1)"	"unprognostic (8.85e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (8.32e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.59e-1)"	51.6	41.9	46.2	39.1	47.2	19.0	31.7	18.2	41.1	46.1	33.5	41.1	25.6	41.3	39.4	49.0	101.3	33.8	37.0	43.4	46.5	45.4	55.8	63.4	33.6	32.2	61.2	31.6	45.1	32.7	19.6	34.7	36.6	47.3	38.7	20.3	33.4	42.6	34.1	70.5	37.7	45.0	41.5	68.7	38.0	26.9	19.4	35.8	30.3	44.2	42.3	39.3	50.0	59.8	60.4	66.8	112.7	53.3	38.0	48.6	65.5	69.1	8.0	23.3	19.3	32.7	24.9	19.0	30.6	8.3	9.0	16.7	8.5	23.1	47.6	23.7	29.2	16.8	13.6	10.3	25.3	14.1	31.9	10.2	19.7	18.5	29.9	9.8	32.3	21.6	26.0	21.2	12.9	5.6	42.0	15.0	13.7	17.5	19.9	33.0	19.9	20.9	30.2	11.8	26.9	8.2	15.0	31.2	12.1	17.0	15.8	14.7	23.8	23.2	30.8	15.9	23.9	16.5	16.9	29.5	33.3	19.8	20.1	12.4	33.6	34.4	22.1	62.6	13.4	18.8	69.3	50.7	60.4	40.1	53.3	38.7	60.4	47.8	45.0	42.7	46.4	48.4	46.9	112.7	38.0	49.0	66.8	48.6	65.5	46.2	47.2	18.2	41.1	46.5	45.4	61.2	31.6	47.3	35.8	145.9	143.1	236.2	239.8	280.2	80.9	421.0	165.6	215.5	144.5	211.1	23.6	289.6	325.0	242.8	18.7	229.5	160.4	23.3	156.7	297.9	248.2	254.6	179.3	378.8	279.6	144.6	65.7	200.7	283.9	15.8	155.1	255.4	189.0	413.8	155.2	139.4	215.9	181.4	202.6	865.1	58.0	194.1	282.9	205.3	54.1	303.0	372.8	183.3	101.9	339.6
CACNA1A	"APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6"	ENSG00000141837	"Calcium voltage-gated channel subunit alpha1 A"	O00555	19	13206442-13633025	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 77.9"	"Group enriched"	"Detected in many"	8	"Bipolar cells: 68.3;Horizontal cells: 235.2;Intestinal endocrine cells: 205.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	4	"cerebellum: 77.9"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 31.2;U-87 MG: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064258, HPA068138, HPA071902"	Enhanced	Supported	Uncertain	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA064258: AB_2685229, HPA068138: , HPA071902: "	"unprognostic (1.09e-1)"	"unprognostic (3.73e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.78e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.47e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (4.32e-4)"	"unprognostic (5.31e-3)"	"unprognostic (5.03e-6)"	"unprognostic (6.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (6.25e-2)"	2.2	5.3	7.6	1.0	12.2	0.7	0.9	77.9	19.7	0.8	1.5	1.8	0.0	3.9	1.2	2.8	0.7	2.2	0.8	1.1	5.7	5.1	0.7	0.5	0.7	1.3	3.9	7.3	1.1	3.0	0.7	1.5	0.6	7.2	0.8	1.7	1.2	0.9	0.8	1.3	0.7	2.8	0.9	3.3	1.3	7.7	1.9	2.8	0.0	0.7	0.0	1.0	0.8	0.3	2.8	0.8	1.9	1.1	0.8	0.8	0.4	0.0	0.1	0.0	3.9	0.1	0.3	0.0	1.6	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.1	3.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	2.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.1	0.9	0.0	0.2	0.4	0.0	0.1	0.0	0.1	31.2	0.0	0.0	0.0	0.2	0.1	0.0	1.2	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.0	17.6	0.0	0.4	1.9	0.4	0.7	0.5	0.5	0.8	2.8	0.5	0.3	0.4	1.7	0.6	0.7	1.6	0.8	1.1	0.8	0.6	0.4	7.6	12.2	77.9	17.4	5.7	5.1	3.9	7.3	7.2	2.8	6.0	2.7	1.3	1.4	0.6	68.3	2.2	0.0	6.7	2.3	1.8	15.7	0.0	0.0	0.6	22.1	4.2	0.0	0.0	0.3	0.1	2.1	0.8	1.1	0.0	0.5	235.2	205.4	1.8	1.3	17.9	1.1	2.1	0.0	1.0	1.1	2.9	1.9	0.0	0.4	2.0	6.2	0.0	4.2	4.1	5.1	0.1	0.2	4.3	0.8	0.9
CALR	"cC1qR, CRT, FLJ26680, RO, SSA"	ENSG00000179218	Calreticulin	P27797	19	12938578-12944489	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Extravillous trophoblasts: 1318.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001513, HPA002242, CAB019952, CAB079775"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		450000000	"Endoplasmic reticulum"		"CAB001513: , CAB019952: AB_2069792, CAB079775: AB_303403, HPA002242: AB_1078384"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.44e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (2.37e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.27e-2)"	67.5	55.5	31.9	58.9	36.1	86.4	64.6	20.9	38.9	50.2	52.3	42.5	65.7	44.1	61.6	108.4	65.2	49.1	67.5	62.5	31.6	35.2	81.9	302.6	61.8	83.6	33.5	33.4	59.6	124.3	56.4	60.3	98.0	35.7	53.1	60.0	43.2	121.0	68.6	25.1	34.2	53.8	56.9	42.1	66.6	49.7	65.0	32.7	61.6	250.6	55.0	65.2	39.4	68.0	25.1	57.2	16.1	38.6	26.3	48.4	16.2	118.3	46.8	64.3	140.1	81.3	73.4	58.9	158.3	130.0	95.4	139.0	71.5	95.3	76.0	146.2	183.6	85.6	47.2	70.3	100.9	96.7	56.5	40.1	63.3	57.0	108.7	192.1	254.0	85.9	68.0	46.8	88.4	74.9	126.5	114.8	52.2	54.1	38.6	77.4	81.7	70.4	166.1	57.2	66.7	66.4	54.6	54.5	92.0	83.8	67.8	24.5	52.3	98.1	54.0	32.3	79.5	72.2	105.4	99.3	79.7	50.2	113.4	70.7	48.2	42.9	76.4	112.3	110.8	87.6	16.1	19.5	10.1	48.4	38.6	34.3	25.1	29.2	36.7	20.4	22.4	21.6	39.2	6.6	26.3	30.8	57.2	21.5	16.2	31.9	36.1	20.9	38.9	31.6	35.2	33.5	33.4	35.7	32.7	137.0	125.9	216.1	284.2	232.4	67.7	39.5	168.2	151.3	164.9	211.1	119.8	557.7	54.7	494.3	20.8	202.2	487.4	140.2	249.9	1318.6	319.8	346.7	204.2	513.5	724.5	33.4	339.2	328.4	165.0	18.8	295.1	261.1	202.4	256.1	263.3	298.5	397.7	287.1	292.4	139.9	115.0	200.5	213.6	255.0	394.6	186.7	806.5	193.7	294.0	285.1
CALU		ENSG00000128595	Calumenin	O43852	7	128739292-128771807	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Extravillous trophoblasts: 431.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 156.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006018	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		15000000	"Endoplasmic reticulum"		"HPA006018: AB_1845934"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-3)"	"unprognostic (3.16e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.52e-3)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.30e-11)"	"unprognostic (3.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.60e-5)"	33.6	20.7	10.2	30.8	13.6	6.2	27.6	7.8	13.0	33.6	35.0	13.9	34.0	8.4	57.0	29.4	29.7	27.3	24.0	60.0	10.5	9.0	23.6	38.3	31.4	17.0	14.0	9.8	28.5	21.5	18.6	19.7	104.6	14.4	29.9	21.1	18.7	26.9	40.2	26.5	12.5	16.6	78.1	17.4	26.6	25.6	14.3	10.8	8.1	25.5	16.7	13.4	57.0	27.6	14.0	19.5	13.4	22.9	13.7	18.5	16.4	16.4	13.9	32.5	10.4	90.8	88.3	17.9	113.8	99.3	41.9	55.3	18.0	25.6	8.2	20.7	156.9	48.5	9.6	16.8	22.3	63.2	5.0	11.7	9.0	20.8	19.9	41.6	12.8	16.8	59.4	16.5	57.7	22.5	57.4	37.9	8.0	15.3	11.9	81.1	9.4	9.4	7.5	21.9	15.6	14.0	7.7	23.5	12.8	17.4	9.2	3.4	19.5	36.7	33.9	45.9	62.4	7.2	10.1	50.8	116.1	15.0	96.8	50.3	19.2	23.7	15.2	120.9	16.2	118.3	11.2	21.7	13.4	18.5	22.9	17.0	14.0	12.7	13.8	18.6	10.0	11.3	13.4	2.8	13.7	18.2	19.5	13.6	16.4	10.2	13.6	7.8	13.0	10.5	9.0	14.0	9.8	14.4	10.8	20.8	32.6	29.2	53.7	72.2	27.3	197.2	22.9	49.5	37.5	24.4	17.7	103.1	14.9	67.6	7.8	81.7	12.2	0.0	52.9	431.1	239.3	93.2	58.8	48.7	119.8	27.0	18.9	138.7	55.3	4.7	92.9	49.6	114.7	20.8	39.1	30.4	58.9	7.0	111.7	16.5	11.7	58.2	119.2	21.2	38.7	67.1	203.2	20.3	23.0	60.8
CANX	"CNX, IP90, P90"	ENSG00000127022	Calnexin	P27824	5	179678628-179730925	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 109.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004738, HPA009433, HPA009696"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		82000000	"Endoplasmic reticulum"		"CAB004738: AB_626784, HPA009433: AB_1078380, HPA009696: AB_1078379"	"unprognostic (6.56e-2)"	"unprognostic (9.34e-3)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.57e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.17e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.12e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (2.15e-1)"	49.3	35.4	40.0	35.8	40.9	57.6	37.8	27.3	49.1	93.0	33.6	37.1	48.3	44.0	42.7	115.4	31.6	31.7	30.0	51.3	36.9	50.9	61.6	120.8	34.7	30.1	47.5	27.9	41.0	78.2	13.7	33.0	70.5	44.9	33.5	55.1	32.2	121.5	48.5	28.5	23.4	68.5	60.5	48.8	38.2	31.7	34.3	30.0	31.0	113.4	25.9	29.9	41.4	47.6	10.1	26.3	25.9	28.9	18.7	22.6	30.0	8.4	23.8	20.2	12.3	43.5	32.3	10.2	43.5	47.8	50.3	42.7	20.7	19.5	63.9	61.1	34.8	25.6	5.8	31.7	23.7	57.5	16.4	9.6	10.3	59.3	13.4	59.3	19.6	9.7	6.3	43.6	27.0	78.5	15.4	20.8	4.9	8.1	24.9	5.5	7.8	9.9	0.3	4.1	3.6	1.4	10.3	14.7	7.0	37.0	24.9	10.2	2.4	12.2	5.2	109.0	25.3	41.2	8.7	38.6	11.5	19.2	13.0	33.7	7.6	26.2	16.1	17.4	12.8	11.2	25.9	28.9	8.8	17.7	21.2	22.6	10.1	13.9	16.3	26.3	7.7	9.5	10.6	6.1	18.7	18.0	25.3	10.1	30.0	40.0	40.9	27.3	33.3	36.9	50.9	47.5	27.9	44.9	30.0	184.6	236.5	93.5	89.0	131.9	112.0	432.6	180.9	323.9	284.4	172.7	149.2	138.7	41.4	148.7	197.6	180.1	166.6	46.7	132.3	187.5	146.3	221.3	188.7	393.6	206.3	151.0	170.9	163.9	186.1	659.2	147.3	192.4	167.0	120.8	179.5	201.8	157.0	97.9	179.6	160.8	108.3	90.5	152.7	141.2	80.8	141.4	204.7	88.6	178.9	131.5
CCDC47	GK001	ENSG00000108588	"Coiled-coil domain containing 47"	Q96A33	17	63745250-63776351	"Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029674, HPA072573, HPA075958"	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029674: AB_10602703, HPA072573: AB_2686535, HPA075958: "	"unprognostic (6.33e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.16e-1)"	26.2	42.1	26.7	18.7	43.3	11.4	26.7	32.4	31.3	24.4	38.2	23.0	29.2	39.9	20.6	26.3	28.9	21.2	22.8	42.4	26.5	24.0	40.0	71.8	27.4	13.9	29.4	24.8	27.0	30.5	49.3	28.5	49.9	26.4	29.3	38.4	17.7	30.0	29.7	71.9	23.5	44.0	20.7	31.5	26.8	35.9	15.1	34.7	13.3	29.4	24.3	18.1	29.8	24.5	19.9	41.9	37.4	30.8	20.8	25.7	24.2	38.6	36.7	22.8	20.0	32.3	21.5	44.6	39.6	25.7	27.1	32.1	32.4	35.3	30.5	21.2	27.6	31.4	31.8	27.6	24.2	48.1	10.7	28.1	43.9	30.3	31.6	31.0	35.0	23.1	22.6	34.2	37.3	32.2	19.2	22.5	15.3	48.8	26.8	22.0	31.2	26.8	12.9	19.9	48.6	37.4	24.9	44.5	41.9	32.5	44.1	21.0	28.6	26.5	68.0	31.7	30.3	44.8	19.1	28.7	50.8	32.5	36.8	45.4	26.8	31.8	31.5	29.6	22.4	40.9	22.2	30.7	37.4	22.1	30.8	25.7	19.9	21.9	20.3	41.9	16.0	22.9	20.2	24.5	20.8	30.4	27.9	23.4	24.2	26.7	43.3	32.4	31.3	26.5	24.0	29.4	24.8	26.4	34.7	134.0	106.5	47.7	83.7	89.5	39.7	111.9	63.7	88.3	134.2	57.6	13.7	93.7	8.3	87.2	11.3	69.1	81.5	46.7	91.7	81.3	51.1	84.9	42.9	81.9	52.3	54.0	50.2	59.5	48.5	10.0	44.3	53.4	37.1	57.7	79.0	57.4	77.1	56.1	52.6	28.2	22.6	71.1	79.8	53.4	31.7	79.4	120.5	30.6	79.3	73.5
CCR10	GPR2	ENSG00000184451	"C-C motif chemokine receptor 10"	P46092	17	42678889-42683917	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.1"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 12.0;Sertoli cells: 19.4;Smooth muscle cells: 10.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 31.1"	"Group enriched"	"Detected in many"	9	"dendritic cells: 10.9;T-cells: 31.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.8;RPMI-8226: 6.4;U-266/70: 18.1;U-266/84: 8.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB011684, HPA048007, HPA069188"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB011684: AB_731502, HPA048007: AB_2680232, HPA069188: AB_2686100"	"unprognostic (3.25e-2)"	"unprognostic (2.71e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.23e-3)"	"unprognostic (5.18e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.32e-11)"	"unprognostic (2.84e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.87e-1)"	10.0	5.4	5.7	4.8	5.3	0.7	3.0	7.3	7.3	3.9	9.7	0.9	1.5	5.1	5.8	1.4	1.5	4.5	1.5	2.5	3.5	5.0	1.6	0.5	2.2	12.5	1.9	5.0	5.2	2.6	0.4	14.0	2.3	4.1	2.1	1.0	1.1	4.0	2.0	9.1	1.1	8.7	1.8	4.4	4.3	5.0	2.2	1.2	0.5	1.5	0.3	3.6	1.0	2.0	2.3	10.9	0.1	0.3	0.0	31.1	0.7	0.5	0.8	1.1	5.0	0.3	0.8	1.2	2.5	0.5	0.2	0.4	0.7	0.3	0.1	0.3	0.3	2.2	0.9	0.0	0.1	0.2	2.3	1.2	0.0	3.2	0.4	0.7	0.0	0.3	0.8	0.0	0.4	0.0	0.9	0.2	0.3	2.6	8.8	0.0	0.3	0.1	2.4	0.6	0.0	1.2	0.6	0.2	6.4	1.1	0.0	0.8	1.1	0.7	0.0	0.2	0.5	0.8	0.9	2.4	2.9	0.6	0.9	0.3	18.1	8.2	2.6	1.4	0.7	0.9	0.0	0.3	0.1	0.2	0.0	0.1	2.3	5.2	2.6	0.2	2.1	0.6	0.8	0.0	0.0	0.1	10.9	31.1	0.7	5.7	5.3	7.3	7.3	3.5	5.0	1.9	5.0	4.1	1.2	0.0	0.0	0.0	0.2	0.7	12.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.3	0.4	1.4	0.0	0.0	0.5	0.2	2.3	0.3	0.0	0.0	1.7	1.6	1.7	1.3	1.8	1.8	5.2	1.2	5.0	5.4	0.1	2.0	0.2	0.0	2.5	0.6	3.1	19.4	10.3	0.7	0.7	0.3	0.0	0.5	0.4	0.1
CD1D		ENSG00000158473	"CD1d molecule"	P15813	1	158179947-158184896	"Cancer-related genes, CD markers, Predicted membrane proteins"	"Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 49.5;lymphoid tissue: 17.8"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 27.5;Kupffer cells: 52.9;Macrophages: 34.3"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in many"	6	"classical monocyte: 49.5;intermediate monocyte: 22.4;myeloid DC: 49.5"	"Group enriched"	"Detected in many"	8	"dendritic cells: 49.5;monocytes: 49.5"	"Cell line enriched"	"Detected in some"	4	"JURKAT: 45.7"					"Low region specificity"	"Detected in all"			"CAB016107, HPA072662"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		720000	"Endoplasmic reticulum"		"CAB016107: AB_626960, HPA072662: AB_2686545"	"unprognostic (8.67e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.85e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.37e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (9.31e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.38e-1)"	1.5	1.2	0.0	8.6	0.0	2.6	1.2	0.0	0.0	0.8	2.5			9.5	1.5	0.0	0.4	1.4	2.0	1.4	0.0	0.1	1.6	10.5	2.3	5.5	0.2		0.3	0.7	0.0	0.6	0.0		1.4	3.7		0.7	0.3	0.6	0.0	12.2	2.2	0.4	17.8	1.4	1.4			1.8		3.4	1.6	0.5	6.3	49.5	2.5	49.5	0.1	0.1	23.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.0	2.9	0.0	5.5	0.0	0.0	0.0	0.1	0.0	0.0	8.5	0.1	0.0	3.2	0.4	0.0	0.6	0.0	0.0	45.7	0.0	0.0	0.0	0.0	11.2	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.3	0.0	3.1	0.4	0.0	49.5	0.1	0.0	22.4	0.1	6.3	0.0	0.0	49.5	4.7	0.0	0.0	2.5	0.1	3.6	0.5	0.0	23.5											0.0	5.1	27.5	0.4	0.2	0.4	0.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.5	1.2	2.2	0.0	0.0	0.1	0.2	0.0	1.1	5.3	11.3	1.6	2.4	4.3	52.9	0.9	0.0	34.3	0.0	10.0	2.0	0.3	0.0	3.7	0.0	0.0	0.1	0.0	0.5	0.5	0.9	0.1	0.1	0.0	3.9	0.0
CD3D	T3D	ENSG00000167286	"CD3d molecule"	P04234	11	118338954-118342744	"CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 108.7;lymphoid tissue: 181.4"	"Cell type enriched"	"Detected in many"	12	"T-cells: 532.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	53	"gdT-cell: 105.6;MAIT T-cell: 68.6;memory CD4 T-cell: 88.1;memory CD8 T-cell: 97.6;naive CD4 T-cell: 78.8;naive CD8 T-cell: 98.6;T-reg: 108.7"	"Lineage enriched"	"Detected in many"	63	"T-cells: 108.7"	"Cell line enhanced"	"Detected in some"		"JURKAT: 69.9;MOLT-4: 149.5;NB-4: 27.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB013055, HPA071778"	Enhanced		Uncertain	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB013055: , HPA071778: "	"prognostic favorable (3.00e-4)"	"prognostic favorable (8.46e-5)"	"unprognostic (1.05e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (6.00e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (3.82e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (9.00e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.66e-2)"	"prognostic favorable (6.16e-4)"	2.6	0.8	0.5	17.4	0.7	4.8	1.7	0.5	0.7	1.3	4.1	0.7	0.8	4.1	1.2	1.6	3.2	1.9	2.9	1.0	0.7	0.4	2.6	1.9	6.1	40.8	0.9	0.5	1.0	1.2	0.0	0.7	0.8	0.7	2.2	4.3	1.1	9.0	0.8	0.7	1.3	19.3	1.0	1.5	28.6	4.4	0.8	0.5	181.4	2.7	2.8	32.6	5.7	2.4	0.5	0.3	1.7	0.3	0.2	108.7	64.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.9	5.7	0.0	0.0	0.0	149.5	27.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.2	105.6	0.2	68.6	0.5	88.1	97.6	0.3	0.2	78.8	98.6	1.7	0.2	0.3	0.3	108.7	64.9	0.5	0.7	0.5	0.7	0.7	0.4	0.9	0.5	0.7	0.5	6.0	45.4	3.0	0.3	13.6	0.0	2.5	0.0	2.7	4.5	3.5	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	5.1	0.1	11.6	2.0	0.6	0.0	1.2	9.8	7.6	0.4	0.0	6.1	11.8	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	5.6	0.0	0.0	10.3	0.2	532.0	0.3	0.0
CDS2		ENSG00000101290	"CDP-diacylglycerol synthase 2"	O95674	20	5126786-5197887	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 60.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019698	Approved		Approved	"Endoplasmic reticulum"		No	No		200000	"Endoplasmic reticulum"		"HPA019698: AB_1846464"	"unprognostic (4.59e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.53e-9)"	"unprognostic (8.89e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.44e-1)"	14.8	16.1	22.2	9.9	25.5	12.1	12.1	36.0	34.5	12.7	11.8	21.4	6.7	5.9	12.9	9.8	10.5	12.5	10.0	26.6	22.0	34.0	16.9	14.2	14.5	10.9	26.7	24.0	10.9	7.2	20.6	15.6	11.1	28.3	15.9	12.3	19.8	8.0	19.7	9.4	6.2	9.9	20.2	16.2	9.8	10.6	13.0	12.5	8.1	14.2	4.6	13.6	11.6	8.2	7.6	7.9	28.3	9.7	6.5	11.1	11.7	9.6	10.8	10.8	5.6	6.4	5.9	4.9	5.3	10.9	8.8	12.7	6.6	9.5	7.3	2.7	9.9	16.0	13.8	8.8	11.1	9.3	7.7	3.0	8.4	3.1	10.1	6.0	5.4	3.2	5.1	6.2	11.5	4.5	7.8	11.7	10.1	4.0	9.5	8.2	1.7	10.8	2.0	5.2	4.7	3.3	9.3	8.7	3.3	5.6	9.4	4.5	6.3	5.9	10.1	13.6	13.7	6.2	2.5	8.5	6.3	5.0	5.6	5.3	8.3	60.6	6.1	2.8	4.3	3.8	24.1	9.7	11.5	10.0	8.0	10.6	7.6	10.2	11.1	7.9	7.4	8.0	7.8	28.3	6.5	7.3	6.3	11.1	11.7	22.2	25.5	36.0	31.6	22.0	34.0	26.7	24.0	28.3	12.5	17.9	14.9	30.8	25.7	15.7	61.3	45.6	25.5	9.4	11.4	31.4	90.3	19.1	5.0	29.0	54.7	32.9	11.8	0.0	19.9	30.4	16.4	18.4	20.7	17.5	51.1	41.3	10.3	27.0	37.0	25.0	15.0	23.1	30.4	28.9	11.5	22.0	25.6	14.8	23.3	13.5	58.9	19.4	53.6	21.6	29.8	13.4	13.6	30.2	12.8	26.9
CERS1	"LAG1, LASS1, UOG1"	ENSG00000223802	"Ceramide synthase 1"	P27544	19	18868545-18896727	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 86.3"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 85.2"	"Cancer enhanced"	"Detected in many"		"glioma: 13.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.7;EFO-21: 13.0;HEK 293: 18.1;NB-4: 19.4;NTERA-2: 13.3"									HPA045724	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA045724: AB_10969762"	"unprognostic (8.25e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.04e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.49e-1)"	2.4	4.7	28.9	2.3	32.9	1.7	1.7	12.5	86.3	2.2	2.1	40.5	0.0	1.6	2.0	2.1	2.5	2.1	3.9	3.4	29.5	23.2	1.6	1.6	1.9	1.6	31.9	20.5	4.3	2.4	1.7	3.2	1.9	33.8	2.0	1.8	1.8	2.3	2.1	17.8	2.0	1.9	3.0	37.8	1.7	1.8	15.7	22.2	0.0	2.4	0.0	1.6	2.6	0.4	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.1	1.8	10.9	17.7	0.6	0.2	0.3	1.2	0.1	3.1	2.2	8.7	0.6	0.0	13.0	0.8	2.5	0.1	8.0	0.3	1.2	0.0	18.1	0.1	0.4	6.5	1.4	1.8	0.2	0.6	0.1	1.0	0.3	3.5	0.7	0.1	1.1	0.1	2.1	4.5	0.1	19.4	13.3	0.0	0.3	0.0	0.3	0.3	2.4	0.0	9.3	9.3	0.4	0.0	7.9	3.7	3.0	10.8	0.3	0.0	2.5	1.7	2.5	0.3	0.2	0.0	0.0	0.6	6.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	28.9	32.9	12.5	35.7	29.5	23.2	31.9	20.5	33.8	22.2	0.0	0.0	0.0	0.1	0.5	2.0	0.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	18.9	0.4	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	85.2	1.1	0.0	1.7	0.0	0.0	9.2	0.0	0.0	1.1	0.0	1.2	0.0	0.3	0.9	2.7	0.4	0.2	0.0	0.0	0.0
CES1	"CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1"	ENSG00000198848	"Carboxylesterase 1"	P23141	16	55802851-55833337	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 355.0"	"Group enriched"	"Detected in many"	7	"Cholangiocytes: 565.6;Hepatocytes: 2145.0"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 711.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	18	"classical monocyte: 32.6;myeloid DC: 32.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 32.9;monocytes: 32.6"	"Group enriched"	"Detected in some"	5	"Hep G2: 96.2;THP-1: 103.6"	"Not detected"	"Not detected"							"HPA012023, HPA046717"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	No	NA		40000000	"Endoplasmic reticulum"		"HPA012023: AB_1846554, HPA046717: AB_2679770"	"unprognostic (1.04e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (9.92e-4)"	27.1	1.7	0.3	0.5	0.4	2.1	24.7	0.4	0.6	3.1	8.9	0.5	1.5	2.4	7.3	2.1	4.5	6.7	57.7	8.1	0.3	0.0	0.7	355.0	19.8	2.3	0.3	0.6	3.9	1.3	0.0	0.8	1.1	0.6	11.2	1.0	3.8	3.9	4.0	1.6	1.4	3.5	10.2	0.7	4.4	7.0	1.0	0.3	0.4	1.7	2.3	1.5	8.2	16.1	0.2	32.9	0.2	32.6	0.1	1.6	12.1	0.0	0.6	0.0	0.0	14.4	0.0	0.4	0.0	0.0	0.0	0.0	6.7	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	103.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	20.8	0.0	0.0	32.6	0.1	1.3	1.8	0.5	0.2	0.2	1.6	32.9	0.2	0.2	0.4	0.2	0.1	0.4	1.7	0.1	12.1	0.3	0.4	0.4	0.6	0.3	0.0	0.3	0.6	0.6	0.3	14.9	74.9	21.0	2.5	14.8	0.0	0.6	565.6	202.1	28.4	15.7	0.0	0.4	0.0	16.2	77.2	1.5	0.0	70.0	17.2	0.8	45.8	1.1	5.8	2145.0	18.9	0.0	36.2	43.0	88.2	134.3	17.3	20.4	37.1	0.0	0.0	8.3	0.9	0.2	93.0	0.5	0.5	0.0	7.2	0.9	1.0	10.2	0.7	20.3	0.0	1.7
CHKA	"CHK, CKI"	ENSG00000110721	"Choline kinase alpha"	P35790	11	68052859-68121444	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 282.2;Late spermatids: 221.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 9.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 57.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024153, CAB072803"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB072803: , HPA024153: AB_1846664"	"unprognostic (5.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (7.75e-4)"	"unprognostic (2.36e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.97e-3)"	"unprognostic (5.00e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.73e-2)"	8.9	15.5	18.1	6.4	19.5	25.5	18.6	10.2	19.3	10.8	18.2	30.9	28.8	19.0	5.8	19.2	3.9	6.5	10.7	5.4	18.7	15.4	8.0	17.4	11.4	7.5	26.5	12.5	10.4	29.3	9.2	10.0	5.0	21.5	13.5	11.8	17.4	36.9	37.4	3.9	4.2	22.8	8.2	20.9	13.5	18.8	55.9	22.7	3.1	19.9	2.2	5.2	8.7	4.7	1.3	1.5	9.5	2.5	1.6	0.7	0.4	8.0	7.0	8.2	7.9	2.8	1.9	8.3	2.6	4.2	7.2	4.7	30.1	22.8	6.2	9.6	3.7	7.8	5.4	11.5	1.8	5.5	2.8	4.1	7.7	9.2	34.8	7.9	8.1	4.3	3.8	3.1	3.3	1.6	4.1	4.1	4.0	7.2	10.8	3.8	6.2	4.3	22.1	13.2	27.3	4.8	7.0	8.7	17.4	6.1	9.1	6.1	6.5	4.9	25.1	57.8	7.1	10.6	11.2	2.3	4.6	5.8	10.9	3.3	12.7	13.0	10.8	5.0	10.7	4.2	0.0	1.4	9.5	0.2	2.5	0.0	1.3	0.1	0.4	1.5	0.6	0.7	0.5	0.8	1.6	1.5	1.2	0.3	0.4	18.1	19.5	10.2	19.3	18.7	15.4	26.5	12.5	21.5	22.7	41.7	30.1	4.5	14.6	14.1	10.2	2.2	33.1	17.4	14.8	3.5	31.4	6.1	11.6	8.8	282.2	8.5	26.2	0.0	16.5	3.2	9.5	16.9	18.5	16.9	14.9	54.0	26.9	9.2	22.6	221.9	5.8	13.0	21.9	9.0	14.3	20.0	14.9	20.1	2.5	3.7	25.8	0.0	10.3	56.6	19.2	9.2	10.9	2.9	21.7	33.5
CISD2	"ERIS, Miner1, NAF-1, WFS2, ZCD2"	ENSG00000145354	"CDGSH iron sulfur domain 2"	Q8N5K1	4	102868974-102892807	"Disease related genes, Predicted membrane proteins"	Autophagy		"Deafness, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015914	Approved		Supported	"Endoplasmic reticulum"		NA	NA		80000	"Endoplasmic reticulum"		"HPA015914: AB_1846794"	"unprognostic (1.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.54e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.48e-3)"	"unprognostic (9.12e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	8.1	13.8	14.8	13.5	11.3	13.7	11.2	14.5	16.1	13.5	8.3	9.3	9.3	5.0	9.4	14.4	8.5	8.2	11.5	10.6	14.5	17.7	19.8	40.5	8.0	12.8	17.9	8.2	8.2	29.7	13.3	10.7	9.5	15.6	7.8	10.7	9.4	16.3	10.5	4.9	7.7	12.5	8.0	16.7	13.0	7.0	7.6	8.4	11.2	21.2	5.6	8.9	6.8	9.3	5.1	6.9	11.0	5.7	7.9	6.6	4.2	10.6	3.6	3.8	4.8	9.6	10.5	2.4	8.4	3.1	3.6	5.5	4.1	18.0	7.8	7.4	7.8	8.6	5.3	18.3	6.6	16.5	6.8	2.8	6.6	2.5	4.2	7.0	11.9	10.7	3.9	10.1	15.1	11.9	3.4	6.4	4.3	14.5	14.0	9.6	2.9	10.3	3.5	7.5	3.6	2.7	4.3	3.9	14.1	8.7	3.4	8.9	5.3	4.9	8.5	7.8	4.6	5.6	2.5	2.8	10.6	11.8	14.3	5.0	10.8	14.6	15.8	7.6	3.7	8.1	7.2	5.6	11.0	5.4	5.1	5.8	5.1	5.5	5.6	5.3	4.0	3.8	4.9	4.1	7.9	5.7	6.9	6.6	4.2	14.8	11.3	14.5	16.1	14.5	17.7	17.9	8.2	15.6	8.4	23.8	25.0	53.7	38.3	76.1	29.8	24.8	48.4	17.4	23.9	73.3	19.6	67.4	61.3	82.9	9.3	26.3	58.3	210.2	67.5	102.3	44.1	55.3	57.6	142.1	102.4	28.6	41.2	19.0	73.8	4.2	22.2	68.4	65.8	85.6	58.6	24.6	77.7	83.4	31.8	182.4	24.3	32.3	31.1	25.1	30.9	78.7	47.5	45.7	58.6	44.3
CLCC1	MCLC	ENSG00000121940	"Chloride channel CLIC like 1"	Q96S66	1	108929508-108963457	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009087, HPA013210"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA009087: AB_1078532, HPA013210: AB_1846895"	"unprognostic (2.95e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (4.32e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.68e-3)"	"unprognostic (9.65e-2)"	17.4	19.5	17.5	13.2	24.8	7.1	19.1	22.8	26.1	19.0	16.4	28.4	22.9	15.6	22.1	31.2	12.2	16.9	15.8	20.2	19.5	15.2	12.2	23.5	15.1	10.9	24.4	16.3	23.3	28.5	26.6	24.4	20.0	20.5	23.1	15.3	17.7	21.8	24.1	29.3	16.1	14.8	19.3	21.5	13.7	17.9	8.3	24.3	5.1	21.7	10.4	12.9	17.1	16.0	7.7	9.5	9.0	15.4	7.1	9.4	5.5	23.8	10.4	13.5	23.3	18.8	17.1	17.5	19.9	16.4	14.1	15.3	11.2	10.0	5.7	21.4	15.7	9.2	9.2	12.2	7.5	18.1	18.1	10.9	14.1	13.0	10.3	15.1	13.9	15.6	12.5	11.3	16.3	13.4	14.5	12.9	6.7	17.0	23.3	10.3	9.5	1.3	5.5	10.2	8.4	9.4	12.9	6.9	13.6	11.8	14.2	8.1	12.4	23.3	25.2	18.0	10.8	7.9	9.5	13.9	18.9	15.1	18.0	19.5	17.0	13.9	8.8	23.0	11.3	40.6	4.1	9.2	9.0	9.1	11.1	9.4	7.7	7.7	7.2	8.0	5.9	8.7	7.9	1.6	7.1	15.4	9.5	9.2	5.5	17.5	24.8	22.8	26.1	19.5	15.2	24.4	16.3	20.5	24.3	23.8	18.1	4.5	11.7	3.3	13.1	4.5	15.3	18.7	19.4	10.4	27.5	24.4	0.0	15.5	6.1	7.1	5.7	0.0	18.3	10.5	14.6	15.9	11.5	19.2	11.6	20.6	3.5	10.4	4.3	2.1	18.4	5.7	8.5	11.8	8.8	14.5	17.7	0.0	17.7	5.6	15.6	19.4	8.0	4.2	4.6	5.5	15.4	6.4	10.1	8.9
CLGN		ENSG00000153132	Calmegin	O14967	4	140388455-140427968	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 40.3;pituitary gland: 23.6;testis: 52.6"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 243.4;Early spermatids: 78.2;Muller glia cells: 200.1;Spermatocytes: 280.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 21.7;U-251 MG: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020709, HPA048761, HPA058627"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB020709: , HPA048761: AB_2680514, HPA058627: AB_2683782"	"unprognostic (6.74e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.73e-3)"	"unprognostic (6.14e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.01e-1)"	0.4	3.6	2.1	0.7	3.7	1.2	1.6	5.9	3.5	0.8	1.4	0.5	0.0	0.4	1.0	1.6	0.9	7.0	0.4	40.3	0.9	3.4	0.4	3.7	0.5	0.5	1.4	1.6	1.8	1.6	0.2	23.6	0.3	8.6	11.9	0.8	2.4	0.6	0.6	0.4	0.3	0.8	0.9	0.8	0.3	1.6	52.6	0.3	3.1	1.5	0.0	0.8	0.6	0.4	0.5	1.0	3.4	1.1	0.0	0.0	0.1	0.0	4.0	4.2	2.7	1.7	8.8	1.0	0.0	3.7	4.0	7.5	0.1	0.3	0.0	11.5	0.4	3.5	0.1	2.9	0.0	6.6	0.2	3.4	1.1	4.0	2.9	17.5	14.6	0.2	1.0	16.1	0.4	0.4	21.7	0.1	3.9	0.7	0.0	0.0	0.2	18.3	0.2	4.8	0.1	11.4	12.2	0.0	0.1	0.0	0.1	6.8	12.3	2.5	1.6	0.7	1.6	0.8	2.2	0.0	11.0	2.0	4.0	28.9	5.8	12.6	7.9	17.7	0.6	1.2	3.4	1.1	1.5	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	3.7	5.9	3.5	0.9	3.4	1.4	1.6	8.6	0.3	0.0	2.1	0.0	1.0	0.0	8.5	243.4	0.0	28.1	4.5	0.0	3.9	0.3	0.0	0.9	78.2	1.1	0.0	23.3	3.7	0.1	0.5	35.3	0.0	2.6	0.1	23.8	5.1	0.0	0.0	42.6	4.6	0.0	1.7	0.0	0.0	200.1	1.4	0.0	4.2	0.0	11.8	0.0	0.3	280.7	9.8	0.1	0.2	0.0	0.4	0.9
CLPTM1L	"CRR9, FLJ14400"	ENSG00000049656	"CLPTM1 like"	Q96KA5	5	1317744-1345099	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 83.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014791	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA014791: AB_1847250"	"unprognostic (2.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.75e-4)"	"unprognostic (3.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.47e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.77e-3)"	"unprognostic (8.57e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.17e-2)"	15.8	14.1	10.6	20.5	12.4	13.5	16.3	6.7	16.9	13.8	19.0	11.1	12.1	24.6	12.0	10.6	15.7	11.7	20.7	13.1	11.3	12.2	29.4	56.1	20.0	17.6	14.8	8.3	11.3	57.6	10.0	14.6	15.8	11.6	13.9	11.0	13.1	33.3	14.5	8.3	12.3	23.6	12.1	9.2	22.5	25.6	20.0	9.8	37.2	30.9	11.3	21.1	13.8	9.8	10.4	12.3	12.3	9.6	12.8	9.7	5.2	12.7	21.7	7.4	20.0	12.1	5.2	19.6	13.1	8.7	11.8	11.7	23.6	20.4	12.2	40.5	12.2	26.3	11.2	10.0	10.9	5.4	49.6	27.5	6.4	50.7	15.6	13.6	16.8	16.5	8.3	12.5	10.9	10.2	8.7	9.6	28.1	14.5	41.9	8.9	20.9	18.5	22.1	13.7	14.2	23.6	15.7	12.1	37.4	9.2	12.2	7.8	15.5	22.9	19.9	9.9	6.5	33.5	25.3	7.1	14.2	40.8	9.8	18.8	75.8	83.6	19.7	10.6	25.4	16.1	4.6	6.7	12.3	7.9	6.2	9.3	9.7	8.4	7.8	6.0	10.4	8.0	9.6	5.2	12.8	9.6	12.3	9.7	5.2	10.6	12.4	6.7	16.9	11.3	12.2	14.8	8.3	11.6	9.8	53.6	65.0	17.1	16.0	19.8	9.7	11.3	50.9	32.1	38.7	27.9	13.7	9.6	5.0	15.2	2.0	19.5	35.1	23.3	27.7	17.2	13.6	39.9	24.3	114.3	20.9	20.6	42.9	25.8	37.2	2.6	16.1	17.0	15.1	6.4	46.8	21.2	37.1	28.5	18.0	58.6	10.5	12.9	13.3	18.9	35.7	20.6	9.2	18.1	32.0	28.8
COL10A1		ENSG00000123500	"Collagen type X alpha 1 chain"	Q03692	6	116118923-116158747	"Disease related genes, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 12.2;retina: 32.7"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 2: 1.1;Club cells: 1.2;Horizontal cells: 1.6;Muller glia cells: 2.0"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 51.9"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.7"	"Cell line enriched"	"Detected in some"	6	"hTEC/SVTERT24-B: 30.1"	"Region enhanced"	"Detected in single"		"amygdala: 1.0"	"Low region specificity"	"Detected in single"			HPA053268			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		21000	"Endoplasmic reticulum"		"HPA053268: "	"unprognostic (3.83e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.20e-2)"	"unprognostic (7.45e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.37e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.38e-11)"	"unprognostic (2.16e-3)"	"unprognostic (7.22e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.06e-3)"	0.9	0.1	0.4	0.8	0.7	0.1	0.3	0.3	1.4	1.4	0.3	0.9	0.3	0.0	0.6	0.3	0.5	0.0	12.2	0.3	0.6	0.2	0.8	0.7	3.5	0.4	0.3	0.6	5.4	4.2	0.5	0.9	0.3	3.2	2.6	0.0	32.7	6.5	0.9	0.3	0.7	0.3	0.5	0.3	2.9	0.2	0.5	0.3	0.8	1.4	0.3	2.0	0.3	0.3	0.6	0.3	2.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	2.2	0.3	4.6	0.0	0.0	0.1	0.0	0.7	0.0	0.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	30.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	4.9	0.1	0.3	0.4	0.0	0.0	0.1	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.3	0.4	0.7	0.3	1.4	0.6	0.2	0.3	0.6	3.2	0.3	0.0	1.1	0.0	0.0	0.1	0.7	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0
COL11A1	"CO11A1, COLL6, STL2"	ENSG00000060718	"Collagen type XI alpha 1 chain"	P12107	1	102876467-103108872	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Cataract, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 33.3"	"Group enriched"	"Detected in some"	7	"Early spermatids: 12.1;Melanocytes: 10.1;Muller glia cells: 27.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 38.5;BJ: 13.5;BJ hTERT+ SV40 Large T+ RasG12V: 28.8;HBF TERT88: 16.3;HSkMC: 48.5;SuSa: 21.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA058335			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	No	No		270000	"Endoplasmic reticulum"		"HPA058335: AB_2683682"	"unprognostic (2.60e-3)"	"unprognostic (6.61e-4)"	"unprognostic (9.58e-2)"	"unprognostic (5.06e-5)"	"unprognostic (2.83e-1)"	"unprognostic (2.85e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.23e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.01e-12)"	"unprognostic (1.27e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.32e-2)"	1.2	1.8	8.6	1.3	9.1	0.8	1.5	2.0	7.9	2.3	1.1	4.1	0.0	1.0	1.8	1.0	0.8	0.8	5.9	0.8	8.3	8.6	1.0	0.8	1.2	0.9	8.1	5.9	1.2	1.9	1.0	5.5	33.3	11.1	1.1	1.4	5.9	3.3	2.2	0.9	2.4	0.9	1.3	9.0	2.2	0.9	4.7	5.8	0.0	0.9	0.6	0.8	1.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	38.5	0.0	1.5	2.1	0.0	13.5	5.2	7.8	28.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	48.5	0.0	0.3	0.0	5.9	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	2.7	0.0	0.0	0.0	2.4	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.2	9.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.6	9.1	2.0	7.9	8.3	8.6	8.1	5.9	11.1	5.8	0.0	2.1	0.0	0.0	1.5	0.6	0.4	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.5	2.1	0.0	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.9	1.1	0.6	10.1	0.0	0.0	27.8	0.1	0.0	0.0	0.0	1.7	0.0	1.9	0.5	0.4	1.0	0.2	0.0	0.0	0.0
COL15A1		ENSG00000204291	"Collagen type XV alpha 1 chain"	P39059	9	98943179-99070792	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	22	"Fibroblasts: 113.2;Leydig cells: 302.6;Peritubular cells: 454.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.7;NK-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 13.3;BJ hTERT+: 27.8;HDLM-2: 11.8;K-562: 9.0;U-2197: 23.0;U-87 MG: 10.5;WM-115: 15.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA017913, HPA017915"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		23000000	"Endoplasmic reticulum"		"HPA017913: AB_1847099, HPA017915: AB_1847100"	"unprognostic (4.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.66e-3)"	"unprognostic (8.98e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (3.08e-4)"	36.1	17.6	0.5	12.7	0.7	0.0	21.4	0.4	0.7	22.4	19.7	1.4	5.0	3.0	42.4	22.0	26.6	9.0	25.2	41.2	0.5	0.7	8.7	1.0	5.6	11.7	1.6	0.8	28.9	13.7	4.5	3.4	66.9	2.1	16.6	4.0	11.4	23.4	6.2	12.8	6.7	11.1	27.3	1.3	3.9	14.8	22.8	0.4	5.1	10.5	21.7	8.6	21.3	8.8	0.6	0.1	0.0	0.4	1.7	1.7	0.2	0.0	0.0	0.0	0.0	2.4	1.3	0.0	13.3	27.8	0.7	0.2	0.0	0.0	0.1	0.4	2.8	0.1	0.0	0.0	0.0	0.1	11.8	0.0	0.1	6.7	0.0	0.5	0.2	1.3	3.9	0.0	3.0	0.1	0.0	0.0	0.0	9.0	0.0	1.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	7.4	0.1	0.0	0.0	0.0	0.0	0.4	2.0	3.5	0.1	0.1	0.3	0.0	0.0	0.3	23.0	0.2	0.1	0.0	0.0	10.5	0.1	15.6	0.0	0.3	0.0	1.7	0.4	0.1	0.6	0.4	0.5	0.1	0.1	0.1	0.3	0.0	1.7	0.2	0.0	0.4	0.2	0.5	0.7	0.4	0.7	0.5	0.7	1.6	0.8	2.1	0.4	0.0	0.0	0.0	0.1	17.3	0.0	5.6	0.0	0.0	0.0	0.0	0.0	3.1	0.0	2.1	5.2	71.7	0.0	0.0	0.7	3.0	113.2	0.8	0.0	0.0	7.0	0.0	0.0	0.0	0.3	11.0	302.6	1.0	16.9	1.0	0.0	0.0	0.8	0.0	454.3	0.0	0.0	12.9	16.5	1.7	1.4	14.3	6.4	0.0	0.0	0.1
COL1A2	OI4	ENSG00000164692	"Collagen type I alpha 2 chain"	P08123	7	94394561-94431232	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Dwarfism, Ehlers-Danlos syndrome, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 244.6"	"Cell type enhanced"	"Detected in many"	15	"Fibroblasts: 1445.8;Ito cells: 427.2;Leydig cells: 918.4;Peritubular cells: 470.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 154.3;ASC TERT1: 185.1;BJ: 151.4;BJ hTERT+: 111.2;fHDF/TERT166: 512.4;HSkMC: 160.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB032650, HPA059738"	Approved		Supported	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		21000000	"Endoplasmic reticulum"		"CAB032650: AB_2082039, HPA059738: AB_2684116"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.31e-3)"	44.7	9.8	1.2	34.9	4.3	0.0	33.4	1.7	2.4	244.6	26.5	2.1	54.1	3.8	166.9	139.1	28.2	36.6	101.4	45.1	1.3	0.8	10.2	4.1	37.1	20.4	1.8	2.8	68.3	10.9	1.8	6.0	70.6	3.8	40.3	10.1	23.0	17.5	28.0	12.1	35.6	15.2	100.7	3.2	16.4	16.1	49.7	1.1	5.6	14.7	42.7	12.6	62.4	55.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	57.1	154.3	185.1	0.0	151.4	111.2	24.9	33.3	0.0	0.1	0.0	0.1	512.4	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	40.4	0.0	0.0	160.7	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.5	63.6	0.0	39.4	4.2	0.0	0.0	0.0	15.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.3	1.7	2.4	1.3	0.8	1.8	2.8	3.8	1.1	3.0	17.5	0.0	0.5	198.1	0.1	13.3	0.0	1.4	5.7	1.8	0.0	23.0	0.0	2.8	7.1	30.1	0.0	0.0	0.2	19.3	1445.8	1.2	9.3	1.1	95.1	0.0	0.0	427.2	1.0	22.0	918.4	12.0	226.0	4.6	0.0	3.0	8.5	0.0	470.9	0.3	0.3	297.5	291.6	5.1	3.2	163.7	59.2	0.0	0.0	0.7
COL3A1	EDS4A	ENSG00000168542	"Collagen type III alpha 1 chain"	P02461	2	188974320-189012746	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Aortic aneurysm, Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 304.2;endometrium 1: 208.0"	"Cell type enriched"	"Detected in many"	4	"Fibroblasts: 1855.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 81.7;ASC diff: 151.5;ASC TERT1: 263.7;fHDF/TERT166: 106.1;HHSteC: 104.2;HSkMC: 196.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA007583, CAB016766, CAB059993"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		16000000	"Endoplasmic reticulum"		"CAB016766: , CAB059993: AB_2314211, HPA007583: AB_1078548"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.94e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (3.59e-10)"	"unprognostic (1.70e-3)"	"unprognostic (3.76e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.17e-3)"	41.7	9.7	0.7	34.1	3.4	0.0	29.7	0.8	1.2	304.2	41.3	1.3	23.8	3.9	208.0	82.0	31.3	32.3	116.3	41.0	1.0	0.3	14.4	12.1	32.9	39.3	1.3	1.1	54.9	14.4	1.7	2.3	161.2	3.2	27.4	18.3	32.0	15.1	22.4	14.5	28.3	24.2	114.1	1.7	29.5	25.3	45.5	0.7	9.5	12.8	44.8	15.4	64.8	51.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.7	3.1	151.5	263.7	0.0	32.9	29.3	14.4	12.9	0.4	0.0	0.0	0.0	106.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	13.9	0.0	104.2	0.1	0.0	196.1	0.0	17.5	2.8	0.0	0.7	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.4	0.0	1.2	0.8	0.0	0.0	60.2	0.0	0.0	0.0	0.1	1.7	7.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.4	0.8	1.2	1.0	0.3	1.3	1.1	3.2	0.7	3.0	20.2	0.0	0.4	152.4	0.0	9.8	0.0	2.7	2.3	0.0	0.0	40.3	0.0	2.5	21.6	52.5	0.0	0.0	0.0	34.9	1855.8	0.5	5.8	0.9	81.7	0.0	5.8	358.5	0.8	11.8	299.1	3.8	163.6	0.0	0.0	0.0	6.1	0.0	221.7	0.0	0.0	446.3	215.4	1.1	1.0	136.1	105.6	0.0	0.0	0.3
COL4A6		ENSG00000197565	"Collagen type IV alpha 6 chain"	Q14031	X	108155607-108439497	"Disease related genes, Predicted secreted proteins"	"Cell adhesion"		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 60.9"	"Cell type enhanced"	"Detected in some"	11	"Basal glandular cells: 19.4;Cardiomyocytes: 9.2;Muller glia cells: 7.7;Peritubular cells: 8.5;Smooth muscle cells: 8.0;Urothelial cells: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 18.4;HeLa: 16.2;HHSteC: 24.9;hTERT-HME1: 18.2;HUVEC TERT2: 16.8;TIME: 37.6"	"Low region specificity"	"Detected in single"							HPA065393			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA			"Endoplasmic reticulum"		"HPA065393: AB_2685483"	"unprognostic (8.47e-3)"	"unprognostic (4.50e-3)"	"unprognostic (9.75e-3)"	"unprognostic (9.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.54e-3)"	"unprognostic (3.51e-1)"	2.1	0.4	0.4	0.8	0.5	0.0	1.7	0.2	0.4	12.1	1.0	1.3	8.0	0.7	22.9	17.1	25.0	11.3	35.8	3.6	0.6	0.6	3.0	0.3	2.1	0.0	1.0	0.9	6.4	0.3	7.6	11.3	1.9	0.9	16.5	1.3	8.3	1.4	15.6	1.0	4.1	1.8	60.9	1.4	1.1	10.4	2.1	0.7	0.2	0.6	1.4	0.5	24.7	6.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	12.4	4.0	0.0	10.1	0.7	0.0	0.0	0.7	0.1	0.1	7.1	0.0	0.0	0.0	0.0	1.6	2.3	4.1	18.4	0.3	0.1	3.5	0.3	16.2	0.1	24.9	0.0	0.0	1.0	11.4	2.6	18.2	0.0	16.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.6	0.0	1.5	0.0	0.0	0.0	0.8	1.3	0.0	0.0	0.9	0.0	0.0	7.8	0.3	0.0	37.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.4	0.6	0.6	1.0	0.9	0.9	0.7	0.0	0.0	0.0	19.4	5.7	0.0	9.2	0.0	2.7	2.3	1.8	0.0	0.1	1.7	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.9	3.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	7.7	0.1	0.0	8.5	0.0	0.2	0.0	8.0	0.3	0.2	3.1	0.0	0.0	0.0	10.6
CPVL		ENSG00000106066	"Carboxypeptidase, vitellogenic like"	Q9H3G5	7	28995231-29195451	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 111.9;lymphoid tissue: 84.0"	"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 263.6;Kupffer cells: 230.2;Macrophages: 292.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 95.8;intermediate monocyte: 81.6;myeloid DC: 111.9"	"Group enriched"	"Detected in many"	52	"dendritic cells: 111.9;monocytes: 95.8"	"Cell line enriched"	"Detected in many"	4	"RPTEC TERT1: 131.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003697, HPA045715, HPA056466"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		510000	"Endoplasmic reticulum"		"CAB003697: AB_425990, HPA045715: AB_2679429, HPA056466: AB_2683140"	"unprognostic (4.72e-2)"	"unprognostic (7.08e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.49e-2)"	"unprognostic (6.85e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.07e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.46e-3)"	"prognostic unfavorable (4.99e-4)"	19.0	6.2	4.0	15.0	9.1	11.9	7.7	11.6	3.4	9.1	10.0	7.7	4.2	7.6	6.9	20.4	6.4	7.2	10.2	30.2	6.1	4.4	39.1	12.3	13.5	30.5	6.6	2.3	10.1	8.5	0.2	6.1	31.3	20.1	8.4	6.0	15.8	3.5	5.2	7.9	5.1	13.3	8.1	9.7	84.0	4.7	10.6	4.2	29.7	51.9	5.0	8.1	11.0	15.7	0.1	111.9	1.9	95.8	0.5	0.3	74.4	0.2	0.0	3.3	0.0	0.0	0.0	31.5	0.0	0.0	0.3	0.0	9.5	0.0	0.0	15.0	0.1	15.6	0.5	8.4	0.6	0.1	0.0	7.8	10.6	0.1	22.8	0.0	0.0	0.0	0.0	0.9	0.1	0.2	0.0	0.1	4.4	7.1	0.0	0.2	0.0	9.8	0.0	5.2	0.0	2.6	0.0	0.0	0.0	131.9	3.6	1.9	1.5	8.6	20.6	15.9	16.8	2.4	7.9	0.0	0.0	0.1	0.0	1.9	2.9	31.7	0.1	0.0	3.9	3.3	1.0	95.8	0.4	0.2	81.6	0.3	0.1	0.1	0.1	111.9	0.1	0.1	0.1	1.9	0.5	26.0	2.9	0.1	74.4	4.0	9.1	11.6	3.4	6.1	4.4	6.6	2.3	20.1	4.2	6.0	20.2	17.9	1.1	11.1	0.0	63.1	7.6	2.7	4.5	68.0	0.0	103.1	29.9	0.5	15.2	12.6	0.0	0.0	14.2	103.4	14.2	0.2	4.7	0.5	263.6	0.0	1.7	6.7	230.2	6.4	8.6	292.5	10.1	4.6	0.8	0.2	1.2	0.0	2.8	23.9	0.3	0.0	5.7	15.2	103.9	7.8	99.1	0.9	0.9	0.9
CSGALNACT2	"GALNACT-2, GALNACT2, MGC40204, PRO0082"	ENSG00000169826	"Chondroitin sulfate N-acetylgalactosaminyltransferase 2"	Q8N6G5	10	43138486-43185308	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 80.6"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 62.0;Macrophages: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 37.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031540	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA031540: AB_10599943"	"unprognostic (1.65e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.28e-3)"	"unprognostic (2.85e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.43e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (3.53e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.05e-3)"	18.3	8.2	9.0	16.4	13.0	80.6	11.5	10.0	10.9	11.4	12.5	17.6	4.8	6.8	14.7	7.5	9.8	12.8	18.4	11.5	10.0	9.0	8.2	11.3	24.0	25.7	11.0	6.2	16.2	6.3	7.8	15.0	18.3	11.5	10.4	8.9	19.8	7.9	8.6	12.5	8.1	9.6	15.7	14.4	21.1	8.7	6.7	9.6	24.3	9.2	6.6	12.2	17.8	11.0	2.5	11.6	15.2	16.3	8.7	6.3	5.1	4.9	3.3	6.2	5.9	9.7	16.4	1.5	18.1	24.4	8.0	12.5	1.1	5.1	8.2	4.5	16.3	3.8	4.6	5.1	6.8	13.1	9.8	3.8	4.3	3.1	3.4	21.2	9.9	9.0	16.3	7.5	17.8	37.3	10.1	10.2	12.5	1.8	24.7	16.3	2.6	7.5	5.9	2.7	1.7	4.3	4.7	6.2	3.4	7.1	2.6	5.6	11.1	4.7	4.8	11.3	5.6	6.4	8.2	15.0	6.9	10.9	21.5	12.1	6.4	8.9	4.4	14.6	24.3	3.2	10.7	9.8	15.2	6.3	11.4	5.5	2.5	4.9	4.9	11.6	2.2	5.8	4.8	9.0	8.7	16.3	3.4	5.6	5.1	9.0	13.0	10.0	10.9	10.0	9.0	11.0	6.2	11.5	9.6	14.9	16.0	7.2	10.1	15.8	11.9	9.2	2.5	6.7	14.8	10.4	9.8	1.9	0.0	5.4	2.1	14.0	1.4	0.0	6.0	5.6	26.7	10.2	46.2	10.4	15.8	7.9	8.6	14.1	62.0	0.4	15.8	59.7	8.5	7.2	2.1	4.4	9.8	1.7	11.7	3.4	8.3	25.8	25.1	11.7	17.2	10.7	1.3	32.8	1.6	6.0
CTAGE5	"cTAGE-5A, cTAGE-5B, cTAGE-5C, cTAGE-5D, MEA6, MGEA, MGEA11, MGEA6"	ENSG00000150527	"CTAGE family member 5, ER export factor"	"O15320, Q96PC5"	14	39230231-39388513	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 72.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 43.4"									"HPA000387, HPA000922, HPA054066, HPA055459"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA000387: AB_1078582, HPA000922: AB_1078581, HPA054066: AB_2682368, HPA055459: AB_2682819"	"unprognostic (2.62e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.27e-4)"	"unprognostic (3.21e-4)"	"unprognostic (2.63e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.93e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.97e-2)"	9.3	16.9	7.3	11.4	7.3	7.3	7.9	5.1	7.9	12.1	22.8	5.8	13.5	28.5	8.5	17.9	18.5	8.4	15.1	7.5	6.4	5.9	34.7	52.2	10.6	9.0	7.8	6.5	8.6	20.6	22.9	20.6	6.0	21.1	8.9	12.6	6.0	22.3	17.0	17.4	6.4	52.4	6.9	9.7	9.7	16.0	8.7	8.6	10.1	17.0	15.9	7.0	8.3	10.9	8.7	12.5	24.5	13.5	9.8	11.6	8.4	7.7	8.6	3.6	6.4	7.4	8.4	5.1	4.6	4.8	3.3	3.4	6.7	43.4	9.3	14.3	5.1	6.7	11.8	4.4	5.1	3.9	7.2	3.7	5.8	4.2	35.8	17.4	7.8	10.8	5.1	29.5	3.2	24.6	20.9	5.3	11.0	5.5	23.9	4.9	7.4	4.9	6.3	4.2	29.6	7.2	5.1	6.4	11.6	15.1	8.4	3.1	1.8	10.6	11.3	6.9	4.8	10.9	8.4	8.3	5.0	3.3	3.6	3.0	13.7	11.7	9.2	2.8	4.9	4.1	22.5	11.8	17.6	11.6	12.3	10.5	8.5	8.9	10.8	12.5	8.7	11.0	10.2	24.5	9.8	13.5	8.7	8.1	8.4	7.3	7.3	5.1	7.9	6.4	5.9	7.8	6.5	21.1	8.6	35.7	36.1	11.6	6.2	3.8	11.5	0.0	43.3	72.3	29.6	0.0	31.4	4.5	0.0	0.0	4.3	3.1	34.6	0.0	0.0	4.0	5.3	11.6	24.4	38.4	6.8	7.9	31.2	11.1	12.4	2.2	11.8	7.6	5.0	0.0	21.2	4.3	0.0	20.1	11.0	0.0	13.0	0.0	3.1	17.9	13.4	3.0	5.8	13.8	14.3	12.8
CYB5R3	DIA1	ENSG00000100243	"Cytochrome b5 reductase 3"	P00387	22	42617840-42649568	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 117.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001566	Approved		Supported	"Endoplasmic reticulum"		NA	NA		67000000	"Endoplasmic reticulum"		"HPA001566: AB_1078601"	"unprognostic (4.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (2.13e-5)"	"unprognostic (2.45e-1)"	"unprognostic (8.22e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.24e-2)"	79.7	57.1	33.2	22.8	32.6	19.3	86.8	19.5	33.1	52.4	31.9	37.6	51.8	25.9	51.9	35.0	39.1	39.3	38.6	86.4	31.3	24.1	43.3	78.2	43.5	30.3	31.8	25.4	58.8	21.9	15.1	27.2	32.1	33.9	40.6	21.3	37.9	29.3	96.4	34.4	43.1	32.5	55.5	36.3	20.2	33.7	44.0	25.9	14.1	30.1	28.4	23.2	43.4	53.5	28.6	37.6	70.3	39.7	14.2	22.3	19.7	16.5	10.6	17.5	10.8	117.8	93.7	10.3	48.8	45.3	36.5	32.6	13.9	13.0	7.8	21.8	90.2	15.8	15.3	11.7	24.1	18.8	8.4	26.2	11.1	18.4	26.8	30.0	15.5	20.8	56.4	19.1	26.2	17.4	26.7	30.1	10.1	9.6	40.9	49.5	18.3	15.2	14.3	7.0	17.3	19.6	11.2	21.3	17.4	28.0	12.2	7.8	10.1	16.1	15.6	17.8	13.5	12.4	15.0	46.1	39.6	24.7	26.6	18.3	10.9	11.7	9.6	46.1	9.0	32.5	26.3	25.7	70.3	19.7	32.4	19.9	28.6	19.1	21.6	37.6	26.4	13.6	14.3	13.4	14.2	39.7	34.3	22.3	19.7	33.2	32.6	19.5	33.1	31.3	24.1	31.8	25.4	33.9	25.9	80.4	44.4	45.6	76.5	97.8	15.9	86.2	112.1	24.1	47.8	57.6	3.9	94.2	41.4	197.4	3.7	128.1	83.6	116.8	93.8	165.0	171.8	78.6	62.2	149.9	98.1	15.9	80.4	125.8	48.8	6.9	235.1	65.2	167.0	156.9	41.0	91.8	117.8	80.6	263.8	100.0	17.3	187.5	253.9	15.8	48.1	98.5	98.6	40.1	48.2	75.8
CYP2S1		ENSG00000167600	"Cytochrome P450 family 2 subfamily S member 1"	Q96SQ9	19	41193049-41207539	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.1;gallbladder: 29.1;intestine: 62.7;stomach 1: 45.9"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 16.5;Enterocytes: 23.2;Mucus-secreting cells: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 9.5;myeloid DC: 33.1"	"Group enriched"	"Detected in many"	121	"dendritic cells: 33.1;monocytes: 9.5"	"Cell line enhanced"	"Detected in many"		"A549: 31.3;CACO-2: 16.1;HaCaT: 16.8;NTERA-2: 23.7;OE19: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA049227, HPA069248"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA049227: AB_2680681, HPA069248: AB_2732128"	"unprognostic (1.49e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.45e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.60e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.66e-2)"	1.2	0.8	0.8	2.3	1.0	0.5	0.6	0.1	1.0	1.7	18.3	1.2	0.5	37.6	0.3	0.9	10.1	2.4	29.1	1.0	1.4	1.6	0.9	2.1	3.8	3.3	5.6	0.4	0.8	0.6	0.0	0.9	1.6	4.5	0.9	7.2	1.1	3.8	0.3	0.1	2.0	62.7	0.6	1.1	4.0	45.9	0.5	1.2	2.6	0.4	15.8	21.0	3.2	2.7	0.0	33.1	0.0	9.5	0.0	0.1	3.9	1.2	31.3	0.0	0.0	0.0	0.0	1.5	0.2	0.2	0.3	0.0	16.1	4.5	0.0	3.7	0.2	0.0	16.8	5.5	8.5	0.1	0.0	0.1	4.2	1.7	5.8	6.6	0.0	0.1	0.2	0.4	0.4	0.2	0.0	0.2	1.4	1.9	0.1	0.0	0.6	0.1	0.0	23.7	51.4	4.1	0.0	0.0	0.3	0.5	6.7	0.0	0.2	3.1	0.0	0.0	9.7	4.1	1.6	3.6	0.0	1.3	0.6	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	9.5	0.0	0.0	2.3	0.1	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	3.9	0.8	1.0	0.1	1.0	1.4	1.6	5.6	0.4	4.5	1.2	0.0	8.6	0.0	1.6	2.3	0.0	0.8	0.0	8.1	7.9	1.8	0.0	16.5	0.0	0.8	0.3	0.0	23.2	0.0	0.9	0.6	1.3	0.4	1.1	0.0	12.8	0.0	0.0	0.6	4.7	0.0	0.0	11.5	0.0	8.2	29.0	0.0	13.8	14.8	0.0	0.0	0.0	0.0	0.3	0.1	0.4	2.5	8.6	0.0	13.9	0.1
CYP51A1	"CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1"	ENSG00000001630	"Cytochrome P450 family 51 subfamily A member 1"	Q16850	7	92112151-92142952	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.9"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 62.5;Alveolar cells type 2: 133.7;Club cells: 77.3;Early spermatids: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 96.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041325, HPA043508"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA041325: AB_2677411, HPA043508: AB_2678520"	"unprognostic (6.68e-2)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (3.48e-2)"	"unprognostic (1.18e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.59e-9)"	"unprognostic (1.82e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.09e-3)"	10.3	27.0	16.7	8.1	22.1	10.5	15.5	13.3	32.0	11.8	21.1	32.9	6.3	33.1	9.1	15.3	23.4	7.1	10.3	9.9	18.6	20.8	18.6	80.9	22.2	5.0	17.2	13.7	21.0	20.2	32.4	11.9	8.8	47.1	18.2	16.9	17.1	11.0	7.7	4.3	12.8	28.8	8.3	43.7	7.3	18.1	35.7	19.5	2.3	14.1	18.7	10.0	9.0	13.2	14.2	14.1	3.5	13.9	6.7	10.7	7.1	21.4	10.5	26.6	17.0	18.7	30.7	3.8	7.3	22.1	9.5	26.0	25.3	39.3	18.7	11.6	12.6	96.2	18.8	23.1	46.1	11.1	7.8	16.4	5.4	11.2	19.0	25.6	11.0	8.1	22.2	21.0	37.1	39.0	8.4	9.7	3.8	20.2	43.2	11.1	22.0	2.3	10.2	19.8	8.8	10.5	7.6	5.5	42.2	43.0	36.4	18.7	12.5	15.5	30.9	22.6	12.6	11.2	13.2	11.5	13.0	14.6	18.8	9.5	14.7	13.1	17.1	10.0	14.6	16.6	1.8	9.7	3.5	10.7	13.9	7.1	14.2	7.6	8.4	14.1	10.7	7.2	9.2	1.5	6.7	8.3	12.4	5.8	7.1	16.7	22.1	13.3	32.0	18.6	20.8	17.2	13.7	47.1	19.5	62.5	133.7	7.5	1.0	2.3	2.1	1.2	7.6	28.1	77.3	1.8	2.0	1.3	1.7	9.2	70.7	2.1	14.4	23.3	17.0	0.8	1.8	1.3	27.7	4.2	1.3	0.0	10.4	8.6	6.6	27.7	3.4	2.1	0.0	1.0	12.0	1.9	12.3	10.4	1.4	1.7	1.8	0.0	2.8	3.2	1.5	4.6	3.7	1.0	11.5	2.1
DDOST	"GATD6, KIAA0115, OST, OST48, WBP1"	ENSG00000244038	"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit"	P39656	1	20651767-20661544	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009746, HPA046841, HPA052867"	Supported		Supported	"Endoplasmic reticulum"		NA	NA		3300000	"Endoplasmic reticulum"		"CAB009746: AB_2092075, HPA046841: AB_2679834, HPA052867: AB_2681977"	"unprognostic (8.57e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.57e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (4.88e-4)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (2.70e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-1)"	"prognostic unfavorable (9.05e-7)"	"unprognostic (1.07e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.07e-1)"	25.7	42.7	17.0	28.7	21.6	37.1	42.5	13.9	26.7	32.8	35.3	16.4	52.0	27.3	37.1	54.7	33.2	32.7	40.0	53.2	13.9	15.7	36.0	59.8	37.2	84.7	16.5	18.3	42.4	146.9	25.4	37.2	71.6	16.1	24.9	39.1	29.5	51.3	58.3	25.5	25.1	35.6	32.2	12.8	49.8	36.5	35.1	15.0	32.5	51.5	28.7	34.5	26.7	30.0	45.6	80.1	50.1	57.1	49.7	58.9	80.7	46.3	29.8	26.0	77.0	51.8	54.2	54.3	39.1	78.7	63.7	65.8	39.6	97.2	38.6	65.3	63.4	35.0	40.3	35.8	47.9	47.2	30.5	36.8	33.3	19.4	52.0	77.2	51.8	86.3	55.5	53.5	53.3	64.5	76.8	72.7	25.9	16.1	64.3	38.2	35.5	24.5	42.8	26.8	74.4	31.6	21.6	34.9	68.4	52.0	20.5	18.9	33.0	42.2	43.0	58.1	39.2	34.4	80.3	37.3	36.8	38.7	63.4	36.0	76.3	82.0	25.9	60.6	69.2	49.3	44.7	55.7	50.1	55.7	57.1	58.9	45.6	48.2	51.3	80.1	39.6	44.1	46.6	14.2	49.7	48.5	65.4	49.2	80.7	17.0	21.6	13.9	26.7	13.9	15.7	16.5	18.3	16.1	15.0	32.8	59.5	70.0	69.0	44.6	15.7	18.9	58.6	75.0	70.5	33.2	27.5	298.3	33.2	141.7	21.4	50.9	44.9	23.3	130.8	225.3	93.6	64.6	76.3	67.1	126.3	15.9	69.0	62.0	66.8	12.2	69.0	83.0	81.0	115.4	106.2	51.5	92.2	91.2	57.3	44.9	19.3	45.3	41.9	107.7	187.2	46.9	292.5	81.2	128.2	58.0
DERL1	"DER-1, DER1, derlin-1, FLJ13784, MGC3067, PRO2577"	ENSG00000136986	"Derlin 1"	Q9BUN8	8	123013164-123042423	"Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Protein transport, Transport, Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 135.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016562, CAB037269"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB037269: AB_609868, HPA016562: AB_1847611"	"prognostic unfavorable (2.43e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (5.66e-5)"	"unprognostic (9.48e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.42e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.35e-1)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.88e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	31.2	34.3	12.7	24.5	14.6	43.4	31.6	18.6	19.5	17.3	23.9	16.6	21.4	22.9	21.3	17.0	23.4	17.5	20.2	23.8	11.7	12.4	25.4	73.3	23.4	42.3	14.1	11.5	23.5	33.6	11.7	23.0	25.0	14.9	16.4	21.5	17.9	21.9	24.4	48.0	16.3	32.6	16.9	14.4	35.3	18.1	22.4	13.0	17.9	25.2	20.9	31.2	23.3	18.3	34.0	26.6	32.8	35.1	34.6	47.3	35.1	20.5	15.3	9.2	11.9	16.6	12.6	7.6	17.3	11.8	11.6	14.3	9.7	20.7	23.8	21.7	14.2	13.5	17.3	8.6	11.2	16.4	27.6	9.6	24.8	10.7	8.1	15.2	9.6	18.6	11.3	14.7	12.6	15.2	10.5	10.2	9.8	14.8	31.8	12.9	41.0	10.5	6.0	6.9	26.6	13.7	10.9	7.6	39.9	29.3	14.8	10.0	14.7	17.5	135.8	11.0	10.4	16.0	8.7	11.8	13.8	26.0	12.1	16.2	40.1	67.1	21.4	22.7	12.1	12.9	27.3	28.8	32.8	45.1	35.1	47.3	34.0	30.6	37.1	23.4	26.2	21.6	33.3	19.8	34.6	34.2	26.6	36.6	35.1	12.7	14.6	18.6	19.5	11.7	12.4	14.1	11.5	14.9	13.0	29.8	23.4	47.9	34.8	37.5	21.5	25.5	12.7	10.7	21.6	27.9	19.6	36.4	8.3	77.0	57.1	33.4	43.9	46.7	65.5	54.9	36.5	51.0	42.6	68.3	62.7	17.5	29.2	42.4	44.8	14.7	22.7	41.9	57.3	51.3	45.8	25.2	57.9	42.1	24.1	23.1	22.1	45.3	37.1	43.5	36.8	44.4	65.2	61.8	30.5	53.3
DERL2	"CGI-101, derlin-2, F-LAN-1, F-LANa, FLANa"	ENSG00000072849	"Derlin 2"	Q9GZP9	17	5471251-5486811	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 180.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB037287, HPA048957, HPA056551"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB037287: AB_1078641, HPA048957: AB_2680570, HPA056551: AB_2683171"	"unprognostic (2.54e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.83e-2)"	"prognostic favorable (7.26e-4)"	"unprognostic (1.51e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.91e-2)"	12.2	18.9	8.8	11.6	10.7	22.4	13.5	8.1	9.7	11.9	10.7	10.5	17.0	10.9	12.4	23.6	13.4	11.5	13.2	9.6	10.6	6.8	18.1	28.7	12.8	18.8	12.5	4.4	13.1	49.1	12.2	14.7	16.6	11.5	11.0	9.5	10.7	30.3	19.4	9.5	9.5	15.9	11.3	11.0	14.9	13.5	21.0	11.3	11.4	22.1	7.6	16.7	13.8	10.5	33.4	36.6	39.3	36.3	29.5	40.6	53.3	16.8	21.9	10.3	17.4	17.8	13.4	13.3	24.0	19.7	16.6	20.3	14.9	15.2	11.7	21.9	15.3	18.7	18.9	7.1	13.9	16.7	15.5	15.0	5.7	14.3	16.0	24.5	4.2	14.0	12.4	11.6	22.4	19.5	14.7	17.1	12.2	6.2	20.6	22.4	8.8	9.0	6.5	10.0	11.1	8.7	11.0	14.7	8.6	17.8	8.7	4.4	12.8	14.7	10.2	25.2	11.9	13.5	6.3	12.9	19.7	13.3	12.0	22.9	14.4	15.9	10.4	20.6	10.6	15.5	31.4	34.4	39.3	36.5	36.3	37.8	33.4	35.4	38.6	25.7	29.3	28.1	34.8	32.3	29.5	27.8	36.6	40.6	53.3	8.8	10.7	8.1	9.7	10.6	6.8	12.5	4.4	11.5	11.3	11.9	25.8	37.1	44.0	30.5	17.1	26.9	33.1	36.1	26.1	41.8	21.6	60.0	13.3	71.9	180.2	34.2	29.0	23.3	78.4	83.8	58.7	59.6	47.4	52.3	67.1	11.1	17.7	27.6	34.8	40.2	40.6	40.1	43.9	79.4	23.7	29.0	76.1	28.1	33.2	37.4	20.7	58.2	30.9	77.5	49.8	27.1	80.4	41.7	25.9	52.1
DHCR7	SLOS	ENSG00000172893	"7-dehydrocholesterol reductase"	Q9UBM7	11	71428193-71452868	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.8"	"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 43.9;Hepatocytes: 67.2;Syncytiotrophoblasts: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044280	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044280: AB_10794893"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-3)"	"unprognostic (8.57e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.45e-2)"	"prognostic favorable (6.93e-7)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (5.67e-4)"	8.0	40.1	12.1	5.6	14.5	19.0	16.8	5.3	22.8	5.5	9.3	27.9	8.8	20.8	4.0	27.3	14.6	5.2	5.8	10.7	13.7	13.2	7.1	64.8	12.0	2.7	20.6	12.3	21.5	7.3	14.0	7.0	3.7	23.4	10.0	6.6	16.6	10.0	3.9	5.4	22.9	15.8	4.5	20.5	5.9	8.5	17.7	15.5	2.8	5.4	12.1	7.7	4.3	7.4	6.3	6.2	3.5	1.9	4.6	12.1	5.7	21.2	19.3	18.9	20.9	8.9	13.8	5.9	8.8	23.5	7.5	20.5	71.9	70.0	14.9	14.0	8.4	67.3	41.0	22.5	47.6	7.9	5.6	16.9	5.7	16.3	30.7	22.8	10.6	2.7	15.9	21.1	28.2	19.4	6.2	11.1	19.5	26.6	31.8	7.5	57.2	8.7	12.0	27.1	21.1	11.5	7.9	26.6	64.0	28.2	32.2	25.7	9.6	8.4	27.8	20.0	9.6	26.9	5.8	10.4	2.0	11.4	0.6	10.5	10.5	12.7	15.9	6.0	18.9	8.5	3.5	1.9	1.7	9.7	1.2	11.8	6.3	8.2	9.0	2.5	5.4	10.5	12.1	1.0	4.6	1.2	6.2	5.1	5.7	12.1	14.5	5.3	22.8	13.7	13.2	20.6	12.3	23.4	15.5	3.0	12.6	6.7	7.1	0.7	6.8	11.3	10.2	5.3	9.1	21.0	11.8	13.8	6.6	29.1	0.1	6.6	7.8	0.0	43.9	21.8	9.3	14.2	0.0	67.2	9.8	0.0	9.1	6.2	3.7	0.0	7.8	3.0	5.0	9.0	11.8	20.9	19.8	7.0	4.6	2.9	8.0	12.9	2.5	0.6	5.9	1.0	45.3	10.2	14.5	7.1
DIP2B	"FLJ34278, KIAA1463"	ENSG00000066084	"Disco interacting protein 2 homolog B"	Q9P265	12	50504985-50748667	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038472, HPA046133, HPA056045"	Enhanced		Approved	"Endoplasmic reticulum"		No	No			"Endoplasmic reticulum"		"HPA038472: AB_2676033, HPA046133: AB_2679551, HPA056045: AB_2683019"	"prognostic unfavorable (2.60e-4)"	"unprognostic (2.85e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.86e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.57e-3)"	"unprognostic (3.90e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.70e-3)"	8.6	12.2	20.3	11.2	33.0	14.3	14.2	37.7	25.6	10.0	12.4	35.9	5.3	8.3	8.6	5.1	17.1	6.3	9.5	7.6	24.5	17.2	8.4	14.7	9.0	11.9	35.2	17.4	13.2	10.2	21.4	8.9	13.9	24.8	9.3	14.6	9.0	11.1	6.2	6.7	22.6	8.3	9.7	35.6	18.4	9.3	9.9	34.4	11.4	11.2	6.4	15.1	9.0	10.4	3.9	2.5	7.7	5.6	0.9	3.1	1.2	13.7	8.6	13.0	9.1	7.5	7.3	18.0	7.9	9.4	7.8	5.9	15.3	7.8	9.3	9.6	8.8	8.0	14.5	20.8	15.2	9.2	10.7	7.4	14.7	7.3	19.4	11.7	17.6	9.0	8.2	13.2	8.7	12.7	13.6	14.7	8.6	20.3	9.0	6.8	11.0	13.6	8.9	7.4	8.0	15.0	15.9	12.7	4.5	8.8	11.0	12.2	8.5	19.8	11.8	12.2	15.8	16.6	12.4	14.8	6.3	7.4	5.7	6.5	6.5	10.7	11.0	8.8	8.2	8.6	1.7	2.0	4.3	0.7	2.3	1.2	2.5	1.8	0.7	2.5	3.9	3.1	2.5	7.7	0.9	5.6	0.7	1.6	1.2	20.3	33.0	37.7	23.2	24.5	17.2	35.2	17.4	24.8	34.4	6.0	8.0	14.5	21.8	48.8	26.2	8.5	15.3	4.0	4.5	8.7	60.9	11.0	0.0	8.9	1.4	14.6	15.5	0.0	14.9	15.4	8.7	29.0	10.4	16.6	16.5	11.1	30.1	14.7	25.2	2.2	9.5	12.8	15.1	7.2	20.1	15.6	16.0	14.4	9.6	4.5	31.3	0.0	6.8	11.2	18.4	58.5	31.8	6.9	10.2	19.5
DNAJB11	"EDJ, ERdj3, HEDJ"	ENSG00000090520	"DnaJ heat shock protein family (Hsp40) member B11"	Q9UBS4	3	186567403-186585800	"Predicted intracellular proteins"		Chaperone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA010814, HPA017051"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		18000	"Endoplasmic reticulum"		"HPA010814: AB_1078691, HPA017051: AB_1847792"	"unprognostic (4.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.86e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.05e-3)"	"prognostic unfavorable (3.44e-9)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.82e-1)"	18.8	16.4	14.0	27.7	21.2	26.4	22.3	12.4	14.4	18.7	21.6	15.9	21.5	19.7	20.0	28.1	19.9	18.1	18.2	27.3	14.7	14.9	29.5	83.5	21.7	31.5	17.4	10.2	13.9	67.4	20.6	18.0	26.2	19.6	14.4	22.7	13.3	37.2	18.4	13.2	13.9	25.4	17.3	17.4	25.6	21.3	16.1	19.6	17.9	47.6	15.7	20.3	19.0	26.0	19.3	42.2	19.0	21.6	22.6	23.7	16.8	33.2	13.1	19.3	33.4	15.9	12.3	33.2	37.7	21.6	31.2	33.0	40.4	22.2	24.3	76.4	24.7	45.3	31.0	22.0	19.5	32.9	27.2	19.4	21.5	13.0	29.8	37.0	25.2	34.0	10.9	19.9	17.5	30.8	17.2	26.0	13.4	11.9	58.6	20.6	25.3	16.9	20.7	18.9	45.7	17.7	17.0	21.9	40.8	23.3	14.4	16.7	23.3	24.2	40.5	26.1	24.8	46.6	38.5	19.6	17.4	22.5	22.5	53.4	46.8	34.4	38.4	23.0	30.8	37.3	16.6	18.3	19.0	23.7	21.6	19.9	19.3	12.2	19.2	22.9	11.5	11.8	16.0	8.4	22.6	15.8	42.2	16.7	16.8	14.0	21.2	12.4	14.4	14.7	14.9	17.4	10.2	19.6	19.6	17.9	18.1	40.2	176.4	129.0	21.7	133.1	73.9	14.7	21.6	14.0	17.7	80.7	3.3	86.5	28.0	75.2	81.9	46.7	74.8	136.3	69.6	91.0	55.2	85.7	131.5	22.3	136.1	66.3	76.0	7.2	29.1	64.3	97.8	20.8	37.6	45.1	80.8	43.8	24.4	17.2	21.3	64.7	67.3	102.4	77.5	98.1	163.2	65.0	43.1	144.4
DNAJC1	"DNAJL1, ERdj1, MTJ1"	ENSG00000136770	"DnaJ heat shock protein family (Hsp40) member C1"	Q96KC8	10	21756537-22003769	"Predicted membrane proteins, Transcription factors"		"Chaperone, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013432	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA013432: AB_1847797"	"unprognostic (7.00e-2)"	"unprognostic (9.81e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.12e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (3.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.36e-2)"	"prognostic favorable (2.33e-4)"	"unprognostic (4.44e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.22e-2)"	14.8	16.0	8.6	13.5	13.4	11.1	14.6	8.3	11.2	14.5	17.8	9.6	16.2	19.9	15.5	14.0	14.1	10.9	16.4	14.2	10.2	7.2	22.1	41.3	20.5	9.5	13.5	6.8	13.4	33.7	27.1	34.3	16.6	13.8	29.2	13.6	12.6	28.5	14.3	10.6	11.6	18.5	22.8	15.0	13.7	19.9	7.7	13.9	12.2	21.8	11.6	11.5	25.9	28.8	6.5	21.5	5.4	15.2	17.9	21.1	7.7	12.7	8.3	18.7	6.9	17.6	12.5	8.1	17.4	7.6	7.3	11.5	11.4	11.3	5.6	7.7	10.6	10.9	12.3	4.2	8.7	4.0	29.4	14.1	13.4	6.8	6.8	42.7	1.0	5.7	12.7	16.2	8.6	9.9	10.7	9.5	5.6	14.0	32.4	8.1	13.0	3.1	4.3	2.4	11.1	7.0	4.6	6.5	20.6	10.0	3.0	3.9	6.0	12.8	21.5	12.6	21.5	6.8	14.4	14.5	7.1	15.6	11.9	9.8	10.4	3.2	3.9	10.6	42.7	4.2	5.4	9.2	3.6	20.9	8.7	21.1	4.9	12.0	16.6	8.3	6.5	7.8	9.9	5.2	17.9	15.2	21.5	8.4	7.7	8.6	13.4	8.3	11.2	10.2	7.2	13.5	6.8	13.8	13.9	32.8	26.9	21.2	53.6	34.5	28.0	12.9	56.0	21.4	22.7	29.6	43.2	13.3	23.2	67.3	35.8	46.6	45.3	23.3	64.6	86.2	53.4	72.0	40.5	79.1	47.8	36.5	36.8	46.6	37.7	15.6	87.8	31.8	64.1	40.5	54.8	41.6	73.1	46.5	62.9	69.2	144.0	58.2	37.3	70.7	72.9	38.6	29.5	94.8	50.0	63.1
DNAJC3	"ERdj6, HP58, P58, P58IPK, PRKRI"	ENSG00000102580	"DnaJ heat shock protein family (Hsp40) member C3"	Q13217	13	95677139-95794989	"Disease related genes, Predicted intracellular proteins"	"Antiviral defense, Stress response, Translation regulation, Unfolded protein response"	"Chaperone, Repressor"	"Deafness, Diabetes mellitus, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039336, HPA041326"	Uncertain		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		2900000	"Endoplasmic reticulum"		"HPA039336: AB_2676451, HPA041326: AB_2677412"	"unprognostic (1.44e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.12e-2)"	"prognostic favorable (3.47e-5)"	"unprognostic (8.18e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.19e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.30e-3)"	"unprognostic (8.18e-2)"	19.1	16.1	11.2	13.5	14.5	24.5	25.4	8.5	12.3	24.4	15.5	10.0	35.5	14.7	18.5	25.9	13.9	15.8	14.0	16.6	9.8	9.8	22.1	61.9	18.7	19.0	12.8	9.0	15.0	44.8	14.8	33.9	31.6	13.8	22.8	17.1	10.8	43.3	34.0	10.3	11.6	22.0	14.2	17.5	17.2	17.9	8.6	12.9	8.9	40.7	10.4	12.8	19.1	19.2	4.5	18.0	32.5	13.0	8.9	10.6	5.6	12.2	7.0	5.6	16.1	23.4	11.7	16.9	17.4	15.8	8.0	7.4	8.7	26.0	11.3	16.6	17.4	11.4	12.6	7.3	13.2	12.4	10.9	3.3	15.5	10.0	13.9	32.3	18.8	20.6	13.9	14.2	11.8	27.4	14.8	17.4	5.1	5.2	0.1	13.5	5.0	6.3	6.8	4.2	28.8	5.5	6.5	9.8	8.6	17.8	15.3	3.2	6.2	12.3	29.6	8.5	13.5	14.7	20.9	19.7	15.7	5.4	10.4	8.9	24.2	10.5	5.2	26.4	11.4	21.5	21.9	10.6	32.5	10.2	12.5	10.6	4.5	8.5	8.5	6.8	3.8	6.1	8.2	30.6	8.9	13.0	18.0	5.1	5.6	11.2	14.5	8.5	12.3	9.8	9.8	12.8	9.0	13.8	12.9	74.5	58.8	47.9	69.5	83.6	21.8	45.1	71.4	64.3	56.9	45.4	25.5	47.0	18.3	87.5	152.1	55.4	52.5	23.3	103.7	111.5	93.0	145.2	65.8	125.0	73.0	23.8	40.2	63.3	61.2	22.1	66.4	81.8	113.1	51.3	45.2	44.2	87.6	42.4	71.1	57.9	16.8	90.5	89.1	33.5	81.0	81.2	158.7	51.7	36.6	100.0
DUSP9	"MKP-4, MKP4"	ENSG00000130829	"Dual specificity phosphatase 9"	Q99956	X	153642492-153651326	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 23.0;placenta: 63.1"	"Group enriched"	"Detected in some"	14	"Cytotrophoblasts: 876.9;Distal tubular cells: 616.8;Syncytiotrophoblasts: 1451.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"Hep G2: 90.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"amygdala: 4.4;basal ganglia: 2.7;cerebral cortex: 3.5;hippocampal formation: 3.7;hypothalamus: 3.6"	HPA003336	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA003336: AB_1078709"	"unprognostic (4.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-3)"	"unprognostic (9.36e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.68e-7)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.52e-2)"	0.2	0.1	3.2	0.2	4.4	0.1	0.3	0.2	2.0	0.2	0.1	0.7	0.0	0.2	0.1	0.3	0.3	0.2	0.1	0.2	2.5	0.6	23.0	0.7	0.2	0.2	1.1	0.6	1.9	0.5	0.1	0.0	63.1	0.9	0.2	0.1	0.0	0.8	1.5	0.1	0.2	0.2	0.1	0.5	0.2	0.2	1.1	0.8	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	8.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.6	0.5	0.0	4.0	0.0	0.3	1.8	10.1	0.2	0.0	0.2	1.8	0.0	0.7	90.8	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.2	0.2	0.4	3.7	0.0	0.0	0.0	0.0	2.3	0.1	0.3	0.6	0.7	0.3	0.2	0.1	0.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	4.4	0.2	2.0	2.5	0.6	1.1	0.6	0.9	0.8	0.0	0.0	0.0	0.6	0.6	0.0	1.8	0.0	0.0	0.0	10.4	0.0	876.9	616.8	0.1	0.0	0.0	0.0	0.0	0.0	57.4	0.2	0.3	0.0	0.8	72.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.1	0.0	0.0	0.0	0.7	8.3	0.0	1451.1	0.0	0.0	0.9
EBP	"CDPX2, CHO2, CPX, CPXD"	ENSG00000147155	"Emopamil binding protein (sterol isomerase)"	Q15125	X	48521158-48528716	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase	"Cataract, Disease mutation, Dwarfism, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.1"	"Cell type enhanced"	"Detected in all"	7	"Hepatocytes: 389.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003130	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA003130: AB_1078717"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.04e-2)"	"unprognostic (5.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.36e-1)"	3.7	33.2	5.3	4.3	5.7	10.5	10.5	10.1	6.3	8.6	19.6	2.8	3.4	17.2	4.0	3.7	20.6	3.9	4.5	21.7	4.7	4.3	12.8	74.1	14.9	13.0	3.5	8.0	4.8	11.7	6.0	3.7	4.2	8.8	8.6	15.7	5.2	8.7	4.8	3.5	9.1	30.0	5.6	7.0	7.9	8.1	5.4	2.8	9.0	4.6	9.8	10.4	5.0	10.0	17.1	22.9	21.5	12.6	13.3	29.9	18.1	33.6	7.1	18.9	11.3	10.5	7.8	6.1	8.6	7.2	11.5	16.6	14.1	56.2	18.2	6.1	6.0	11.3	37.9	31.6	46.7	8.7	14.0	15.8	9.2	9.5	12.1	7.7	33.8	22.8	7.6	17.0	15.3	11.4	2.9	7.6	12.9	11.7	17.3	9.4	14.7	18.8	20.7	19.0	9.7	23.4	13.0	1.9	51.6	28.1	6.0	16.1	8.1	31.8	16.4	4.5	12.6	18.0	8.1	8.0	5.9	10.0	22.7	9.4	7.4	11.6	18.4	13.7	34.1	5.6	17.4	8.9	21.5	29.9	11.7	25.1	17.1	22.2	27.5	12.3	12.6	20.1	25.5	1.8	13.3	12.6	22.9	22.4	18.1	5.3	5.7	10.1	6.3	4.7	4.3	3.5	8.0	8.8	2.8	29.8	39.6	41.7	45.2	33.0	23.7	36.3	81.5	22.7	21.6	50.6	7.9	40.6	33.2	80.2	5.4	24.3	135.6	46.7	207.1	93.9	32.6	42.4	40.3	389.0	57.0	7.9	28.8	28.8	26.6	7.8	12.4	34.4	35.4	47.7	72.4	13.4	126.3	129.8	13.8	76.4	15.9	12.9	20.6	8.6	20.0	39.6	31.4	74.7	134.2	61.7
EBPL	EBRP	ENSG00000123179	"Emopamil binding protein like"	Q9BY08	13	49660723-49691475	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 285.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA049891	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA049891: AB_2680937"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.81e-1)"	"unprognostic (8.63e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (7.18e-8)"	"unprognostic (1.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.95e-2)"	10.2	32.6	5.8	13.4	5.7	11.1	17.1	4.5	8.6	21.5	13.9	4.7	8.8	10.1	21.1	7.0	32.9	13.0	7.2	6.8	4.8	7.1	12.8	64.8	14.5	17.9	6.1	5.0	21.8	46.4	6.6	5.9	7.3	9.4	22.4	11.7	8.2	21.0	14.6	4.9	15.5	8.8	13.5	6.0	13.7	13.6	8.4	3.7	11.1	22.2	21.8	19.7	14.7	22.6	7.0	6.7	9.3	4.8	5.5	10.4	1.7	14.3	11.6	7.5	30.8	9.5	23.1	12.2	14.9	11.1	11.4	8.3	22.4	21.0	17.6	6.9	8.1	9.8	30.3	13.7	15.9	15.5	13.9	39.0	15.2	8.1	31.8	26.8	22.1	11.4	26.9	33.0	8.3	23.5	17.5	18.5	20.9	10.8	7.7	14.0	9.6	8.6	41.9	24.5	51.4	24.3	18.1	4.3	28.3	22.8	4.8	6.5	17.0	5.8	20.9	6.8	8.0	18.0	17.9	9.1	7.8	7.9	6.6	12.4	4.8	11.9	14.8	3.4	22.1	7.2	2.8	4.0	1.1	3.4	4.7	10.0	5.8	7.3	7.2	6.7	7.0	10.4	5.8	9.3	5.5	4.8	4.5	4.9	1.7	5.8	5.7	4.5	8.6	4.8	7.1	6.1	5.0	9.4	3.7	32.8	17.2	59.6	137.3	96.5	6.8	3.8	76.5	5.3	14.8	22.7	7.9	26.0	34.9	55.4	11.6	57.3	12.7	0.0	44.5	33.3	44.2	104.1	18.4	285.3	33.1	1.6	26.8	65.7	45.6	8.4	87.2	31.9	43.9	3.6	79.1	13.6	42.9	21.0	65.7	52.5	8.0	19.4	53.6	31.6	14.1	135.1	12.7	39.8	112.1	100.9
EDEM3	C1orf22	ENSG00000116406	"ER degradation enhancing alpha-mannosidase like protein 3"	Q9BZQ6	1	184690231-184754913	"Enzymes, Predicted intracellular proteins"	"Unfolded protein response"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025754, HPA025755, HPA027297"	Approved		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA025754: AB_1845638, HPA025755: AB_1845639, HPA027297: AB_2672205"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.82e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (1.63e-6)"	"unprognostic (4.72e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.01e-1)"	12.5	12.6	10.8	11.3	13.8	6.4	11.1	15.2	11.8	13.2	17.6	7.5	10.8	16.0	11.7	7.7	10.9	10.2	10.4	10.4	9.1	8.2	9.6	27.8	13.3	8.9	13.5	8.4	8.8	27.3	18.4	26.4	17.9	10.6	12.3	21.3	7.6	18.3	14.3	20.8	7.1	14.4	10.6	13.3	9.5	31.3	6.2	11.5	15.8	11.5	6.3	10.6	11.6	16.1	2.7	5.9	7.4	6.8	4.0	6.3	3.4	6.6	5.0	7.0	6.1	25.4	26.2	11.3	13.5	9.4	5.2	5.4	2.6	19.3	4.6	14.8	10.2	5.2	9.1	6.6	7.0	7.6	4.5	5.4	6.1	5.3	3.7	9.8	15.9	9.0	14.9	8.7	12.5	11.2	9.7	13.8	12.5	16.0	21.7	9.8	5.5	12.7	8.3	9.7	15.1	4.7	5.6	5.3	15.8	7.5	4.7	7.8	11.1	6.6	11.5	9.3	12.1	10.8	25.0	16.2	7.4	3.4	15.7	11.3	33.3	12.8	6.2	9.9	18.2	16.2	7.4	6.8	4.1	2.9	6.7	5.1	2.7	4.5	3.5	5.9	2.0	6.3	3.3	6.9	4.0	6.3	3.0	3.0	3.4	10.8	13.8	15.2	11.8	9.1	8.2	13.5	8.4	10.6	11.5	17.9	13.4	12.2	6.8	14.8	27.8	13.7	10.2	22.7	23.9	14.0	23.6	10.6	0.0	11.1	14.7	22.4	27.1	0.0	30.7	9.0	21.5	26.1	20.7	38.0	11.5	20.6	29.4	20.9	41.6	5.6	19.0	19.1	18.6	4.6	60.6	8.0	21.3	21.0	17.0	8.1	14.2	19.4	14.1	14.3	8.1	17.9	16.2	13.1	29.1	15.2
ELOVL1	Ssc1	ENSG00000066322	"ELOVL fatty acid elongase 1"	Q9BW60	1	43363397-43368074	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 101.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033426, HPA056557"	Enhanced		Supported	"Endoplasmic reticulum"		NA	Yes			"Endoplasmic reticulum"		"CAB033426: AB_2099896, HPA056557: AB_2683173"	"unprognostic (5.23e-2)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (8.00e-2)"	"unprognostic (8.45e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (2.79e-7)"	"unprognostic (4.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-1)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.00e-2)"	21.2	15.6	16.2	15.3	25.3	18.3	24.1	6.8	32.5	16.1	23.6	101.5	11.7	20.7	14.1	13.0	46.6	15.1	17.3	11.5	30.3	18.3	26.6	23.8	22.9	22.7	51.4	14.1	9.3	18.3	16.7	8.4	20.9	45.6	21.6	20.1	8.6	20.6	21.6	6.8	54.0	21.7	20.7	99.5	17.2	22.8	8.4	37.2	7.2	23.9	15.6	21.7	20.4	22.6	30.9	61.1	46.9	54.8	30.5	32.3	48.8	23.8	26.9	5.2	10.3	35.6	33.5	16.3	28.3	35.7	36.1	29.1	23.8	41.9	16.5	22.0	44.3	31.2	27.5	18.4	34.8	22.2	21.2	12.4	21.4	18.6	17.2	30.9	18.4	22.9	25.6	39.6	42.6	47.1	27.1	36.1	6.5	14.8	12.6	41.3	17.6	4.3	15.5	7.6	31.1	27.9	9.7	13.9	20.1	45.5	29.1	6.4	6.7	16.7	59.7	23.8	16.2	28.1	18.4	29.8	30.6	19.4	37.0	35.8	6.3	6.8	7.9	29.8	18.9	27.5	29.0	54.8	46.9	32.3	50.6	28.6	30.9	30.7	31.4	61.1	25.5	20.1	28.1	38.2	30.5	48.1	42.9	31.4	48.8	16.2	25.3	6.8	32.5	30.3	18.3	51.4	14.1	45.6	37.2	17.9	8.4	18.1	20.4	13.9	5.4	3.6	45.9	5.3	7.9	38.4	9.8	79.2	6.6	86.7	2.5	28.7	74.3	70.0	86.6	103.3	20.2	33.0	20.7	13.7	66.2	3.2	18.4	23.4	47.0	3.4	18.7	37.1	11.8	129.8	30.5	12.4	99.9	40.7	24.1	21.3	8.4	19.4	15.3	6.7	8.6	27.0	80.2	24.6	36.9	43.7
ELOVL5	"dJ483K16.1, HELO1, SCA38"	ENSG00000012660	"ELOVL fatty acid elongase 5"	Q9NYP7	6	53267398-53349179	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 250.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017042, HPA047752, HPA054197"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB017042: , HPA047752: AB_2680147, HPA054197: AB_2682413"	"unprognostic (7.33e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (1.58e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (2.76e-2)"	75.7	48.7	17.9	24.2	22.0	33.9	78.8	13.3	22.1	18.2	13.9	38.3	91.2	9.7	15.7	18.0	10.8	16.5	18.0	14.6	18.3	17.5	13.5	36.8	24.4	33.6	41.1	12.3	13.1	5.7	8.1	11.6	13.6	26.4	45.2	6.7	16.1	9.4	88.4	3.6	11.4	17.3	18.0	46.4	18.5	9.5	34.8	29.1	28.7	17.6	5.6	33.6	16.6	19.4	23.8	18.1	60.7	11.3	8.4	25.3	10.4	25.3	18.5	32.5	59.3	86.2	50.1	13.8	29.6	33.3	23.9	33.6	16.4	29.4	28.8	21.5	30.7	37.6	15.0	32.0	27.1	35.9	24.2	22.5	28.4	17.3	22.8	47.4	22.4	20.8	46.2	21.3	23.9	30.1	24.2	26.5	57.5	35.4	16.8	17.2	2.7	66.5	19.9	17.5	0.9	14.2	26.0	22.3	10.0	45.0	15.2	30.3	20.8	24.5	12.8	24.8	22.1	29.2	21.0	25.1	26.3	23.4	46.8	38.9	14.1	13.0	21.9	13.7	32.6	18.6	9.0	11.3	40.7	8.8	8.1	14.2	21.6	14.7	10.6	18.1	23.8	7.2	6.7	60.7	8.4	9.6	4.8	25.3	10.4	17.9	22.0	13.3	20.2	18.3	17.5	41.1	12.3	26.4	29.1	74.5	46.1	107.2	78.7	46.5	7.7	20.2	22.9	49.5	31.8	12.2	2.0	21.5	13.3	32.0	79.1	51.7	5.1	0.0	31.8	46.1	52.2	250.9	98.0	83.9	32.1	7.9	24.0	41.1	61.4	135.1	19.2	53.0	45.5	16.2	0.6	75.7	19.7	0.6	30.1	34.2	5.2	64.7	88.4	20.7	10.4	53.2	26.1	87.3	4.3	62.0
ERLIN1	"C10orf69, Erlin-1, KE04, SPFH1, SPG62"	ENSG00000107566	"ER lipid raft associated 1"	O75477	10	100150094-100188334	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 81.4"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA011252	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA011252: AB_1853965"	"unprognostic (3.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (1.26e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.99e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.10e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.93e-1)"	12.9	8.0	5.4	6.9	10.1	23.2	13.9	6.7	6.1	11.3	18.6	5.7	7.0	13.8	11.9	6.6	17.9	11.2	6.8	6.8	6.2	3.7	12.3	81.4	8.7	10.1	7.3	3.8	13.9	17.7	5.9	8.8	24.2	4.7	9.2	13.5	8.2	9.8	5.7	5.5	10.8	18.9	7.7	4.1	9.7	12.7	17.4	5.4	8.6	11.8	10.3	14.3	14.7	14.6	6.2	12.6	18.2	16.0	7.5	9.0	7.0	23.5	23.4	12.0	21.8	28.9	28.4	24.5	37.5	34.8	31.0	35.8	15.7	27.5	10.5	15.2	34.7	25.4	24.6	10.7	22.1	43.0	6.3	9.5	9.0	10.5	19.8	12.0	31.5	10.0	16.1	13.4	27.1	32.9	29.2	22.4	10.8	8.9	6.4	32.6	9.5	8.1	11.5	8.5	15.8	9.8	6.9	19.7	7.6	13.3	9.4	4.9	7.9	21.3	6.0	13.2	14.4	15.0	26.1	25.3	31.1	23.9	18.5	39.4	5.0	8.4	14.3	27.3	49.9	15.3	4.3	16.0	18.2	8.5	11.7	7.6	6.2	6.6	7.0	12.6	5.5	6.8	9.0	11.6	7.5	8.6	2.9	3.8	7.0	5.4	10.1	6.7	6.1	6.2	3.7	7.3	3.8	4.7	5.4	0.0	8.6	8.0	9.7	14.1	4.7	3.7	2.5	34.8	12.5	14.0	5.9	17.0	0.0	8.5	15.7	14.3	24.4	23.3	9.6	54.3	14.0	10.1	8.1	68.9	12.5	3.2	12.7	11.1	15.9	10.0	14.1	7.2	10.1	10.0	23.4	5.6	8.4	17.5	7.4	10.3	5.3	0.0	6.6	35.7	16.8	17.8	20.7	5.0	23.6	11.9
ERLIN2	"C8orf2, Erlin-2, NET32, SPFH2, SPG18"	ENSG00000147475	"ER lipid raft associated 2"	O94905	8	37736599-37759101	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002025, CAB014894"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"CAB014894: , HPA002025: AB_1080077"	"unprognostic (5.82e-3)"	"unprognostic (2.45e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (3.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.67e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.78e-3)"	"prognostic favorable (6.67e-6)"	"unprognostic (4.78e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.33e-1)"	14.5	17.7	15.6	9.5	17.6	8.9	17.5	11.0	13.8	16.6	16.2	21.4	26.9	11.8	18.1	23.1	19.5	21.8	20.6	11.9	13.1	11.3	28.5	31.1	12.0	16.5	13.2	16.0	22.3	45.7	34.2	12.9	26.8	15.2	21.2	17.9	23.3	23.2	18.9	13.0	12.4	19.1	22.8	15.3	12.0	16.6	15.9	12.5	13.8	32.4	14.8	14.0	20.5	13.5	4.9	8.7	14.8	9.8	2.8	5.8	3.5	16.3	17.1	18.7	12.5	20.9	15.6	19.6	24.5	23.3	13.8	15.0	8.6	20.7	8.0	41.4	27.0	13.5	17.0	14.1	21.2	22.9	4.5	10.5	11.4	10.9	9.5	13.9	7.3	16.4	19.1	21.3	20.6	21.7	17.9	14.4	7.7	21.2	7.6	20.9	8.1	10.5	5.8	18.9	22.0	7.2	7.4	13.2	5.8	16.7	17.8	3.5	9.1	15.9	4.8	14.5	23.7	26.7	11.0	12.9	13.2	11.8	24.6	13.1	10.2	16.6	10.0	23.7	11.9	18.0	1.7	7.5	14.8	5.2	7.5	4.3	4.9	3.5	4.2	6.0	2.8	5.4	4.8	9.6	2.8	9.8	8.7	5.8	3.5	15.6	17.6	11.0	13.8	13.1	11.3	13.2	16.0	15.2	12.5	11.9	14.7	6.5	9.1	8.7	24.5	28.3	33.1	52.2	20.5	31.4	19.6	15.2	8.3	18.0	17.6	10.5	17.4	0.0	19.3	19.3	14.4	18.4	3.5	34.7	17.8	15.9	10.9	15.4	21.0	11.9	10.9	14.6	13.5	7.2	23.9	21.9	17.5	17.3	16.6	17.4	17.9	19.4	8.5	42.7	17.2	6.5	13.2	7.0	25.9	10.5
ESYT1	"FAM62A, KIAA0747, MBC2"	ENSG00000139641	"Extended synaptotagmin 1"	Q9BSJ8	12	56118250-56144671	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016858, HPA076926"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		2600000	"Endoplasmic reticulum"		"HPA016858: AB_1848404, HPA076926: AB_2686819"	"unprognostic (5.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.28e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.29e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (3.04e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.98e-2)"	49.8	25.9	10.8	17.6	11.5	7.8	40.3	14.3	16.5	22.8	25.1	15.9	13.7	8.3	33.7	16.4	21.7	24.4	21.1	15.2	10.1	11.3	17.8	27.6	21.8	20.2	11.3	10.8	28.9	25.8	24.7	8.6	19.1	28.1	25.4	18.4	15.9	18.4	24.7	23.4	15.7	18.5	36.6	9.2	23.6	19.1	19.7	12.7	24.3	17.9	18.1	23.5	27.1	22.0	11.7	15.2	70.9	13.4	13.6	29.2	26.3	22.7	16.8	13.8	34.8	20.4	15.3	11.8	25.8	28.3	30.2	21.1	15.4	25.0	8.7	20.6	43.2	11.2	25.9	16.1	25.9	27.1	12.4	11.8	52.7	13.1	12.2	28.3	41.1	83.5	17.3	27.4	32.5	18.2	32.3	25.5	8.4	32.3	58.2	26.9	16.9	14.6	24.0	17.4	9.3	22.4	22.5	19.0	22.6	25.1	19.3	11.6	12.1	38.3	11.5	17.2	16.4	24.5	27.0	33.9	23.5	21.6	13.2	18.3	13.9	20.7	12.7	21.9	17.1	24.5	63.2	6.2	70.9	23.4	12.0	29.2	11.7	24.2	23.7	15.2	9.5	19.5	22.5	1.7	13.6	13.4	5.1	23.9	26.3	10.8	11.5	14.3	16.5	10.1	11.3	11.3	10.8	28.1	12.7	8.9	9.4	28.3	15.0	14.4	4.9	7.2	10.2	2.7	10.3	29.6	9.8	25.2	0.0	30.2	1.6	24.5	2.3	0.0	22.8	13.7	14.6	18.2	61.2	28.0	40.0	0.0	24.2	27.0	18.1	1.9	16.1	21.3	33.7	60.5	11.2	5.8	24.0	0.0	23.7	4.2	5.8	51.8	24.5	3.7	2.6	10.5	31.7	34.6	9.2	13.7
FAM234B	KIAA1467	ENSG00000084444	"Family with sequence similarity 234 member B"	A2RU67	12	13044284-13142521	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 17.4;Erythroid cells: 23.3"	"Cancer enhanced"	"Detected in all"		"breast cancer: 16.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010803, HPA010850"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA010803: AB_1079200, HPA010850: AB_2732402"	"unprognostic (1.85e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.03e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.85e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.06e-3)"	"unprognostic (7.62e-2)"	4.4	3.6	9.6	2.3	17.5	3.5	21.2	21.3	28.5	3.4	1.6	4.4	4.2	2.6	3.6	4.4	2.8	4.0	2.4	1.9	10.8	12.4	7.3	3.0	3.6	2.1	9.1	16.7	3.5	3.4	4.8	5.2	7.1	13.6	8.1	1.9	3.4	3.4	5.0	2.8	15.5	2.5	3.2	5.1	2.9	1.7	6.8	5.0	0.5	10.9	0.1	2.2	3.6	2.8	6.8	4.3	1.9	6.9	2.7	4.5	1.4	2.9	3.0	9.2	6.5	7.3	7.1	7.2	2.0	2.3	4.5	8.9	3.1	4.4	12.0	2.5	2.4	7.9	4.5	11.5	2.2	9.5	1.4	6.4	7.1	3.3	2.5	3.9	6.2	4.1	5.4	4.7	6.5	5.0	6.8	5.9	8.4	1.8	4.4	4.9	9.8	5.2	4.0	12.1	2.3	1.7	6.8	12.0	1.3	2.8	7.2	12.9	4.2	4.4	2.9	3.5	16.5	3.7	3.5	3.0	3.0	5.1	5.5	2.1	2.4	3.1	7.8	9.6	2.8	3.7	0.3	2.7	1.9	2.6	4.5	3.4	4.6	2.9	2.5	2.3	6.8	4.3	4.5	0.7	2.7	6.9	4.3	2.3	1.4	9.6	17.5	21.3	28.5	10.8	12.4	9.1	16.7	13.6	5.0	3.0	3.5	0.9	1.7	0.0	11.3	0.0	2.5	0.0	0.0	17.4	2.0	5.6	1.7	1.9	7.0	0.0	0.0	23.3	1.2	2.7	1.0	3.8	0.0	2.0	3.1	3.2	11.7	4.9	1.3	2.7	5.2	0.5	0.0	2.8	0.1	3.8	1.2	0.0	4.9	1.0	2.9	0.0	0.0	8.8	10.9	0.0	3.0	0.0	0.0	1.1
FBLN1	FBLN	ENSG00000077942	"Fibulin 1"	P23142	22	45502238-45601135	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 287.9;vagina: 228.2"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 571.3;Extravillous trophoblasts: 448.0;Fibroblasts: 795.3;Syncytiotrophoblasts: 1016.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"pons and medulla: 29.1"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 5.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.9;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 157.8;ASC TERT1: 70.0;BJ: 84.6;BJ hTERT+: 134.5;HSkMC: 115.4;RT4: 121.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001612, HPA001613, CAB004393, CAB068187"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		34000000000	"Endoplasmic reticulum"		"CAB004393: AB_671972, CAB068187: AB_2665634, HPA001612: AB_1078825, HPA001613: AB_1078824"	"unprognostic (6.62e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (9.28e-4)"	"unprognostic (1.26e-3)"	"unprognostic (4.82e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.02e-10)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.64e-2)"	42.3	14.9	2.6	16.9	3.7	0.0	101.2	2.9	6.0	141.6	20.5	11.6	30.3	8.6	62.4	69.7	48.3	47.1	123.7	86.4	6.6	1.3	8.1	2.9	42.5	9.2	3.8	4.2	46.6	12.3	30.0	10.0	287.9	29.1	99.0	10.0	35.3	12.8	21.8	11.5	33.1	16.9	136.1	6.1	2.7	30.3	20.7	2.8	1.1	21.6	18.9	5.3	67.1	228.2	0.4	2.9	0.9	5.7	0.1	0.3	0.2	1.4	3.4	10.2	21.4	157.8	70.0	46.9	84.6	134.5	7.5	2.8	14.5	0.4	0.0	3.6	3.1	0.2	7.4	6.4	0.2	0.9	0.0	1.7	0.0	18.4	9.7	20.9	0.0	0.0	115.4	1.3	7.5	2.7	0.1	0.0	0.1	0.0	0.1	5.2	0.2	0.0	0.2	14.4	0.3	1.2	0.1	0.0	0.1	3.4	121.1	0.7	13.6	10.4	49.3	0.0	30.3	0.3	0.4	0.6	1.4	9.4	38.9	0.0	0.1	0.0	0.1	0.1	0.0	3.6	0.9	0.1	0.0	0.2	0.7	0.2	0.1	0.2	0.1	1.2	0.4	0.3	0.2	0.6	0.1	5.7	2.9	0.2	0.2	2.6	3.7	2.9	6.0	6.6	1.3	3.8	4.2	29.1	2.8	6.0	2.2	0.0	92.6	151.8	0.0	8.6	12.7	1.4	13.6	1.8	0.0	571.3	0.0	0.5	8.4	22.5	0.0	0.0	0.2	448.0	795.3	17.7	1.1	0.4	73.2	0.0	0.0	36.2	0.0	18.3	85.4	3.3	161.9	0.0	0.0	0.0	0.7	0.0	28.7	0.3	0.5	116.4	93.7	18.7	76.7	113.9	1016.7	0.0	0.2	69.1
FDFT1		ENSG00000079459	"Farnesyl-diphosphate farnesyltransferase 1"	P37268	8	11795573-11839309	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008874	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA008874: AB_1078844"	"unprognostic (2.33e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (4.92e-5)"	"unprognostic (1.29e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.57e-1)"	"prognostic favorable (6.59e-9)"	"unprognostic (2.28e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.06e-1)"	20.8	44.3	26.3	22.7	27.7	30.6	57.5	19.5	43.6	27.6	41.7	45.9	20.0	44.6	26.9	29.1	59.4	27.5	19.9	27.1	29.8	32.1	24.9	45.9	30.7	23.4	36.2	34.4	22.9	18.0	17.1	18.2	22.1	47.4	38.8	32.9	32.4	46.5	20.6	71.2	38.4	30.2	18.0	56.5	18.4	35.4	41.3	40.5	25.9	24.7	32.2	25.4	25.8	34.2	44.0	30.5	42.2	19.6	22.6	31.0	29.0	21.6	10.5	47.1	18.8	10.2	17.5	14.3	8.5	14.5	9.0	18.7	14.7	26.8	30.1	4.2	8.5	52.3	18.0	23.3	71.0	7.3	5.0	24.9	14.1	8.0	35.0	21.7	7.3	9.9	15.7	18.0	20.1	10.0	6.9	11.3	35.0	20.3	39.7	8.8	14.1	25.7	17.4	41.2	18.0	6.2	15.8	10.9	61.8	41.8	78.8	15.1	9.4	7.4	12.6	21.3	18.7	20.7	21.3	14.1	4.2	10.5	1.9	5.3	8.2	20.7	32.8	7.4	24.8	12.4	42.2	19.6	22.6	21.6	17.2	20.8	44.0	22.7	21.2	30.5	35.3	21.5	20.3	18.6	22.6	11.7	22.7	31.0	29.0	26.3	27.7	19.5	43.6	29.8	32.1	36.2	34.4	47.4	40.5	50.6	130.3	65.1	88.1	46.6	14.4	61.6	107.0	89.7	86.4	75.0	13.7	242.8	74.6	133.2	225.3	35.0	92.9	46.7	248.7	118.9	42.5	90.7	54.4	67.1	77.6	11.1	75.9	16.5	49.7	171.1	71.4	48.9	96.2	125.4	83.9	56.6	133.6	63.2	50.2	63.4	19.7	51.8	62.1	181.7	75.9	77.7	146.3	48.4	83.2	141.3
FGA		ENSG00000171560	"Fibrinogen alpha chain"	P02671	4	154583126-154590766	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Amyloidosis, Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	740	"liver: 2009.3"	"Cell type enriched"	"Detected in many"	40	"Hepatocytes: 16694.6"	"Cancer enriched"	"Detected in many"	43	"liver cancer: 2431.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 96.9"	"Not detected"	"Not detected"							"CAB016776, HPA051370, HPA064755"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	407000000	170000000000	"Endoplasmic reticulum"		"CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345"		"unprognostic (5.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.02e-1)"		"unprognostic (5.68e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.29e-3)"			"unprognostic (1.84e-1)"		"prognostic unfavorable (4.23e-6)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.7	2009.3	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	96.9	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.4	83.9	0.0	0.0	0.0	0.4	420.4	17.4	5.7	0.0	0.0	0.0	1.7	5.5	23.9	0.0	0.0	256.9	1.5	0.0	0.0	0.0	0.0	16694.6	0.1	0.0	0.0	255.3	257.1	29.3	0.6	0.0	0.0	0.0	0.0	0.0	31.5	0.0	1.1	1.0	0.0	0.0	0.0	14.4	0.6	0.0	0.1	4.3	0.0	0.0
FGB		ENSG00000171564	"Fibrinogen beta chain"	P02675	4	154562956-154571086	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	189	"liver: 1908.6"	"Cell type enriched"	"Detected in some"	33	"Hepatocytes: 15347.2"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 2262.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 77.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001900, HPA001901, CAB008624"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		120000000000	"Endoplasmic reticulum"		"CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-1)"			"unprognostic (2.20e-3)"	"unprognostic (1.42e-2)"			"unprognostic (1.79e-1)"		"prognostic unfavorable (5.72e-5)"	"unprognostic (2.48e-2)"	"unprognostic (7.91e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.1	1908.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	77.7	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	153.8	0.0	0.0	0.0	0.4	257.4	0.0	0.0	3.5	0.0	0.0	1.7	3.0	0.4	0.0	0.0	467.2	3.2	0.1	0.0	0.0	0.0	15347.2	0.3	0.0	1.7	349.9	342.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.0
FGFR3	"ACH, CD333, CEK2, JTK4"	ENSG00000068078	"Fibroblast growth factor receptor 3"	P22607	4	1793293-1808872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skin 1: 131.7"	"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 92.2;Cholangiocytes: 94.3;Suprabasal keratinocytes: 77.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.3;HaCaT: 15.1;Hep G2: 32.5;NTERA-2: 15.8;RT4: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004231, HPA067204"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		670000	"Endoplasmic reticulum"		"CAB004231: AB_627596, HPA067204: AB_2685804"	"unprognostic (1.34e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.97e-1)"	1.5	1.5	24.7	1.7	30.3	1.6	4.2	10.2	22.0	4.1	4.9	15.8	3.4	9.9	1.8	2.7	26.9	2.0	5.0	2.0	21.6	11.7	9.6	7.4	4.5	1.3	17.6	21.5	1.1	23.0	1.2	3.0	5.6	15.1	3.7	3.8	1.7	3.8	9.0	1.7	131.7	7.4	1.3	9.0	2.1	4.9	8.1	10.6	0.1	1.3	8.5	7.3	8.5	10.1	0.1	0.6	0.1	0.1	0.2	0.3	0.0	0.0	1.5	9.2	2.6	0.0	0.1	9.4	1.1	0.1	0.4	0.2	19.3	0.4	0.0	7.7	0.3	0.4	15.1	2.6	0.1	0.1	0.1	9.7	6.0	1.5	32.5	0.0	0.0	0.2	0.0	5.1	0.1	0.0	0.0	0.0	0.9	6.5	0.0	0.0	9.6	0.4	0.2	15.8	8.8	0.0	0.5	0.5	0.1	1.3	19.3	2.7	0.7	0.8	1.6	0.0	11.1	9.0	1.1	0.4	0.0	0.9	0.2	0.6	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.6	0.1	0.0	24.7	30.3	10.2	22.0	21.6	11.7	17.6	21.5	15.1	10.6	0.0	23.8	2.4	3.6	92.2	0.0	2.0	94.3	0.0	21.6	14.0	0.0	0.4	0.0	4.8	5.4	0.9	20.6	0.0	0.6	9.2	7.0	3.3	0.0	27.0	0.5	0.0	4.1	14.7	1.2	0.4	0.6	1.2	11.8	1.0	20.7	0.2	0.4	17.3	0.4	7.5	0.6	0.0	2.8	0.4	17.9	77.5	0.7	0.0	13.0	11.8
FGG		ENSG00000171557	"Fibrinogen gamma chain"	P02679	4	154604134-154612967	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	495	"liver: 2225.7"	"Cell type enriched"	"Detected in many"	15	"Hepatocytes: 7797.1"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 1503.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	55	"Hep G2: 128.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027529, CAB033120, HPA074638"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	267000000000	68000000000	"Endoplasmic reticulum"		"CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: "	"unprognostic (1.26e-2)"				"unprognostic (4.77e-3)"	"unprognostic (6.33e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.18e-3)"		"unprognostic (9.63e-2)"	"unprognostic (7.57e-3)"		"prognostic unfavorable (1.00e-6)"	"unprognostic (1.75e-3)"	"unprognostic (3.21e-1)"		"unprognostic (1.14e-1)"	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	2.7	2225.7	4.4	0.0	0.0	0.0	0.2	0.7	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	128.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	17.9	218.6	146.9	0.0	0.0	0.0	0.2	507.0	2.7	4.5	0.0	0.0	0.0	0.0	3.8	2.8	0.0	0.0	327.1	40.0	0.1	0.0	0.0	10.5	7797.1	0.2	0.0	0.0	232.7	240.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	266.1	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.6	0.0	0.3	20.1	0.0	0.0
FKBP7	FKBP23	ENSG00000079150	"FK506 binding protein 7"	Q9Y680	2	178463664-178478600	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 116.0;Fibroblasts: 67.2;Leydig cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 52.8;ASC TERT1: 32.8;HSkMC: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008707	Approved	Supported	Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA008707: AB_1848624"	"unprognostic (1.33e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (4.61e-6)"	"unprognostic (3.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.10e-1)"	9.6	4.6	1.5	4.3	4.1	0.7	11.1	3.5	2.3	20.5	6.9	1.0	10.0	1.8	21.4	21.9	8.4	12.4	12.8	12.1	1.5	1.5	5.5	7.4	6.8	5.2	4.0	1.8	34.6	4.3	1.5	11.1	8.2	2.9	19.5	4.2	7.1	4.9	9.7	4.4	4.0	3.9	19.9	3.9	3.0	5.3	8.3	2.2	2.2	8.7	8.0	2.3	15.5	9.9	2.8	5.8	0.2	1.6	1.2	2.8	0.8	0.0	0.6	6.1	9.0	52.8	32.8	0.5	10.9	18.1	2.0	6.4	0.1	0.6	1.7	2.4	19.9	1.8	0.1	2.3	0.9	3.5	1.4	1.3	1.7	2.5	1.7	8.1	1.1	1.3	22.0	0.5	8.0	1.1	14.7	6.5	2.1	0.8	1.1	8.4	0.1	1.9	1.9	1.2	1.1	0.9	2.5	10.7	2.3	2.7	0.2	3.2	10.6	2.3	0.0	1.8	4.5	0.1	2.1	6.0	3.7	2.3	4.3	1.0	2.1	2.2	0.8	6.8	2.7	8.0	0.0	1.1	0.1	2.3	1.6	2.8	2.8	2.0	1.6	5.8	1.7	2.2	2.4	0.2	1.2	0.0	4.5	2.2	0.8	1.5	4.1	3.5	2.3	1.5	1.5	4.0	1.8	2.9	2.2	6.0	2.6	2.2	6.7	6.3	4.6	12.6	2.5	2.7	3.4	7.0	0.0	6.2	1.7	9.1	116.0	18.6	0.1	0.0	7.4	18.5	67.2	3.6	13.9	9.8	5.3	4.8	1.2	13.5	4.3	22.0	59.2	4.8	16.9	1.8	4.8	3.7	4.0	0.0	45.6	3.5	3.3	6.5	39.2	3.7	5.5	5.1	4.2	5.0	2.6	3.4
FLT3	"CD135, FLK2, STK1"	ENSG00000122025	"Fms related tyrosine kinase 3"	P36888	13	28003274-28100592	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.9;brain: 19.3;lymphoid tissue: 15.0"	"Cell type enhanced"	"Detected in some"	25	"Kupffer cells: 29.6;Macrophages: 12.4;monocytes: 55.9"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.8"	"Region enhanced"	"Detected in many"		"cerebellum: 19.3"	"Group enriched"	"Detected in some"	11	"myeloid DC: 29.9;plasmacytoid DC: 12.1"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 29.9"	"Group enriched"	"Detected in some"	11	"REH: 28.5;THP-1: 17.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047539			Approved	"Endoplasmic reticulum"		NA	NA		180000	"Endoplasmic reticulum"		"HPA047539: AB_2680080"	"unprognostic (2.19e-3)"	"unprognostic (3.16e-3)"	"unprognostic (6.54e-3)"	"unprognostic (9.96e-2)"	"unprognostic (3.88e-1)"	"unprognostic (3.96e-7)"	"unprognostic (7.99e-3)"	"unprognostic (1.65e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.22e-1)"	0.9	0.6	0.6	7.2	1.1	7.5	2.6	19.3	3.5	0.9	1.2	0.1	0.1	0.4	0.8	0.8	1.0	1.2	4.6	0.5	0.9	1.7	2.8	0.7	2.7	15.0	1.8	1.1	0.5	5.7	0.0	0.4	0.0	7.4	0.6	1.4	0.1	2.3	0.6	0.4	1.2	3.0	1.3	4.4	8.8	0.9	1.2	0.0	8.2	0.6	0.0	5.8	2.4	0.7	0.1	29.9	1.4	1.8	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.1	0.5	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.8	1.4	0.0	0.3	0.0	0.1	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.8	0.0	12.1	0.0	1.2	0.6	1.1	19.3	3.5	0.9	1.7	1.8	1.1	7.4	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	1.3	29.6	1.6	0.0	12.4	1.7	55.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.5	0.0	0.0	0.0	0.0
FNDC3B	"DKFZp762K137, FAD104, FLJ23399, PRO4979, YVTM2421"	ENSG00000075420	"Fibronectin type III domain containing 3B"	Q53EP0	3	172039628-172401665	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 22.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007859	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA007859: AB_1078900"	"unprognostic (7.18e-2)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (6.03e-2)"	"unprognostic (6.38e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (2.17e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (9.06e-5)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (5.65e-7)"	"unprognostic (4.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.00e-2)"	39.6	22.1	4.0	16.5	5.7	18.2	27.3	2.9	5.1	20.8	18.4	4.2	20.9	7.5	28.9	21.7	13.2	12.3	18.3	18.9	4.9	4.2	17.6	35.6	23.1	10.9	6.7	2.3	26.4	30.7	12.3	21.4	64.1	5.9	15.1	11.5	13.4	27.7	19.8	22.0	8.1	13.1	17.8	6.6	17.5	15.0	10.5	5.0	4.8	21.2	10.5	12.8	25.4	25.8	0.6	2.7	22.7	5.0	2.4	2.6	1.8	12.2	14.2	9.9	12.0	31.0	21.4	24.0	17.6	19.9	11.9	16.3	7.8	27.1	1.2	47.2	26.5	23.7	7.3	3.4	14.3	21.0	7.0	2.5	1.7	9.1	21.4	31.2	15.7	27.6	21.6	7.3	22.2	21.2	28.6	31.7	2.2	2.8	8.9	12.5	3.8	0.6	6.9	5.7	4.7	5.8	1.4	10.2	5.9	13.1	10.9	0.6	3.0	16.8	8.7	14.6	14.3	8.2	8.1	45.8	16.8	7.8	21.2	13.8	18.7	20.7	2.4	17.7	9.1	16.5	7.8	5.0	11.4	2.6	3.0	1.1	0.6	0.8	1.4	2.7	0.0	0.9	1.6	22.7	2.4	1.5	0.4	0.7	1.8	4.0	5.7	2.9	5.1	4.9	4.2	6.7	2.3	5.9	5.0	80.4	43.5	12.0	47.6	56.7	7.5	43.1	50.9	13.4	35.2	43.6	11.8	35.6	13.3	62.0	7.7	56.2	22.4	0.0	39.5	90.0	84.5	54.9	15.0	60.6	44.9	0.0	16.1	62.0	65.2	5.3	53.2	61.1	65.8	50.5	28.4	16.6	73.1	40.8	51.2	30.5	12.2	51.8	50.5	2.4	2.7	29.4	29.1	19.2	20.0	74.5
FXYD5	OIT2	ENSG00000089327	"FXYD domain containing ion transport regulator 5"	Q96DB9	19	35154730-35169883	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 407.2;Kupffer cells: 403.3;Macrophages: 433.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA010817	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA010817: AB_1849214"	"unprognostic (3.97e-3)"	"unprognostic (5.49e-2)"	"unprognostic (6.37e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.39e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-3)"	"unprognostic (3.85e-1)"	"unprognostic (5.66e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.75e-2)"	"prognostic unfavorable (3.71e-9)"	"unprognostic (6.07e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.74e-1)"	58.8	10.6	6.0	47.4	9.0	72.4	66.9	2.7	7.1	44.3	15.6	14.4	10.4	8.8	33.6	25.9	31.3	26.0	28.6	29.1	7.0	7.9	13.7	13.2	39.5	110.7	12.0	7.6	18.9	8.0	3.4	11.7	56.9	11.8	27.3	14.0	19.8	19.7	16.7	17.0	22.7	27.0	18.7	18.2	80.3	20.8	10.8	9.3	33.9	16.0	26.9	97.4	36.6	59.8	73.3	91.4	66.5	76.9	99.6	109.0	94.6	98.9	23.7	0.0	0.1	35.4	44.9	23.8	56.9	75.9	40.7	30.4	6.7	29.1	22.8	15.6	68.7	14.6	23.3	14.6	35.1	26.3	28.1	9.6	42.6	13.1	0.0	27.9	24.2	42.5	26.6	15.7	29.5	51.1	24.0	38.3	6.3	39.9	110.3	25.3	0.1	2.8	10.1	7.3	92.0	13.8	13.6	5.0	28.8	14.9	0.5	4.3	0.0	31.4	16.5	33.2	13.5	8.6	19.5	54.0	50.3	19.1	54.5	4.3	0.1	1.6	5.8	76.6	56.4	76.7	66.5	73.5	13.4	60.3	76.9	56.8	73.3	102.5	62.8	91.4	66.7	68.0	55.0	18.1	99.6	74.5	41.9	109.0	94.6	6.0	9.0	2.7	7.1	7.0	7.9	12.0	7.6	11.8	9.3	3.0	14.9	263.7	53.6	95.1	0.3	2.4	22.9	1.4	7.9	94.2	0.0	9.5	0.0	153.7	1.1	336.6	0.8	0.0	176.3	377.4	156.4	26.1	356.4	4.3	407.2	0.0	10.3	249.2	403.3	2.7	6.1	433.0	199.1	27.9	5.1	0.0	365.9	7.0	0.7	2.5	0.2	64.7	75.9	1.1	7.0	60.5	42.6	318.2	5.2	88.0
FZD8		ENSG00000177283	"Frizzled class receptor 8"	Q9H461	10	35638249-35642278	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 17.9;Muller glia cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 10.8;PC-3: 27.5;U-138 MG: 10.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045025, HPA071142"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA045025: AB_10795888, HPA071142: AB_2686349"	"unprognostic (1.20e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.21e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.19e-1)"	8.9	2.6	7.4	2.7	5.1	0.7	4.9	0.5	8.5	5.2	10.4	4.9	0.6	1.8	3.4	2.2	2.1	7.9	3.9	12.5	12.0	1.7	13.1	5.0	9.5	4.3	2.7	3.8	4.9	9.5	6.0	4.0	1.8	7.1	3.4	4.6	14.2	4.5	3.5	5.8	4.6	2.6	3.6	1.4	21.3	10.4	4.1	5.5	3.3	14.7	2.4	3.0	2.8	5.4	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	2.9	0.5	0.0	1.2	0.0	1.8	3.2	0.1	0.1	0.1	0.3	0.5	0.0	0.5	1.4	3.3	1.0	0.3	1.0	0.0	0.0	8.4	0.0	0.3	0.1	0.6	0.0	0.2	1.0	4.1	6.7	2.6	10.8	2.3	0.0	0.1	0.0	0.9	1.2	0.0	0.0	2.7	0.2	27.5	2.7	1.7	0.0	5.2	0.2	8.3	0.2	0.6	0.2	0.0	4.0	0.0	0.4	5.5	10.3	1.6	5.0	8.8	0.0	0.0	0.0	5.9	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.4	5.1	0.5	8.5	12.0	1.7	2.7	3.8	7.1	5.5	17.9	3.5	0.0	0.6	0.2	0.2	8.9	2.5	1.4	0.0	0.0	2.0	0.1	0.0	2.2	0.0	4.4	5.3	0.0	2.7	0.1	1.1	0.8	0.0	3.4	0.5	0.0	1.2	9.2	0.6	0.0	1.1	0.8	0.0	0.0	2.9	31.4	2.6	0.0	2.1	3.1	1.0	6.5	2.3	0.1	1.1	1.0	0.1	0.0	3.5	0.1
G6PC3	UGRP	ENSG00000141349	"Glucose-6-phosphatase catalytic subunit 3"	Q9BUM1	17	44070735-44076344	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Gluconeogenesis	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067052			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA067052: AB_2685771"	"unprognostic (9.13e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (1.11e-4)"	"unprognostic (1.88e-3)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (9.61e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.87e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.49e-2)"	25.4	38.1	25.8	15.6	25.4	11.1	23.4	12.9	35.3	25.3	17.8	37.8	28.3	21.1	22.0	50.9	14.4	27.7	20.5	22.2	25.4	37.8	42.8	15.3	18.7	29.8	32.9	21.3	28.1	29.1	38.4	37.7	22.2	34.0	26.1	15.2	37.4	27.7	33.8	22.9	9.9	17.7	17.8	33.1	19.7	18.2	20.7	16.0	18.5	35.1	11.4	14.8	21.4	14.0	5.9	33.4	3.1	19.0	7.2	6.1	6.5	10.2	61.3	21.4	34.5	22.8	17.0	15.1	11.7	24.2	27.6	18.5	25.3	16.6	23.6	17.0	26.2	19.0	17.7	16.3	25.1	13.2	12.1	25.2	13.0	41.5	46.1	23.7	11.6	16.4	22.3	12.1	26.1	18.4	16.8	22.8	10.1	13.3	30.1	20.6	28.6	5.7	18.0	26.8	13.4	39.9	11.9	13.4	54.7	37.4	24.1	25.8	22.8	13.0	15.6	15.0	25.3	43.0	11.8	22.8	27.3	14.5	7.3	16.3	20.1	14.3	6.7	30.4	10.2	34.7	1.2	15.2	3.1	4.6	19.0	5.6	5.5	3.6	4.4	24.6	5.9	4.6	6.1	0.5	7.2	11.1	33.4	3.5	6.5	25.8	25.4	12.9	35.3	25.4	37.8	32.9	21.3	34.0	16.0	3.0	11.7	11.1	13.2	2.3	9.0	5.9	15.3	16.0	13.6	38.4	11.8	55.8	11.6	46.4	3.3	15.6	15.1	0.0	43.1	32.6	15.4	16.0	17.4	5.0	51.3	4.8	22.1	18.4	20.6	4.0	18.7	18.3	13.5	22.6	12.2	34.1	31.2	14.0	21.5	29.3	7.9	12.9	8.6	27.2	28.1	2.3	35.6	8.2	16.9	12.9
GANAB	"G2AN, GIIA, GluII, KIAA0088"	ENSG00000089597	"Glucosidase II alpha subunit"	Q14697	11	62624826-62646726	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026874, HPA061426"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		37000000	"Endoplasmic reticulum"		"HPA026874: AB_1849745, HPA061426: AB_2684516"	"unprognostic (2.12e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.65e-2)"	"prognostic unfavorable (1.27e-5)"	"unprognostic (5.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (9.54e-4)"	33.6	34.6	16.2	23.3	20.7	17.9	30.1	19.9	31.0	38.9	31.5	29.8	43.4	26.0	44.0	38.6	29.2	34.2	33.8	32.6	17.2	16.5	35.9	91.5	31.4	30.2	21.7	19.5	49.0	51.4	56.6	27.3	61.1	20.0	29.4	32.6	33.7	43.5	40.7	28.2	24.5	39.8	37.4	19.5	37.4	31.2	27.7	20.2	41.8	45.6	25.2	34.0	36.0	29.4	14.6	17.5	16.5	18.8	22.5	20.0	17.6	42.5	37.3	46.7	84.6	72.1	63.1	50.6	48.0	72.1	66.5	57.5	31.1	79.2	29.2	97.1	84.8	52.9	58.2	56.3	53.9	68.9	23.5	24.3	28.8	51.2	12.9	53.3	44.6	36.3	61.2	35.0	66.1	69.4	84.2	61.6	30.0	40.8	52.7	59.7	37.4	23.2	14.5	39.5	35.0	30.3	31.0	56.0	73.3	32.6	34.8	24.7	33.5	68.6	44.5	51.1	52.5	58.3	38.1	46.3	66.6	42.6	52.2	44.6	52.9	61.2	22.3	73.1	24.0	64.7	16.5	15.0	14.4	20.0	18.8	20.0	14.6	13.8	15.9	17.5	13.1	17.9	16.3	7.0	22.5	16.4	11.6	13.0	17.6	16.2	20.7	19.9	31.0	17.2	16.5	21.7	19.5	20.0	20.2	11.9	26.8	19.7	22.3	25.1	29.5	6.5	61.1	10.7	7.9	64.6	56.9	71.8	5.0	43.0	15.3	31.5	35.1	0.0	36.9	114.6	43.7	31.3	10.5	80.2	51.7	33.4	30.6	51.5	41.2	11.0	54.1	24.9	33.7	36.9	50.5	40.2	38.3	25.9	64.0	24.2	33.9	32.3	26.7	18.4	48.6	27.4	67.1	24.2	55.2	26.0
GDAP1L1		ENSG00000124194	"Ganglioside induced differentiation associated protein 1 like 1"	Q96MZ0	20	44247099-44280917	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 47.4"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 8.8;Early spermatids: 7.1;Horizontal cells: 14.3;Late spermatids: 21.0"	"Cancer enriched"	"Detected in single"	14	"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 9.8;SCLC-21H: 24.2;SH-SY5Y: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054182, HPA063265"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA054182: , HPA063265: AB_2684972"	"unprognostic (6.58e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.23e-4)"	"unprognostic (3.69e-1)"	"unprognostic (5.15e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.07e-1)"	"unprognostic (4.74e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.81e-5)"	"unprognostic (8.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.13e-1)"	1.1	3.9	18.9	1.3	14.9	1.2	1.1	17.8	47.4	1.2	1.2	1.4	0.0	1.0	1.5	1.1	1.1	1.2	1.1	1.3	13.1	14.3	1.1	1.0	1.0	1.0	9.1	12.2	3.0	1.8	2.4	7.1	1.0	10.6	1.1	1.1	0.9	1.0	1.1	1.1	1.5	1.3	1.2	2.6	1.0	1.9	2.8	1.6	0.0	1.1	0.0	1.0	1.1	0.0	0.1	0.0	0.7	0.1	0.5	0.8	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.6	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	11.8	0.0	0.1	1.0	0.2	0.0	3.1	0.1	0.9	0.5	0.2	0.0	0.0	0.1	0.6	0.8	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.7	0.5	0.1	0.0	0.0	0.0	18.9	14.9	17.8	25.7	13.1	14.3	9.1	12.2	10.6	1.6	0.0	0.0	0.0	0.0	0.0	8.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.3	0.0	0.0	0.0	21.0	0.6	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.4	0.0	4.1	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0
GDAP2	"dJ776P7.1, FLJ20142, MACROD3"	ENSG00000196505	"Ganglioside induced differentiation associated protein 2"	Q9NXN4	1	117863485-117929630	"Predicted intracellular proteins"			"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046185	Approved		Approved	"Endoplasmic reticulum"		Yes	No			"Endoplasmic reticulum"		"HPA046185: AB_10960897"	"unprognostic (4.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.26e-3)"	"unprognostic (2.26e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.28e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.68e-1)"	12.1	9.7	9.3	10.2	10.8	18.9	11.3	12.9	12.7	10.7	10.5	10.7	13.1	11.1	10.4	12.9	12.7	7.6	9.2	9.5	8.6	7.3	13.5	14.5	15.3	13.9	11.7	8.8	10.6	15.2	17.1	12.3	11.8	11.5	10.3	12.6	9.7	12.8	10.5	7.8	11.0	13.3	12.0	8.8	12.7	11.8	12.6	10.7	13.0	13.1	6.2	11.9	12.3	12.9	2.7	7.0	13.1	7.8	4.2	4.4	3.3	8.6	4.9	6.0	5.0	6.5	3.1	8.9	5.1	6.6	10.2	9.9	5.2	6.0	3.4	6.2	6.8	7.8	5.2	7.9	6.6	12.6	6.8	4.6	5.1	6.8	5.6	7.9	6.3	6.6	2.5	8.4	12.8	9.9	4.6	6.7	7.8	5.3	7.5	8.4	9.0	5.6	5.2	10.4	6.6	8.6	3.0	16.5	5.0	5.8	8.8	4.5	5.0	6.1	10.5	8.0	19.0	3.6	6.5	4.1	7.3	8.6	8.4	6.8	7.8	5.6	4.8	9.4	4.6	8.9	9.6	7.4	13.1	2.8	7.8	4.4	2.7	3.1	3.3	7.0	2.7	2.9	2.8	7.1	4.2	7.6	1.6	4.0	3.3	9.3	10.8	12.9	12.7	8.6	7.3	11.7	8.8	11.5	10.7	8.9	7.5	8.2	5.5	11.9	13.4	6.3	5.1	6.7	9.1	3.5	17.7	10.7	6.6	9.4	13.4	7.3	13.1	0.0	5.5	9.5	6.2	9.8	0.0	7.8	11.8	14.3	4.1	6.2	16.1	2.2	5.5	13.5	10.1	5.4	9.9	9.7	9.0	7.2	6.7	8.8	13.2	0.0	8.3	30.5	10.4	12.0	17.6	6.9	7.0	8.2
GGNBP2	"DIF-3, DIF3, FLJ21230, FLJ22561, LZK1, ZFP403, ZNF403"	ENSG00000278311	"Gametogenetin binding protein 2"	Q9H3C7	17	36544888-36589848	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018914, HPA073392"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA018914: AB_2294667, HPA073392: AB_2686599"	"unprognostic (2.68e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.41e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.95e-2)"	9.6	7.3	8.7	13.4	10.0	24.7	8.3	11.3	10.7	8.5	11.0	5.7	9.2	9.5	7.4	7.9	8.2	6.3	7.0	7.6	8.3		8.8	10.2	7.6	12.8	7.5	9.9	9.6	8.5	10.8	9.6	8.9	12.4	8.8	9.1	5.6	8.2	10.2	14.0	8.7	12.8	9.5	8.0	11.1	7.3	15.9	8.6	11.7	8.3	7.2	12.6	12.1	12.3	20.6	33.3	24.4	14.1	12.9	26.1	8.4	15.0	17.1	15.2	12.8	17.8	21.2	12.4	20.2	15.1	15.0	14.5	16.2	11.1	20.9	13.6	15.5	15.3	16.8	12.1	18.1	19.6	13.0	14.3	14.1	19.6	14.2	19.1	20.5	16.7	20.8	22.5	15.0	20.5	18.6	12.3	15.8	17.3	21.0	20.1	9.3	20.8	16.5	4.9	9.7	8.7	14.7	20.6	13.8	19.0	31.2	13.1	11.6	20.5	10.9	30.0	16.6	20.8	20.4	14.4	21.4	15.4	14.7	20.1	15.1	17.5	16.6	13.5	11.6	12.7	14.7	12.9	24.4	15.1	13.7	17.7	20.6	18.7	16.0	16.3	19.8	26.1	24.5	17.0	12.9	14.1	33.3	17.3	8.4											62.5	73.4	96.8	86.9	85.3	64.7	70.3	63.7	83.0	92.1	29.6	35.3	68.3	44.7	65.2	295.0	68.7	91.1	46.7	59.8	64.7	78.6	71.7	93.7	58.0	65.0	54.0	55.0	51.0	64.6	83.5	73.6	82.5	55.6	75.7	64.7	66.9	62.7	67.1	67.8	56.8	68.4	58.2	83.9	159.7	97.9	84.3	80.0	101.5	82.1	88.7
GIMAP1	"HIMAP1, IAN2, IMAP1, IMAP38"	ENSG00000213203	"GTPase, IMAP family member 1"	Q8WWP7	7	150716557-150724284	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 75.5;Hofbauer cells: 34.2;Ito cells: 91.4;Kupffer cells: 83.8;T-cells: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 16.9;MOLT-4: 9.7;TIME: 4.3"	"Low region specificity"	"Detected in all"							"HPA044887, HPA053441"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044887: AB_10960351, HPA053441: AB_2682152"	"unprognostic (1.60e-2)"	"unprognostic (6.58e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-3)"	"prognostic favorable (1.09e-4)"	"unprognostic (1.66e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.60e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (7.49e-2)"	"unprognostic (1.96e-1)"	18.9	3.6	3.5	11.5	4.9	1.3	10.3	1.2	4.1	8.5	4.1	2.8	3.6	4.2	12.4	5.5	6.2	5.5	5.9	7.4	3.8	2.9	5.3	4.6	11.2	23.8	4.1	2.1	2.6	3.7	1.8	2.2	8.3	4.4	6.3	3.0	5.2	3.6	2.8	6.4	3.6	8.2	4.9	4.6	28.9	3.8	2.9	3.8	6.7	7.9	5.4	12.0	4.9	11.5	0.2	5.1	1.0	11.5	14.6	27.4	11.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	16.9	2.2	0.0	0.0	0.0	0.0	9.7	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.9	11.5	0.0	17.2	10.4	20.3	0.1	18.8	21.4	5.1	0.2	27.4	22.2	1.0	14.6	10.4	0.3	11.8	11.4	3.5	4.9	1.2	4.1	3.8	2.9	4.1	2.1	4.4	3.8	3.0	1.0	6.5	0.5	4.8	0.2	4.8	2.5	0.0	1.2	0.0	0.0	0.3	0.0	0.1	0.1	75.5	0.0	0.0	0.3	0.2	1.8	0.5	8.1	1.6	34.2	0.0	0.0	91.4	83.8	0.8	1.4	15.8	8.5	2.8	0.0	0.2	0.1	0.0	0.0	0.5	0.9	0.0	3.8	0.2	0.2	2.8	0.3	81.2	0.0	0.5
GIMAP1-GIMAP5		ENSG00000281887	"GIMAP1-GIMAP5 readthrough"		7	150716668-150743646	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 37.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"monocytes: 15.5;NK-cells: 21.5;T-cells: 37.5"	"Group enriched"	"Detected in some"	8	"HUVEC TERT2: 8.4;JURKAT: 5.0;MOLT-4: 13.1;THP-1: 3.2;TIME: 6.2"									HPA053441			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA053441: AB_2682152"																		12.2	2.1	1.8	12.9	2.7	1.0	6.4	0.0	2.2	5.2	2.2	1.3	1.8	7.0	7.8	3.1	3.6	2.1	3.3	3.8	1.9		3.0	2.5	6.2	15.5	2.0	0.8	1.6	1.9	0.7	0.0	4.6	2.3	3.6	0.5	2.9	2.2	0.9	4.4	0.2	3.1	2.7	2.5	16.4	3.0	1.3	2.0	3.9	4.7	3.0	7.6	2.5	7.2	0.2	4.8	1.5	15.5	21.5	37.5	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	5.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	15.5	0.0	23.3	13.5	27.9	0.2	26.4	34.0	4.8	0.2	37.5	30.2	1.5	21.5	9.8	0.3	16.4	20.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPANK1	"ANKRD59, BAT4, D6S54E, G5, GPATCH10"	ENSG00000204438	"G-patch domain and ankyrin repeats 1"	O95872	6	31661229-31666283	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 161.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006301	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA006301: AB_1078267"	"unprognostic (2.03e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.81e-2)"	"prognostic favorable (5.89e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-1)"	8.6	8.0	8.4	9.8	9.0	8.1	11.3	9.8	11.9	8.8	17.5	12.3	4.3	5.6	10.8	10.8	9.3	14.4	8.8	14.6	7.7	6.9	11.7	10.4	11.1	12.1	9.0	6.8	20.8	10.6	1.1	11.5	13.8	9.0	10.8	9.4	11.6	13.7	8.4	16.9	12.2	11.6	7.2	8.8	12.0	9.8	26.7	10.2	40.3	13.8	9.3	10.1	10.7	10.0	3.9	4.8	11.4	3.7	4.7	5.4	2.8	3.2	3.3	1.7	5.0	8.5	6.5	4.7	3.1	4.9	3.8	4.5	0.4	5.0	10.6	5.4	3.3	3.7	4.8	0.0	8.3	2.2	5.9	5.1	11.2	0.0	3.3	5.6	3.2	3.9	2.9	3.8	10.3	7.3	6.3	3.7	10.3	2.6	9.3	3.9	2.5	10.7	3.7	0.0	4.8	1.1	3.9	6.8	6.5	5.1	2.5	13.3	7.9	4.1	1.8	4.5	5.0	4.8	8.0	3.9	6.5	6.9	0.0	0.0	5.9	8.4	3.3	7.4	7.3	4.1	10.9	3.7	11.4	5.4	3.0	5.1	2.4	4.1	3.2	3.8	3.9	5.2	4.3	10.6	4.7	3.1	4.8	5.2	2.8	8.4	9.0	9.8	11.9	7.7	6.9	9.0	6.8	9.0	10.2	35.7	20.0	26.8	20.9	22.1	26.8	33.6	25.5	16.0	18.2	17.4	33.4	24.3	38.1	26.7	27.1	28.6	27.3	0.0	20.7	31.7	23.0	23.7	33.6	28.2	24.1	11.1	26.0	22.1	26.4	38.0	31.9	22.9	18.6	47.7	22.5	36.1	20.0	26.2	23.3	53.2	41.2	19.4	35.7	161.5	75.2	29.9	39.4	34.1	25.0	17.4
GPR89A	UNQ192	ENSG00000117262	"G protein-coupled receptor 89A"	B7ZAQ6	1	145607990-145670648	"Predicted membrane proteins"	"Ion transport, Protein transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 40.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA076096			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA076096: AB_2686777"	"unprognostic (1.19e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.51e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.14e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.02e-5)"	"unprognostic (1.42e-1)"	"unprognostic (3.70e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.21e-1)"	4.0	9.3	4.3	3.8	5.4	2.2	9.2	4.6	6.9	6.2	4.7	7.0	7.5	5.4	9.0	4.5	4.1	4.7	5.9	5.9	5.2	5.1	17.5	15.3	4.8	9.6	4.9	4.0	4.2	13.6	5.9	4.2	3.5	3.9	5.5	7.5	4.9	9.0	9.9	7.6	3.3	7.0	6.1	4.7	2.9	8.7	6.7	4.0	3.3	6.6	6.5	7.0	5.2	8.8	6.2	5.5	6.3	5.1	7.6	8.3	2.8	10.4	6.9	8.4	3.7	19.6	17.7	8.2	9.8	10.8	13.9	17.7	14.5	9.0	3.1	5.4	13.4	5.7	9.1	9.0	9.9	12.8	7.6	6.2	3.9	7.8	7.9	11.1	12.1	3.1	18.7	13.8	11.7	13.1	7.0	8.5	7.4	11.2	14.9	22.2	13.4	5.0	6.3	11.0	12.4	11.1	5.5	10.0	18.4	9.4	6.0	2.6	7.8	9.1	20.6	7.4	13.7	15.4	9.4	5.0	13.2	3.4	7.9	10.5	6.0	12.8	8.7	9.5	7.5	9.9	6.3	4.2	4.0	7.1	4.7	8.3	6.2	5.2	7.2	5.5	3.0	5.2	6.1	0.3	7.6	5.1	5.4	6.1	2.8	4.3	5.4	4.6	6.9	5.2	5.1	4.9	4.0	3.9	4.0	20.8	5.1	11.8	7.8	6.8	6.5	11.1	12.7	5.3	6.8	14.0	11.8	17.5	0.0	12.8	5.5	4.7	9.2	0.0	17.6	17.8	8.8	7.2	5.7	9.0	8.2	3.2	13.1	7.4	4.0	6.8	8.9	4.5	10.1	8.2	9.4	6.9	13.3	6.6	6.7	10.2	6.2	12.9	7.6	40.7	17.9	7.4	13.5	14.1	8.9	4.7
GPR89B	"GPR89, GPR89C, SH120"	ENSG00000188092	"G protein-coupled receptor 89B"	P0CG08	1	147928393-147993521	"Predicted membrane proteins"	"Ion transport, Protein transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 23.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA076096			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA076096: AB_2686777"	"unprognostic (7.78e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.15e-4)"	4.0	5.1	4.0	4.0	4.0	2.0	5.4	5.1	5.4	6.0	4.1	4.0	4.0	6.0	4.9	4.0	4.0	3.6	4.0	4.0	4.0	4.8	20.3	9.4	4.0	4.0	4.0	4.0	4.7	5.1	4.4	4.0	4.0	4.0	4.8	3.9	4.0	4.7	4.3	5.2	5.4	7.9	4.0	5.3	4.0	4.8	7.6	4.0	4.0	4.0	4.0	4.0	4.0	4.0	8.2	9.5	9.3	8.1	10.8	12.6	7.1	7.1	1.0	7.1	7.4	8.3	9.0	10.7	8.8	7.9	10.5	11.2	10.2	11.2	13.8	8.4	7.3	8.2	10.2	10.2	7.2	8.5	12.7	11.0	8.4	7.4	4.6	14.6	10.0	5.4	8.5	10.4	6.7	13.9	3.4	9.5	9.8	6.6	11.8	6.6	16.3	11.5	5.9	13.6	17.8	10.8	10.6	11.8	21.1	13.7	6.8	4.7	5.8	19.2	6.1	8.7	13.3	11.8	10.8	3.0	7.6	3.5	11.5	10.7	19.2	16.0	8.5	9.8	7.6	5.4	6.7	7.7	9.3	11.3	6.1	12.6	7.6	12.4	12.0	9.5	8.2	11.3	10.7	4.3	10.8	8.1	7.9	9.7	7.1	4.0	4.0	5.1	4.1	4.0	4.8	4.0	4.0	4.0	4.0	6.0	4.0	6.9	5.2	0.1	3.2	5.7	0.0	6.7	6.8	5.2	2.0	12.1	0.0	6.1	3.4	3.8	7.7	0.0	6.2	11.1	5.1	3.6	6.9	6.6	3.7	0.0	4.6	3.1	1.0	3.6	5.2	2.9	0.0	3.6	6.8	2.9	5.5	7.8	3.2	20.0	3.6	0.0	5.1	23.7	9.1	0.0	13.2	11.8	5.1	3.1
HACD3	"B-ind1, HSPC121, PTPLAD1"	ENSG00000074696	"3-hydroxyacyl-CoA dehydratase 3"	Q9P035	15	65530418-65578352	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014837, HPA060347"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		27000	"Endoplasmic reticulum"		"HPA014837: AB_1855914, HPA060347: AB_2684260"	"unprognostic (1.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.57e-1)"	"prognostic favorable (3.09e-5)"	"unprognostic (3.44e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.04e-2)"	9.6	37.4	31.0	7.4	36.0	6.2	33.3	28.6	37.6	18.5	12.5	24.2	10.1	12.2	13.1	19.4	8.4	14.3	14.7	5.9	29.2	44.8	35.0	50.0	12.7	7.2	36.5	26.0	21.7	12.6	22.5	33.9	15.9	45.9	18.5	15.1	17.9	11.6	15.8	3.3	11.7	12.0	12.2	41.5	8.5	29.0	13.9	19.7	8.9	30.7	5.6	8.3	18.8	10.4	13.0	9.0	2.7	6.1	11.7	19.9	11.2	19.4	43.6	48.5	24.2	30.6	18.5	23.0	21.6	18.7	24.6	27.8	33.4	29.2	24.5	18.9	23.4	30.7	53.9	78.2	18.0	22.1	13.6	43.6	19.5	21.9	36.4	15.5	24.1	15.0	18.9	13.5	16.8	12.2	23.8	23.9	14.7	25.5	9.3	39.6	23.2	17.8	18.8	41.3	52.2	14.8	20.2	41.1	27.6	35.1	33.9	29.3	25.9	23.3	26.3	24.4	47.7	26.7	12.8	18.9	31.3	27.6	15.3	29.9	18.2	54.0	34.6	20.9	23.6	18.7	2.7	3.9	1.2	17.6	5.8	19.9	13.0	16.1	16.6	6.8	13.0	18.9	18.5	0.4	11.7	6.1	9.0	12.4	11.2	31.0	36.0	28.6	34.1	29.2	44.8	36.5	26.0	45.9	19.7	59.6	49.7	22.9	50.2	0.0	116.3	6.4	61.1	66.9	51.2	167.5	94.2	155.3	21.6	61.1	83.6	35.9	7.7	46.7	39.9	101.8	47.3	63.7	15.1	153.2	44.7	131.9	42.1	42.4	18.0	21.8	80.8	16.2	0.0	3.6	25.8	78.8	35.8	14.0	83.1	44.0	65.7	77.6	27.2	123.2	116.2	0.0	94.6	13.1	52.6	77.6
HM13	"dJ324O17.1, H13, IMP1, IMPAS, PSENL3, PSL3, SPP, SPPL1"	ENSG00000101294	"Histocompatibility minor 13"	Q8TCT9	20	31514428-31577923	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hofbauer cells: 292.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045089, HPA056062"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA045089: AB_10962054, HPA056062: AB_2683022"	"unprognostic (8.03e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.87e-3)"	"prognostic unfavorable (1.95e-5)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-2)"	"prognostic unfavorable (4.64e-12)"	"unprognostic (3.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.17e-2)"	25.2	34.3	9.2	20.1	11.1	19.8	36.4	10.2	17.5	37.9	17.0	13.2	64.7	18.1	23.3	40.7	39.2	21.4	24.1	17.9	9.3	13.0	30.2	121.3	25.5	38.7	10.8	9.8	20.8	132.3	24.4	28.6	45.9	14.5	22.4	16.3	15.4	149.6	84.3	13.1	15.0	17.8	17.9	11.0	22.0	25.3	11.7	9.0	15.5	33.5	21.5	30.5	18.1	21.4	16.7	48.2	50.1	65.3	19.4	29.8	52.6	24.8	26.3	10.6	15.6	48.3	31.1	36.5	42.6	39.9	29.1	30.0	52.1	29.9	16.1	57.4	46.4	38.5	45.5	14.9	28.6	19.1	8.1	20.1	35.5	19.1	31.2	53.8	20.2	14.3	28.4	18.7	24.6	33.7	29.4	22.5	10.6	15.6	63.9	27.0	29.4	17.3	14.6	12.2	40.8	45.0	11.0	49.9	74.9	28.1	13.3	13.9	16.9	43.5	42.0	34.4	11.0	32.6	19.3	27.3	44.3	23.6	44.6	23.9	41.3	24.5	12.7	60.4	72.9	39.1	18.4	65.3	31.8	21.7	64.0	29.8	16.7	20.5	20.9	46.0	12.6	13.8	16.2	50.1	19.4	58.6	48.2	18.1	52.6	9.2	11.1	10.2	17.5	9.3	13.0	10.8	9.8	14.5	9.0	47.6	55.6	31.3	46.0	29.8	39.1	11.5	58.6	38.8	43.3	50.6	115.8	131.4	11.6	140.0	12.3	43.8	63.3	23.3	146.7	111.1	86.5	75.1	40.5	74.0	292.9	41.3	59.0	58.3	73.4	10.6	56.1	83.9	62.4	38.7	63.2	49.7	138.8	42.7	41.1	44.1	38.7	32.3	39.1	21.7	29.0	30.9	178.6	56.7	51.9	55.3
HSD17B2	"HSD17, SDR9C2"	ENSG00000086696	"Hydroxysteroid 17-beta dehydrogenase 2"	P37059	16	82035004-82098534	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.1;liver: 52.9;placenta: 110.8"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 137.6;Enterocytes: 250.1;Hepatocytes: 98.5;Paneth cells: 199.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 22.4;Hep G2: 17.8;hTERT-HME1: 10.7;OE19: 32.8;RT4: 36.8;TIME: 20.6"	"Group enriched"	"Detected in some"	5	"midbrain: 2.6;pons and medulla: 3.5"	"Not detected"	"Not detected"			"HPA021826, HPA050235"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA021826: AB_10961148, HPA050235: AB_2681059"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.35e-2)"	"unprognostic (6.05e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.31e-4)"	"unprognostic (5.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.83e-4)"	0.7	0.1	0.2	4.1	0.2	0.0	3.9	0.2	0.3	0.7	41.3	0.3	0.2	71.3	0.6	0.2	1.7	0.2	13.3	0.2	0.2	0.2	2.8	52.9	1.0	0.2	0.2	0.2	0.2	16.0	0.0	0.6	110.8	0.4	3.1	9.4	21.3	9.4	0.2	0.3	1.8	83.1	1.5	0.2	0.2	3.2	0.2	0.2	0.2	0.2	1.1	1.3	21.4	6.6	1.3	1.4	3.6	1.1	1.0	0.7	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	22.4	0.0	0.0	4.1	0.6	0.0	4.5	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.1	0.1	17.8	0.1	0.1	0.1	0.0	1.2	0.0	10.7	0.2	0.3	0.0	0.0	0.1	3.3	0.0	0.0	0.3	0.1	32.8	8.1	0.0	0.0	0.4	0.4	36.8	0.2	0.6	0.0	1.0	0.1	0.0	0.0	0.0	20.6	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	1.6	1.1	0.6	0.7	0.5	0.4	0.6	0.4	0.4	0.3	1.3	0.4	0.6	3.6	1.0	0.6	1.4	0.3	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2	3.0	3.8	0.0	2.7	0.3	0.1	0.4	137.6	6.7	2.3	0.0	0.0	2.1	0.0	47.5	0.1	0.2	250.1	0.0	5.5	1.5	3.1	1.8	0.0	98.5	3.0	0.0	2.9	3.1	2.4	0.8	0.0	0.0	1.7	0.0	19.3	42.0	13.6	199.9	0.0	1.0	0.6	0.0	0.3	0.0	0.0	1.0	5.4	0.0	33.8	10.0
HSP90B1	"GP96, GRP94, TRA1"	ENSG00000166598	"Heat shock protein 90 beta family member 1"	P14625	12	103930107-103953645	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 325.1;thyroid gland: 338.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003901, CAB005224, HPA008424, CAB078151"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		410000000	"Endoplasmic reticulum"		"CAB005224: AB_2119181, CAB078151: AB_2665765, HPA003901: AB_1851181, HPA008424: AB_1851184"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-2)"	"unprognostic (7.22e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.03e-10)"	"unprognostic (2.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-2)"	49.0	57.1	26.9	50.0	32.0	45.9	60.3	16.5	25.5	45.7	43.4	17.5	108.5	32.1	42.2	127.2	34.3	42.0	32.4	67.0	27.1	32.0	74.0	325.1	46.6	49.2	31.5	26.0	53.9	95.5	47.1	50.0	123.6	29.4	46.9	46.9	15.8	43.8	136.8	25.4	19.2	54.4	45.0	37.8	89.3	37.0	25.7	27.9	44.5	338.5	24.0	36.9	66.1	106.1	25.6	81.0	22.2	23.8	40.2	53.3	33.9	72.0	39.1	78.9	81.0	80.8	76.3	107.1	121.5	91.9	64.7	86.4	69.7	67.6	21.1	96.6	127.5	83.5	50.4	77.7	130.5	87.4	49.8	29.6	56.7	44.1	71.9	124.7	57.1	44.4	44.7	58.2	79.7	114.4	219.3	124.5	25.7	45.3	80.2	85.5	25.9	34.3	63.9	64.9	73.3	47.1	31.3	50.9	88.1	86.6	45.5	23.4	56.2	75.8	78.5	76.6	126.8	63.8	84.9	71.6	49.0	42.0	39.8	50.6	82.1	76.8	39.0	97.7	42.3	75.8	22.2	21.2	6.9	45.6	23.8	53.3	25.6	26.7	39.3	28.0	15.9	18.0	31.3	4.9	40.2	19.3	81.0	16.4	33.9	26.9	32.0	16.5	25.5	27.1	32.0	31.5	26.0	29.4	27.9	220.3	319.5	129.9	714.2	274.9	44.0	581.2	221.7	394.9	445.9	244.3	147.3	520.4	48.0	366.6	40.3	299.0	344.0	186.9	218.9	824.3	597.0	564.5	392.9	721.4	494.0	73.1	389.8	556.8	268.7	19.1	521.5	350.1	399.9	234.4	276.1	146.4	329.7	262.6	317.5	229.3	75.2	213.4	401.9	313.5	187.6	227.8	770.3	202.8	314.4	519.2
IER3IP1		ENSG00000134049	"Immediate early response 3 interacting protein 1"	Q9Y5U9	18	47152834-47176374	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Diabetes mellitus, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 322.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA010027	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA010027: AB_1079098"	"unprognostic (6.13e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (6.47e-6)"	"unprognostic (9.86e-2)"	"unprognostic (5.13e-2)"	"prognostic favorable (8.59e-4)"	"unprognostic (6.44e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.53e-3)"	"unprognostic (8.55e-2)"	"unprognostic (2.71e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.27e-3)"	16.9	21.7	13.1	13.7	12.9	15.0	33.1	22.4	21.4	15.7	17.7	7.3	18.4	20.3	15.6	19.6	19.2	12.8	17.9	40.2	12.3	15.3	38.1	45.7	28.3	25.7	12.5	9.1	15.7	30.6	16.3	30.5	29.7	13.9	17.7	16.4	13.3	29.8	17.9	33.8	16.7	27.7	17.7	11.3	22.7	19.0	17.0	7.6	16.4	19.7	24.8	17.6	17.9	15.9	14.2	24.5	10.7	12.4	11.5	18.6	11.8	12.8	7.4	11.3	10.0	15.4	17.3	7.9	30.5	14.9	15.2	16.1	6.0	11.0	12.6	9.6	13.5	12.4	15.7	10.6	10.7	16.7	20.6	9.5	11.0	11.6	18.1	16.5	33.1	16.5	13.6	13.7	13.7	10.3	14.4	13.0	11.5	9.0	19.5	16.1	7.1	11.7	15.9	5.7	5.5	9.0	11.7	17.8	17.9	15.3	12.5	13.1	14.6	10.4	8.9	17.9	8.5	8.8	19.1	18.7	22.7	11.6	10.9	16.6	28.4	30.9	13.4	17.6	21.2	18.1	8.3	12.4	10.7	18.6	11.2	16.6	13.2	16.0	16.0	11.7	14.2	15.3	15.9	1.3	11.5	11.6	24.5	15.8	11.8	13.1	12.9	22.4	21.4	12.3	15.3	12.5	9.1	13.9	7.6	80.4	47.5	40.4	52.1	0.0	44.4	56.7	71.4	48.2	35.2	48.8	7.9	93.8	119.3	98.9	15.0	64.4	58.4	46.7	121.4	103.0	48.3	96.8	12.8	120.7	96.4	38.1	36.3	71.2	54.7	10.5	78.6	44.2	0.0	84.8	96.6	50.4	129.9	66.6	45.6	322.7	34.3	51.8	36.5	70.2	134.6	0.0	148.2	59.8	85.7	73.1
IGFBP2	IBP2	ENSG00000115457	"Insulin like growth factor binding protein 2"	P18065	2	216632828-216664436	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Growth regulation"	"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 165.3;pancreas: 228.7"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 536.0;Collecting duct cells: 251.2;Hepatocytes: 556.2;Intestinal endocrine cells: 307.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 141.7;HMC-1: 330.5;NB-4: 68.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA077723			Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	303000000	1000000000	"Endoplasmic reticulum"		"HPA077723: AB_2686853"	"unprognostic (2.58e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.32e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-3)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (2.22e-5)"	"unprognostic (5.04e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.22e-1)"	21.7	6.4	0.9	13.7	2.8	2.6	17.5	1.0	10.4	11.9	12.6	4.5	20.6	11.4	28.7	37.7	26.4	19.4	11.8	29.6	1.5	0.9	21.3	165.3	8.7	3.8	1.4	3.4	35.7	228.7	0.8	8.2	32.0	7.6	25.7	5.2	8.0	9.1	32.6	5.3	3.1	7.8	7.5	1.8	46.7	50.2	13.7	1.0	12.1	8.4	29.3	12.9	23.4	11.4	0.0	0.3	0.0	0.4	2.0	0.8	1.3	0.0	3.2	25.9	25.2	141.7	43.3	0.5	7.8	3.9	0.3	0.0	0.0	0.0	0.0	11.1	0.0	0.9	0.7	9.3	9.9	0.0	0.0	5.3	5.6	0.0	1.6	3.5	2.3	330.5	14.4	1.0	0.1	0.4	0.8	0.0	11.7	0.2	0.7	0.1	6.3	9.8	68.2	27.9	6.1	0.3	8.5	0.5	0.1	0.1	7.3	5.4	28.6	0.0	0.2	0.1	24.6	21.2	4.1	0.0	0.1	0.1	0.1	0.3	0.4	0.0	0.5	0.3	10.8	30.2	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.0	1.3	0.9	2.8	1.0	10.4	1.5	0.9	1.4	3.4	7.6	1.0	3.0	1.1	8.3	536.0	12.2	0.0	11.2	10.2	13.4	3.4	251.2	2.0	1.6	24.9	2.4	0.6	38.2	7.3	0.0	111.9	2.0	21.3	92.5	4.6	556.2	4.8	0.0	307.8	26.4	24.0	2.6	5.2	2.5	3.3	1.8	53.3	3.8	95.4	31.9	74.6	1.0	1.6	103.5	14.6	2.8	44.3	4.8	1.8	13.8	47.1	201.7
IGLL1	"14.1, CD179B, IGL5, IGLL, IGVPB"	ENSG00000128322	"Immunoglobulin lambda like polypeptide 1"	P15814	22	23573125-23580308	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	35	"blood: 11.6;bone marrow: 37.7;lymphoid tissue: 29.4;testis: 20.8"	"Group enriched"	"Detected in some"	10	"Early spermatids: 60.5;Late spermatids: 104.2;Melanocytes: 113.1"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 11.6;naive B-cell: 9.8"	"Lineage enriched"	"Detected in many"	8	"B-cells: 11.6"	"Cell line enriched"	"Detected in some"	34	"REH: 129.9"									"HPA051134, HPA071406"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		100000000000	"Endoplasmic reticulum"		"HPA051134: AB_2681356, HPA071406: AB_2686393"	"unprognostic (6.21e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.91e-6)"		"unprognostic (1.08e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.17e-3)"	"unprognostic (5.89e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-2)"	0.0	0.0	0.1	0.1	0.2	37.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	20.8	0.0	29.4	0.0	0.0	1.1	0.0	0.0	11.6	1.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.4	0.0	0.0	0.0	129.9	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.5	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	60.5	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	104.2	1.1	0.0	113.1	0.0	0.0	0.0	0.0	0.0	0.4	4.4	0.0	0.0	0.0	9.7	0.5	0.3	0.0	0.0	0.0	0.1
IKBIP	"FLJ31051, IKIP"	ENSG00000166130	"IKBKB interacting protein"	Q70UQ0	12	98613405-98645113	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 19.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 19.8"	"Cell line enhanced"	"Detected in all"		"BJ: 53.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038677, HPA038678, HPA061541"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA038677: AB_2676146, HPA038678: AB_10672723, HPA061541: AB_2684555"	"unprognostic (3.06e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (4.00e-5)"	"unprognostic (6.28e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.83e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (4.60e-9)"	"unprognostic (7.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.16e-2)"	21.0	8.9	3.7	12.2	4.6	3.6	13.6	1.1	4.0	17.0	12.3	1.7	6.0	3.3	9.5	10.2	8.5	7.3	11.0	23.6	4.0	3.7	17.0	25.3	16.1	14.0	4.2	1.7	12.8	5.8	4.1	12.6	22.1	6.3	12.2	6.1	3.6	7.6	6.7	10.0	3.2	6.2	13.3	5.2	30.6	5.3	5.8	3.8	15.2	19.8	6.2	7.8	15.1	26.2	3.3	3.7	19.8	4.3	3.7	2.4	1.1	3.2	10.1	11.6	7.2	27.9	29.5	10.1	53.6	32.9	14.2	18.1	2.2	3.2	10.8	9.2	32.9	9.9	7.0	4.5	20.5	24.1	3.2	6.9	4.1	6.5	15.2	10.7	7.6	8.2	22.1	4.4	16.3	14.7	26.0	19.9	2.0	6.2	4.3	34.9	3.0	3.4	17.6	4.4	2.6	8.8	3.0	16.7	5.4	23.4	3.7	1.7	5.6	15.3	1.1	8.5	20.3	3.3	9.5	18.6	30.3	10.8	13.3	13.7	4.6	4.9	8.1	9.0	7.0	21.8	6.0	4.3	12.6	2.1	3.3	2.4	3.3	1.3	2.1	3.7	2.2	1.4	1.5	19.8	3.7	3.7	2.6	1.6	1.1	3.7	4.6	1.1	4.0	4.0	3.7	4.2	1.7	6.3	3.8	11.9	17.8	22.0	12.9	6.8	3.2	2.6	0.0	5.3	21.6	3.5	3.9	28.7	10.0	9.6	1.6	38.4	1.1	0.0	5.0	49.4	34.3	6.4	19.7	8.9	40.4	3.2	0.0	32.5	25.0	2.5	28.4	36.1	13.5	21.6	3.8	2.3	5.8	2.9	15.9	8.5	2.5	38.8	19.1	30.8	14.0	6.4	8.5	20.8	1.7	4.6
IL18BP	IL18BPa	ENSG00000137496	"Interleukin 18 binding protein"	O95998	11	71998541-72005715	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 54.3;lymphoid tissue: 71.5"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 11.8;Hofbauer cells: 10.7;Macrophages: 11.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"CAB025980, HPA041061"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	3070000	14000000	"Endoplasmic reticulum"		"CAB025980: , HPA041061: AB_2677280"	"unprognostic (2.66e-3)"	"unprognostic (2.04e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.70e-2)"	"unprognostic (5.58e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.93e-6)"	"unprognostic (1.19e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.93e-2)"	23.7	10.6	6.5	19.7	7.7	6.0	7.2	6.2	5.7	6.3	6.7	6.7	1.0	7.1	6.1	4.1	4.1	5.8	7.2	4.7	3.8	4.1	37.0	54.3	20.8	20.2	7.0	1.9	10.1	4.9	2.8	6.4	28.4	9.0	8.9	9.8	5.3	6.4	4.0	6.2	5.1	9.2	11.4	6.1	71.5	6.1	3.0	6.3	6.1	17.3	3.6	15.6	8.6	6.2	13.6	22.3	22.2	30.5	1.9	23.4	13.9	2.0	2.7	6.2	3.6	1.3	1.9	7.0	3.4	2.0	3.3	4.5	13.2	2.6	1.2	2.7	1.7	3.8	5.1	3.7	2.8	2.6	3.0	4.4	5.2	7.0	3.7	1.4	3.0	12.6	2.9	3.2	3.0	1.6	4.5	6.4	8.1	8.9	2.3	1.8	3.4	3.8	6.5	4.5	2.4	2.5	5.8	6.4	2.1	2.2	5.5	3.3	6.4	3.8	4.3	5.0	6.6	4.3	2.8	13.8	5.4	4.2	6.2	2.1	3.7	2.2	2.5	2.3	11.0	2.6	2.3	8.5	22.2	23.4	30.5	10.5	13.6	12.4	13.8	15.5	7.0	10.4	15.0	3.6	1.9	23.7	22.3	6.1	13.9	6.5	7.7	6.2	5.7	3.8	4.1	7.0	1.9	9.0	6.3	6.0	3.5	5.7	0.4	1.8	3.1	0.8	0.0	2.7	1.2	0.0	9.8	0.7	0.0	1.9	0.0	7.9	0.7	0.0	11.8	0.9	2.3	0.9	7.0	0.5	10.7	3.2	0.0	8.0	7.2	0.0	0.9	11.1	0.0	0.0	0.7	1.6	7.3	0.0	0.7	0.7	3.0	0.0	1.2	0.5	0.4	1.8	0.7	3.2	0.6	0.1
JSRP1	"FLJ32416, JP-45"	ENSG00000167476	"Junctional sarcoplasmic reticulum protein 1"	Q96MG2	19	2252252-2269759	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"skeletal muscle: 92.0;tongue: 33.9"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 13.1;Late spermatids: 14.7;Melanocytes: 43.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"naive B-cell: 4.8"	"Lineage enriched"	"Detected in single"	6	"B-cells: 4.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 35.8;RPMI-8226: 22.4;U-266/70: 97.8;U-266/84: 11.7"	"Group enriched"	"Detected in many"	6	"amygdala: 8.6;basal ganglia: 11.5;cerebral cortex: 10.1;hippocampal formation: 4.9"					HPA044741	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044741: AB_10794295"	"unprognostic (9.41e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.64e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.87e-2)"	"unprognostic (8.64e-5)"	"unprognostic (3.63e-1)"	"unprognostic (4.43e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.71e-1)"	1.1	0.1	0.0	0.9	0.1	0.2	0.1	0.0	0.1	0.4	3.0	0.0	0.0	0.9	0.1	4.5	1.7	0.1	0.1	0.1	0.0	0.1	0.6	0.1	0.2	1.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	0.1	0.0	2.7	0.0	92.0	0.0	0.6	0.0	0.0	1.4	0.6	0.3	0.0	0.0	1.8	33.9	5.0	0.6	0.1	4.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	22.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.8	11.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.5	0.3	0.8	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.3	0.5	0.7	0.4	0.0	2.7	0.0	0.0	2.0	0.2	0.0	1.3	13.1	0.3	0.7	0.0	0.9	0.6	0.5	0.2	5.8	0.5	0.4	0.0	5.2	1.3	1.5	14.7	0.6	1.0	43.9	0.0	1.6	0.3	0.6	0.0	0.0	0.1	0.5	0.0	0.4	4.7	2.1	0.9	0.2	3.8	0.6	0.1
KCNQ2	"BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2"	ENSG00000075043	"Potassium voltage-gated channel subfamily Q member 2"	O43526	20	63400210-63472677	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 50.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 10.8;Horizontal cells: 12.7;Late spermatids: 5.7;Spermatocytes: 6.6;Spermatogonia: 17.0"	"Cancer enriched"	"Detected in some"	9	"glioma: 8.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.2;T-reg: 1.5"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"AF22: 8.5;AN3-CA: 14.0;NTERA-2: 7.8;SCLC-21H: 27.5;SH-SY5Y: 48.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016642, HPA057112"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA016642: AB_1855555, HPA057112: AB_2683339"	"unprognostic (2.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-4)"	"unprognostic (8.21e-6)"	"unprognostic (6.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.96e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.43e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.70e-2)"	1.2	10.0	18.7	1.3	21.4	1.2	1.2	24.1	50.8	1.2	1.3	2.4	0.0	1.3	1.2	1.3	1.2	1.7	1.7	1.2	15.4	10.0	1.2	1.2	1.2	1.2	8.4	14.1	1.2	1.9	1.2	9.2	1.2	8.9	2.8	1.2	0.0	1.2	1.2	1.2	1.2	1.3	1.2	2.6	1.2	1.3	6.9	4.2	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	8.5	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	3.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	27.5	48.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	1.5	0.0	18.7	21.4	24.1	31.2	15.4	10.0	8.4	14.1	8.9	4.2	0.0	0.0	0.0	0.0	0.1	1.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	12.7	0.0	0.0	0.0	5.7	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	2.1	0.0	0.0	6.6	17.0	0.0	0.0	0.0	0.0	0.0
KDELR3		ENSG00000100196	"KDEL endoplasmic reticulum protein retention receptor 3"	O43731	22	38468062-38483447	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 48.5;salivary gland: 57.2"	"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 62.1;Fibroblasts: 54.4;Mucus-secreting cells: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 58.3;BJ: 36.7;BJ hTERT+: 37.8;fHDF/TERT166: 59.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043477, HPA076405"	Uncertain		Supported	"Endoplasmic reticulum"		No	No			"Endoplasmic reticulum"		"HPA043477: AB_10962952, HPA076405: AB_2686797"	"unprognostic (1.76e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (6.05e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.07e-2)"	10.5	4.0	1.3	3.4	1.4	0.2	11.6	0.9	1.3	15.7	7.7	1.8	5.3	6.6	6.2	14.8	5.5	5.7	20.9	14.2	1.5	1.1	10.9	44.5	8.6	5.8	1.0	1.2	7.2	48.5	9.3	12.4	11.6	1.8	9.2	10.3	5.5	57.2	7.1	2.1	3.6	15.1	6.6	2.2	3.0	15.5	4.1	0.9	1.1	6.7	6.5	16.9	6.8	6.5	1.2	4.3	0.9	0.1	0.3	2.4	0.3	7.0	2.2	1.8	7.8	30.9	58.3	1.3	36.7	37.8	9.0	22.5	4.0	9.3	0.0	7.8	59.5	3.2	1.0	1.8	2.2	10.9	0.0	4.1	0.5	1.9	11.1	13.6	0.0	4.9	21.4	1.7	11.3	1.2	12.8	10.8	0.0	1.7	0.0	14.8	11.5	0.0	0.2	0.4	30.6	6.4	0.0	0.5	2.3	10.9	0.9	0.1	0.9	9.4	0.5	4.6	0.8	2.7	0.4	8.2	9.7	6.1	33.3	3.6	0.3	0.1	0.0	15.6	0.0	13.4	0.0	0.1	0.0	0.8	0.1	2.4	1.2	0.8	0.2	0.2	0.4	0.8	0.8	0.9	0.3	0.1	4.3	0.7	0.3	1.3	1.4	0.9	1.3	1.5	1.1	1.0	1.2	1.8	0.9	0.0	3.7	1.5	4.6	6.8	1.0	2.4	7.6	8.1	7.9	14.0	2.0	4.0	6.6	16.9	0.1	8.7	9.7	0.0	28.0	62.1	54.4	28.3	1.1	5.0	4.1	0.0	4.7	22.1	1.9	0.2	30.2	1.7	15.1	1.8	58.9	5.7	29.2	3.5	15.2	0.5	1.0	0.0	7.6	0.2	1.9	6.1	6.9	0.0	9.9	4.8
KIAA1324L	"EIG121L, FLJ31340"	ENSG00000164659	"KIAA1324 like"	A8MWY0	7	86876906-87059699	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 28.9"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 73.9;Early spermatids: 53.7;Horizontal cells: 31.8;Late spermatids: 70.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 5.8"	"Group enriched"	"Detected in many"	5	"B-cells: 2.7;NK-cells: 4.8;T-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"AF22: 15.4;hTERT-HME1: 17.9;HUVEC TERT2: 15.0;K-562: 23.0;SCLC-21H: 19.1;SuSa: 17.5;TIME: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044527, HPA076093"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044527: AB_10963793, HPA076093: AB_2686776"	"unprognostic (2.78e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.15e-4)"	"unprognostic (3.79e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.82e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.37e-1)"	11.1	4.5	7.7	2.3	17.3	1.0	6.5	15.6	15.8	4.0	5.0	28.9	1.2	1.8	4.3	1.0	4.5	3.9	5.0	5.5	10.8	8.7	2.9	1.5	24.4	3.8	22.4	10.4	2.7	5.5	11.7	13.5	9.0	22.7	7.6	6.5	2.4	3.6	6.3	3.5	3.4	2.7	6.4	23.5	6.4	4.1	3.6	21.7	0.0	6.1	1.0	4.0	5.9	2.8	2.7	0.9	0.4	0.0	4.8	5.8	0.7	0.9	0.0	15.4	0.0	0.2	0.0	4.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	3.8	0.3	0.1	0.0	1.6	0.0	0.0	3.7	0.3	11.8	4.1	1.3	0.1	0.1	1.5	1.2	0.0	0.0	17.9	0.1	15.0	5.8	23.0	0.4	1.7	4.7	0.3	0.0	8.4	0.0	3.8	0.0	1.0	2.4	1.6	6.8	19.1	14.3	4.1	5.4	1.7	17.5	1.6	0.3	17.6	0.2	6.0	0.1	0.0	8.5	5.0	0.1	4.5	0.0	0.2	0.0	0.0	0.4	0.7	0.0	5.8	0.9	2.1	1.3	0.4	2.7	2.2	1.2	0.0	4.8	0.0	0.9	0.7	0.7	7.7	17.3	15.6	15.8	10.8	8.7	22.4	10.4	22.7	21.7	11.9	73.9	0.0	1.4	1.0	11.6	2.0	0.0	6.7	3.4	3.5	9.8	0.4	3.3	1.3	53.7	10.0	1.7	0.0	1.0	0.4	3.1	3.6	2.3	0.0	0.3	31.8	8.1	0.6	0.8	70.4	2.3	1.6	0.0	0.0	2.7	1.1	1.0	1.9	2.1	0.7	3.2	6.5	6.2	0.7	2.1	1.4	0.1	0.7	2.6	1.4
KTN1	"CG1, KIAA0004, KNT"	ENSG00000126777	"Kinectin 1"	Q86UP2	14	55559072-55701526	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003178, CAB015331, HPA017876"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB015331: , HPA003178: AB_1079218, HPA017876: AB_1852652"	"unprognostic (7.00e-3)"	"unprognostic (2.99e-2)"	"unprognostic (8.60e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.83e-5)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.72e-2)"	"prognostic favorable (1.01e-6)"	"unprognostic (1.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	26.5	27.5	30.8	18.9	37.3	9.5	44.2	30.8	35.2	22.7	28.8	15.8	23.4	13.0	18.8	30.8	26.1	16.8	18.1	36.1	32.2	25.3	33.1	31.8	21.2	16.9	39.3	24.5	23.1	22.8	48.3	54.7	21.3	49.5	26.9	28.7	13.1	21.4	24.0	101.9	41.4	20.1	40.5	51.9	22.1	18.9	40.9	42.0	14.5	33.3	37.9	17.9	32.7	39.7	35.6	58.3	27.0	15.5	19.6	24.0	4.8	40.7	28.2	21.1	23.0	29.2	28.0	30.6	33.3	26.8	20.9	18.6	18.8	50.7	31.4	47.7	34.2	22.3	76.3	25.8	29.0	35.4	52.8	14.1	22.2	46.7	35.6	27.6	32.5	18.0	26.0	26.6	25.8	44.8	45.0	34.3	25.1	21.6	18.4	40.1	31.8	27.9	19.3	16.2	18.9	42.1	22.3	55.5	14.9	52.5	64.1	26.0	21.7	52.7	24.2	29.2	45.0	25.1	20.9	48.3	42.8	54.8	21.9	31.2	8.3	11.2	23.4	50.1	19.1	23.7	27.0	14.8	14.6	19.6	13.1	18.7	28.3	23.2	22.1	14.2	35.6	24.0	20.6	9.4	19.6	15.5	58.3	14.8	4.8	30.8	37.3	30.8	35.2	32.2	25.3	39.3	24.5	49.5	42.0	285.9	218.9	134.1	191.3	581.3	188.0	751.3	254.8	254.3	215.0	406.5	339.7	116.7	26.6	214.2	480.1	300.8	208.9	46.7	262.9	169.7	168.2	247.6	130.6	360.3	102.3	308.3	215.0	264.6	155.1	281.2	230.1	161.1	163.6	161.5	208.3	454.2	307.7	252.8	415.1	100.9	370.8	329.8	235.9	615.9	350.9	632.0	137.8	123.1	224.4	298.6
LAMA3	"BM600-150kDa, epiligrin, kalinin-165kDa, LAMNA, nicein-150kDa"	ENSG00000053747	"Laminin subunit alpha 3"	Q16787	18	23689443-23955066	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 70.8"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 107.2;Pancreatic endocrine cells: 340.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"HBEC3-KT: 154.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA009309, CAB010757"	Uncertain		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		810000	"Endoplasmic reticulum"		"CAB010757: AB_477162, HPA009309: AB_1079224"	"unprognostic (1.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.82e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavorable (3.58e-6)"	"unprognostic (1.98e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.15e-1)"	"unprognostic (9.91e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.13e-1)"	8.2	0.9	2.9	8.2	1.9	0.0	16.7	0.6	2.3	18.2	13.3	2.4	5.4	11.2	19.1	9.5	12.4	7.8	8.1	2.7	1.8	1.5	3.1	1.3	26.2	7.0	2.4	0.9	5.8	3.1	10.3	2.3	70.8	1.6	8.7	5.2	5.7	14.9	9.1	2.2	20.7	27.8	10.2	1.3	0.8	19.7	3.8	0.5	3.3	1.8	9.7	8.0	11.5	15.2	0.0	0.0	0.8	0.0	0.0	1.3	0.2	17.3	2.2	0.0	0.0	0.9	0.2	0.0	0.3	0.2	0.1	0.2	0.7	20.1	0.0	2.3	0.2	0.0	31.7	0.0	154.2	0.1	0.0	1.2	0.0	0.6	0.3	0.1	0.0	0.0	0.2	17.3	0.1	18.3	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	5.4	2.0	0.3	0.0	0.0	6.8	2.0	0.0	0.3	0.7	0.3	0.0	0.0	0.6	0.2	1.6	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	2.9	1.9	0.6	2.3	1.8	1.5	2.4	0.9	1.6	0.5	107.2	23.7	0.5	53.6	27.8	3.8	2.0	5.1	13.4	23.9	1.8	0.0	0.1	0.0	30.0	3.7	2.8	50.4	0.0	30.6	0.2	2.0	16.7	5.7	0.8	0.2	0.0	7.9	1.8	0.0	2.8	5.5	1.1	1.7	1.0	11.0	0.0	340.7	31.6	3.2	0.0	1.9	6.5	19.6	3.1	1.9	8.7	0.1	0.7	6.6	15.4
LCN2	"24p3, NGAL"	ENSG00000148346	"Lipocalin 2"	P80188	9	128149071-128153455	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Apoptosis, Immunity, Innate immunity, Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 199.7;gallbladder: 173.3;lymphoid tissue: 178.1;salivary gland: 168.7"	"Cell type enhanced"	"Detected in many"	16	"Ductal cells: 4866.3;Exocrine glandular cells: 1633.7;Pancreatic endocrine cells: 4295.8;Urothelial cells: 1384.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"basophil: 5.4;neutrophil: 11.4;non-classical monocyte: 4.5"	"Group enriched"	"Detected in many"	72	"granulocytes: 11.4;monocytes: 4.5"	"Group enriched"	"Detected in some"	11	"CAPAN-2: 277.6;EFO-21: 113.7"									"HPA002695, CAB016549, CAB016550"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA	297000000	870000000	"Endoplasmic reticulum"		"CAB016549: , CAB016550: , HPA002695: AB_1852758"	"prognostic favorable (9.61e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.11e-2)"	0.3	0.5	0.2	24.6	0.3	199.7	2.7	0.2	0.5	78.7	19.4	1.0	0.5	2.4	7.9	9.1	77.0	4.0	173.3	20.4	0.2	0.2	12.7	12.8	32.6	0.2	0.2	0.1	6.7	17.4	0.0	5.4	7.1	0.8	17.0	10.5	1.0	168.7	0.9	1.0	3.1	17.0	0.7	0.2	8.1	35.1	5.8	0.1	5.0	3.8	142.0	178.1	68.9	48.5	0.0	0.0	11.4	4.5	0.0	0.1	9.6	8.7	2.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	277.6	0.0	113.7	0.0	0.2	18.1	0.0	0.5	0.0	0.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	5.1	0.0	0.0	0.6	0.1	0.0	0.2	1.2	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	4.5	0.0	0.0	9.6	0.2	0.3	0.2	0.5	0.2	0.2	0.2	0.1	0.8	0.1	0.0	17.3	2.4	352.2	0.2	0.0	0.2	932.5	180.7	184.2	130.9	0.0	0.3	0.0	4866.3	1.9	0.1	78.8	23.3	1633.7	0.3	0.2	349.2	13.8	18.3	0.5	0.0	55.6	2.5	0.6	10.5	3.1	0.6	0.0	103.6	135.4	0.0	4295.8	131.2	0.0	0.7	0.0	0.0	3.1	0.0	0.2	0.0	0.2	0.7	262.6	1384.7
LOX		ENSG00000113083	"Lysyl oxidase"	P28300	5	122063195-122078360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		Oxidoreductase	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 34.9;Fibroblasts: 69.8;Peritubular cells: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 105.1;fHDF/TERT166: 160.3;HSkMC: 39.1;hTERT-RPE1: 42.3;U-138 MG: 53.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043930			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		290000	"Endoplasmic reticulum"		"HPA043930: AB_2678736"	"unprognostic (5.10e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-3)"	"unprognostic (8.92e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (3.93e-8)"	"unprognostic (1.11e-3)"	"unprognostic (9.92e-2)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (3.32e-4)"	33.8	1.8	1.0	7.2	1.2	0.0	37.4	0.9	0.9	16.1	11.7	0.1	4.1	3.8	6.3	20.1	11.1	7.6	12.8	21.4	1.2	1.3	6.5	2.4	20.6	4.3	0.9	1.1	15.7	6.0	0.8	1.5	14.8	1.6	11.2	3.0	3.2	3.4	3.5	12.7	11.3	4.5	9.5	1.5	7.7	4.0	10.6	0.1	0.7	10.8	4.2	2.7	36.9	10.4	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.1	0.0	0.3	0.1	18.3	21.6	0.0	105.1	22.1	8.1	28.7	0.1	0.0	0.0	2.5	160.3	0.4	0.0	0.4	0.2	17.4	0.0	0.3	0.0	2.1	0.8	23.1	0.0	0.0	39.1	0.4	13.5	0.6	42.3	10.1	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.8	0.0	0.4	0.0	0.0	0.5	7.4	0.0	0.7	3.4	0.0	0.0	0.8	53.3	3.6	31.5	1.4	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	1.0	1.2	0.9	0.9	1.2	1.3	0.9	1.1	1.6	0.1	8.9	0.6	0.0	1.6	6.9	0.6	1.2	0.0	4.0	1.2	0.0	0.0	0.7	0.0	7.1	34.9	3.3	0.0	0.0	0.5	17.3	69.8	1.8	0.0	0.4	1.9	1.6	0.0	14.1	1.5	2.4	13.0	0.3	5.0	1.0	0.0	0.0	1.4	0.0	36.7	0.0	1.1	19.4	8.2	0.5	0.0	9.4	4.0	0.0	0.0	0.7
LOXL1	"LOL, LOXL"	ENSG00000129038	"Lysyl oxidase like 1"	Q08397	15	73925989-73952137	"Disease related genes, Plasma proteins, Predicted secreted proteins"		Oxidoreductase	Glaucoma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 84.0;Extravillous trophoblasts: 135.9;Fibroblasts: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 6.5"	"Lineage enriched"	"Detected in single"	45	"T-cells: 6.5"	"Cell line enhanced"	"Detected in many"		"BJ: 23.4;BJ hTERT+: 26.8;hTERT-RPE1: 26.7;U-87 MG: 22.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA042111, HPA063583"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	No	No		120000	"Endoplasmic reticulum"		"HPA042111: AB_10794412, HPA063583: AB_2685050"	"unprognostic (6.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (7.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.76e-2)"	9.4	2.5	2.4	6.7	1.2	0.9	5.0	0.4	1.8	19.3	7.0	1.6	7.0	2.3	12.3	8.4	9.9	6.9	12.4	19.1	2.4	1.6	7.9	1.3	7.0	13.6	1.3	1.6	9.6	3.0	3.8	7.4	16.1	4.4	14.8	1.7	26.7	5.7	15.5	4.2	4.7	5.3	26.6	2.1	2.8	6.5	3.7	1.3	1.2	3.9	10.5	10.4	16.9	11.7	0.1	0.0	0.0	0.0	0.0	6.5	0.6	1.1	0.0	0.3	0.0	16.7	20.3	0.7	23.4	26.8	9.9	17.6	0.4	0.6	0.0	4.3	17.2	2.5	6.9	0.1	0.0	2.4	0.0	1.5	0.0	0.7	0.1	2.3	0.0	0.0	16.5	0.0	7.4	0.0	26.7	0.3	0.4	0.0	0.1	11.8	0.8	0.1	0.4	2.2	1.5	16.0	0.0	13.8	0.2	0.9	4.1	1.9	0.0	0.7	0.1	0.0	2.4	0.1	0.0	1.7	19.5	17.3	15.3	8.9	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.9	0.1	2.9	1.5	0.0	0.1	0.7	0.8	0.0	0.0	0.0	0.0	6.5	0.6	2.4	1.2	0.4	1.8	2.4	1.6	1.3	1.6	4.4	1.3	0.0	1.1	0.0	5.2	5.3	0.4	84.0	0.0	0.0	0.0	8.7	0.0	1.8	3.3	2.5	1.2	2.9	0.0	0.0	1.2	135.9	59.0	2.9	1.1	0.0	5.6	0.0	3.4	19.0	0.0	1.0	9.2	0.0	10.1	0.0	0.1	5.2	8.2	0.0	19.8	1.4	0.2	0.0	20.5	2.6	1.9	3.0	4.2	0.0	0.9	3.1
LRPAP1	"A2MRAP, HBP44, RAP"	ENSG00000163956	"LDL receptor related protein associated protein 1"	P30533	4	3506376-3532559	"Disease related genes, Predicted intracellular proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 500.6;Syncytiotrophoblasts: 580.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008001, CAB025518"	Enhanced	Supported	Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"CAB025518: , HPA008001: AB_1853292"	"unprognostic (3.20e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.89e-3)"	"unprognostic (8.58e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (4.67e-11)"	"unprognostic (6.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.61e-2)"	9.4	11.3	13.7	8.7	34.4	17.4	8.5	11.4	22.1	10.1	9.3	9.1	15.5	10.6	11.1	16.7	7.2	10.5	11.2	28.1	11.6	13.1	17.7	16.5	10.8	9.9	10.6	14.5	13.2	28.8	20.0	18.1	35.2	9.9	11.2	7.6	11.5	23.0	18.9	12.5	10.9	10.3	8.4	7.2	10.9	10.7	10.9	12.0	4.8	11.6	6.9	6.5	8.6	8.0	6.2	8.8	37.7	15.9	7.3	7.1	15.1	4.3	9.1	6.6	9.6	9.3	4.9	14.2	7.1	8.1	6.4	5.2	17.9	8.7	2.3	7.5	6.8	8.8	7.0	4.2	7.6	3.8	1.8	9.9	3.2	9.1	11.8	5.8	5.3	15.3	6.2	5.9	5.1	2.8	6.1	7.9	4.5	5.8	8.9	5.6	7.0	3.4	20.3	5.5	6.5	9.5	4.6	5.1	8.5	7.0	9.9	6.0	5.3	8.7	3.6	9.2	4.4	7.8	9.8	6.4	6.2	5.8	4.8	9.2	5.0	3.3	3.2	7.4	15.7	8.4	11.2	15.9	37.7	6.5	12.5	5.6	6.2	6.0	6.1	8.8	5.9	6.7	6.1	13.3	7.3	11.4	6.6	7.1	15.1	13.7	34.4	11.4	22.1	11.6	13.1	10.6	14.5	9.9	12.0	101.3	71.8	70.1	148.3	60.2	64.5	138.2	94.3	111.1	83.0	184.9	43.2	500.6	43.1	137.9	29.8	84.7	141.2	0.0	93.8	144.8	164.2	115.9	79.6	88.4	225.9	36.5	79.3	47.9	91.5	43.0	116.8	129.5	140.0	128.0	72.2	127.1	91.5	101.7	142.5	235.8	70.5	77.6	128.1	198.2	166.9	53.6	580.0	69.2	81.2	127.8
LRRC59	"FLJ21675, PRO1855"	ENSG00000108829	"Leucine rich repeat containing 59"	Q96AG4	17	50375059-50397553	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030827, HPA030829"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		5400000	"Endoplasmic reticulum"		"HPA030827: AB_10602704, HPA030829: AB_10670045"	"unprognostic (4.73e-2)"	"unprognostic (2.15e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (5.63e-3)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (1.00e-5)"	"prognostic unfavorable (3.12e-6)"	"unprognostic (1.88e-3)"	"unprognostic (9.95e-2)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (3.68e-2)"	"prognostic unfavorable (1.19e-6)"	"unprognostic (2.77e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.39e-3)"	"prognostic unfavorable (1.90e-5)"	20.7	40.5	10.6	21.8	14.5	28.4	16.3	11.5	21.6	28.2	30.0	11.4	28.8	19.6	17.2	24.9	23.5	15.8	22.8	17.4	10.2	8.8	22.1	74.7	23.0	15.9	12.7	11.5	15.8	87.9	15.4	11.6	35.3	10.8	17.7	31.5	10.0	48.6	26.2	16.0	11.2	27.3	22.0	8.9	19.0	30.7	18.2	10.4	18.0	22.8	22.4	20.8	13.7	17.0	8.6	14.9	14.4	19.6	5.9	9.1	9.0	62.1	47.4	13.6	20.5	23.2	27.4	24.5	51.0	28.5	47.8	42.3	108.3	18.0	27.2	35.0	58.0	29.4	22.7	33.9	43.5	57.1	14.4	49.4	47.6	26.9	57.9	48.7	46.7	22.6	24.1	35.4	51.1	59.6	13.9	35.2	15.8	44.0	25.9	31.3	42.3	32.9	22.2	15.4	58.8	69.5	28.2	43.9	52.0	26.0	31.7	33.5	27.8	17.6	19.8	25.9	21.2	33.4	25.4	37.5	55.5	23.0	51.1	66.3	39.0	31.9	35.2	37.6	31.8	34.8	14.4	15.7	13.4	7.4	19.6	9.1	8.6	7.5	8.9	14.9	6.4	5.0	6.3	8.0	5.9	18.6	12.1	7.5	9.0	10.6	14.5	11.5	21.6	10.2	8.8	12.7	11.5	10.8	10.4	20.8	21.3	38.0	75.9	123.9	20.8	4.0	38.2	14.7	35.2	19.2	2.0	78.1	24.9	166.2	37.0	22.6	79.6	23.3	164.5	210.3	84.3	117.1	30.0	58.2	94.9	20.6	36.8	25.8	26.9	12.2	32.8	46.2	62.4	46.9	93.0	24.6	158.0	71.6	27.3	38.3	11.1	12.9	67.0	41.7	28.5	115.9	197.4	27.7	82.6	133.9
LRRN2	"FIGLER7, GAC1, LRANK1, LRRN5"	ENSG00000170382	"Leucine rich repeat neuronal 2"	O75325	1	204617170-204685733	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.3"	"Cell type enriched"	"Detected in some"	5	"Horizontal cells: 49.3"	"Group enriched"	"Detected in many"	6	"breast cancer: 6.1;endometrial cancer: 10.6;glioma: 16.8;ovarian cancer: 18.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 7.1;NTERA-2: 14.3;RPMI-8226: 22.2;SuSa: 8.2;T-47d: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029124	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029124: AB_10601545"	"unprognostic (2.16e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.59e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.59e-3)"	4.9	6.6	11.8	3.7	16.5	2.4	3.3	9.7	20.3	1.9	7.9	5.3	1.0	1.9	3.9	0.8	2.4	10.2	6.1	6.0	11.7	12.8	7.3	0.7	2.5	2.9	6.3	13.8	3.3	1.4	19.1	9.7	1.3	8.1	1.6	7.5	12.2	2.8	3.7	2.2	0.7	3.3	9.9	3.1	6.3	1.4	3.8	6.1	3.2	2.8	0.0	1.3	2.1	1.5	0.4	0.1	1.7	0.3	0.7	0.8	0.2	0.0	3.3	2.7	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	7.1	0.5	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.7	1.1	0.0	14.3	0.0	0.1	0.2	0.0	22.2	0.0	0.1	1.9	0.3	4.4	0.1	0.0	8.2	7.9	0.0	0.0	0.0	3.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.2	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.4	0.1	0.2	0.7	0.7	0.0	0.1	0.8	0.2	11.8	16.5	9.7	15.7	11.7	12.8	6.3	13.8	8.1	6.1	0.0	0.0	0.0	0.5	0.3	4.6	1.0	0.0	0.0	0.0	1.8	2.0	0.1	0.0	2.7	0.0	0.7	1.7	0.0	0.8	0.1	1.1	0.3	0.0	0.0	5.3	49.3	10.9	4.9	0.0	0.0	0.0	0.0	0.0	0.0	1.9	3.9	3.3	0.3	0.0	2.7	0.9	0.0	0.4	0.0	0.2	0.1	0.3	0.0	0.7	0.3
MANF	"ARMET, ARP"	ENSG00000145050	"Mesencephalic astrocyte derived neurotrophic factor"		3	51385047-51389397	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 383.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 32.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011175	Approved		Supported	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA			"Endoplasmic reticulum"		"HPA011175: AB_1845039"	"unprognostic (2.90e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.84e-2)"	"prognostic unfavorable (9.58e-6)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.10e-2)"	13.2	14.6	11.6	18.9	16.8	8.3	19.8	6.7	12.4	20.7	16.1	5.2	47.4	11.6	15.1	52.8	19.9	14.0	16.1	23.4	9.7	9.8	22.2	65.6	16.9	15.9	12.9	5.7	11.5	64.2	6.5	23.4	23.3	20.9	16.1	16.8	5.1	64.7	37.9	7.8	13.1	11.9	14.3	8.8	21.7	16.4	14.3	12.5	12.7	64.4	20.7	21.4	14.0	37.2	5.4	32.7	19.2	4.8	7.4	11.2	4.9	18.5	9.3	24.9	30.7	17.2	22.4	26.6	29.9	24.7	30.5	29.3	14.4	43.5	40.7	25.0	18.5	70.4	11.1	30.9	30.8	29.8	18.7	15.6	32.7	14.0	33.1	56.3	15.6	21.0	9.6	26.0	31.6	42.5	29.4	39.3	16.9	7.0	44.6	28.2	11.3	25.9	31.2	21.6	44.2	40.4	11.2	16.0	41.8	25.6	12.4	9.4	30.4	25.1	15.1	18.1	28.6	12.1	21.0	18.4	17.3	17.0	21.0	32.8	36.2	14.7	26.3	30.3	31.2	33.5	19.2	4.8	2.7	8.9	3.8	11.2	5.4	6.5	8.5	4.7	3.5	4.9	5.1	2.4	7.4	2.4	32.7	3.9	4.9	11.6	16.8	6.7	12.4	9.7	9.8	12.9	5.7	20.9	12.5	29.8	19.2	79.0	180.0	144.9	12.1	43.7	68.8	24.1	18.2	52.4	5.9	166.0	36.5	141.5	75.3	67.4	57.1	0.0	109.7	259.3	107.8	169.1	63.3	130.9	163.5	11.1	111.7	81.0	38.0	80.4	55.5	75.0	172.1	98.2	64.3	32.2	172.7	66.6	48.4	54.7	15.7	64.7	82.0	145.8	74.5	140.4	383.9	60.7	57.1	181.4
MARCH6	"MARCH-VI, RNF176, TEB4"	ENSG00000145495	"Membrane associated ring-CH-type finger 6"	O60337	5	10353703-10440388	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040841, HPA063246"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA040841: AB_2677162, HPA063246: AB_2684970"	"unprognostic (3.31e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.80e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.06e-2)"	"unprognostic (9.52e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.94e-2)"	"unprognostic (5.58e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.57e-1)"	"unprognostic (8.50e-3)"	22.5	25.6	28.6	21.2	25.5	57.0	62.4	42.0	53.8	21.4	23.0	24.0	18.3	28.6	24.7	24.2	22.8	25.1	22.0	35.5	27.6	23.7	31.9	28.9	35.0	33.2	29.8	39.1	34.0	41.5	56.0	27.4	20.3	33.4	21.4	18.4	20.3	28.0	23.4	49.8	23.9	32.1	27.4	38.6	31.2	26.0	25.6	26.9	18.0	26.8	17.1	20.3	24.6	36.4	13.4	7.3	15.6	12.1	9.9	15.7	9.4	12.6	19.0	31.9	24.7	18.3	14.7	26.1	20.1	18.7	17.3	22.2	18.1	33.9	13.3	30.6	18.7	24.0	17.6	16.9	13.0	23.5	28.2	15.4	17.3	63.2	12.3	12.9	20.5	19.5	17.1	14.4	17.3	19.0	17.9	16.0	14.4	20.7	30.1	15.7	14.4	11.1	15.9	11.6	10.2	13.4	17.3	13.3	19.2	13.5	24.6	13.7	19.9	37.3	20.4	13.1	15.4	17.0	11.1	15.4	21.0	20.5	10.3	14.9	21.1	30.3	19.0	15.5	14.3	14.9	15.6	8.5	13.6	13.5	9.6	15.4	13.4	13.4	13.4	7.3	11.5	15.7	14.6	13.7	9.9	12.1	5.6	11.7	9.4	28.6	25.5	42.0	53.8	27.6	23.7	29.8	39.1	33.4	26.9	50.6	44.3	66.5	0.0	124.9	104.6	89.0	53.5	62.9	56.9	68.0	62.8	47.1	18.3	0.0	9.4	58.6	66.9	93.5	0.0	24.4	54.5	0.0	48.5	71.6	32.5	128.7	95.5	58.9	54.8	10.0	64.5	39.1	89.4	0.0	73.5	52.7	0.0	56.1	72.2	52.5	79.3	77.6	80.4	84.4	67.3	119.4	68.0	58.0	58.3	0.0
MFAP4		ENSG00000166482	"Microfibril associated protein 4"	P55083	17	19383442-19387240	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Fibroblasts: 593.8;Peritubular cells: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"eosinophil: 2.3;intermediate monocyte: 4.0;non-classical monocyte: 4.2"	"Group enriched"	"Detected in many"	15	"granulocytes: 2.3;monocytes: 4.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 60.2;ASC TERT1: 91.9;fHDF/TERT166: 41.1;HHSteC: 42.1;HSkMC: 63.7;MOLT-4: 52.6;SH-SY5Y: 52.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA054097	Supported		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		140000000	"Endoplasmic reticulum"		"HPA054097: AB_2682378"	"unprognostic (3.02e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.80e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.83e-7)"	"unprognostic (1.07e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (7.12e-4)"	41.5	10.0	1.3	37.3	4.1	0.0	34.9	1.3	3.7	62.5	44.8	5.1	18.1	12.1	64.3	58.7	64.2	32.2	150.2	46.9	1.8	1.3	15.9	12.0	106.1	10.7	2.4	5.8	57.6	8.5	0.0	15.8	43.3	6.8	102.4	17.2	102.5	16.3	16.6	18.7	25.9	43.8	88.9	3.2	7.6	31.4	26.2	1.3	8.4	20.3	55.3	39.0	79.2	73.7	0.0	0.2	2.3	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	60.2	91.9	0.1	6.5	23.5	0.6	0.4	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	42.1	2.0	0.0	63.7	0.0	0.3	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	52.6	4.8	1.0	0.0	0.0	3.7	3.7	0.0	0.0	0.0	5.3	52.5	0.0	0.0	0.0	0.3	0.0	11.8	0.0	7.6	0.5	0.3	0.0	0.0	0.0	0.0	7.3	2.2	0.0	0.0	0.3	2.3	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	1.3	4.1	1.3	3.7	1.8	1.3	2.4	5.8	6.8	1.3	3.0	15.5	0.0	0.5	42.2	0.7	9.5	0.0	5.3	5.7	1.8	0.0	5.9	0.0	0.0	0.3	4.4	0.0	0.0	0.0	3.1	593.8	1.2	1.1	0.0	8.2	0.0	0.0	19.0	0.0	2.0	72.5	2.4	64.1	0.0	0.0	71.0	0.1	0.0	225.6	0.0	2.9	19.4	95.8	0.2	0.5	35.9	16.2	0.0	0.0	0.4
MMRN1	"ECM, EMILIN4, GPIa*, MMRN"	ENSG00000138722	"Multimerin 1"	Q13201	4	89879532-89954629	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Endothelial cells: 46.9;Ito cells: 114.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"NK-cell: 9.3;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.4;NK-cells: 9.3"	"Cell line enriched"	"Detected in some"	13	"HUVEC TERT2: 168.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035769	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		300000000	"Endoplasmic reticulum"		"HPA035769: AB_10696511"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.77e-4)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.23e-2)"	13.9	1.9	1.4	5.3	1.4	0.5	14.8	0.7	1.3	22.8	14.9	0.1	9.0	2.6	9.2	12.2	17.4	18.1	11.5	4.9	1.6	1.3	3.3	9.5	22.4	30.7	2.6	0.0	10.2	2.2	0.1	1.3	38.1	2.7	10.0	8.1	3.7	3.3	2.4	6.8	6.5	10.1	14.2	3.4	1.6	5.3	16.7	2.1	2.3	43.1	7.0	3.7	19.6	30.4	0.8	3.4	0.1	0.0	9.3	0.3	1.7	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	168.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.8	0.3	0.0	0.1	9.3	0.0	3.4	0.3	1.7	1.4	1.4	0.7	1.3	1.6	1.3	2.6	0.0	2.7	2.1	0.0	11.8	6.1	0.1	3.8	0.0	2.0	0.0	2.7	1.2	0.0	0.0	0.0	1.7	0.0	11.8	46.9	0.0	0.0	0.0	0.0	1.5	0.1	2.3	0.8	0.4	0.0	0.0	114.2	6.3	3.2	0.3	2.5	1.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	1.4	1.7	0.0	4.0	0.0	0.0	0.0	0.1
MOGS	"CWH41, DER7, GCS1"	ENSG00000115275	"Mannosyl-oligosaccharide glucosidase"	Q13724	2	74461057-74465410	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	10	"Late spermatids: 186.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011322, HPA011969"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		88000000	"Endoplasmic reticulum"		"HPA011322: AB_2668483, HPA011969: AB_1849579"	"unprognostic (5.66e-2)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.91e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (2.34e-6)"	"unprognostic (1.48e-2)"	"unprognostic (2.66e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.36e-1)"	"prognostic unfavorable (2.79e-8)"	"unprognostic (1.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.59e-3)"	15.8	12.8	8.7	15.2	10.6	8.5	13.1	11.3	12.1	13.9	19.4	10.8	24.9	36.5	14.2	15.8	15.5	13.4	16.4	11.2	7.7	6.1	14.8	40.5	17.2	15.6	9.2	7.9	14.2	30.6	20.4	15.7	35.8	8.3	15.9	11.2	11.7	24.5	25.3	14.1	17.4	35.8	9.8	7.1	22.4	22.3	11.9	8.1	17.6	18.9	11.4	19.5	14.1	12.9	3.9	3.4	2.3	4.4	12.7	5.1	2.5	22.2	19.8	13.1	12.6	27.1	19.2	40.3	18.2	26.5	27.7	26.7	36.2	23.8	24.1	16.3	18.4	20.8	22.4	19.8	20.6	17.2	20.8	19.2	11.3	12.8	27.7	22.4	26.4	22.7	11.2	33.0	19.6	19.2	30.9	31.0	14.3	19.6	23.4	12.2	27.7	14.3	20.3	17.3	28.2	11.0	16.4	29.3	31.2	15.1	13.8	10.8	14.2	8.7	36.3	23.7	13.0	17.5	14.2	22.1	12.8	22.3	18.5	24.1	36.2	14.9	10.7	20.1	21.6	17.3	2.3	4.0	1.1	5.0	2.5	5.1	2.5	4.2	4.5	3.4	3.9	3.7	2.4	0.7	12.7	4.4	3.2	3.8	2.5	8.7	10.6	11.3	12.1	7.7	6.1	9.2	7.9	8.3	8.1	6.0	15.7	9.0	17.4	14.1	14.2	5.8	15.3	9.4	12.5	22.7	17.7	32.9	5.0	19.7	52.1	10.9	21.0	23.3	22.8	34.8	8.7	19.5	4.6	22.1	17.5	6.4	13.4	17.8	7.9	186.6	14.1	16.0	10.1	27.1	24.4	8.3	19.0	20.3	6.7	8.4	12.7	12.9	7.6	8.6	3.2	15.2	43.5	14.0	17.9	17.3
MOK	"RAGE, RAGE1, STK30"	ENSG00000080823	"MOK protein kinase"	Q9UQ07	14	102224500-102305200	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"testis: 45.0"	"Cell type enhanced"	"Detected in many"	13	"Ciliated cells: 214.2;Cone photoreceptor cells: 174.7;Early spermatids: 171.0;Rod photoreceptor cells: 441.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 10.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 28.6;hTEC/SVTERT24-B: 72.8;NB-4: 90.6;U-138 MG: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA027292			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA027292: AB_10600989"	"unprognostic (8.16e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.68e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.49e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.48e-1)"	5.9	6.8	12.9	2.7	17.3	3.7	7.8	9.7	15.9	7.6	3.6	8.7	6.2	4.7	7.6	10.2	3.9	26.4	6.4	8.3	13.5	10.2	7.7	3.6	6.1	2.5	6.0	13.7	12.4	8.6	9.4	22.1	3.6	16.6	5.1	3.0	15.2	6.1	5.4	1.9	8.6	4.1	5.9	6.2	3.8	11.7	45.0	6.2	0.4	11.7	2.3	2.2	6.2	3.9	0.7	3.9	0.9	1.1	10.6	2.4	1.3	3.4	3.0	0.4	1.7	0.7	2.5	0.7	7.0	2.0	10.1	12.2	0.2	8.4	2.6	0.5	1.3	2.2	0.7	0.6	3.6	28.6	2.9	2.6	0.6	0.4	2.3	3.1	0.3	3.4	2.1	0.9	72.8	6.7	7.9	0.3	0.5	0.6	0.1	6.6	2.3	0.2	90.6	0.1	1.5	7.4	0.4	0.2	0.0	4.1	0.1	1.1	0.7	1.2	0.4	19.6	0.1	2.1	0.2	0.2	38.5	1.9	1.4	2.2	0.2	0.4	0.2	7.7	0.2	17.4	0.0	1.1	0.0	0.7	0.7	1.2	0.0	0.5	1.9	3.9	0.7	1.1	2.4	0.9	10.6	0.1	0.0	0.0	1.3	12.9	17.3	9.7	15.9	13.5	10.2	6.0	13.7	16.6	6.2	17.9	17.4	0.5	6.5	9.5	36.2	12.2	10.2	214.2	43.3	12.2	174.7	1.0	5.0	7.0	171.0	6.7	3.8	0.0	14.2	2.1	7.6	3.6	3.5	1.7	2.0	15.9	4.6	7.4	1.8	130.3	28.1	4.2	75.9	0.0	2.0	58.0	5.6	0.0	15.2	8.1	441.5	25.8	12.1	81.9	27.2	5.1	1.0	6.7	3.8	3.0
MOSPD2	MGC26706	ENSG00000130150	"Motile sperm domain containing 2"	Q8NHP6	X	14873441-14922327	"Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 30.2"	"Group enriched"	"Detected in all"	4	"granulocytes: 30.2;monocytes: 8.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003334	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA003334: AB_2146004"	"unprognostic (2.74e-1)"	"unprognostic (4.39e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.57e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (8.91e-4)"	"unprognostic (1.51e-1)"	"unprognostic (7.24e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.96e-2)"	11.2	7.1	11.9	10.4	20.8	12.4	8.5	8.0	18.0	11.3	6.2	24.6	8.5	7.4	9.1	9.9	11.9	6.5	10.9	5.9	16.7	11.1	8.6	8.3	12.2	11.1	33.0	13.8	10.4	7.8	6.6	11.5	14.1	33.9	7.1	8.1	4.9	18.5	6.4	3.7	21.4	7.3	8.0	40.4	12.0	7.3	5.6	27.0	7.8	13.1	6.2	9.2	7.8	10.6	2.3	2.7	30.2	8.4	4.3	2.3	2.7	5.5	7.4	5.6	3.0	18.9	11.9	6.0	12.6	11.9	9.0	10.9	3.7	6.8	7.0	3.5	21.1	14.3	8.9	6.9	5.3	12.0	5.3	6.3	2.4	7.1	3.4	11.7	4.6	7.0	10.8	7.6	8.0	10.8	9.0	8.0	7.7	3.2	10.1	8.6	2.4	4.6	3.8	3.8	4.9	6.7	4.4	7.4	5.9	7.4	3.7	1.8	4.2	9.7	4.5	20.5	22.7	3.9	6.8	8.0	8.6	3.6	29.0	4.9	6.0	5.6	4.7	11.2	3.8	11.7	7.8	8.3	3.9	2.0	7.9	2.1	1.2	1.8	1.2	2.7	2.3	2.0	2.3	30.2	4.3	8.4	1.1	1.9	2.7	11.9	20.8	8.0	18.0	16.7	11.1	33.0	13.8	33.9	27.0	20.8	15.6	11.3	5.6	7.6	6.2	5.7	5.1	17.4	13.6	21.0	5.9	8.8	8.3	5.5	4.4	12.3	5.9	0.0	5.4	7.5	12.6	7.4	7.0	6.8	19.6	6.4	12.1	22.1	28.4	12.1	9.8	26.2	10.1	23.4	7.7	6.8	5.9	5.8	14.2	9.1	4.3	12.9	7.4	3.4	8.3	11.2	19.7	6.9	5.9	5.8
MTDH	"3D3, AEG-1, LYRIC"	ENSG00000147649	Metadherin	Q86UE4	8	97644179-97728770	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010932, HPA015104, CAB068204, CAB068205"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB068204: AB_2665655, CAB068205: AB_2665654, HPA010932: AB_1079422, HPA015104: AB_1854173"	"unprognostic (1.01e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (7.76e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (3.84e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.40e-1)"	26.5	28.5	17.2	28.3	21.9	44.5	29.0	21.8	20.2	27.5	24.9	20.7	24.7	23.2	31.6	28.6	27.6	23.6	23.5	23.6	18.7	16.6	24.3	97.8	21.9	31.4	26.5	19.6	26.7	22.7	27.1	18.0	13.4	23.0	24.0	22.8	16.4	22.3	21.2	49.8	19.5	32.7	29.5	34.6	35.8	21.8	19.0	24.8	40.0	30.5	22.7	27.5	27.5	35.7	26.2	42.4	17.4	26.6	19.2	20.9	10.1	38.8	20.2	13.2	18.1	22.0	23.3	6.5	35.0	29.8	22.4	17.4	11.9	29.1	36.0	39.5	34.3	24.8	25.9	32.0	24.3	31.4	38.3	16.8	66.1	21.9	14.1	26.7	34.6	30.8	17.8	24.5	27.1	61.8	21.2	25.7	26.6	43.1	64.0	23.7	16.1	58.3	9.6	8.1	34.0	24.6	38.2	15.7	52.3	14.6	22.4	20.0	15.0	24.8	21.9	27.4	13.3	33.4	22.2	26.7	31.8	11.4	29.2	25.8	35.7	38.9	36.5	29.2	40.7	27.7	17.4	26.6	13.4	14.2	17.8	20.1	26.2	20.4	20.9	32.6	18.6	20.8	18.4	3.8	19.2	19.5	42.4	11.7	10.1	17.2	21.9	21.8	20.2	18.7	16.6	26.5	19.6	23.0	24.8	119.1	103.5	196.6	171.8	232.4	0.0	87.6	201.2	52.2	100.1	134.3	0.0	9.1	21.6	197.1	211.2	149.0	122.0	46.7	201.2	89.0	152.1	236.8	136.0	389.3	243.9	0.0	116.8	148.0	225.6	132.2	180.9	250.7	175.5	149.7	148.0	0.0	214.1	126.3	203.3	76.1	0.0	219.9	203.9	116.5	108.0	275.1	11.4	146.0	177.0	291.2
MXRA7	"FLJ46603, PS1TP1, TMAP1"	ENSG00000182534	"Matrix remodeling associated 7"	P84157	17	76672551-76711016	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 140.1;Muller glia cells: 291.2;Peritubular cells: 134.7;Rod photoreceptor cells: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 93.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044819, HPA075316"	Uncertain		Enhanced	"Endoplasmic reticulum"	"Secreted - unknown location"	NA	NA			"Endoplasmic reticulum"		"HPA044819: AB_10964134, HPA075316: "	"unprognostic (1.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.07e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.39e-3)"	"unprognostic (4.67e-3)"	"unprognostic (6.21e-2)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (1.80e-5)"	28.4	46.7	14.7	18.2	43.2	1.8	32.4	15.6	30.5	31.0	44.0	14.6	16.9	6.6	44.5	40.4	33.2	28.0	28.1	93.3	15.1	13.1	14.1	5.1	24.7	13.3	16.2	16.3	36.1	16.4	40.1	7.8	21.1	20.6	32.8	14.5	41.9	15.0	61.7	13.9	10.8	13.3	59.9	15.8	31.4	21.9	20.7	10.0	6.4	51.0	9.3	6.6	44.7	31.4	2.9	3.6	1.9	3.9	7.8	7.0	4.0	2.5	7.6	11.4	21.5	60.5	55.4	5.7	36.1	29.3	26.4	25.8	10.2	0.4	0.0	16.4	49.9	27.6	10.3	12.7	20.0	43.2	0.1	12.6	6.5	5.7	16.9	37.0	3.0	0.8	34.4	23.9	30.6	25.2	59.4	38.8	1.6	4.6	0.1	60.8	0.7	0.3	2.1	3.6	4.0	21.6	5.7	44.9	2.1	21.2	0.6	4.0	29.1	10.7	0.1	20.6	34.0	7.1	3.9	47.5	59.7	12.7	24.3	37.9	3.4	0.6	0.1	93.7	1.3	8.6	1.5	3.9	0.8	6.3	1.2	4.8	2.9	3.5	7.0	3.1	0.7	2.3	4.9	1.9	7.8	0.4	3.6	0.8	4.0	14.7	43.2	15.6	30.5	15.1	13.1	16.2	16.3	20.6	10.0	14.9	10.5	2.9	23.3	9.2	140.1	103.5	2.5	9.4	11.4	29.6	90.3	1.0	1.7	20.9	3.3	36.2	0.9	0.0	3.6	4.2	41.8	16.2	2.3	3.2	2.8	104.9	6.4	54.0	5.6	6.6	93.7	2.2	13.5	1.8	5.6	291.2	7.9	0.0	134.7	5.8	125.1	12.9	36.0	1.2	12.1	7.8	0.7	9.6	1.2	18.1
MYLK2	"KMLC, MLCK2, skMLCK"	ENSG00000101306	"Myosin light chain kinase 2"	Q9H1R3	20	31819308-31834689	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 176.1"	"Cell type enhanced"	"Detected in single"	29	"Hofbauer cells: 1.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.3;RH-30: 13.5;RPMI-8226: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA059704, HPA059890"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA059704: AB_2684108, HPA059890: AB_2684153"	"unprognostic (1.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.84e-2)"	"unprognostic (5.27e-2)"	"prognostic favorable (4.00e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.38e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.25e-11)"	"unprognostic (2.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.70e-2)"	1.4	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.4	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.3	176.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.1	18.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.8	0.0	0.0	0.5	0.1	0.0	0.4	0.1	0.3	0.3	0.6	0.4	0.0	0.2	0.1	0.1	0.0	0.2	0.2	0.2	0.7	0.3	0.0	0.0	0.6	0.1	0.0	0.0	0.4	0.0	1.7	1.0	0.7	0.2	5.3	0.1	0.8	0.7	0.4	0.7	0.0	0.4	0.8	13.5	10.9	0.1	0.1	0.7	0.6	3.4	0.1	0.0	0.1	0.1	0.1	2.7	0.3	1.0	0.6	3.0	0.1	1.0	0.2	0.2	3.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0
NAT8	"ATase2, GLA, Hcml1, TSC501"	ENSG00000144035	"N-acetyltransferase 8 (putative)"	Q9UHE5	2	73640832-73642393	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"kidney: 140.4"	"Cell type enriched"	"Detected in some"	12	"Proximal tubular cells: 1951.9"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 242.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 16.9"					"Low region specificity"	"Detected in all"			"HPA067855, HPA074519"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA067855: AB_2732774, HPA074519: AB_2686699"	"unprognostic (4.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.13e-2)"	"unprognostic (8.36e-5)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.7	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	140.4	15.8	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	1.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	16.9	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.3	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.9	0.0	0.0	159.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	40.4	0.0	0.0	0.0	22.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	1951.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NCEH1	"AADACL1, KIAA1363, NCEH"	ENSG00000144959	"Neutral cholesterol ester hydrolase 1"	Q6PIU2	3	172630249-172711218	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 30.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 15.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 70.8;LHCN-M2: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026888, HPA043873"	Enhanced		Approved	"Endoplasmic reticulum"		No	No			"Endoplasmic reticulum"		"HPA026888: AB_10601557, HPA043873: "	"unprognostic (3.19e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.88e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (5.29e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.28e-1)"	17.0	14.8	6.5	7.1	23.8	6.0	5.1	14.3	30.1	4.1	9.8	2.3	1.4	3.5	3.9	2.9	4.4	3.5	6.0	14.6	13.2	9.6	18.8	4.2	17.0	11.2	6.6	11.4	2.5	4.0	6.3	4.2	5.7	17.7	6.0	10.7	4.3	8.2	4.2	6.6	2.7	4.1	2.9	5.0	9.1	10.9	2.0	4.0	1.9	3.9	3.1	9.3	5.1	3.4	3.0	10.6	4.8	15.1	2.8	2.3	4.8	23.3	13.6	0.4	0.7	0.8	0.9	1.9	17.6	11.7	11.7	6.8	3.4	70.8	1.9	26.5	10.6	11.2	4.7	0.5	8.6	27.2	6.5	1.1	1.3	2.2	2.6	1.0	3.5	4.9	0.4	0.8	8.0	12.0	11.0	7.8	1.0	0.3	1.7	33.1	1.9	0.5	1.2	0.6	6.6	11.2	0.5	1.3	2.4	20.9	3.1	0.4	0.2	10.6	11.2	2.3	0.8	3.8	1.6	21.1	18.0	2.7	8.4	31.8	2.0	3.8	1.6	13.4	3.4	13.6	4.8	15.1	0.5	2.3	9.6	1.5	3.0	1.5	1.6	10.6	1.9	1.5	1.8	0.5	2.8	6.2	0.6	1.3	4.8	6.5	23.8	14.3	30.1	13.2	9.6	6.6	11.4	17.7	4.0	44.7	19.9	6.4	16.9	6.1	12.9	27.7	25.5	30.8	28.4	15.7	21.6	6.2	3.3	54.9	4.5	8.7	13.1	46.7	26.6	3.8	6.1	23.2	4.7	1.6	48.4	4.8	7.5	5.5	34.7	2.6	0.9	14.5	5.0	1.8	9.7	4.9	50.0	10.5	2.5	25.4	19.2	6.5	5.8	0.0	0.9	3.0	8.8	3.8	6.0	22.8
NCR1	"CD335, LY94, NK-p46, NKP46"	ENSG00000189430	"Natural cytotoxicity triggering receptor 1"	O76036	19	54906150-54916140	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 5.5;lymphoid tissue: 13.9"	"Cell type enriched"	"Detected in some"	9	"T-cells: 10.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049311			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA049311: AB_2680707"	"unprognostic (3.92e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.87e-4)"	"unprognostic (2.89e-1)"	"unprognostic (6.32e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-5)"	"unprognostic (1.82e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.81e-3)"	"unprognostic (6.05e-3)"	1.4	0.2	0.1	3.7	0.4	2.1	0.3	0.1	0.3	0.3	2.1	0.0	0.5	0.1	1.2	1.3	0.3	0.2	2.1	1.9	0.2	0.2	0.3	2.5	5.5	3.8	0.2	0.0	0.2	0.1	0.1	0.2	0.4	0.0	0.6	0.2	1.0	0.4	0.1	0.3	0.5	3.4	1.2	0.2	13.9	0.3	0.4	0.0	2.0	0.3	0.1	2.6	0.7	0.3	0.2	0.2	1.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.1	0.2	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.2	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.4	0.1	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.1
NECAP2	FLJ10420	ENSG00000157191	"NECAP endocytosis associated 2"	Q9NVZ3	1	16440672-16460078	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cone photoreceptor cells: 296.5;monocytes: 288.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028077	Approved		Approved	"Endoplasmic reticulum"		No	No			"Endoplasmic reticulum"		"HPA028077: AB_10601273"	"unprognostic (6.92e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.35e-1)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (5.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.38e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.58e-2)"	23.6	22.0	13.6	25.0	15.0	12.6	19.4	10.2	13.8	15.9	18.6	19.8	12.6	11.9	18.2	15.9	24.1	17.6	18.6	12.5	12.6	11.0	19.3	23.6	26.5	39.4	17.5	12.2	28.0	19.5	12.0	12.4	37.8	14.4	16.9	15.6	15.6	21.1	11.7	9.8	25.7	19.2	15.5	18.1	48.1	15.1	27.4	14.5	43.3	20.8	15.9	36.1	22.1	17.5	25.7	27.5	24.8	57.1	26.7	47.9	54.4	16.7	9.3	9.7	11.4	19.8	21.5	5.7	19.3	26.4	25.0	22.0	10.0	28.3	15.1	23.2	35.1	11.4	11.2	13.6	19.0	20.7	31.4	14.0	14.8	11.1	13.6	25.8	18.4	13.8	23.9	19.8	17.5	14.4	21.3	40.7	17.2	20.5	49.7	21.7	11.0	17.1	19.4	8.6	12.7	13.3	19.3	8.9	24.1	24.6	9.6	6.1	15.9	14.8	8.8	19.0	15.2	10.0	20.4	47.6	16.2	8.8	18.6	12.9	23.6	22.9	14.8	13.7	26.7	15.6	17.3	40.2	24.8	23.8	53.7	23.3	25.7	40.9	28.1	27.5	23.2	42.2	26.7	15.5	26.7	57.1	16.4	47.9	54.4	13.6	15.0	10.2	13.8	12.6	11.0	17.5	12.2	14.4	14.5	20.8	30.2	42.2	31.9	46.4	24.0	6.5	17.8	24.1	14.8	19.2	296.5	43.0	19.9	64.1	42.7	55.5	29.6	23.3	47.5	51.8	39.4	35.2	26.6	11.0	106.9	14.3	18.0	94.5	78.3	29.5	27.6	75.8	23.6	288.6	28.3	23.1	86.4	42.1	31.8	18.6	50.9	38.8	26.5	25.6	26.1	48.9	41.3	67.3	20.6	51.6
NOMO1	PM5	ENSG00000103512	"NODAL modulator 1"	Q15155	16	14833681-14896160	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 40.0"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.0;Hep G2: 37.3;RPMI-8226: 23.8;SiHa: 43.2"									"CAB025192, HPA046697, HPA061174"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB025192: , HPA046697: AB_2679758, HPA061174: AB_2684444"	"unprognostic (5.33e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.27e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (3.15e-4)"	4.2	3.3	4.4	10.1	11.1	0.8	4.6	7.9	10.2	2.4	3.7	5.4	1.5	1.4	6.1	3.6	3.4	8.3	2.8	12.9	5.2	6.4	11.3	8.9	4.1	3.4	4.6	10.6	11.7	40.0	1.2	3.3	9.1	6.6	5.9	10.3	2.7	4.1	5.9	12.2	6.9	7.0	9.0	3.5	1.8	5.9	15.0	2.8	1.5	9.9	1.5	2.4	2.6	1.9	1.2	3.8	5.2	4.0	1.4	1.0	1.0	0.3	12.7	16.0	21.0	0.0	1.5	10.4	1.3	3.2	3.9	4.0	0.2	0.9	1.3	1.0	2.9	0.3	0.2	2.9	0.1	4.0	1.9	0.0	1.2	17.0	37.3	13.9	1.8	1.0	0.2	0.2	2.0	2.2	0.4	2.9	0.0	7.2	0.8	18.0	0.0	0.5	0.0	0.0	0.0	0.0	0.8	1.5	23.8	0.0	0.7	0.3	11.8	43.2	0.0	0.2	0.8	17.6	0.1	0.4	0.5	0.0	1.8	14.8	0.0	0.6	1.5	0.9	0.7	0.5	5.2	0.6	0.6	0.3	1.2	0.7	0.2	0.3	0.9	0.5	1.2	0.5	0.8	1.6	1.4	4.0	3.8	1.0	1.0	4.4	11.1	7.9	10.2	5.2	6.4	4.6	10.6	6.6	2.8	3.0	8.0	5.2	1.2	5.7	8.3	40.4	2.5	4.0	5.7	10.4	5.9	5.1	0.0	13.8	22.9	7.4	13.6	0.0	25.8	11.0	5.7	1.6	24.1	6.8	5.7	33.4	7.5	8.6	10.4	6.4	2.6	2.6	5.0	6.4	10.8	5.1	26.8	8.6	6.0	8.2	7.1	6.5	7.2	9.8	13.8	5.1	8.0	4.4	11.1	1.3
NOTUM		ENSG00000185269	"Notum, palmitoleoyl-protein carboxylesterase"	Q6P988	17	81952507-81961840	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"placenta: 127.4"	"Cell type enriched"	"Detected in some"	47	"Extravillous trophoblasts: 865.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 96.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA022851			Approved	"Endoplasmic reticulum"	"Secreted in female reproductive system"	NA	NA		59000	"Endoplasmic reticulum"		"HPA022851: "	"unprognostic (1.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.97e-1)"	"unprognostic (9.02e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.48e-6)"	"unprognostic (1.76e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.00e-1)"	0.2	0.1	1.1	0.2	1.2	0.1	0.2	0.3	1.0	0.2	0.2	0.2	0.5	0.6	1.0	1.3	0.3	0.2	0.3	0.3	0.5	0.9	0.8	10.4	1.8	0.2	0.7	0.4	0.2	0.2	0.0	0.2	127.4	0.6	0.4	0.0	0.2	0.3	0.2	4.9	2.4	0.2	0.2	0.3	0.3	0.9	3.0	0.5	0.2	0.2	0.3	0.2	1.3	1.3	0.7	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.4	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.5	0.6	96.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	15.6	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.3	0.9	0.4	1.4	0.5	0.0	1.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	1.2	0.3	1.0	0.5	0.9	0.7	0.4	0.6	0.5	0.0	3.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	865.2	2.3	0.0	0.0	0.9	17.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.8	0.0	18.4	0.0	0.0	0.0
OGN	"mimecan, OIF, SLRR3A"	ENSG00000106809	Osteoglycin	P20774	9	92383967-92404696	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 68.7"	"Group enriched"	"Detected in many"	5	"Fibroblasts: 137.8;Leydig cells: 153.9;Peritubular cells: 199.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"T-reg: 5.1"	"Lineage enriched"	"Detected in single"	8	"T-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 18.1;HSkMC: 8.1;JURKAT: 11.6;MOLT-4: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013132	Approved		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		190000000	"Endoplasmic reticulum"		"HPA013132: AB_1854825"	"unprognostic (2.31e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-4)"	"unprognostic (4.42e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.86e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavorable (2.03e-4)"	35.6	3.9	0.7	7.1	1.3	0.0	14.7	2.0	2.2	47.8	15.2	0.7	11.7	1.5	25.2	19.8	11.7	12.9	47.5	27.6	0.9	0.7	1.9	1.0	7.8	1.3	2.8	1.6	26.1	1.9	68.7	7.1	9.7	2.9	27.7	5.7	10.7	2.9	4.9	2.4	1.6	5.9	31.1	6.0	0.8	9.4	10.7	0.8	1.3	5.9	7.0	1.5	32.0	10.0	0.6	0.3	0.0	0.0	0.4	5.1	0.2	0.0	0.0	0.0	0.0	3.9	18.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	23.6	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.4	0.5	0.3	0.6	0.1	0.1	0.0	0.4	0.0	0.1	5.1	0.2	0.7	1.3	2.0	2.2	0.9	0.7	2.8	1.6	2.9	0.8	6.0	1.0	0.0	0.0	3.8	0.6	2.4	0.0	5.3	13.6	3.5	0.0	1.6	0.0	0.0	1.2	3.5	0.0	0.0	0.0	1.5	137.8	0.2	1.1	0.0	4.2	0.0	0.0	30.7	0.3	1.3	153.9	1.2	1.7	0.0	0.0	0.0	0.0	0.0	199.4	0.0	0.2	6.5	11.8	0.6	0.3	4.0	4.8	0.0	0.0	0.1
ORMDL1		ENSG00000128699	"ORMDL sphingolipid biosynthesis regulator 1"	Q9P0S3	2	189770323-189784371	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA065643			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA065643: AB_2685525"	"unprognostic (1.45e-1)"	"unprognostic (5.34e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.86e-2)"	"unprognostic (6.70e-3)"	"prognostic favorable (3.04e-5)"	"unprognostic (5.90e-3)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (5.84e-9)"	"unprognostic (2.62e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.87e-2)"	"prognostic favorable (1.49e-5)"	24.9	31.1	23.1	27.3	29.6	28.5	36.8	29.4	30.8	24.7	23.1	24.1	56.0	24.2	28.9	63.8	21.8	25.7	28.5	17.9	22.6	25.1	26.5	30.3	31.5	40.4	30.6	24.1	25.7	39.9	25.1	50.6	37.5	29.9	29.7	30.5	30.4	55.2	41.2	18.3	47.0	38.1	25.6	25.1	63.1	28.1	37.3	24.7	26.3	31.1	21.7	40.3	24.6	23.9	28.7	36.8	29.0	35.2	21.0	37.7	26.2	13.2	10.4	27.6	21.4	37.6	42.7	30.4	25.8	28.1	33.7	33.7	20.4	21.8	22.8	19.5	20.8	18.8	20.7	19.2	17.2	36.6	26.1	24.1	32.4	36.6	25.5	47.8	28.0	27.1	47.7	21.6	28.2	32.3	39.3	24.1	26.3	21.7	35.4	32.6	13.8	26.1	52.4	29.8	15.7	47.5	17.7	23.7	32.4	39.0	20.4	18.1	20.8	14.4	13.8	34.7	32.7	15.7	31.0	22.1	29.8	22.3	21.5	28.5	32.4	26.9	23.9	32.4	30.5	16.3	25.7	25.0	29.0	28.7	30.5	28.6	28.7	33.3	31.1	20.5	24.5	37.7	34.6	10.0	21.0	35.2	36.8	33.8	26.2	23.1	29.6	29.4	30.8	22.6	25.1	30.6	24.1	29.9	24.7	74.5	42.8	77.9	46.4	50.0	133.7	29.1	35.7	62.9	48.9	34.9	164.9	178.2	28.2	47.2	32.5	57.1	35.5	46.7	58.9	59.1	53.0	65.1	43.9	30.6	77.0	62.0	40.7	40.5	102.6	15.7	68.7	72.5	37.1	81.2	33.3	99.7	53.1	47.6	45.6	41.1	186.8	51.8	49.5	126.1	133.3	53.1	182.4	89.2	41.3	44.2
ORMDL2	"adoplin-2, HSPC160, MST095, MSTP095"	ENSG00000123353	"ORMDL sphingolipid biosynthesis regulator 2"	Q53FV1	12	55817919-55821879	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA065643			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA065643: AB_2685525"	"unprognostic (1.12e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (3.30e-5)"	"unprognostic (6.92e-2)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.68e-2)"	19.5	20.3	6.7	14.1	8.5	9.5	26.9	6.5	10.0	14.6	23.9	11.7	25.7	14.6	15.4	29.9	37.6	13.7	23.3	17.2	7.3	8.2	32.0	44.4	20.1	22.5	10.1	7.7	18.6	34.7	15.9	15.6	31.9	11.4	15.8	27.8	9.1	24.0	20.9	14.5	16.9	24.8	14.5	13.0	24.0	16.2	31.9	8.7	28.4	22.2	23.0	22.0	14.6	17.5	38.8	53.3	45.2	44.6	29.8	45.8	29.0	15.4	29.5	12.5	6.4	24.1	12.1	13.9	19.0	18.9	16.6	14.7	32.9	38.3	9.6	20.3	22.8	17.1	28.7	9.9	39.5	16.6	10.0	14.8	13.0	28.5	18.3	25.6	15.6	13.8	15.1	36.4	29.1	30.4	21.5	23.2	10.9	6.8	26.3	21.1	24.8	9.5	7.0	6.0	24.6	23.5	6.3	10.0	24.7	43.1	45.1	10.9	6.9	24.2	28.9	10.5	19.8	34.6	11.3	16.8	9.0	12.6	10.5	12.0	12.7	10.4	7.9	14.3	6.3	12.4	21.1	32.8	45.2	40.5	39.9	36.2	38.8	39.3	42.9	32.6	34.2	32.9	39.2	41.1	29.8	44.6	53.3	45.8	29.0	6.7	8.5	6.5	10.0	7.3	8.2	10.1	7.7	11.4	8.7	68.5	31.8	52.9	52.0	20.7	9.4	3.4	58.6	69.6	43.3	50.6	11.8	65.8	24.9	118.7	136.0	35.0	96.4	0.0	146.5	97.7	20.3	85.8	49.8	82.3	112.2	7.9	44.3	33.2	42.9	45.2	23.6	61.7	54.0	155.1	48.2	22.3	157.8	91.2	21.9	66.7	14.0	19.4	14.1	69.9	49.6	29.2	126.8	41.5	43.3	74.9
ORMDL3		ENSG00000172057	"ORMDL sphingolipid biosynthesis regulator 3"	Q8N138	17	39921041-39927601	"Disease related genes, Predicted membrane proteins"			Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 239.1;Late spermatids: 240.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 92.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065643			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA065643: AB_2685525"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.31e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (9.29e-4)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.55e-1)"	"unprognostic (1.09e-3)"	"prognostic favorable (5.18e-4)"	48.9	12.4	16.1	19.9	20.6	11.7	36.1	14.9	18.2	14.9	17.4	12.6	29.9	17.2	15.3	23.8	10.9	10.4	17.3	21.6	16.1	12.5	14.1	83.0	16.9	17.3	14.6	16.3	15.7	68.4	14.9	21.0	28.6	12.6	17.0	13.7	14.4	24.4	24.1	13.5	15.4	16.2	14.1	13.5	15.5	16.9	18.1	16.1	29.7	20.9	11.0	24.9	17.8	10.4	11.9	8.8	24.9	4.3	7.4	24.8	15.9	7.2	8.9	9.4	7.8	24.6	9.4	8.6	10.6	12.4	11.4	11.1	10.1	8.1	5.4	10.2	13.1	7.8	12.4	6.6	8.5	10.7	92.6	11.9	5.2	5.0	24.4	9.6	6.1	9.2	10.2	9.0	7.9	4.5	13.0	5.1	15.3	6.6	43.9	6.2	6.5	18.2	6.9	5.3	9.6	4.5	15.4	8.5	16.9	6.3	17.7	8.3	8.4	7.0	44.4	7.0	11.0	15.9	6.7	4.1	6.2	7.8	5.3	8.0	23.7	20.0	7.5	6.4	6.0	4.6	3.5	2.0	24.9	17.5	3.1	12.5	11.9	17.8	19.3	1.7	10.8	20.9	24.8	3.3	7.4	4.3	8.8	11.3	15.9	16.1	20.6	14.9	18.2	16.1	12.5	14.6	16.3	12.6	16.1	47.6	27.5	22.9	12.1	14.5	16.0	23.6	17.8	2.7	15.9	40.1	0.0	21.4	3.3	16.6	239.1	10.5	23.4	70.0	25.7	14.9	13.9	17.1	18.4	78.8	7.0	12.7	24.9	3.7	5.7	240.9	17.3	5.8	15.1	32.5	22.8	38.4	28.9	17.5	26.9	10.2	9.8	25.8	13.7	6.4	5.7	12.5	7.8	34.8	16.6	11.3
OS9	"ERLEC2, OS-9"	ENSG00000135506	"OS9, endoplasmic reticulum lectin"	Q13438	12	57693955-57721557	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"RH-30: 291.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011518, HPA013694"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"CAB011518: AB_776918, HPA013694: AB_1854812"	"unprognostic (1.67e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.32e-3)"	"unprognostic (4.78e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.67e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.67e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.21e-2)"	39.3	32.9	24.4	28.1	27.6	32.2	38.0	27.0	34.9	37.4	39.1	27.6	34.5	37.2	36.2	37.7	35.2	32.0	33.0	39.2	23.2	23.1	42.9	94.4	40.2	34.2	27.7	22.0	44.2	110.7	49.5	29.2	47.0	28.2	34.7	34.1	42.0	53.2	28.5	19.0	36.9	47.4	28.1	18.6	37.5	35.7	21.4	24.0	23.8	47.6	23.2	34.4	33.3	35.1	11.5	35.8	54.1	48.7	11.4	16.1	36.7	6.7	13.8	7.0	17.4	36.7	24.9	15.6	17.0	21.7	12.6	12.8	14.3	22.1	8.7	28.4	20.3	9.7	12.3	6.5	11.0	10.0	11.1	7.9	9.8	9.8	12.9	24.0	15.3	25.2	22.8	17.7	12.3	12.6	43.4	20.9	5.8	7.4	34.7	13.1	11.7	4.1	18.6	7.9	13.5	9.8	5.4	291.6	21.8	9.6	16.8	7.2	9.6	24.2	16.7	13.7	13.4	19.9	30.2	19.1	17.0	10.2	11.5	10.7	20.7	17.8	9.0	14.4	11.2	23.4	30.6	48.7	54.1	16.1	44.4	15.2	10.9	13.7	14.2	35.8	11.5	10.7	12.3	52.0	11.4	35.0	31.1	15.0	36.7	24.4	27.6	27.0	34.9	23.2	23.1	27.7	22.0	28.2	24.0	80.4	110.4	55.1	75.1	51.3	42.6	12.6	91.7	93.7	103.5	69.8	72.6	122.4	8.3	114.5	4.8	76.5	142.5	46.7	96.4	106.6	99.6	64.6	86.8	139.4	128.9	47.7	99.5	76.7	105.2	9.1	105.0	115.3	113.1	158.7	107.2	85.8	84.7	129.8	74.3	44.0	34.1	90.5	57.7	33.4	54.8	45.0	165.3	69.2	78.8	57.0
P4HB	"DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PO4DB, PO4HB, PROHB"	ENSG00000185624	"Prolyl 4-hydroxylase subunit beta"	P07237	17	81843159-81860694	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Chaperone, Isomerase"	"Craniosynostosis, Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 383.4;pancreas: 677.5"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 1160.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012463, HPA018884"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted - unknown location"	No	No		140000000	"Endoplasmic reticulum"		"CAB012463: , HPA018884: AB_1854896"	"unprognostic (9.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.75e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (2.30e-11)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.19e-3)"	18.0	34.7	6.3	15.4	8.4	35.0	16.1	6.1	6.5	22.1	40.5	9.0	45.0	42.6	14.7	29.1	40.3	12.8	42.3	20.7	6.3	5.9	27.2	383.4	20.9	29.1	7.9	4.5	14.3	677.5	6.4	23.4	58.5	7.2	22.5	8.5	12.3	251.9	42.5	31.0	24.3	112.8	11.0	5.2	36.7	31.6	9.1	7.2	10.5	29.7	50.7	46.4	16.5	20.5	21.6	71.3	45.8	60.8	38.8	55.9	70.8	58.4	50.9	18.9	60.8	51.0	60.1	44.7	114.3	73.7	49.8	67.5	37.4	51.3	23.6	50.3	73.4	30.1	41.5	20.7	44.7	28.9	15.2	35.1	35.3	53.6	152.0	67.1	111.5	58.5	45.3	30.4	39.9	42.3	64.5	82.1	16.9	25.0	102.0	35.5	53.4	31.9	88.6	14.8	62.0	46.4	26.1	33.8	46.8	38.7	70.7	22.7	25.1	57.0	164.5	59.3	32.6	74.4	131.4	63.7	93.6	46.9	53.1	55.7	73.4	53.1	22.3	123.0	43.0	71.3	45.8	60.8	38.3	53.5	38.7	55.9	21.6	36.4	42.8	43.4	18.7	21.2	31.5	20.0	38.8	27.6	71.3	25.7	70.8	6.3	8.4	6.1	6.5	6.3	5.9	7.9	4.5	7.2	7.2	95.3	135.6	82.0	139.4	106.7	53.8	19.6	234.4	58.9	83.0	106.4	31.4	682.3	34.9	562.2	31.8	104.1	635.2	0.0	930.3	1160.9	218.5	265.2	99.1	768.8	403.4	58.8	191.7	211.1	166.1	51.9	130.9	120.0	129.9	349.9	361.7	113.5	636.3	443.3	105.4	92.7	40.7	155.2	103.8	85.8	107.3	126.5	837.3	139.5	385.8	170.2
PCNX2	"FLJ11383, KIAA0435, PCNXL2"	ENSG00000135749	"Pecanex homolog 2"	A6NKB5	1	232983435-233295713	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 29.6"	"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 8.9;Ciliated cells: 8.1;Club cells: 12.5;Collecting duct cells: 12.2;Distal tubular cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013815, HPA014427"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA013815: AB_2236561, HPA014427: AB_1855081"	"unprognostic (3.15e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (2.27e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.29e-1)"	4.7	4.7	11.4	7.5	16.8	4.2	7.7	29.6	23.1	4.9	3.9	6.3	4.2	3.4	6.6	14.0	5.2	9.0	8.1	2.3	11.9	8.2	5.4	1.2	4.7	9.4	8.0	13.1	11.4	5.2	8.6	18.6	2.4	14.3	6.2	4.8	6.0	6.0	8.1	5.6	6.3	5.6	5.2	5.8	5.3	5.8	5.5	5.5	4.0	7.9	3.4	8.8	6.0	5.7	1.5	1.8	0.9	0.9	0.8	3.1	1.1	3.8	9.4	5.1	0.1	8.4	9.2	1.5	2.3	6.8	2.4	4.3	3.0	4.7	8.1	5.5	6.3	9.0	6.4	2.3	6.7	5.7	6.8	6.9	0.1	4.8	0.0	3.8	2.6	1.6	7.0	5.9	4.8	19.1	8.3	4.5	6.1	0.0	4.3	2.4	2.3	7.4	0.2	16.5	3.3	5.7	0.1	1.4	1.1	4.4	6.0	8.8	7.3	3.4	1.5	1.4	3.0	3.4	0.7	1.7	6.8	4.4	7.7	7.6	5.2	5.4	0.1	6.2	3.0	7.8	0.9	0.9	0.4	3.1	0.5	2.4	1.5	2.5	2.9	1.8	1.3	1.1	2.1	0.7	0.8	0.7	0.6	2.7	1.1	11.4	16.8	29.6	23.1	11.9	8.2	8.0	13.1	14.3	5.5	8.9	5.1	0.0	0.0	0.0	0.0	0.0	0.0	8.1	12.5	12.2	0.0	0.3	6.6	5.1	0.0	0.0	0.0	0.0	2.9	1.1	0.0	0.0	1.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.8	0.0	0.0	4.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
PDE3B	HcGIP1	ENSG00000152270	"Phosphodiesterase 3B"	Q13370	11	14643723-14872044	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	Angiogenesis	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 42.6"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 34.7;Hepatocytes: 50.5;Spermatocytes: 45.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 19.2"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 5.0;T-cells: 8.7"	"Cell line enhanced"	"Detected in many"		"HL-60: 13.6;Karpas-707: 15.7;THP-1: 16.7;U-266/70: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056111			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA056111: AB_2683041"	"unprognostic (1.05e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.76e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.03e-3)"	42.6	1.0	2.3	12.6	2.2	6.7	17.0	19.2	3.0	2.9	21.8	0.9	0.8	2.2	0.9	1.4	2.6	1.0	6.9	4.7	2.2	2.1	2.4	18.2	10.2	14.1	1.6	1.6	0.9	7.3	0.3	5.1	5.5	1.5	10.7	8.1	1.9	16.5	1.3	0.8	0.9	6.3	9.7	2.1	8.7	3.0	12.5	0.8	7.8	1.2	2.3	7.1	10.5	4.5	0.3	0.4	5.0	1.2	0.1	8.7	1.8	0.0	1.5	3.4	5.5	6.8	0.0	1.3	0.4	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	1.6	0.0	5.1	0.0	0.0	0.1	11.3	0.1	8.3	10.2	2.4	13.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	4.0	11.9	15.7	0.0	0.1	2.7	6.6	4.6	1.8	2.5	6.5	1.5	10.3	0.0	1.1	5.2	9.7	1.3	8.8	3.0	1.6	0.0	16.7	0.0	0.0	0.8	0.0	0.0	17.7	5.4	0.4	0.1	2.3	1.0	0.0	0.7	2.9	1.4	0.7	2.9	0.3	4.2	3.2	0.4	0.2	8.7	7.5	5.0	0.1	1.2	0.1	4.2	1.8	2.3	2.2	19.2	3.0	2.2	2.1	1.6	1.6	1.5	0.8	14.9	9.9	1.9	0.8	0.2	0.4	8.2	0.0	6.7	11.4	1.8	0.0	1.0	1.7	0.0	12.4	2.2	2.6	23.3	4.3	1.9	8.5	3.4	34.7	50.5	6.3	0.0	1.2	7.4	14.0	10.1	1.4	12.3	0.0	1.0	13.1	4.5	2.9	17.5	8.5	1.9	0.3	0.0	0.1	45.1	11.1	0.1	2.1	11.7	9.7	0.9
PDIA3	"ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PI-PLC"	ENSG00000167004	"Protein disulfide isomerase family A member 3"	P30101	15	43746392-43773279	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 877.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002645, HPA003230, CAB011199, CAB015181, CAB075744"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		390000000	"Endoplasmic reticulum"		"CAB011199: AB_609902, CAB015181: AB_2160857, CAB075744: AB_2665750, HPA002645: AB_1079031, HPA003230: AB_1079030"	"unprognostic (9.20e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (8.95e-5)"	"unprognostic (1.67e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.11e-8)"	"unprognostic (1.82e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.63e-2)"	16.9	21.2	10.0	20.5	13.5	20.8	31.1	12.7	9.2	24.7	19.4	12.3	33.9	22.2	19.7	42.4	21.7	18.4	25.1	20.6	10.2	12.7	27.3	112.5	20.0	34.6	12.4	10.3	22.4	46.8	21.1	21.7	44.0	13.3	24.6	21.2	13.7	43.4	36.9	8.7	17.9	28.8	15.8	11.4	25.2	20.5	17.1	14.3	15.6	74.0	16.4	19.8	14.7	28.3	7.7	18.3	13.5	10.8	11.7	14.1	14.5	12.3	4.6	9.8	21.9	19.9	21.4	30.1	24.7	24.5	18.4	22.9	12.9	12.7	14.1	16.1	28.2	12.3	19.7	12.4	24.0	16.1	10.2	18.4	19.1	7.4	11.9	32.8	10.7	13.9	13.7	19.9	13.9	23.5	21.7	32.0	4.5	11.0	6.9	17.9	4.2	3.6	12.2	9.9	19.0	18.7	7.1	15.4	10.6	15.7	10.1	9.9	11.0	20.6	19.8	7.8	10.4	13.8	11.0	21.6	15.3	8.1	12.3	12.0	3.2	3.6	14.8	19.6	17.0	11.5	10.0	10.3	13.5	13.4	10.5	14.1	6.5	8.5	10.8	9.6	7.7	7.2	8.4	2.9	11.7	10.8	18.3	6.7	14.5	10.0	13.5	12.7	9.2	10.2	12.7	12.4	10.3	13.3	14.3	178.6	134.5	154.1	249.6	170.7	50.3	49.5	142.7	231.6	287.8	158.7	39.3	559.5	59.7	337.0	18.9	151.7	227.1	23.3	345.2	636.6	296.9	292.3	254.2	280.2	396.2	66.7	178.5	269.5	152.1	20.5	234.7	267.6	231.2	285.9	259.4	139.7	260.6	167.0	260.3	106.7	46.2	122.9	160.2	185.1	135.1	129.7	877.1	174.3	233.4	256.5
PDIA4	"ERP70, ERP72"	ENSG00000155660	"Protein disulfide isomerase family A member 4"	P13667	7	149003062-149028641	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 164.3"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 542.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006139, HPA006140, CAB017368"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		12000000	"Endoplasmic reticulum"		"CAB017368: AB_10621725, HPA006139: AB_1848256, HPA006140: AB_1848257"	"unprognostic (1.98e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-3)"	"unprognostic (6.08e-3)"	"unprognostic (3.20e-2)"	"prognostic unfavorable (5.20e-9)"	"unprognostic (1.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	17.6	13.0	7.7	25.6	11.9	7.4	27.4	5.1	7.9	25.5	20.9	12.1	28.8	18.2	19.4	46.3	15.2	20.8	28.1	16.9	7.3	8.0	27.7	164.3	19.1	29.1	11.6	6.2	19.4	76.3	7.0	19.1	24.7	12.0	18.0	21.9	7.8	36.4	26.5	5.8	10.1	21.3	17.8	13.9	27.9	23.7	11.5	11.3	19.2	89.8	11.9	24.3	17.4	22.6	26.6	63.3	16.2	21.2	21.5	35.9	34.5	32.4	30.9	33.6	93.9	30.7	21.9	48.7	45.7	30.6	26.2	42.8	25.6	87.8	23.4	102.6	37.5	72.2	21.3	22.6	43.3	23.1	16.6	13.3	11.2	8.9	56.1	41.2	25.5	31.7	21.5	19.4	28.7	23.1	34.2	53.2	12.0	18.3	63.8	23.0	35.5	24.3	29.1	50.1	66.4	18.0	16.0	26.1	56.6	30.6	25.5	10.7	28.2	41.5	29.9	15.9	41.9	17.0	19.7	29.0	20.7	11.7	50.1	32.1	48.6	21.8	16.4	48.3	30.2	70.3	16.2	20.1	12.1	34.3	21.2	35.9	26.6	22.6	26.7	19.4	15.1	21.5	22.7	2.7	21.5	21.0	63.3	16.6	34.5	7.7	11.9	5.1	7.9	7.3	8.0	11.6	6.2	12.0	11.3	26.8	33.4	29.0	71.4	30.8	3.3	20.4	96.8	65.6	44.3	40.1	3.9	152.3	13.3	102.2	2.7	35.1	89.5	46.7	79.9	277.0	90.5	103.6	57.6	542.5	131.4	0.0	59.1	95.8	80.7	3.2	54.7	53.4	82.7	48.7	104.5	19.3	96.2	87.1	40.3	54.4	6.1	32.3	34.2	53.4	71.9	25.0	192.7	54.6	97.0	59.2
PFKM	"PFK-1, PFKX, PPP1R122"	ENSG00000152556	"Phosphofructokinase, muscle"	P08237	12	48105139-48146404	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 284.3"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 326.0;Horizontal cells: 114.4;Muller glia cells: 114.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002117	Approved		Approved	"Endoplasmic reticulum"		NA	NA		1100000	"Endoplasmic reticulum"		"HPA002117: AB_1855245"	"unprognostic (4.60e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (5.85e-6)"	"unprognostic (4.97e-1)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (5.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.29e-3)"	"unprognostic (6.73e-2)"	"prognostic favorable (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.30e-2)"	4.4	11.6	10.0	3.0	16.2	2.3	3.9	13.0	23.6	5.8	5.3	6.1	5.4	3.0	6.4	5.8	9.1	5.4	4.8	55.5	8.2	10.1	10.9	2.7	3.6	2.4	9.4	10.8	10.8	3.0	14.2	11.4	3.3	17.9	7.1	4.2	10.8	5.2	9.4	284.3	2.6	2.8	8.3	4.6	2.7	4.1	10.3	3.8	0.0	5.5	54.9	4.6	5.3	3.7	10.7	6.7	8.7	3.2	2.2	5.4	3.5	8.7	8.5	27.0	24.5	27.5	20.0	5.5	23.7	21.8	20.5	14.5	21.0	11.0	52.1	19.6	11.4	12.0	9.7	23.3	23.9	19.3	1.2	12.2	14.8	19.3	0.6	14.7	0.7	8.6	28.3	14.1	18.0	29.7	34.3	23.2	0.8	17.8	26.3	18.8	6.6	18.3	1.2	19.2	9.6	26.5	30.8	15.7	40.0	14.0	9.7	31.9	23.5	14.0	22.2	23.7	22.4	22.5	3.2	20.9	9.5	13.1	13.9	19.7	14.4	38.3	28.5	18.4	1.5	7.9	0.4	3.2	8.7	2.5	2.8	1.0	10.7	4.3	2.4	6.7	7.0	5.4	3.0	0.8	2.2	2.3	1.0	3.8	3.5	10.0	16.2	13.0	23.6	8.2	10.1	9.4	10.8	17.9	3.8	14.9	5.9	6.8	17.7	6.5	38.0	326.0	17.8	9.4	7.9	21.0	41.2	2.2	56.3	9.4	29.7	15.8	2.2	0.0	2.2	3.5	16.7	6.1	1.1	2.5	3.5	114.4	8.7	9.8	2.7	19.6	28.4	3.2	52.3	18.0	6.2	114.5	3.3	0.0	44.9	25.8	41.0	25.8	26.2	46.8	11.5	4.5	2.1	4.4	12.1	7.6
PID1	"FLJ20701, NYGGF4"	ENSG00000153823	"Phosphotyrosine interaction domain containing 1"	Q7Z2X4	2	228850526-229271285	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 116.5;Leydig cells: 81.4;Peritubular cells: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 23.5;intermediate monocyte: 26.5;myeloid DC: 28.1"	"Group enriched"	"Detected in many"	58	"dendritic cells: 28.1;monocytes: 26.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 21.4;hTEC/SVTERT24-B: 32.9;LHCN-M2: 21.8;REH: 22.9;RH-30: 35.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036103	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA036103: AB_10602144"	"unprognostic (8.46e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.52e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.91e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.34e-2)"	"unprognostic (9.61e-6)"	18.9	24.8	21.4	11.3	12.7	2.5	29.6	2.7	34.4	17.8	19.4	3.9	12.1	4.9	13.8	16.0	11.6	15.5	14.1	11.5	13.6	11.7	5.3	52.4	22.8	18.8	15.7	16.7	27.1	11.4	1.8	5.3	20.9	11.9	16.6	18.2	17.9	5.8	13.1	14.6	11.4	13.8	27.8	6.2	15.6	15.6	6.2	6.2	0.1	9.8	8.9	3.4	16.8	50.6	0.0	28.1	0.4	26.5	0.0	0.1	8.1	0.0	0.7	0.0	0.0	21.4	4.1	0.0	3.4	13.1	2.2	2.8	0.2	0.0	0.0	0.1	4.8	6.9	0.6	0.0	0.6	3.0	0.0	0.0	0.0	1.6	0.0	8.8	0.0	0.0	7.7	5.9	32.9	5.4	6.2	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.3	2.8	2.0	22.9	35.0	0.0	0.4	0.0	0.7	0.9	7.3	0.7	0.0	0.3	0.0	0.0	0.0	8.7	3.2	8.1	3.2	0.0	0.0	0.0	11.4	0.0	1.4	0.0	23.5	0.0	0.0	26.5	0.1	0.0	0.0	0.0	28.1	0.0	0.0	0.0	0.4	0.0	5.1	0.1	0.1	8.1	21.4	12.7	2.7	15.1	13.6	11.7	15.7	16.7	11.9	6.2	6.0	52.7	1.4	5.0	13.9	3.7	1.9	10.2	4.0	14.8	0.0	0.0	1.3	0.0	2.3	0.1	2.2	40.7	0.0	3.5	27.3	55.1	10.1	5.8	116.5	3.1	0.0	4.7	6.7	36.8	1.1	81.4	58.0	20.3	0.0	13.0	11.8	1.9	20.1	70.7	0.0	1.3	0.0	9.2	0.2	0.5	12.7	4.0	2.2	26.1	1.0
PKD2	"Pc-2, PC2, PKD4, TRPP2"	ENSG00000118762	"Polycystin 2, transient receptor potential cation channel"	Q13563	4	88007668-88077777	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Potassium transport, Transport, Wnt signaling pathway"	"Calcium channel, Ion channel, Potassium channel, Voltage-gated channel"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 66.3;Peritubular cells: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 36.9;BJ hTERT+: 56.1;fHDF/TERT166: 44.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004544, HPA015794"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB004544: AB_672377, HPA015794: AB_1855437"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.51e-1)"	18.4	13.6	8.2	7.7	10.9	5.0	15.1	15.1	10.7	31.4	19.4	15.5	18.5	5.6	42.7	9.8	13.9	25.7	15.3	12.8	9.0	5.2	27.5	7.9	13.4	5.5	12.6	6.4	27.0	9.8	21.9	8.1	12.8	9.2	15.6	7.3	14.1	7.4	22.3	5.4	6.2	9.6	29.3	7.2	5.4	14.8	9.9	12.0	5.5	10.2	3.3	4.9	13.9	21.4	0.5	1.3	4.8	0.8	1.0	1.4	0.4	1.9	10.9	12.3	6.3	28.6	19.1	3.6	36.9	56.1	17.3	17.3	0.5	3.4	1.0	8.1	44.4	6.6	2.4	2.2	5.5	15.2	5.5	1.9	1.7	5.6	1.1	15.9	4.2	3.5	15.8	2.5	13.5	7.3	23.7	7.8	2.0	0.2	2.9	15.0	3.7	2.9	2.0	6.4	1.4	1.8	5.6	7.3	1.5	15.4	4.6	2.5	5.5	6.8	0.3	8.7	13.0	2.6	3.2	12.0	16.4	3.6	4.6	4.9	2.4	0.7	1.2	9.7	0.6	15.0	4.8	0.5	0.9	0.8	0.8	1.4	0.5	0.8	0.6	0.3	0.5	0.9	0.6	0.9	1.0	0.3	1.3	0.4	0.4	8.2	10.9	15.1	10.7	9.0	5.2	12.6	6.4	9.2	12.0	3.0	4.6	1.4	4.2	6.5	14.6	6.3	20.4	16.0	10.3	66.3	9.8	8.7	0.0	10.3	0.3	11.2	0.7	0.0	3.3	3.5	23.9	4.3	1.1	6.8	10.3	25.4	6.4	20.9	4.9	0.7	21.3	8.3	21.9	9.0	2.7	20.1	3.0	5.7	47.7	14.7	1.5	25.8	20.6	0.7	0.9	5.8	2.3	0.7	2.6	2.5
PMFBP1		ENSG00000118557	"Polyamine modulated factor 1 binding protein 1"	Q8TBY8	16	72112157-72176878	"Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 13.6;testis: 30.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 98.0;Late spermatids: 189.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 21.0;SH-SY5Y: 10.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA056716, HPA075825"	Approved		Uncertain	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA056716: AB_2683215, HPA075825: "	"unprognostic (1.46e-1)"	"unprognostic (3.62e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.06e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.68e-5)"	"unprognostic (9.85e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.67e-2)"	1.1	0.9	1.1	1.1	1.1	3.9	1.1	2.1	1.1	1.1	2.1	1.1	1.1	2.6	1.1	13.6	1.6	0.9	1.1	1.1	1.1	0.7	1.3	1.6	1.1	1.5	1.1	1.1	1.5	4.2	2.9	1.5	1.1	1.1	2.1	3.3	1.1	1.1	1.1	1.1	4.1	2.9	1.1	1.1	2.9	1.1	30.8	1.1	1.1	1.1	1.1	1.1	1.1	1.1	0.5	1.9	0.9	2.0	0.0	0.3	0.2	0.2	0.4	2.8	2.5	0.0	0.6	1.8	0.5	0.2	0.5	2.1	1.0	2.6	1.8	0.4	0.1	0.1	1.8	1.0	0.1	1.3	0.2	4.2	1.8	3.0	2.9	0.0	4.1	3.2	0.0	0.8	0.1	2.1	0.6	0.8	2.1	0.3	1.6	0.1	2.3	1.0	6.0	0.8	0.1	1.2	2.7	0.2	1.4	0.3	0.7	21.0	10.5	0.0	0.0	0.2	2.0	0.5	2.6	1.7	1.3	2.1	0.6	1.3	3.9	1.4	1.2	0.6	2.7	0.7	0.0	1.6	0.9	0.1	0.5	0.0	0.0	0.1	0.2	1.6	0.5	0.1	0.1	0.2	0.0	2.0	1.9	0.3	0.2	1.1	1.1	2.1	1.1	1.1	0.7	1.1	1.1	1.1	1.1	0.0	1.1	0.0	0.1	0.3	0.0	0.7	0.0	2.7	2.3	0.0	0.0	0.0	0.0	0.0	98.0	0.2	0.0	0.0	0.2	0.1	0.2	0.1	3.5	0.0	4.6	28.6	5.2	0.0	1.0	189.3	1.1	2.8	0.0	0.0	0.3	1.3	0.1	0.0	1.4	0.3	0.1	0.0	0.1	1.6	0.8	0.0	0.1	0.0	0.5	0.0
POGLUT1	"9630046K23Rik, C3orf9, hCLP46, KDELCL1, KTELC1, MDS010, MDSRP, MGC32995, Rumi"	ENSG00000163389	"Protein O-glucosyltransferase 1"	Q8NBL1	3	119468938-119494708	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Gastrulation	"Developmental protein, Glycosyltransferase, Transferase"	"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	13	"monocytes: 247.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037855, HPA037856"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA037855: AB_10672728, HPA037856: AB_2732477"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.02e-7)"	"unprognostic (3.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (2.23e-4)"	11.9	12.1	7.6	10.7	12.0	3.9	10.9	13.9	10.6	10.1	9.5	9.8	27.4	5.9	13.7	11.7	9.3	10.1	6.9	8.3	7.3	8.9	8.3	10.3	9.1	14.3	15.0	5.6	10.5	29.2	12.1	14.5	11.5	10.9	9.4	10.9	8.7	7.8	25.7	5.1	14.0	12.1	15.2	14.0	14.9	8.2	4.7	8.9	11.7	8.6	4.1	15.6	10.6	10.2	9.9	14.3	9.4	11.5	19.8	16.0	10.3	7.5	5.1	8.8	9.8	22.3	12.8	6.3	12.1	12.4	9.9	13.5	8.3	4.9	11.7	16.4	15.2	7.9	9.0	11.8	12.0	15.7	10.1	7.7	13.7	8.0	8.9	14.6	15.0	16.2	13.2	7.9	9.7	13.7	11.5	11.2	7.9	7.5	14.3	10.0	7.6	8.6	14.6	9.1	13.3	9.3	8.5	9.0	17.2	8.6	9.8	9.7	14.8	5.8	3.6	9.4	9.0	9.7	12.6	14.1	9.7	6.0	2.8	6.2	19.7	17.1	15.9	8.4	15.3	13.6	1.9	11.5	9.4	12.0	10.8	13.8	9.9	13.6	12.5	14.3	7.0	16.0	15.2	0.9	19.8	7.0	8.0	14.7	10.3	7.6	12.0	13.9	10.6	7.3	8.9	15.0	5.6	10.9	8.9	0.0	3.8	8.8	5.8	14.9	14.7	3.4	15.3	6.7	7.9	19.2	5.9	9.2	0.0	6.3	0.5	13.9	6.5	0.0	4.5	12.3	10.1	5.0	17.3	9.8	7.5	4.8	9.1	11.1	13.0	0.0	8.1	16.5	11.8	247.1	11.4	12.1	5.1	7.0	15.9	5.5	12.5	12.9	9.9	1.4	0.9	13.0	5.5	14.6	12.1	5.8
PREB	SEC12	ENSG00000138073	"Prolactin regulatory element binding"	Q9HCU5	2	27130756-27134675	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 89.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013582, HPA014133"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA013582: AB_1855694, HPA014133: AB_1855695"	"unprognostic (2.32e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.24e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.13e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.28e-2)"	18.7	17.1	11.4	14.4	12.3	7.9	15.7	13.8	16.9	18.5	15.5	14.9	29.1	13.4	23.6	51.1	15.1	17.6	14.2	19.5	13.8	12.5	21.2	70.1	12.9	15.3	13.0	11.8	27.3	31.5	13.8	17.0	21.5	12.9	16.2	13.2	14.8	42.3	22.4	46.3	11.0	17.3	19.4	11.6	19.8	14.9	15.6	10.1	17.6	19.6	16.3	19.5	15.1	14.2	22.1	35.1	45.8	28.3	28.9	27.0	27.2	15.4	15.5	9.0	14.3	19.6	7.6	16.8	11.2	11.2	16.3	11.5	14.5	9.7	19.2	11.9	11.0	17.6	8.9	17.6	14.0	8.9	14.4	16.1	15.7	7.8	31.3	29.1	17.9	14.9	7.5	17.0	15.3	17.6	8.0	10.5	15.4	11.5	17.3	13.9	17.9	16.6	13.9	9.4	20.0	16.5	15.7	18.1	89.8	10.8	8.2	20.4	11.0	10.8	22.3	16.0	8.4	10.0	30.9	6.2	8.7	12.7	7.5	12.5	38.6	16.1	23.2	14.6	20.5	16.5	28.2	28.3	45.8	24.7	23.4	27.0	22.1	21.1	25.0	29.5	20.1	20.5	21.1	12.0	28.9	24.3	35.1	22.8	27.2	11.4	12.3	13.8	16.9	13.8	12.5	13.0	11.8	12.9	10.1	14.9	10.1	22.3	8.5	16.0	12.0	14.1	20.4	1.4	3.4	19.2	11.8	39.5	29.9	25.3	2.8	9.0	22.4	0.0	31.0	52.2	16.7	13.3	24.1	28.8	33.7	6.4	8.1	13.5	17.2	6.0	21.9	12.8	18.6	16.2	13.2	20.3	27.2	17.5	42.1	21.4	9.6	32.3	19.8	29.8	46.7	15.2	64.8	24.9	17.0	11.2
PREX2	"DEP.2, DEPDC2, FLJ12987, P-REX2, PPP1R129"	ENSG00000046889	"Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2"	Q70Z35	8	67952118-68237030	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 31.5;Endothelial cells: 35.0;Ito cells: 52.8;Muller glia cells: 74.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 12.8;HUVEC TERT2: 17.4;JURKAT: 7.5;NTERA-2: 11.1;RH-30: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015234, HPA075956"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA015234: AB_1847604, HPA075956: AB_2686769"	"unprognostic (2.25e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.19e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.53e-2)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (8.30e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (6.64e-2)"	18.8	3.0	14.1	3.3	17.9	1.0	8.5	11.4	16.4	10.8	4.4	13.1	3.0	4.3	6.2	4.5	4.4	12.4	7.6	7.6	15.5	8.1	4.1	3.2	9.1	2.4	12.4	10.0	5.2	3.1	3.7	4.4	17.5	17.2	6.3	4.4	2.6	3.0	5.7	4.9	4.4	4.0	6.1	12.7	3.5	4.1	2.7	16.2	0.0	12.1	3.9	2.9	5.9	15.8	1.1	0.3	0.8	0.1	0.2	0.4	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	7.5	0.0	0.0	0.0	0.0	2.6	0.0	11.1	0.0	0.0	0.0	5.0	0.0	0.6	0.0	3.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.1	0.1	0.4	0.1	0.2	0.5	0.2	0.2	0.0	1.1	0.2	0.3	0.5	0.2	0.1	0.3	0.0	0.0	14.1	17.9	11.4	13.6	15.5	8.1	12.4	10.0	17.2	16.2	3.0	5.3	0.0	3.2	3.5	24.6	4.4	0.0	1.4	5.7	1.8	2.0	0.0	0.0	0.0	31.5	35.0	0.0	0.0	0.0	0.0	5.5	0.5	1.1	0.4	0.1	4.8	0.0	52.8	3.1	4.9	10.3	0.2	8.5	0.0	0.0	74.9	0.0	0.0	9.9	0.0	3.0	25.8	3.4	0.7	0.7	2.3	0.0	0.0	0.0	1.4
PRKCSH	"G19P1, GIIB, PCLD, PLD1, VASAP-60"	ENSG00000130175	"Protein kinase C substrate 80K-H"	P14314	19	11435288-11450968	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004465, HPA041940, HPA043560"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		62000000	"Endoplasmic reticulum"		"CAB004465: AB_626622, HPA041940: AB_2677758, HPA043560: AB_2678553"	"unprognostic (2.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (1.63e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.18e-1)"	46.9	37.4	26.9	32.5	28.5	50.9	45.0	37.8	39.4	46.8	42.6	36.3	50.1	43.6	50.1	48.4	41.2	50.2	50.2	31.5	27.7	27.3	41.2	85.6	39.9	53.2	29.6	32.1	72.6	77.7	52.9	40.3	72.7	27.0	48.8	38.4	43.9	58.8	53.1	31.3	43.8	41.8	40.1	38.6	42.5	37.9	42.8	29.8	51.6	60.1	32.7	41.9	44.6	44.9	26.2	44.1	32.8	29.8	19.5	28.5	19.4	48.4	34.0	37.8	63.3	64.8	84.0	39.3	52.2	71.3	61.2	57.8	49.6	54.6	31.2	84.6	71.8	30.6	48.2	38.9	56.8	49.6	33.4	25.0	27.1	42.7	43.0	48.5	42.2	39.8	76.7	42.5	57.5	45.4	75.7	41.9	35.1	31.3	70.7	52.9	71.5	32.9	48.8	79.5	23.1	44.0	35.2	34.5	79.3	42.6	42.5	24.0	47.3	45.6	47.5	42.7	36.1	48.8	46.8	42.2	74.4	35.1	70.5	61.1	87.0	103.5	21.7	56.9	44.4	50.7	15.9	29.8	23.8	24.9	22.2	28.5	23.9	21.0	23.8	22.6	26.2	20.3	21.3	32.8	19.5	24.4	44.1	22.0	19.4	26.9	28.5	37.8	39.4	27.7	27.3	29.6	32.1	27.0	29.8	11.9	16.3	75.4	50.7	37.2	17.1	7.8	66.2	16.0	11.4	61.1	31.4	147.4	28.2	75.5	15.3	39.1	147.7	0.0	111.1	158.0	54.4	53.8	41.5	78.4	82.6	9.5	56.6	52.2	73.7	39.6	72.8	59.1	50.6	87.4	103.8	61.8	88.9	99.5	68.2	54.0	21.2	38.8	46.2	36.5	51.7	33.1	120.0	55.4	107.3	50.1
PRR11	FLJ11029	ENSG00000068489	"Proline rich 11"	Q96HE9	17	59155499-59204705	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.8"	"Cell type enhanced"	"Detected in many"	14	"Erythroid cells: 46.7;Extravillous trophoblasts: 19.2;Kupffer cells: 13.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 10.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023923, HPA052376"	Uncertain		Approved	"Endoplasmic reticulum"		Yes	Yes			"Endoplasmic reticulum"		"HPA023923: AB_1855783, HPA052376: AB_2681803"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.35e-7)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.56e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.55e-3)"	3.2	1.4	2.8	13.8	4.2	14.9	2.0	0.9	2.8	3.1	4.2	2.2	0.7	6.9	2.0	2.1	10.3	1.7	2.1	1.4	3.1	2.3	1.7	1.1	3.4	9.6	3.2	1.6	1.7	1.0	0.2	0.6	4.8	2.0	1.2	5.5	1.2	2.2	0.5	1.3	2.9	4.8	3.2	5.1	7.3	2.5	2.5	2.1	40.8	1.3	7.7	11.7	2.8	3.2	1.4	3.0	2.5	10.6	0.7	2.0	0.8	27.6	13.3	21.0	6.1	0.6	4.9	8.6	17.2	10.8	17.9	14.3	16.4	18.7	17.9	17.6	12.6	14.6	10.2	16.1	17.7	39.3	24.8	10.3	19.7	14.7	11.0	0.2	20.8	8.3	1.1	1.3	19.7	26.2	4.4	20.2	15.0	10.7	19.5	19.1	21.5	20.4	3.7	8.7	13.0	22.5	16.4	31.5	11.5	4.8	7.5	9.1	12.6	14.2	5.2	7.5	10.6	14.0	8.0	13.7	36.8	43.0	18.5	30.6	12.6	24.2	18.0	8.2	11.6	35.9	1.0	2.3	2.5	0.8	5.1	0.3	1.4	0.6	1.0	3.0	0.9	0.6	0.8	2.3	0.7	10.6	1.6	2.0	0.8	2.8	4.2	0.9	2.8	3.1	2.3	3.2	1.6	2.0	2.1	0.0	1.7	7.0	1.9	1.6	2.0	0.8	0.0	0.0	2.3	0.0	0.0	1.8	0.0	0.3	0.5	1.1	0.4	46.7	0.4	19.2	1.6	1.0	2.3	0.0	6.5	1.6	4.7	3.7	13.3	0.2	0.9	5.1	1.7	6.4	2.2	0.8	0.6	0.0	2.1	0.3	2.8	0.0	2.1	3.0	5.1	1.1	1.7	2.5	4.3	1.4
PTGES	"MGST-IV, MGST1-L1, MGST1L1, PIG12, TP53I12"	ENSG00000148344	"Prostaglandin E synthase"	O14684	9	129738331-129753047	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 59.8;placenta: 51.7;seminal vesicle: 182.9"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 118.4;Extravillous trophoblasts: 226.1;Fibroblasts: 92.9;Syncytiotrophoblasts: 231.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 16.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 30.0;BEWO: 31.9;GAMG: 57.8;HaCaT: 41.7;SK-BR-3: 30.6;U-2197: 79.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA045064	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA045064: AB_10795889"	"unprognostic (2.92e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (2.22e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.20e-2)"	17.0	0.6	1.1	6.2	1.7	3.0	16.7	1.1	1.8	11.9	4.2	0.8	59.8	1.2	2.0	9.1	8.7	2.7	4.1	4.2	2.1	3.5	3.9	0.4	3.5	3.1	1.3	0.7	2.7	0.6	6.3	0.7	51.7	2.1	11.2	2.0	2.9	16.3	182.9	2.5	19.8	3.7	4.8	1.4	1.3	3.4	9.9	0.6	2.3	1.7	6.6	14.1	14.5	15.0	0.0	0.1	16.8	3.2	0.0	0.0	0.1	0.2	18.7	0.0	8.9	30.0	10.4	31.9	1.4	12.3	0.2	0.3	0.9	13.7	0.0	0.5	3.4	57.8	41.7	0.1	1.4	0.1	0.0	0.1	0.0	13.3	0.0	0.7	0.0	0.0	6.1	9.7	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	8.9	1.6	0.0	0.0	0.0	1.0	19.9	0.1	0.7	16.7	30.6	0.1	1.3	16.0	0.0	0.0	0.0	0.0	79.1	0.0	0.0	0.0	0.0	15.7	0.0	0.1	16.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	3.2	0.0	0.0	0.1	1.1	1.7	1.1	1.8	2.1	3.5	1.3	0.7	2.1	0.6	0.0	0.0	0.0	8.2	15.9	0.0	0.0	0.0	0.0	4.5	3.5	0.0	118.4	1.7	10.6	0.4	0.3	0.0	0.0	1.0	226.1	92.9	6.9	1.1	0.0	15.4	0.0	7.0	0.0	0.0	0.0	0.3	3.8	13.5	12.6	6.4	0.0	5.7	0.0	0.0	0.5	0.0	0.0	11.2	0.3	0.0	37.6	231.0	0.0	0.3	38.2
PTGIS	"CYP8A1, PGIS"	ENSG00000124212	"Prostaglandin I2 synthase"	Q16647	20	49503874-49568146	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Lyase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 88.2"	"Group enriched"	"Detected in many"	8	"Ito cells: 78.5;Leydig cells: 24.7;Peritubular cells: 98.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"ASC diff: 17.8;ASC TERT1: 17.9;U-2197: 55.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009517, HPA014193, HPA052244"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB009517: AB_2173209, HPA014193: AB_1855746, HPA052244: AB_2732574"	"unprognostic (7.68e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.45e-2)"	"unprognostic (5.22e-2)"	"prognostic unfavorable (4.74e-8)"	"unprognostic (2.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (9.99e-5)"	18.2	2.5	0.6	8.0	1.3	0.1	28.3	0.2	1.6	23.3	14.6	0.5	6.5	1.7	36.5	21.7	13.2	32.0	36.3	23.8	0.3	0.5	3.0	3.8	7.5	1.6	0.5	0.9	51.2	1.3	0.2	0.5	1.0	1.0	27.2	3.7	3.2	3.7	4.6	7.0	3.2	4.4	88.2	1.4	0.3	8.7	16.2	0.3	0.0	6.7	5.6	1.7	64.2	36.1	1.0	0.8	2.7	0.6	0.8	0.5	0.1	0.0	0.0	0.7	0.0	17.8	17.9	0.2	0.3	2.1	0.0	0.0	0.0	0.0	0.0	7.1	5.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.3	0.0	0.2	0.0	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.3	0.9	55.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.6	0.4	0.4	0.4	0.3	0.4	0.3	0.3	0.1	1.0	0.4	0.5	2.7	0.8	0.3	0.8	0.2	0.1	0.6	1.3	0.2	1.6	0.3	0.5	0.5	0.9	1.0	0.3	3.0	2.4	0.0	0.6	3.3	0.8	3.4	0.0	4.0	3.4	3.5	0.0	0.3	0.0	0.4	1.7	3.8	0.0	0.0	0.0	0.1	8.3	0.3	0.0	0.6	0.3	0.0	0.0	78.5	1.5	2.2	24.7	0.7	1.7	0.0	0.0	0.3	0.7	0.0	98.6	0.0	4.6	0.0	2.5	0.7	1.1	4.3	0.2	0.5	0.0	0.6
PTGS2	COX2	ENSG00000073756	"Prostaglandin-endoperoxide synthase 2"	P35354	1	186671791-186680427	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"ductus deferens: 324.6;seminal vesicle: 377.9"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 318.6;Glandular cells: 122.9;granulocytes: 329.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"neutrophil: 12.8"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 12.8"	"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 95.4"	"Region enhanced"	"Detected in many"		"hippocampal formation: 16.5"	"Low region specificity"	"Detected in all"			"CAB000113, HPA001335"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"CAB000113: , HPA001335: AB_1079712"	"unprognostic (1.36e-3)"	"unprognostic (9.97e-3)"	"unprognostic (3.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.96e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (8.04e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.74e-2)"	5.7	2.1	1.2	3.7	1.1	32.6	1.5	0.8	1.9	21.1	11.4	1.1	324.6	0.4	2.3	1.8	1.7	4.0	9.5	9.1	1.1	1.0	3.3	2.7	22.1	2.3	1.3	0.8	1.6	0.4	3.1	2.2	2.5	1.9	9.2	2.7	3.9	0.9	377.9	1.0	1.1	2.4	7.7	4.7	0.9	11.4	1.0	0.9	0.6	1.5	3.4	1.3	17.3	1.9	0.0	0.5	12.8	0.8	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.6	0.5	0.0	21.8	95.4	0.1	0.8	3.4	4.0	0.0	0.0	0.1	0.6	2.9	0.0	1.7	0.3	0.0	0.0	0.2	0.5	0.0	3.2	0.0	0.1	0.2	0.6	2.7	6.9	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.2	0.0	0.2	0.6	0.0	0.1	0.3	4.6	0.1	3.2	0.1	0.0	0.0	0.0	6.7	0.1	0.5	0.0	0.4	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	12.8	0.0	0.4	0.0	0.0	0.0	1.2	1.1	0.8	1.9	1.1	1.0	1.3	0.8	1.9	0.9	318.6	102.3	0.5	47.5	105.6	0.0	1.9	0.0	8.1	53.4	0.0	0.0	0.1	0.0	0.8	0.2	14.3	0.0	0.0	0.2	0.2	36.1	122.9	329.1	0.0	11.5	0.0	1.2	6.7	16.5	0.0	0.0	112.3	33.7	0.0	0.5	0.0	3.2	0.0	0.0	0.0	0.2	0.0	21.7	0.1	0.4	24.8	0.5	0.0	1.3	107.5
PTN	"HBGF8, HBNF, NEGF1"	ENSG00000105894	Pleiotrophin	P21246	7	137227341-137343865	"Cancer-related genes, Predicted secreted proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 160.7"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 182.0;Extravillous trophoblasts: 368.5;Fibroblasts: 184.0;Horizontal cells: 497.4;Leydig cells: 159.9;Muller glia cells: 523.9;Peritubular cells: 174.3;Syncytiotrophoblasts: 161.7"	"Cancer enriched"	"Detected in all"	11	"glioma: 514.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"AF22: 190.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017685, HPA073913"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	167000	1800000	"Endoplasmic reticulum"		"CAB017685: AB_1128556, HPA073913: "	"unprognostic (1.51e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	7.8	6.6	55.5	2.0	43.3	0.9	27.7	38.6	58.5	30.7	7.2	26.9	9.9	2.5	25.2	18.7	25.0	7.2	18.2	29.4	42.3	29.7	12.7	3.4	6.5	2.6	31.6	27.0	7.2	3.4	160.7	52.5	11.8	31.4	38.5	7.7	19.0	12.0	18.1	1.5	3.6	4.0	17.7	23.4	12.4	5.4	16.8	23.3	1.3	5.1	8.7	5.3	7.7	18.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	190.8	2.3	0.0	0.1	15.6	4.9	14.6	2.7	3.8	0.0	0.0	0.0	0.0	6.4	1.7	0.1	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	1.8	0.0	2.7	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	14.7	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.9	13.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	4.2	3.7	0.2	10.6	0.0	0.0	0.0	13.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	43.3	38.6	42.0	42.3	29.7	31.6	27.0	31.4	23.3	0.0	0.0	0.0	1.3	20.6	19.5	14.2	0.0	2.7	4.5	1.8	5.9	182.0	8.3	1.2	11.9	8.4	0.0	0.0	0.0	368.5	184.0	17.1	0.0	0.0	18.1	497.4	0.0	8.6	0.3	8.3	159.9	1.4	42.2	0.0	0.0	523.9	0.2	0.0	174.3	5.1	27.0	58.2	33.4	1.8	1.5	12.2	161.7	0.0	0.0	2.0
PTPN1	PTP1B	ENSG00000196396	"Protein tyrosine phosphatase, non-receptor type 1"	P18031	20	50510321-50585241	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 211.4;monocytes: 327.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009329, HPA012542, CAB015217"	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA		11000	"Endoplasmic reticulum"		"CAB009329: AB_2174944, CAB015217: , HPA012542: AB_1855915"	"unprognostic (1.67e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.40e-2)"	"unprognostic (6.47e-3)"	"unprognostic (5.87e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.58e-2)"	22.1	22.2	12.1	31.9	16.0	35.3	17.9	12.9	16.6	18.2	17.8	18.8	14.2	10.5	20.0	16.6	23.2	17.1	18.0	20.5	15.8	9.0	43.8	16.7	42.7	36.1	14.1	14.1	21.8	12.2	31.2	18.8	28.3	18.7	20.0	14.8	21.0	16.3	15.0	41.0	18.6	21.9	16.9	15.8	45.3	17.5	23.5	13.3	26.9	15.7	13.9	42.8	20.0	18.4	15.9	9.4	18.8	16.4	3.9	10.7	6.4	21.1	10.7	12.9	8.9	8.5	11.7	18.4	14.2	13.6	41.9	15.3	31.3	44.6	10.5	25.3	13.1	16.5	18.8	10.2	40.9	26.7	15.5	9.1	14.8	10.4	16.5	16.9	15.4	20.4	13.6	28.7	18.9	23.3	18.4	24.0	12.8	25.8	9.7	22.7	11.8	16.5	12.2	6.8	11.7	14.7	14.7	15.0	10.0	24.1	15.9	10.4	11.9	20.4	26.0	23.0	11.3	16.8	16.5	35.6	36.6	14.7	16.4	17.6	10.6	8.5	12.8	22.9	10.5	13.5	12.0	5.6	18.8	10.7	9.5	7.9	15.9	9.0	8.2	5.5	13.7	7.7	8.3	12.2	3.9	16.4	9.4	7.1	6.4	12.1	16.0	12.9	16.6	15.8	9.0	14.1	14.1	18.7	13.3	211.4	72.3	67.9	44.4	76.4	23.0	27.2	10.2	32.1	47.8	34.9	45.2	41.8	19.9	20.5	47.2	26.1	20.4	0.0	16.9	17.3	21.4	26.7	67.2	18.6	32.9	41.3	17.9	37.4	28.2	22.4	13.0	52.2	35.4	327.4	13.7	13.8	28.9	11.5	11.3	59.6	25.9	19.4	34.0	20.7	24.3	41.3	45.4	43.7	15.5	55.1
PTPN5	"PTPSTEP, STEP, STEP61"	ENSG00000110786	"Protein tyrosine phosphatase, non-receptor type 5"	P54829	11	18727928-18792721	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"brain: 70.0"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 2.4;Distal tubular cells: 1.7;Endothelial cells: 2.4"	"Group enriched"	"Detected in some"	6	"glioma: 1.6;testis cancer: 2.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 70.0"	"Cell type enriched"	"Detected in single"	9	"basophil: 1.5"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HMC-1: 3.7;NTERA-2: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031014, HPA072091"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA031014: AB_10669550, HPA072091: AB_2686487"	"unprognostic (1.23e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.83e-3)"	"unprognostic (3.59e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.58e-1)"	"unprognostic (8.44e-4)"	"unprognostic (4.21e-3)"	"unprognostic (3.90e-2)"	"unprognostic (9.39e-2)"	"unprognostic (8.49e-2)"	2.5	1.6	16.3	1.1	70.0	1.1	1.2	0.9	47.5	1.5	1.1	0.4	0.0	1.1	1.2	1.0	1.3	1.7	1.4	4.3	9.1	8.6	1.1	0.9	2.7	1.1	3.5	16.0	2.5	1.2	1.5	0.5	0.9	6.1	1.6	1.4	0.0	1.3	1.7	1.8	1.0	1.4	1.4	2.1	1.3	1.3	3.4	9.3	0.0	1.2	0.0	1.0	1.5	0.3	0.1	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.1	0.0	3.7	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	5.8	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.4	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	70.0	0.9	25.1	9.1	8.6	3.5	16.0	6.1	9.3	0.0	0.0	0.0	0.0	0.1	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0
PTPRN	"IA-2, ICA512"	ENSG00000054356	"Protein tyrosine phosphatase, receptor type N"	Q16849	2	219289623-219309648	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Receptor	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 89.6;pancreas: 28.9;pituitary gland: 43.4"	"Group enriched"	"Detected in some"	13	"Bipolar cells: 48.9;Cone photoreceptor cells: 56.9;Horizontal cells: 92.2;Intestinal endocrine cells: 45.2;Rod photoreceptor cells: 31.1"	"Group enriched"	"Detected in some"	12	"glioma: 5.3;pancreatic cancer: 18.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"U-2 OS: 20.3;U-87 MG: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007152, HPA007179"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA007152: AB_2667759, HPA007179: AB_1079714"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-4)"	"unprognostic (2.91e-3)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (1.45e-7)"	"unprognostic (3.64e-2)"	"unprognostic (1.24e-4)"	"unprognostic (1.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.20e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-10)"	"unprognostic (1.43e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.61e-2)"	1.7	22.3	19.3	4.7	35.7	1.7	1.3	17.3	89.6	1.2	2.4	2.5	0.0	2.5	1.5	1.2	1.5	1.3	1.5	1.4	21.6	40.1	1.5	1.2	1.4	1.3	14.4	19.8	1.3	28.9	1.2	43.4	1.4	22.0	1.4	1.9	3.1	1.2	1.3	1.2	2.0	2.5	2.4	3.5	1.3	6.0	1.4	2.1	0.0	1.5	0.0	1.2	2.7	0.0	0.1	0.3	0.2	0.0	0.0	0.6	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.3	1.3	2.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.6	0.0	0.1	2.5	0.0	6.2	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	3.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.0	0.0	0.2	75.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.6	3.7	19.3	35.7	17.3	54.0	21.6	40.1	14.4	19.8	22.0	2.1	0.0	0.0	0.0	0.1	0.1	48.9	1.7	0.0	0.0	0.0	0.0	56.9	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	92.2	45.2	0.0	0.0	0.2	0.3	0.0	1.7	0.0	0.0	4.1	4.3	0.0	0.0	0.0	31.1	0.0	0.3	2.2	2.3	0.1	0.0	0.0	0.0	0.0
RAB42	MGC45806	ENSG00000188060	"RAB42, member RAS oncogene family"	Q8N4Z0	1	28592200-28595443	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.3"	"Cell type enriched"	"Detected in some"	7	"Hofbauer cells: 74.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.6;Hep G2: 15.5;HSkMC: 11.0;REH: 8.5"									HPA050290			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA050290: AB_2681075"	"unprognostic (1.10e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.25e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.00e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.07e-3)"	4.3	1.2	0.8	1.8	1.6	0.4	3.2	0.8	1.6	3.7	2.3	0.8	0.8	1.8	3.1	4.1	1.5	1.4	2.4	1.3	1.6	0.5	1.5	3.2	3.4	14.3	1.2	0.8	1.4	0.8	5.0	0.8	6.2	1.2	3.3	2.5	1.7	4.2	0.8	1.5	0.9	2.3	1.8	5.5	5.9	1.6	3.0	0.8	3.4	1.0	0.8	4.4	4.1	1.8	0.7	0.7	1.2	0.9	2.4	0.5	0.1	0.1	1.2	1.0	0.0	4.6	10.6	0.0	0.7	4.4	4.6	6.1	2.2	1.5	0.2	2.9	5.0	0.4	0.1	4.5	0.0	3.0	0.1	0.1	0.4	7.1	15.5	1.8	1.2	0.0	11.0	0.2	2.8	0.0	0.4	1.4	0.1	0.2	0.1	0.9	0.0	0.2	2.4	5.4	0.1	0.0	8.5	0.0	1.8	1.8	0.0	0.3	2.1	4.2	0.1	0.0	0.7	0.1	2.0	0.7	0.0	1.4	4.6	0.1	0.4	2.8	0.2	0.2	4.5	0.1	1.2	0.9	0.2	0.3	0.4	0.3	0.6	0.2	0.2	0.7	0.7	0.5	0.4	0.9	2.4	0.8	0.4	0.1	0.1	0.8	1.6	0.8	1.6	1.6	0.5	1.2	0.8	1.2	0.8	0.0	0.0	0.0	0.2	0.1	0.3	0.3	0.0	0.0	1.2	0.0	0.0	0.5	0.0	6.9	4.0	0.1	0.0	0.0	0.0	0.6	2.3	0.2	0.0	0.0	74.2	0.0	0.0	2.5	2.9	10.0	1.4	4.4	0.0	1.8	0.0	0.9	1.9	0.3	0.0	0.3	0.9	0.0	0.9	1.5	1.9	0.4	0.3	0.0	0.0	0.1
RASGRF2	"GRF2, Ras-GRF2"	ENSG00000113319	"Ras protein specific guanine nucleotide releasing factor 2"	O14827	5	80960672-81230156	"Predicted intracellular proteins, RAS pathway related proteins"		"Calmodulin-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 23.8;ovary: 24.6"	"Cell type enhanced"	"Detected in many"	13	"Cone photoreceptor cells: 55.0;Extravillous trophoblasts: 22.2;Rod photoreceptor cells: 37.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.8;MAIT T-cell: 7.7;memory CD4 T-cell: 3.8;memory CD8 T-cell: 2.2;naive CD4 T-cell: 6.4;naive CD8 T-cell: 4.3"	"Lineage enriched"	"Detected in single"	78	"T-cells: 7.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 23.7;CACO-2: 14.3;EFO-21: 7.5;Hep G2: 19.0;HHSteC: 13.2;hTERT-RPE1: 9.6;SuSa: 10.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 41.1;cerebral cortex: 118.3;hippocampal formation: 72.9;olfactory region: 58.3"	HPA018679	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA018679: AB_1856089"	"unprognostic (1.32e-1)"	"unprognostic (6.96e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.37e-3)"	"unprognostic (2.13e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.12e-1)"	13.3	1.6	11.6	4.3	14.0	1.5	5.4	1.5	23.8	3.8	2.7	18.7	1.5	2.7	3.9	1.6	2.1	2.6	7.1	4.3	11.1	6.6	6.6	1.0	3.8	4.5	8.5	5.5	24.6	1.4	6.8	3.4	13.2	8.9	5.3	2.3	17.1	1.9	2.4	3.1	1.5	2.9	3.8	15.2	3.0	2.3	2.9	5.6	0.0	4.3	1.1	3.9	4.1	2.4	0.0	0.0	0.0	0.0	0.0	7.7	1.5	0.0	1.3	0.3	0.1	0.0	0.0	23.7	0.4	5.7	0.2	0.3	14.3	0.0	0.2	7.5	0.0	0.1	0.4	0.0	0.0	0.7	0.3	2.4	0.1	0.1	19.0	13.2	0.0	0.0	0.6	0.0	5.5	0.0	9.6	0.1	0.3	0.0	0.1	0.0	0.2	0.1	0.1	2.8	0.0	0.0	0.1	2.8	0.0	0.9	0.0	0.2	0.3	0.1	0.0	0.2	10.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	2.8	0.0	7.7	0.0	3.8	2.2	0.0	0.0	6.4	4.3	0.0	0.0	0.0	0.0	0.8	1.5	11.6	14.0	1.5	23.8	11.1	6.6	8.5	5.5	8.9	5.6	0.0	1.4	0.0	0.2	1.4	11.6	3.2	0.0	0.0	1.2	8.7	55.0	0.2	0.0	0.2	9.9	14.6	0.0	0.0	0.0	22.2	0.8	0.2	0.0	0.0	1.0	1.6	0.0	4.9	0.8	2.1	0.9	0.0	1.7	0.0	0.0	2.0	0.4	0.2	8.5	2.1	37.2	0.0	1.0	7.2	1.4	0.5	0.7	4.4	0.8	0.4
RCN1	"FLJ37041, PIG20, Rcal, RCN"	ENSG00000049449	"Reticulocalbin 1"	Q15293	11	32090904-32105755	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 123.1"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 242.1;Muller glia cells: 309.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA038474, HPA062104"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		2300000	"Endoplasmic reticulum"		"HPA038474: AB_10672595, HPA062104: AB_2684683"	"unprognostic (1.65e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.03e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.92e-3)"	"prognostic unfavorable (7.13e-6)"	"unprognostic (8.85e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.32e-2)"	"prognostic unfavorable (2.70e-13)"	"unprognostic (1.78e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.93e-3)"	25.0	19.8	9.6	14.3	38.8	1.6	38.2	7.6	11.4	22.3	13.6	5.8	17.0	10.8	23.3	123.1	12.2	18.2	15.3	19.4	9.2	9.8	12.4	33.7	17.9	20.2	7.0	5.9	35.2	16.4	17.9	34.9	32.6	9.7	22.6	12.6	11.4	37.0	24.2	12.8	9.1	10.5	19.2	10.9	11.5	11.8	11.4	6.9	5.4	16.8	10.0	6.9	25.3	32.3	4.3	11.0	0.5	11.8	7.5	12.4	6.5	13.4	14.5	33.6	22.4	82.6	63.0	38.7	46.2	56.4	32.6	58.9	12.7	17.2	0.0	32.0	75.3	40.8	16.6	12.1	13.7	49.1	6.5	26.4	2.9	10.5	4.6	61.1	2.1	4.4	87.7	17.1	20.6	23.3	36.9	71.4	6.2	1.7	2.4	37.3	11.1	6.1	4.1	14.4	0.1	16.4	4.7	42.1	3.9	27.8	31.3	9.0	4.7	12.3	2.9	35.4	24.6	17.7	8.5	37.2	42.3	24.1	36.6	39.1	0.1	0.1	0.1	58.7	2.7	23.9	0.2	10.0	0.3	12.4	11.8	9.7	4.3	5.7	9.9	11.0	3.5	4.2	8.0	0.5	7.5	7.2	6.4	2.0	6.5	9.6	38.8	7.6	11.4	9.2	9.8	7.0	5.9	9.7	6.9	50.6	33.3	14.5	59.0	37.0	39.4	8.5	35.7	38.8	54.6	45.4	11.8	140.9	6.6	116.4	132.8	75.8	7.0	0.0	39.7	242.1	157.4	112.2	12.7	53.4	41.2	14.3	51.0	85.3	14.3	130.4	74.5	21.1	30.4	70.3	54.8	309.5	40.2	24.6	68.6	12.6	14.1	25.8	71.0	10.7	6.4	24.7	181.5	9.2	62.9	78.0
RCN2	"E6BP, ERC-55, ERC55, TCBP49"	ENSG00000117906	"Reticulocalbin 2"	Q14257	15	76931619-76954392	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 147.5"	"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 314.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030694, HPA030695"	Enhanced	Supported	Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		41000	"Endoplasmic reticulum"		"HPA030694: AB_2673573, HPA030695: AB_2673574"	"unprognostic (1.69e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (7.36e-5)"	"unprognostic (1.74e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.67e-2)"	13.8	14.7	29.9	12.1	32.6	9.9	16.8	25.1	37.5	16.8	15.0	17.3	28.1	10.4	20.6	147.5	14.9	25.0	15.3	17.3	29.5	41.5	22.6	9.3	13.5	12.5	27.2	29.5	18.8	11.0	28.4	17.8	27.7	24.6	19.6	17.2	15.5	12.0	21.9	22.7	10.6	11.0	18.2	18.5	12.4	13.8	48.2	14.8	14.8	22.1	17.0	14.3	17.8	13.3	15.9	12.0	9.8	7.2	14.1	19.0	11.5	20.2	14.4	64.4	30.3	27.9	31.8	40.3	24.2	33.1	31.6	26.5	17.8	17.5	12.7	35.2	26.3	34.1	31.2	48.6	20.9	40.5	9.7	38.0	6.3	21.1	29.4	33.3	22.6	9.7	28.7	28.9	15.5	20.0	33.5	33.3	21.9	15.8	12.7	32.9	13.0	22.4	15.6	49.0	21.4	16.1	23.7	42.4	8.1	20.8	27.4	36.8	36.8	39.6	22.2	46.1	59.9	21.6	25.2	17.8	37.4	30.2	23.7	49.7	18.3	56.3	15.1	21.3	19.1	33.8	4.5	4.8	9.8	14.8	4.4	17.2	14.8	15.7	19.0	10.2	15.9	17.8	17.2	2.6	14.1	7.2	12.0	10.9	11.5	29.9	32.6	25.1	37.5	29.5	41.5	27.2	29.5	24.6	14.8	23.8	40.4	56.2	99.4	72.9	83.3	92.8	50.9	25.4	19.4	94.2	35.3	163.6	41.4	99.8	42.5	52.4	14.8	23.3	39.4	255.8	92.7	76.9	28.8	26.7	49.5	120.8	70.6	55.9	24.2	59.2	57.2	29.6	87.7	34.3	51.1	85.4	53.2	35.1	88.1	44.0	51.5	58.2	72.1	314.9	144.1	61.9	136.8	66.0	76.6	95.7
REEP5	"C5orf18, D5S346, DP1, TB2, Yip2e"	ENSG00000129625	"Receptor accessory protein 5"	Q00765	5	112876379-112922539	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003895, HPA069960"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		13000	"Endoplasmic reticulum"		"HPA003895: AB_1845723, HPA069960: AB_2686221"	"unprognostic (3.26e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (5.23e-6)"	"unprognostic (8.29e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.05e-5)"	"unprognostic (2.88e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.24e-2)"	22.7	35.7	39.7	14.2	47.9	7.3	46.2	33.9	65.2	32.3	21.6	23.1	33.2	17.1	19.7	45.7	16.7	22.1	20.6	42.3	37.9	45.8	50.9	50.6	26.6	13.9	37.8	37.2	25.0	56.7	45.5	21.8	41.3	72.7	34.8	20.7	20.7	49.0	32.4	31.9	20.8	18.9	18.5	33.1	19.0	22.0	10.0	21.7	6.3	84.6	20.1	18.1	22.0	19.9	38.8	42.8	55.3	63.4	23.4	39.1	44.7	19.5	17.0	6.4	13.8	30.6	27.0	21.5	18.1	17.8	19.6	20.0	14.4	26.7	7.6	35.9	22.3	19.9	19.3	14.5	28.7	20.7	37.2	19.1	8.1	13.6	11.4	28.4	6.6	14.1	17.7	28.8	15.9	15.9	21.1	24.4	6.5	4.7	17.5	26.2	18.5	3.0	11.8	8.9	12.7	12.3	4.1	18.0	22.2	51.7	21.5	11.4	8.7	24.5	49.2	17.8	18.2	56.6	12.0	25.6	17.6	6.6	24.1	24.7	18.6	22.7	6.5	30.6	12.2	9.0	34.7	50.7	49.3	33.6	54.7	35.3	38.8	27.2	31.9	42.8	32.4	12.6	23.3	55.3	23.4	63.4	31.2	39.1	44.7	39.7	47.9	33.9	65.2	37.9	45.8	37.8	37.2	72.7	21.7	154.9	81.7	96.8	143.7	82.7	81.7	184.9	124.9	96.4	99.0	184.9	84.4	245.6	69.6	243.7	114.2	118.6	82.0	0.0	360.9	269.2	175.7	189.5	105.2	181.1	246.4	82.6	113.3	107.4	124.9	21.8	107.6	190.0	195.7	116.4	93.7	87.2	282.5	138.2	125.9	116.5	66.5	109.9	132.3	117.2	39.2	88.8	409.6	104.6	92.3	181.0
REEP6	"C19orf32, DP1L1, FLJ25383, Yip2f"	ENSG00000115255	"Receptor accessory protein 6"	Q96HR9	19	1490747-1497927	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 90.8;liver: 119.0;testis: 71.2"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 2546.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 114.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 16.1;Hep G2: 15.4;K-562: 42.7;T-47d: 35.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA003895, HPA048015"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		26000	"Endoplasmic reticulum"		"HPA003895: AB_1845723, HPA048015: AB_2680233"	"unprognostic (1.21e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.24e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.38e-2)"	2.4	20.1	4.1	0.7	5.9	0.6	3.9	3.1	6.0	1.4	41.7	2.8	4.4	60.2	1.0	5.7	2.7	1.4	7.6	0.9	4.5	1.9	6.1	119.0	0.6	0.7	2.6	2.1	1.7	10.1	0.5	2.2	0.7	2.1	4.9	0.7	27.4	5.6	11.8	0.7	1.7	90.8	1.1	1.6	0.6	1.3	71.2	1.1	0.3	1.6	1.1	2.1	3.2	1.2	1.0	4.2	0.1	4.8	5.8	7.1	2.3	2.0	2.5	0.8	10.5	1.6	0.5	11.7	0.5	0.1	0.5	0.5	16.1	6.6	1.1	3.7	0.3	0.7	2.1	2.7	0.1	0.2	0.5	1.1	6.1	0.3	15.4	1.2	0.4	2.0	1.3	1.1	0.0	0.3	0.9	0.3	1.4	42.7	1.5	0.1	8.1	0.5	1.3	3.9	5.9	5.7	1.6	0.3	2.7	3.0	0.9	0.2	5.8	2.8	4.1	1.7	0.4	35.7	1.6	0.9	0.8	1.7	2.5	0.4	5.1	1.4	0.1	3.6	2.6	2.3	0.0	1.5	0.0	7.1	1.7	3.8	0.1	2.1	1.5	2.5	1.0	2.8	3.2	0.1	5.8	4.8	4.2	2.0	2.3	4.1	5.9	3.1	6.0	4.5	1.9	2.6	2.1	2.1	1.1	3.0	2.7	3.4	6.8	6.1	23.2	1.6	86.6	5.3	6.8	5.2	31.4	55.0	6.6	28.9	512.6	2.8	17.0	0.0	61.1	7.5	2.5	15.7	10.3	229.1	8.2	22.3	5.8	4.3	5.7	2546.7	31.7	4.3	28.7	1.8	10.4	27.6	24.6	6.0	15.6	36.0	217.9	19.4	2.6	24.2	30.4	5.8	30.1	5.1	11.0	11.2
RETREG1	"FAM134B, FLJ20152, JK1"	ENSG00000154153	"Reticulophagy regulator 1"	Q9H6L5	5	16473038-16617058	"Disease related genes, Predicted membrane proteins"	Autophagy		"Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 45.0;skeletal muscle: 78.5"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 68.5;Exocrine glandular cells: 51.0;Pancreatic endocrine cells: 69.1;Proximal tubular cells: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 4.0;T-cells: 4.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 16.3;GAMG: 12.6;HSkMC: 18.1;RPTEC TERT1: 16.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012077			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA012077: AB_2668621"	"unprognostic (1.63e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (5.25e-10)"	"unprognostic (3.75e-1)"	"unprognostic (9.96e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.58e-1)"	9.8	2.0	8.5	3.7	11.2	1.1	8.7	9.6	19.6	7.4	12.4	14.9	0.3	6.5	2.3	5.4	2.0	4.1	7.1	45.0	11.2	9.4	30.3	21.8	4.9	3.1	13.2	11.4	1.7	19.0	17.7	8.0	6.7	18.5	5.9	16.9	1.5	3.9	3.0	78.5	5.6	12.8	1.5	16.8	1.6	6.1	5.7	15.4	14.1	3.6	12.5	2.3	2.0	4.4	0.9	0.1	4.0	0.4	0.1	4.4	0.6	0.8	0.3	0.1	2.1	16.3	2.0	9.5	0.1	2.1	1.9	2.6	1.4	0.1	0.2	1.5	0.0	12.6	2.4	4.8	0.5	0.6	2.4	2.1	0.0	7.2	0.0	0.1	3.1	0.0	18.1	7.4	0.3	2.0	4.7	0.0	9.3	0.0	0.1	0.7	0.6	11.9	0.0	0.5	2.1	0.3	1.9	0.0	0.7	16.6	0.5	10.8	1.2	0.6	0.7	7.8	1.2	3.6	1.4	0.0	1.5	0.2	4.0	1.8	0.4	0.0	0.0	9.3	10.7	3.9	4.0	0.4	0.1	0.6	0.0	1.6	0.0	1.5	0.8	0.1	0.9	4.4	2.7	2.3	0.1	0.1	0.0	1.9	0.6	8.5	11.2	9.6	14.4	11.2	9.4	13.2	11.4	18.5	15.4	68.5	7.5	0.0	0.0	0.0	0.0	0.0	0.0	34.8	18.2	41.8	0.0	39.1	14.9	25.9	0.0	0.0	0.0	0.0	51.0	2.5	0.0	0.0	1.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.8	0.0	0.0	69.1	0.0	0.0	147.8	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0
RHAG	"CD241, RH50A, SLC42A1"	ENSG00000112077	"Rh associated glycoprotein"	Q02094	6	49605158-49636884	"CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"		"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"bone marrow: 54.1"	"Cell type enriched"	"Detected in some"	50	"Erythroid cells: 116.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	190	"HEL: 87.8;K-562: 86.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046051, HPA055331"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA046051: , HPA055331: AB_2682785"					"unprognostic (8.16e-2)"						"unprognostic (6.86e-2)"	"unprognostic (1.25e-3)"		"unprognostic (1.65e-1)"				1.2	0.2	0.0	1.1	0.5	54.1	3.2	0.0	0.1	2.3	1.0	0.5	1.7	0.2	0.4	0.1	2.6	0.5	0.8	5.3	0.0	0.0	0.1	0.7	3.3	0.1	0.0	0.0	0.1	0.2	0.1	0.1	5.8	0.1	1.3	0.2	0.0	0.2	0.5	0.4	0.1	0.9	0.1	0.0	4.5	0.6	0.2	0.0	1.7	1.8	0.0	0.1	0.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	116.8	0.2	0.3	0.0	0.0	2.3	0.0	0.4	0.0	0.0	1.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
RHBDD1	DKFZp547E052	ENSG00000144468	"Rhomboid domain containing 1"	Q8TEB9	2	226835581-226999215	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Differentiation, Spermatogenesis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013972, HPA057125"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA013972: AB_2178629, HPA057125: AB_2683343"	"unprognostic (1.42e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.40e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.04e-2)"	12.7	14.8	10.8	16.7	16.0	11.0	13.6	8.3	13.0	13.8	14.3	21.2	9.4	11.0	20.6	16.3	13.6	15.4	12.4	14.5	11.4	9.0	13.6	16.9	12.6	17.7	17.6	11.0	18.8	20.4	18.6	17.1	10.5	13.0	15.7	12.4	13.1	14.3	15.5	13.9	13.0	17.5	15.6	16.5	17.3	13.2	25.6	14.7	56.6	17.3	8.8	18.9	18.7	15.4	19.9	16.6	9.8	15.5	8.8	12.5	8.5	5.2	4.5	4.8	7.4	14.6	14.6	0.0	12.5	10.0	6.2	7.1	3.9	9.1	4.9	10.4	12.6	9.0	6.1	0.0	13.0	11.8	12.5	5.0	7.2	2.9	3.4	15.7	7.6	4.2	13.6	19.0	11.8	25.7	7.2	4.7	13.0	19.3	12.9	6.4	10.0	12.9	3.9	0.0	6.1	4.8	5.6	0.0	7.1	5.0	6.3	4.7	3.6	6.8	2.4	9.2	9.5	6.9	8.8	6.2	2.8	6.3	10.7	3.5	14.4	6.7	35.4	9.1	9.3	8.2	8.1	11.1	9.8	6.1	15.5	9.7	17.3	9.6	7.5	13.7	19.9	10.8	8.9	2.5	8.8	10.3	16.6	12.5	8.5	10.8	16.0	8.3	13.0	11.4	9.0	17.6	11.0	13.0	14.7	11.9	5.4	22.9	7.2	4.6	6.3	14.0	2.5	4.0	7.9	10.4	15.7	6.0	3.3	6.1	12.7	5.8	5.0	0.0	8.0	3.3	5.2	9.4	8.1	11.3	4.6	11.1	1.7	3.1	9.2	13.7	5.2	5.0	11.8	1.8	7.1	9.3	7.2	0.0	6.3	2.9	5.9	0.0	7.2	12.9	7.1	4.8	4.7	6.5	3.7	7.7
RNF5	"G16, NG2, RING5, RMA1"	ENSG00000204308	"Ring finger protein 5"	Q99942	6	32178354-32180793	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 293.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034107, HPA065032"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB034107: AB_2238618, HPA065032: AB_2685408"	"unprognostic (1.94e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.07e-1)"	"prognostic favorable (2.44e-4)"	"unprognostic (1.95e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.91e-3)"	"unprognostic (8.84e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.99e-2)"	9.8	20.6	19.3	9.0	20.6	10.3	14.0	13.6	16.8	11.3	25.7	17.4	14.7	18.1	12.3	14.6	15.9	16.9	13.9	19.2	16.9	12.0	32.7	38.1	14.7	11.6	16.3	14.2	19.0	19.3	7.2	5.8	23.4	12.3	13.1	19.1	12.2	25.3	15.3	24.5	13.4	36.7	13.7	19.7	10.2	14.2	9.6	9.6	10.8	18.0	14.2	12.5	13.2	9.9	6.7	26.9	7.2	6.4	7.5	7.0	6.5	5.3	6.9	4.7	18.1	5.2	3.6	3.7	2.1	2.7	4.7	5.4	9.2	4.5	6.9	7.8	5.2	6.7	4.4	8.8	4.9	5.0	4.3	11.9	5.5	7.8	19.0	6.1	0.0	11.3	3.5	6.6	7.9	6.0	8.6	9.5	12.4	14.1	7.5	6.8	7.5	6.7	15.9	0.0	7.5	2.9	4.6	5.3	9.7	13.3	3.4	4.9	10.2	4.2	4.5	4.7	4.4	9.4	19.4	4.2	5.2	5.1	0.0	8.2	4.1	6.2	8.2	3.6	12.3	3.0	5.1	4.6	7.2	7.0	6.4	6.1	6.7	5.7	6.2	6.6	6.0	6.4	6.3	2.4	7.5	4.5	26.9	5.7	6.5	19.3	20.6	13.6	16.8	16.9	12.0	16.3	14.2	12.3	9.6	17.9	31.3	63.3	54.1	85.1	21.8	54.9	81.5	48.2	43.3	87.2	0.0	66.6	240.4	91.9	15.7	46.6	171.7	70.0	79.3	85.9	60.9	53.6	54.4	112.5	61.3	31.8	70.3	41.7	42.8	15.3	55.0	53.8	81.0	88.4	77.1	59.7	70.4	152.6	68.2	293.3	20.3	64.7	69.2	57.6	36.2	73.8	70.4	52.4	93.3	42.3
RPL41	L41	ENSG00000229117	"Ribosomal protein L41"	P62945	12	56116586-56117943	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053169	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA053169: AB_2682067"	"unprognostic (7.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.19e-1)"	98.5	110.3	143.6	75.9	178.6	148.9	195.6	79.5	215.4	106.8	115.5	35.9	97.1	80.0	92.1	140.7	139.3	117.6	74.2	113.4	104.3	59.9	95.5	109.2	84.1	125.0	91.5	167.3	235.3	238.3	38.1	116.4	78.5	108.2	110.5	115.8	46.3	129.7	105.6	182.5	161.0	92.4	84.6	103.4	112.0	115.2	60.6	80.2	73.6	103.5	133.3	157.2	93.8	118.0	381.7	228.0	112.6	145.3	178.3	351.7	503.4	195.8	249.4	227.8	156.2	248.7	389.2	147.1	178.6	233.8	228.4	184.8	242.0	233.6	371.8	232.6	226.3	72.1	162.8	282.7	287.5	197.4	151.4	278.0	162.6	192.5	245.6	281.3	291.1	141.5	431.9	390.3	207.2	454.5	440.6	263.8	202.3	160.4	356.3	221.5	358.7	264.3	434.8	272.8	250.7	237.1	198.1	216.4	297.2	291.9	280.2	136.2	236.4	167.3	252.7	351.4	162.6	301.6	354.1	165.0	98.5	181.5	122.5	177.4	163.2	283.8	300.4	152.5	236.1	104.3	112.6	145.3	79.4	203.4	128.5	283.3	381.7	331.0	262.1	187.5	334.4	351.7	298.2	59.8	178.3	119.0	228.0	245.5	503.4	143.6	178.6	79.5	215.4	104.3	59.9	91.5	167.3	108.2	80.2	2307.7	3920.9	13212.4	3047.7	18335.7	450.9	526.2	6402.5	3590.9	5100.2	3745.9	206.2	4772.7	8743.8	5307.6	676.1	3878.6	5142.7	2966.8	15534.3	7330.7	6049.5	3737.7	3330.2	8563.3	5181.1	201.8	4950.1	5347.0	8241.5	1910.5	6240.5	5956.9	10547.6	11845.2	12005.5	1116.6	10850.6	10920.7	2745.1	7365.3	553.9	2108.4	5517.6	464.9	549.6	22578.4	5011.8	5870.7	14997.3	3615.1
RPN2	"RIBIIR, RPN-II, RPNII, SWP1"	ENSG00000118705	"Ribophorin II"	P04844	20	37178410-37241623	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Extravillous trophoblasts: 520.7;Syncytiotrophoblasts: 519.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008297, CAB019277, HPA025922"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		2800000	"Endoplasmic reticulum"		"CAB019277: , HPA008297: AB_1856457, HPA025922: AB_1856458"	"unprognostic (9.59e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (1.44e-10)"	"unprognostic (2.83e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (2.44e-4)"	29.2	47.6	16.6	24.2	19.6	30.1	34.8	13.2	21.4	34.3	30.5	23.3	52.6	24.0	38.3	70.3	35.1	29.5	34.8	36.3	14.2	14.1	52.9	105.7	38.7	53.0	19.1	14.7	33.3	72.2	38.2	28.7	110.3	19.8	33.3	34.7	43.1	64.6	49.1	32.9	26.0	43.2	30.2	15.6	47.5	35.7	43.5	14.5	27.9	56.8	26.4	42.3	27.8	27.7	48.1	96.3	55.8	70.1	60.8	72.3	92.9	36.7	33.2	34.8	46.3	48.4	36.3	69.1	48.7	57.9	62.4	53.1	105.4	64.5	28.8	59.6	62.7	58.2	53.6	36.0	57.9	56.9	13.4	22.3	32.9	38.8	70.2	46.8	51.9	55.2	34.2	57.9	49.5	51.5	59.7	59.8	27.0	50.4	93.9	43.7	33.2	29.8	53.0	28.1	93.3	47.2	27.2	64.6	94.4	42.8	35.0	28.8	30.8	59.0	142.5	56.6	42.6	70.4	87.3	38.6	70.9	43.2	36.9	42.2	56.5	67.4	30.3	69.5	35.2	57.2	55.8	70.1	45.1	62.8	66.6	72.3	48.1	59.2	62.8	78.7	37.4	53.8	55.5	13.0	60.8	53.7	96.3	52.9	92.9	16.6	19.6	13.2	21.4	14.2	14.1	19.1	14.7	19.8	14.5	110.2	155.8	75.4	110.3	55.0	62.6	70.6	129.9	77.6	87.6	76.8	43.2	403.6	19.9	222.8	23.6	87.5	73.5	93.5	212.6	520.7	89.4	118.5	102.7	173.2	208.9	60.4	60.5	106.8	138.1	22.0	97.2	119.0	86.0	115.4	110.0	140.5	151.9	100.8	104.3	52.6	62.7	84.1	70.1	327.7	305.6	50.6	519.4	74.0	130.8	106.2
RPS13	S13	ENSG00000110700	"Ribosomal protein S13"	P62277	11	17074389-17077787	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005985	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA		56000	"Endoplasmic reticulum"		"HPA005985: AB_10960703"	"unprognostic (7.74e-3)"	"unprognostic (2.73e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.21e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.85e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.74e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (5.71e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-1)"	119.9	51.1	49.0	80.4	40.3	120.2	120.6	36.0	38.8	129.2	91.3	49.0	52.0	54.5	74.1	70.7	143.1	74.2	83.1	70.5	43.4	38.8	84.9	133.7	97.3	151.2	55.4	26.2	190.8	234.2	29.2	47.8	98.5	34.9	117.2	66.3	57.4	101.7	67.9	203.5	102.6	91.0	90.2	60.3	115.0	75.8	82.1	39.3	146.2	118.0	132.0	127.4	135.4	87.4	166.8	139.3	20.7	103.6	72.0	204.5	216.1	108.5	77.6	77.5	65.0	133.0	202.2	87.1	75.9	93.9	106.5	86.5	121.3	134.6	158.9	53.6	81.1	72.2	79.9	107.0	115.4	106.3	68.4	230.5	71.2	81.1	126.0	161.1	146.3	74.7	156.5	186.8	45.7	181.3	125.0	122.6	103.4	102.3	89.2	101.5	100.2	115.8	193.0	90.8	138.3	153.0	111.2	111.4	98.6	102.1	118.0	64.0	110.7	37.0	140.7	170.4	78.4	63.3	218.2	82.4	51.4	89.8	119.6	94.8	64.7	131.9	123.3	59.7	117.7	68.2	20.7	103.6	15.3	64.2	77.2	126.1	166.8	135.3	93.8	132.8	152.0	204.5	151.5	10.6	72.0	60.9	139.3	94.0	216.1	49.0	40.3	36.0	38.8	43.4	38.8	55.4	26.2	34.9	39.3	860.5	1324.4	3859.3	3661.0	4056.8	255.9	720.6	1864.9	1102.8	1633.3	631.6	98.2	3330.4	2470.2	1793.4	1053.3	2297.1	956.0	817.7	3950.3	4558.3	2409.4	2957.7	1429.6	1826.7	2531.3	85.8	1317.4	1933.5	3782.3	1414.9	3288.7	3755.9	2068.4	3014.5	2386.6	599.7	2990.2	2142.8	1668.1	2743.0	320.5	860.2	2530.8	433.3	316.8	4762.2	3753.8	2537.2	3057.2	3744.2
RRBP1	"ES/130, hES"	ENSG00000125844	"Ribosome binding protein 1"	Q9P2E9	20	17613678-17682295	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 136.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 18.8;plasmacytoid DC: 23.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009026, HPA011924"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		44000	"Endoplasmic reticulum"		"HPA009026: AB_1079852, HPA011924: AB_1856476"	"unprognostic (1.56e-3)"	"unprognostic (2.26e-3)"	"unprognostic (8.46e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (6.63e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (9.38e-4)"	19.9	18.3	6.7	16.1	11.2	5.9	13.8	4.9	7.4	22.1	23.6	17.8	49.5	18.5	16.3	24.4	17.1	12.3	37.3	15.8	7.8	6.3	27.1	88.9	20.5	10.6	13.0	5.6	23.4	136.1	24.7	18.4	51.4	10.4	19.4	16.7	14.8	84.2	56.0	7.7	11.0	32.2	13.0	13.3	20.4	30.0	12.1	12.2	5.0	32.8	11.6	19.2	18.7	18.9	0.9	23.5	18.8	4.7	5.7	2.5	1.5	30.4	21.7	6.5	14.6	30.1	32.7	34.4	47.8	40.2	20.2	27.5	48.3	28.8	11.8	16.1	45.1	20.9	30.7	7.0	38.8	16.6	5.4	5.4	13.6	6.3	49.8	43.3	5.0	17.2	43.1	11.7	32.7	19.4	30.0	19.9	4.2	5.6	11.5	30.3	13.8	1.9	11.5	7.6	67.9	21.0	3.5	17.3	40.5	17.1	10.4	3.3	2.5	27.2	64.6	19.6	14.5	11.3	7.7	35.7	43.3	16.1	22.4	15.7	21.1	16.0	3.9	16.4	5.4	22.0	5.4	4.7	18.8	2.5	2.9	1.7	0.5	0.8	1.4	2.4	0.9	0.8	0.9	4.2	5.7	4.0	23.5	0.7	1.5	6.7	11.2	4.9	7.4	7.8	6.3	13.0	5.6	10.4	12.2	89.3	202.0	34.3	70.6	52.5	17.0	30.9	147.7	131.2	145.6	90.7	29.5	233.8	38.1	171.5	35.2	132.5	313.0	0.0	359.4	194.5	183.3	135.6	113.5	227.0	102.0	23.8	93.1	135.1	51.8	28.3	117.6	73.6	67.4	86.6	259.3	193.4	291.3	208.5	78.1	62.7	35.4	32.3	138.2	74.8	93.6	48.8	445.7	36.3	168.2	180.5
RTBDN	FLJ36353	ENSG00000132026	Retbindin	Q9BSG5	19	12825478-12835428	"Predicted membrane proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 17.3;pituitary gland: 25.8;retina: 57.0"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 329.9;Rod photoreceptor cells: 289.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 1.7;neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 8.2;SH-SY5Y: 5.4;U-266/84: 21.1;U-87 MG: 4.8"					"Not detected"	"Not detected"			HPA052511			Approved	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA			"Endoplasmic reticulum"		"HPA052511: AB_2797243"	"unprognostic (4.55e-4)"	"unprognostic (3.94e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-4)"	"unprognostic (3.33e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.48e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.66e-9)"	"unprognostic (3.55e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.24e-2)"	0.3	6.9	10.2	0.5	3.4	0.9	0.3	2.7	17.3	0.2	0.9	0.4	0.0	1.0	0.3	1.5	0.3	0.3	0.4	0.3	7.3	5.1	0.2	0.4	0.5	0.4	2.8	2.8	0.3	2.5	0.2	25.8	0.3	4.0	0.4	0.9	57.0	0.3	0.3	0.3	0.5	1.0	0.6	1.0	0.4	2.5	3.5	0.0	7.0	0.4	0.0	0.4	0.3	0.0	0.3	0.2	1.8	0.2	0.4	0.2	0.0	0.9	0.1	0.1	0.6	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.3	0.1	0.9	0.9	0.0	0.6	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.4	0.9	0.0	0.1	2.4	0.0	0.0	0.4	0.2	0.0	0.0	0.1	1.2	2.7	0.0	0.1	0.0	0.0	0.9	0.7	1.1	0.7	0.1	1.0	0.0	0.0	8.2	5.4	0.1	0.1	0.4	0.4	2.7	0.7	0.0	0.8	1.0	0.7	0.1	1.2	21.1	4.0	4.8	0.0	0.0	1.7	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.2	1.8	0.4	0.2	0.2	0.1	0.0	10.2	3.4	2.7	8.6	7.3	5.1	2.8	2.8	4.0	0.0	0.0	0.0	0.0	0.0	0.0	47.1	1.4	0.0	0.0	0.0	0.0	329.9	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	45.9	0.1	0.0	0.0	0.0	289.4	0.0	0.0	11.5	5.1	0.0	0.0	0.0	0.0	0.0
RTN3	"ASYIP, HAP, NSPL2, NSPLII, RTN3-A1"	ENSG00000133318	"Reticulon 3"	O95197	11	63681446-63759891	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Stress response, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 122.2;brain: 149.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 122.2"	"Group enriched"	"Detected in all"	6	"granulocytes: 122.2;monocytes: 42.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA015649, HPA015650"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		620000	"Endoplasmic reticulum"		"HPA015649: AB_1856498, HPA015650: AB_1856499"	"unprognostic (8.11e-3)"	"unprognostic (8.51e-2)"	"unprognostic (3.61e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (5.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.57e-2)"	43.6	19.6	72.2	11.9	71.6	22.3	21.5	55.9	149.6	21.7	20.0	50.2	9.3	12.3	14.8	19.7	12.4	21.0	13.1	12.8	78.3	72.9	22.0	19.9	17.7	7.3	72.6	53.5	11.9	20.7	36.4	14.0	14.1	109.9	12.9	18.8	12.7	30.4	18.9	10.8	22.6	14.6	18.6	66.0	9.2	12.8	10.3	39.2	6.8	40.9	5.1	10.7	13.1	8.9	3.3	14.7	122.2	42.2	4.6	7.4	28.1	31.4	23.3	28.1	26.7	52.0	37.0	11.2	28.6	30.5	25.3	27.2	20.2	69.8	37.2	49.0	42.8	24.4	32.4	40.1	14.1	33.5	29.9	21.4	47.6	34.1	14.1	43.3	42.3	38.4	24.3	41.9	30.8	34.4	42.5	34.2	32.8	26.9	60.5	22.2	25.8	22.4	47.1	32.7	25.7	26.4	29.8	19.6	68.6	49.9	17.8	59.5	34.6	46.4	51.2	53.4	21.0	56.4	34.9	31.8	15.1	20.5	52.5	21.9	38.5	33.2	29.8	58.2	35.3	15.9	40.1	42.2	52.8	4.9	21.1	5.3	3.3	5.0	4.9	14.7	2.3	3.7	4.0	122.2	4.6	25.1	8.8	7.4	28.1	72.2	71.6	55.9	118.2	78.3	72.9	72.6	53.5	109.9	39.2	125.0	58.7	40.2	86.8	128.3	148.4	30.7	73.9	174.0	93.3	232.1	66.8	60.7	24.9	121.1	28.8	64.2	94.1	46.7	101.6	81.1	86.1	70.4	76.1	65.2	130.9	77.9	95.7	66.3	177.0	55.9	73.4	125.9	108.0	117.2	63.4	133.1	92.8	64.7	84.5	45.4	75.4	77.6	79.5	130.3	150.5	127.8	72.3	60.9	84.0	86.5
RTN4	"ASY, KIAA0886, NOGO, NSP-CL"	ENSG00000115310	"Reticulon 4"	Q9NQC3	2	54972187-55112621	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Muller glia cells: 3179.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 159.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005388, HPA023977"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA		13000000	"Endoplasmic reticulum"		"CAB005388: AB_2285559, HPA023977: AB_2671391"	"unprognostic (1.31e-2)"	"unprognostic (1.71e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (5.79e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.91e-3)"	"unprognostic (4.38e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.91e-2)"	103.7	60.5	75.1	27.9	85.0	19.3	63.6	66.6	105.5	24.8	35.4	52.9	17.5	45.0	29.3	36.0	43.0	26.3	38.5	30.8	71.9	69.7	86.5	103.5	36.2	19.6	84.9	75.8	27.4	23.7	59.9	16.1	33.8	99.0	45.2	35.7	24.7	23.6	38.1	171.1	48.1	55.2	47.4	92.6	20.1	23.5	14.6	62.7	14.7	25.9	47.2	16.5	48.1	35.4	2.8	6.1	33.3	7.7	16.8	15.8	4.4	33.0	24.0	23.5	6.1	80.1	75.2	13.2	110.1	93.6	34.1	31.9	19.7	31.5	7.2	58.6	74.6	57.1	30.1	15.4	44.3	52.1	20.4	11.8	9.9	14.8	31.1	159.5	17.8	5.1	56.3	42.4	46.6	90.9	68.9	63.9	18.3	20.2	16.7	147.0	9.6	21.7	18.2	21.1	7.2	21.5	9.7	31.0	14.9	79.1	39.9	15.5	18.3	25.2	14.8	30.8	42.1	12.6	13.7	90.6	66.7	28.3	26.2	62.9	10.2	8.2	4.6	67.9	20.7	53.6	33.3	4.3	10.9	4.3	4.9	3.5	2.8	6.9	3.8	4.0	1.6	11.7	4.8	7.0	16.8	7.7	6.1	15.8	4.4	75.1	85.0	66.6	105.5	71.9	69.7	84.9	75.8	99.0	62.7	163.8	161.9	100.2	1062.9	943.4	647.1	108.1	226.7	159.3	127.4	642.0	357.4	421.2	247.1	487.4	360.7	341.8	464.3	70.0	283.5	513.5	379.7	775.3	148.7	573.6	570.9	402.0	213.0	178.0	338.1	193.3	155.1	405.6	323.9	461.7	231.2	3179.0	405.8	189.0	212.5	568.0	465.4	213.4	311.0	240.3	85.0	925.9	302.8	121.8	187.3	1082.8
SAMD8	"FLJ25082, SMSr"	ENSG00000156671	"Sterile alpha motif domain containing 8"	Q96LT4	10	75099586-75182123	"Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 18.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044402			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044402: "	"unprognostic (4.32e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.24e-2)"	"unprognostic (7.87e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.29e-1)"	"unprognostic (3.12e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.26e-3)"	17.6	14.6	18.8	9.3	18.9	20.7	11.9	12.4	34.8	15.6	7.9	20.1	10.2	8.2	15.0	10.1	17.9	9.4	12.5	14.3	18.6	15.9	10.1	10.1	10.7	8.7	22.7	13.8	18.7	7.6	13.0	17.1	14.8	17.4	11.5	7.0	10.9	8.9	11.5	28.3	7.6	9.3	13.7	37.8	10.0	7.7	19.9	15.5	5.5	10.7	7.3	8.6	10.9	18.1	5.7	3.6	18.3	5.9	3.8	3.3	1.5	5.5	5.3	8.1	6.5	17.9	16.6	10.3	10.1	19.3	6.7	9.1	7.9	7.9	4.5	6.7	9.4	7.1	10.1	4.6	6.9	12.0	5.0	6.7	1.8	5.4	5.3	9.9	2.0	4.6	15.9	7.0	12.4	18.0	15.4	9.2	5.1	3.8	7.8	12.8	4.3	3.3	2.5	3.5	3.8	20.9	3.0	7.5	1.6	6.4	4.8	1.2	5.8	9.2	11.0	8.9	9.3	4.6	1.9	15.8	6.6	12.4	8.0	6.6	5.5	4.2	4.3	10.3	4.4	4.2	2.4	3.7	2.2	2.9	4.5	1.9	4.8	3.1	3.3	3.2	5.7	2.7	3.1	18.3	3.8	5.9	3.6	2.8	1.5	18.8	18.9	12.4	21.3	18.6	15.9	22.7	13.8	17.4	15.5	8.9	12.2	13.7	23.3	37.5	19.1	22.6	10.2	25.4	17.0	14.0	13.7	9.1	0.0	9.7	29.4	21.3	9.6	0.0	9.0	9.6	22.6	18.9	12.7	11.6	11.8	17.5	22.4	23.9	16.2	9.0	23.3	27.6	11.8	27.1	3.3	21.8	13.2	8.6	23.7	6.2	31.9	32.3	24.7	47.0	23.4	37.5	56.9	20.1	4.1	32.5
SAR1A	"SAR1, Sara, SARA1"	ENSG00000079332	"Secretion associated Ras related GTPase 1A"	Q9NR31	10	70147289-70170523	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006923, CAB022545, HPA048368"	Supported		Supported	"Endoplasmic reticulum"		NA	NA		10000000	"Endoplasmic reticulum"		"CAB022545: , HPA006923: AB_1856577, HPA048368: AB_2680373"	"unprognostic (3.77e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.13e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (7.00e-5)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.13e-2)"	52.7	40.0	26.7	24.5	31.9	91.1	37.8	27.8	35.7	32.6	26.9	28.6	38.3	17.3	35.7	34.6	30.8	28.2	30.4	34.6	25.6	27.0	31.7	48.8	38.2	27.0	26.6	27.8	36.5	29.8	30.0	37.0	51.6	30.3	28.5	25.3	29.5	39.6	40.5	35.9	27.5	25.1	36.0	28.3	31.8	28.6	18.4	23.5	24.9	34.8	28.9	25.5	36.4	28.8	18.7	22.9	27.7	30.4	40.2	40.1	32.6	21.9	14.6	20.9	36.1	71.7	43.5	15.4	35.0	43.8	33.5	40.4	42.9	19.7	19.7	17.4	42.6	13.0	24.0	27.0	20.1	33.0	25.5	12.8	14.5	17.2	20.9	33.0	22.5	14.9	44.8	19.7	21.3	37.3	34.1	17.6	15.1	19.0	26.9	30.7	14.9	18.9	18.7	17.8	14.0	41.2	18.5	23.3	11.4	25.0	16.9	11.8	20.1	26.4	37.4	18.7	19.9	17.8	15.4	24.4	17.2	24.1	23.9	23.9	17.8	30.8	27.3	23.0	30.1	13.1	25.4	24.7	27.7	36.3	30.4	40.1	18.7	29.3	36.1	22.9	15.0	29.0	38.1	27.4	40.2	26.6	17.8	20.0	32.6	26.7	31.9	27.8	35.7	25.6	27.0	26.6	27.8	30.3	23.5	119.1	113.7	49.2	120.4	209.4	35.6	67.5	58.6	41.5	64.8	47.1	31.4	109.9	46.4	67.1	2.5	99.1	49.2	0.0	67.5	161.5	172.2	111.8	51.9	103.0	90.8	25.4	41.0	67.5	47.8	4.0	50.6	90.6	108.0	65.9	46.7	57.3	62.0	52.1	55.2	76.7	31.0	77.6	129.6	54.3	49.0	217.4	199.8	94.9	47.8	134.4
SAR1B	SARA2	ENSG00000152700	"Secretion associated Ras related GTPase 1B"	Q9Y6B6	5	134601144-134649271	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 296.4;Hepatocytes: 238.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006923, HPA048368"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA006923: AB_1856577, HPA048368: AB_2680373"	"unprognostic (6.14e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.32e-2)"	"prognostic favorable (7.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (5.92e-2)"	"prognostic favorable (6.59e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.87e-2)"	15.0	24.4	14.4	9.2	16.4	9.0	15.0	11.2	17.4	11.7	20.9	23.2	20.5	26.7	8.2	15.8	19.0	7.7	11.6	17.9	15.1	12.7	23.2	78.8	9.6	9.4	26.7	12.1	9.7	17.5	27.9	27.3	11.6	19.7	16.0	15.3	10.9	19.1	16.8	68.6	8.5	45.1	10.8	26.5	11.4	16.6	23.9	20.1	8.6	13.8	30.2	12.9	12.2	10.4	22.0	28.9	23.9	33.2	14.5	33.4	29.3	17.0	14.9	11.1	25.5	35.3	17.2	15.1	28.8	24.8	26.0	40.1	25.2	24.3	9.4	24.5	29.5	36.2	15.9	19.2	27.9	33.8	21.8	11.2	9.9	25.5	24.0	29.0	8.4	13.8	19.2	17.9	30.2	25.8	13.2	19.5	12.6	13.0	22.0	26.5	25.3	11.2	12.9	3.7	21.0	10.5	9.9	19.3	20.7	18.9	28.7	11.3	5.2	20.3	11.1	20.8	15.4	22.7	10.6	15.6	22.7	13.7	20.5	21.5	27.9	61.2	17.1	17.5	16.6	24.8	9.8	32.0	23.9	20.5	31.1	25.1	22.0	23.7	23.6	28.9	13.3	21.1	20.7	11.7	14.5	33.2	19.7	33.4	29.3	14.4	16.4	11.2	17.4	15.1	12.7	26.7	12.1	19.7	20.1	29.8	28.8	28.3	36.3	33.4	28.9	69.9	63.7	46.8	36.4	54.1	39.3	30.5	48.0	41.7	296.4	30.0	96.1	0.0	72.9	33.5	40.9	74.8	25.5	238.0	47.2	31.8	26.6	38.6	54.8	51.0	33.9	46.0	60.8	30.7	50.3	41.1	59.5	28.8	42.1	102.9	37.4	19.4	43.4	103.0	38.3	44.7	96.3	37.4	42.9	76.5
SCARA3	"APC7, CSR, CSR1, MSLR1, MSRL1"	ENSG00000168077	"Scavenger receptor class A member 3"	Q6AZY7	8	27633868-27676776	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 52.2"	"Cell type enhanced"	"Detected in many"	10	"Collecting duct cells: 62.8;Cytotrophoblasts: 37.1;Muller glia cells: 54.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 50.6;HeLa: 55.7;HUVEC TERT2: 38.6;U-2 OS: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029861, HPA047386"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029861: AB_2673225, HPA047386: AB_2680024"	"unprognostic (2.24e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.31e-3)"	"unprognostic (6.03e-3)"	7.5	4.6	16.4	9.0	27.3	0.4	10.6	10.3	26.8	19.9	11.2	7.7	14.2	3.4	33.8	9.4	14.5	52.2	18.4	4.8	16.2	13.0	3.8	2.7	7.8	7.4	16.4	10.3	13.1	2.8	2.2	3.6	11.8	21.2	12.4	5.4	8.6	13.7	42.6	1.1	6.0	5.1	40.5	21.8	2.0	5.9	3.9	12.1	3.2	19.2	4.7	13.2	11.3	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	16.5	2.6	0.0	13.8	50.6	11.5	6.6	10.4	7.2	5.4	6.1	4.3	0.0	15.6	13.3	5.8	12.4	0.0	12.2	3.4	0.0	1.4	4.8	55.7	0.2	1.4	0.0	0.0	21.2	0.7	11.1	0.6	9.6	38.6	1.2	0.0	0.0	4.0	3.0	0.0	0.0	3.5	0.0	6.3	0.0	0.0	0.0	2.2	7.3	0.0	1.7	1.5	8.7	0.0	1.3	8.6	0.1	13.7	5.9	35.7	21.9	3.5	0.0	0.0	0.0	10.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	27.3	10.3	22.5	16.2	13.0	16.4	10.3	21.2	12.1	0.0	0.3	0.0	13.3	3.2	0.4	2.0	7.6	4.0	7.9	62.8	0.0	37.1	0.0	0.2	2.4	3.3	0.0	0.0	0.7	14.6	12.8	2.8	0.0	0.2	4.0	0.0	0.0	12.3	0.3	1.1	14.7	0.8	16.9	1.0	0.0	54.2	1.6	0.0	6.0	0.0	1.1	6.5	13.7	0.2	1.0	3.3	6.9	0.0	0.0	8.6
SCD	"FADS5, SCDOS"	ENSG00000099194	"Stearoyl-CoA desaturase"	O00767	10	100347124-100364834	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 245.0;brain: 130.0;breast: 94.0;heart muscle: 109.2;liver: 130.8"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 300.1;Hepatocytes: 153.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 204.0;CAPAN-2: 141.3"					"Low region specificity"	"Detected in all"			"HPA012107, HPA063921"	Approved		Enhanced	"Endoplasmic reticulum"		No	Yes			"Endoplasmic reticulum"		"HPA012107: AB_1856610, HPA063921: AB_2685154"	"unprognostic (2.10e-1)"	"unprognostic (2.62e-3)"	"unprognostic (7.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (7.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (7.79e-5)"	245.0	21.3	59.8	11.4	32.7	5.5	94.0	12.7	83.9	5.3	10.8	63.6	0.1	21.4	3.7	7.0	13.4	1.7	18.3	109.2	61.5	43.4	5.0	130.8	32.2	23.1	65.1	23.6	12.7	6.1	7.7	1.5	5.3	34.5	24.4	10.1	4.5	24.9	3.7	2.4	3.4	6.1	4.6	130.0	4.2	5.9	12.2	35.4	1.4	2.0	6.9	5.4	3.7	5.0	2.0	5.3	0.2	3.3	2.9	5.1	2.1	31.0	28.6	61.1	41.9	204.0	117.7	12.5	3.3	73.7	8.0	42.8	24.6	141.3	13.1	2.6	7.8	36.6	55.6	33.6	119.4	7.0	4.4	13.9	7.3	18.2	49.2	39.4	10.2	8.0	64.0	36.2	31.1	54.8	21.6	15.2	29.1	20.4	40.1	3.2	48.6	11.6	12.2	21.2	9.1	8.2	5.4	22.6	41.1	34.9	34.9	3.8	14.7	6.6	31.2	64.1	18.5	35.0	22.0	6.0	0.8	9.5	0.7	6.8	11.2	6.0	20.2	14.6	32.0	5.1	0.0	1.5	0.0	3.0	3.3	5.1	1.3	1.2	1.6	5.3	2.0	1.0	2.9	0.2	2.9	0.0	3.0	0.0	2.1	59.8	32.7	12.7	27.9	61.5	43.4	65.1	23.6	34.5	35.4	50.6	300.1	34.7	3.9	3.3	4.0	2.9	35.7	9.4	23.9	0.0	5.9	2.0	0.0	12.5	52.9	9.3	13.7	0.0	59.1	53.1	9.3	26.0	5.8	153.5	29.3	25.4	24.8	41.7	97.6	68.6	3.4	8.2	55.6	17.2	15.7	11.8	21.6	2.9	1.4	3.8	4.7	0.0	4.4	0.9	1.1	1.9	14.5	5.2	16.8	3.5
SEC61A1		ENSG00000058262	"Sec61 translocon alpha 1 subunit"	P61619	3	128051641-128071683	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 178.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022076			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB022076: "	"unprognostic (1.84e-1)"	"unprognostic (8.00e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (7.82e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.07e-6)"	"unprognostic (2.84e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (6.84e-9)"	"unprognostic (2.73e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.51e-2)"	28.6	38.2	15.2	23.2	16.2	18.5	38.4	12.8	16.2	45.0	24.2	15.9	77.9	22.1	32.6	52.8	31.1	28.3	34.4	27.6	14.3	13.5	37.6	132.2	33.2	44.9	17.4	10.3	28.5	178.4	31.5	36.5	51.6	15.2	26.2	26.0	19.0	87.1	81.7	22.7	22.7	32.5	31.3	15.4	28.8	33.8	21.2	15.4	22.9	35.5	28.8	36.6	24.2	26.4	13.8	35.6	40.0	25.1	18.7	39.3	29.0	40.1	21.1	21.2	37.7	60.3	52.1	39.1	64.8	75.2	56.5	61.0	40.0	29.3	26.8	39.1	83.6	42.3	35.7	33.2	45.8	54.8	24.2	18.2	30.5	23.6	42.1	88.9	38.7	34.8	57.1	55.4	53.2	68.8	42.8	49.6	18.7	20.0	65.7	65.5	36.6	19.9	12.8	28.6	35.6	29.6	21.0	19.0	52.5	29.4	35.2	24.2	23.7	32.0	30.5	40.8	25.6	28.4	33.1	48.7	44.6	25.3	51.7	30.2	60.1	28.6	38.6	72.9	25.2	57.5	40.0	25.1	19.1	28.3	23.0	39.3	13.8	20.5	24.8	24.7	8.5	13.0	15.0	6.6	18.7	22.4	35.6	13.1	29.0	15.2	16.2	12.8	16.2	14.3	13.5	17.4	10.3	15.2	15.4	29.8	34.5	23.1	22.5	32.7	16.8	12.9	35.7	10.7	20.5	47.1	33.4	56.4	3.3	77.1	35.8	35.6	73.5	23.3	133.3	103.4	63.4	59.6	25.4	101.3	67.9	25.4	70.7	53.4	26.8	17.6	38.0	27.4	32.1	25.2	85.2	24.5	95.2	53.4	41.1	22.6	14.1	32.3	34.0	9.3	15.8	25.7	107.0	25.4	63.1	30.3
SEC61B		ENSG00000106803	"Sec61 translocon beta subunit"	P60468	9	99222064-99230615	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"monocytes: 2395.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049407	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA049407: AB_2680750"	"unprognostic (1.11e-1)"	"unprognostic (5.99e-3)"	"unprognostic (3.46e-1)"	"prognostic favorable (1.26e-5)"	"unprognostic (1.96e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.75e-1)"	26.2	39.8	20.3	27.1	20.7	41.1	37.2	12.6	20.2	36.5	26.2	15.8	47.9	28.5	32.1	52.7	29.3	26.8	26.4	19.8	19.3	17.7	42.0	153.0	31.9	49.3	19.9	14.8	31.6	175.5	13.6	38.5	36.3	17.7	28.9	19.8	21.3	116.6	50.8	16.9	20.5	31.2	21.0	20.1	41.4	29.7	19.9	16.8	43.8	49.3	29.2	35.9	24.5	24.0	36.9	173.3	71.5	48.5	31.0	52.5	47.1	37.7	37.1	42.9	42.5	42.5	54.5	51.9	56.4	59.3	53.5	46.7	53.0	29.9	51.9	43.2	51.5	58.1	46.8	30.0	45.0	25.8	54.6	41.8	27.1	36.1	74.8	92.7	46.5	34.9	48.6	69.6	42.0	37.6	47.7	65.1	42.6	42.4	101.6	50.3	69.6	42.2	68.1	34.3	90.6	87.3	41.0	36.5	66.9	57.8	27.3	44.7	31.7	31.6	73.6	72.2	35.4	28.5	64.4	45.5	38.3	45.7	63.9	46.8	54.8	36.8	33.2	63.9	30.1	25.2	71.5	48.5	44.5	39.1	38.4	52.5	36.9	43.3	39.3	49.4	25.0	27.5	30.1	40.6	31.0	33.2	173.3	38.3	47.1	20.3	20.7	12.6	20.2	19.3	17.7	19.9	14.8	17.7	16.8	95.3	187.1	256.1	245.3	351.6	50.7	48.6	280.2	210.1	184.2	190.1	29.5	281.8	537.2	460.0	124.8	278.2	231.9	23.3	685.9	442.0	377.2	528.8	210.1	851.3	458.0	50.9	289.9	218.5	275.4	31.8	303.8	326.5	470.7	2395.0	308.0	128.3	615.7	260.3	286.0	654.7	66.5	135.8	230.8	200.9	174.6	387.6	463.2	262.1	249.2	374.6
SEC63	"DNAJC23, ERdj2, PRO2507, SEC63L"	ENSG00000025796	"SEC63 homolog, protein translocation regulator"	Q9UGP8	6	107867756-107958189	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Transport"	Chaperone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053295, HPA060535"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA053295: AB_2682105, HPA060535: AB_2684312"	"prognostic unfavorable (3.32e-4)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.51e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (6.16e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.41e-2)"	19.9	26.0	22.2	14.4	20.0	20.2	17.4	17.3	19.2	22.8	17.6	13.9	21.9	11.5	22.4	21.5	16.3	18.6	15.4	19.5	18.4	14.5	14.2	35.2	17.6	10.6	19.2	17.9	30.5	45.8	24.9	32.3	27.9	16.8	20.0	13.3	14.0	46.6	27.2	15.3	14.6	12.6	20.2	20.0	13.7	18.5	21.6	21.5	16.7	36.2	9.3	11.7	24.2	21.4	6.1	9.6	6.3	12.0	9.2	11.1	4.9	11.3	6.9	19.2	23.8	20.1	23.8	17.3	24.3	26.9	11.6	16.6	12.4	14.2	21.2	20.8	21.8	14.4	16.7	13.3	15.6	17.9	25.4	14.7	22.9	11.0	12.7	31.4	26.1	13.6	18.6	25.9	18.6	41.2	21.1	16.2	13.0	19.1	34.3	23.8	9.0	8.1	11.8	15.1	12.1	7.5	26.0	22.7	17.3	14.1	15.1	16.9	19.2	13.4	20.3	24.3	13.7	14.4	38.7	17.4	17.6	10.9	17.5	18.8	13.1	9.6	21.2	19.4	22.9	20.0	6.3	7.3	6.3	7.0	6.3	11.1	6.1	5.9	5.7	7.4	6.1	6.6	5.1	2.5	9.2	12.0	9.6	3.1	4.9	22.2	20.0	17.3	19.2	18.4	14.5	19.2	17.9	16.8	21.5	110.2	115.9	47.7	57.1	75.6	58.2	69.4	73.9	135.1	136.5	50.6	37.3	67.2	10.0	69.3	20.3	58.5	30.2	0.0	109.1	79.1	85.4	76.0	66.0	118.1	56.0	44.5	51.5	63.3	51.7	13.6	98.4	64.0	75.9	27.1	61.3	52.4	75.9	58.8	111.7	36.6	44.0	45.3	91.8	139.3	53.4	69.9	76.1	46.5	54.2	62.9
SELENOS	"AD-015, MGC2553, SBBI8, SELS, SEPS1, VIMP"	ENSG00000131871	"Selenoprotein S"	Q9BQE4	15	101270817-101277500	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 173.0;Exocrine glandular cells: 166.1;Extravillous trophoblasts: 174.9;Pancreatic endocrine cells: 185.9;Syncytiotrophoblasts: 254.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"plasmacytoid DC: 96.1"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 96.1"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 81.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010025	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA010025: AB_1079900"	"unprognostic (1.90e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.74e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.83e-2)"	"prognostic favorable (5.19e-4)"	"unprognostic (2.42e-3)"	"unprognostic (4.42e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.66e-2)"	25.1	34.7	16.3	19.6	17.1	18.0	38.3	11.4	15.6	22.8	33.7	20.7	51.6	33.2	21.6	33.7	24.8	20.5	21.9	35.0	15.6	14.6	30.9	58.2	27.0	24.5	24.6	13.4	19.3	80.9	14.6	27.5	38.2	21.2	23.5	37.8	16.5	58.0	42.1	28.3	20.6	41.5	21.8	26.8	27.5	26.8	44.4	18.7	9.7	34.0	22.5	26.4	21.0	30.9	10.0	96.1	17.5	14.8	14.3	17.2	9.6	9.4	15.1	13.6	12.0	29.8	21.2	11.3	28.9	22.2	20.2	20.4	17.9	23.0	7.2	10.8	25.6	34.0	27.0	14.7	13.0	13.2	13.0	19.6	12.1	13.5	18.5	47.3	9.1	14.1	18.4	37.3	13.5	40.2	15.9	15.0	9.6	12.1	81.9	21.6	15.2	6.6	14.2	10.3	36.4	9.8	8.5	11.1	15.7	20.3	22.7	7.6	19.3	20.1	19.0	40.2	18.7	14.2	20.7	15.9	19.1	12.5	25.6	21.9	59.5	49.7	10.4	20.8	10.9	22.9	17.5	10.8	12.3	16.0	12.9	15.4	10.0	12.4	17.2	9.3	7.0	9.4	14.0	3.7	14.3	14.8	96.1	10.9	9.6	16.3	17.1	11.4	15.6	15.6	14.6	24.6	13.4	21.2	18.7	110.2	99.5	0.0	0.0	0.0	0.0	0.0	0.0	104.4	118.3	146.5	0.0	113.3	26.6	173.0	0.0	0.0	0.0	0.0	166.1	174.9	0.0	0.0	27.9	0.0	109.2	0.0	0.0	0.0	0.0	0.0	0.0	48.1	0.0	160.5	0.0	0.0	185.9	0.0	0.0	69.8	0.0	0.0	0.0	0.0	0.0	0.0	254.0	0.0	0.0	0.0
SERP1	"FLJ43424, RAMP4"	ENSG00000120742	"Stress associated endoplasmic reticulum protein 1"	Q9Y6X1	3	150541994-150603228	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 122.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038970	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA038970: AB_2676296"	"unprognostic (8.81e-3)"	"unprognostic (2.35e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.29e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.35e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.55e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.78e-1)"	24.5	34.2	23.1	22.4	22.6	25.4	38.0	12.5	18.4	38.6	26.7	15.6	59.9	21.4	20.2	56.7	29.6	28.1	25.1	15.1	17.4	16.5	27.7	93.6	38.1	47.8	17.5	15.6	31.5	137.6	21.1	33.0	33.2	14.7	32.9	23.8	15.6	103.1	58.9	9.7	18.1	33.5	15.6	18.9	42.9	38.4	17.8	16.0	38.4	51.3	17.3	33.6	31.2	29.8	49.6	67.9	76.4	89.1	36.8	68.2	90.5	33.1	7.1	10.9	8.2	16.0	18.8	25.0	23.7	15.3	13.0	15.3	18.5	14.6	26.8	45.8	17.1	10.8	16.2	17.6	12.2	17.3	16.5	15.2	28.4	6.2	18.7	31.3	25.6	19.1	11.2	22.0	7.5	37.7	14.2	15.1	18.3	13.8	37.9	11.0	14.3	21.6	22.3	20.4	21.0	18.5	28.2	8.3	83.3	15.7	10.7	18.8	16.0	9.1	20.1	35.9	13.7	17.7	25.1	14.6	6.2	11.4	13.3	18.2	122.2	34.9	36.0	11.3	25.2	5.7	62.2	88.3	76.4	52.9	81.8	68.2	49.6	56.9	53.3	67.5	47.9	56.7	52.1	64.4	36.8	89.1	67.9	54.3	90.5	23.1	22.6	12.5	18.4	17.4	16.5	17.5	15.6	14.7	16.0	62.5	139.6	390.1	556.3	477.8	73.3	37.8	160.5	156.6	144.5	164.0	55.0	242.2	310.0	207.9	287.5	159.5	300.1	0.0	263.4	394.7	208.5	631.9	219.9	431.3	345.7	39.7	243.7	217.3	540.1	505.4	203.4	389.3	330.7	232.6	361.6	114.7	332.1	414.1	178.9	241.5	64.5	109.9	173.1	132.7	83.4	518.0	790.1	279.9	304.6	899.5
SERP2	"bA269C23.1, C13orf21"	ENSG00000151778	"Stress associated endoplasmic reticulum protein family member 2"	Q8N6R1	13	44373665-44397714	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 40.7"	"Group enriched"	"Detected in many"	13	"Early spermatids: 499.5;Late spermatids: 180.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"basophil: 6.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 5.9;SH-SY5Y: 8.3;U-2197: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038970	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA038970: AB_2676296"	"unprognostic (6.55e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.12e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (1.48e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.89e-2)"	1.7	3.2	30.0	2.0	34.1	0.8	4.0	14.3	40.7	2.7	2.3	3.9	1.3	4.2	4.8	12.4	1.7	3.0	1.8	14.6	24.8	20.9	2.6	1.8	2.0	2.3	19.0	15.6	5.9	2.8	1.9	2.4	1.2	10.1	4.1	2.1	2.0	2.0	5.8	1.4	1.4	3.2	3.4	10.4	1.1	2.4	15.3	6.4	1.2	2.1	0.4	2.1	1.4	1.0	0.0	0.0	6.0	0.0	1.3	0.3	0.2	0.0	0.0	3.4	0.0	0.5	2.9	0.0	0.6	1.0	3.7	2.5	0.0	0.0	0.0	2.9	2.7	0.0	0.1	0.0	0.0	3.6	0.0	0.1	0.6	0.0	0.2	3.2	0.1	0.0	0.4	0.0	2.6	0.0	0.7	0.5	0.0	0.0	0.0	5.9	0.0	0.0	0.3	3.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.9	8.3	0.0	0.4	0.0	0.8	0.0	0.0	0.7	0.0	0.2	7.6	0.0	0.0	0.2	0.0	1.7	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.2	30.0	34.1	14.3	37.2	24.8	20.9	19.0	15.6	10.1	6.4	0.0	1.0	0.0	3.9	1.5	18.6	13.2	7.6	0.0	1.2	8.7	13.7	2.4	14.9	9.3	499.5	2.7	2.9	0.0	11.6	2.3	6.0	5.6	18.4	5.6	0.2	14.3	13.8	2.5	0.0	180.5	12.0	0.6	11.8	1.0	1.9	14.7	4.4	1.7	18.0	5.8	15.3	25.8	5.6	7.9	11.3	0.9	1.7	5.0	2.5	1.4
SERPINH1	"CBP1, CBP2, colligen, HSP47, SERPINH2"	ENSG00000149257	"Serpin family H member 1"	P50454	11	75562056-75572783	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone	"Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 165.4"	"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 237.4;Extravillous trophoblasts: 249.1;Fibroblasts: 319.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 118.7;HHSteC: 105.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004441, HPA029198"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		730000	"Endoplasmic reticulum"		"CAB004441: AB_627757, HPA029198: AB_10601712"	"unprognostic (3.80e-1)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (5.93e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (2.39e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.35e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.22e-15)"	"unprognostic (2.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.96e-2)"	38.2	20.1	10.5	29.3	10.9	1.0	54.1	5.7	8.4	39.4	16.9	6.0	10.3	6.4	32.7	16.8	17.8	23.6	21.4	29.6	11.8	7.0	18.5	11.5	35.7	13.5	17.1	2.7	48.3	13.9	5.9	11.0	69.9	23.2	26.2	11.0	13.8	7.7	16.7	9.5	12.3	9.4	57.8	12.9	14.3	14.2	12.5	13.0	7.4	36.1	8.7	8.2	38.7	165.4	1.3	5.5	5.0	1.6	7.1	7.4	2.4	5.4	18.5	34.8	71.6	54.0	49.8	15.9	50.8	34.6	38.3	48.9	98.2	28.8	0.0	46.2	118.7	0.3	33.0	23.8	15.8	18.6	2.2	4.5	3.9	18.3	19.7	105.3	0.1	0.7	59.3	16.3	36.6	12.3	47.8	52.3	2.0	8.4	1.7	17.9	43.1	0.1	7.0	30.9	20.6	4.9	2.7	19.2	4.5	9.3	10.5	0.8	11.5	31.8	5.9	9.6	56.6	14.2	6.8	27.5	39.6	33.0	26.9	12.3	2.3	2.2	0.5	17.1	0.0	53.0	5.0	1.6	0.1	7.4	1.5	6.7	1.2	5.1	5.3	5.5	1.3	5.7	4.6	0.3	7.1	0.2	4.7	4.2	2.4	10.5	10.9	5.7	8.4	11.8	7.0	17.1	2.7	23.2	13.0	35.7	30.1	6.4	237.4	72.7	2.9	29.5	5.1	9.4	18.2	24.4	55.0	184.7	0.0	59.0	1.8	84.9	20.7	0.0	10.4	249.1	319.9	138.1	9.2	8.6	78.7	6.4	58.5	154.1	6.7	2.7	152.1	16.7	42.2	15.4	21.1	19.3	26.7	20.3	113.5	24.1	1.0	90.5	199.9	9.9	10.2	38.9	138.7	12.1	24.3	59.6
SGPL1	SPL	ENSG00000166224	"Sphingosine-1-phosphate lyase 1"	O95470	10	70815961-70881173	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021125, HPA023086"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA021125: AB_1856803, HPA023086: AB_1856804"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.21e-2)"	"unprognostic (4.68e-3)"	9.6	11.2	12.0	20.2	11.4	4.9	24.4	10.8	10.6	16.2	17.1	16.0	21.9	13.3	15.5	16.8	26.7	13.5	13.4	8.3	11.3	9.8	18.2	27.1	10.4	20.1	11.9	9.5	10.0	34.6	15.4	10.2	11.3	10.4	16.1	15.6	7.6	15.0	19.5	7.6	28.6	32.5	12.1	15.7	22.9	10.3	15.3	11.0	14.7	17.6	12.8	18.0	21.4	26.8	5.6	9.7	8.9	24.8	10.9	11.5	6.6	10.7	14.4	13.9	15.9	3.8	5.0	9.2	6.3	6.8	6.9	9.0	15.6	23.9	9.7	7.5	6.4	6.7	18.2	11.9	12.8	9.9	15.5	6.4	1.0	7.3	18.6	14.5	4.2	8.8	9.4	21.7	9.3	24.5	14.7	4.3	9.2	2.8	8.5	9.8	11.9	5.1	2.8	6.3	14.3	8.0	6.6	10.6	3.6	11.1	45.7	9.5	11.6	12.7	19.5	11.6	11.4	10.1	3.0	8.3	6.3	16.5	4.8	12.1	3.5	4.8	4.5	6.2	7.8	4.4	0.6	11.5	7.9	11.5	20.3	10.4	4.7	7.5	9.4	9.7	5.6	5.7	9.0	8.9	10.9	24.8	5.4	6.8	6.6	12.0	11.4	10.8	10.4	11.3	9.8	11.9	9.5	10.4	11.0	14.9	5.4	9.9	14.9	10.9	6.5	5.6	30.6	14.7	14.8	43.6	19.6	6.6	3.3	32.5	2.3	6.4	38.8	0.0	33.2	10.9	12.4	23.9	14.9	39.5	25.3	14.3	24.1	6.2	30.2	4.5	10.6	15.9	6.8	16.2	20.8	9.3	41.0	17.3	19.1	11.5	8.2	6.5	11.4	19.9	31.5	19.8	5.3	11.4	16.2	20.4
SLC16A14	"FLJ30794, MCT14"	ENSG00000163053	"Solute carrier family 16 member 14"	Q7RTX9	2	230034974-230068999	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Endothelial cells: 4.5;Suprabasal keratinocytes: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"eosinophil: 12.0"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 12.0"	"Cell line enhanced"	"Detected in many"		"HL-60: 16.7;Karpas-707: 11.5;REH: 14.3;RPMI-8226: 12.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040518	Uncertain		Approved	"Endoplasmic reticulum"		No	No			"Endoplasmic reticulum"		"HPA040518: AB_10794877"	"unprognostic (2.99e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.20e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.51e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.10e-1)"	5.4	5.2	7.0	2.2	11.1	6.6	4.0	14.4	16.2	6.5	4.6	3.2	1.1	1.3	4.9	3.2	5.3	4.1	3.6	3.0	6.9	8.2	1.7	2.5	2.5	1.6	6.2	8.2	10.2	1.1	12.4	1.9	1.6	6.7	5.9	5.0	12.0	20.5	4.7	1.3	13.4	1.6	4.9	4.4	10.1	1.8	2.0	1.3	1.1	2.0	3.4	3.3	3.8	4.8	0.4	0.5	12.0	0.0	0.1	0.4	0.1	2.1	1.3	1.0	0.0	0.0	0.2	0.0	0.2	0.0	0.5	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.4	3.7	1.1	0.1	0.0	6.3	0.1	2.5	0.0	0.2	16.7	0.0	0.4	2.9	0.0	0.0	3.1	0.1	3.4	0.0	11.5	0.2	0.0	1.6	2.1	0.8	0.2	2.0	14.3	0.0	12.9	4.4	1.9	4.8	1.5	3.5	0.0	0.1	0.0	5.7	1.5	0.0	0.0	0.9	2.4	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.0	0.4	0.0	0.3	0.4	0.2	0.0	0.5	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	7.0	11.1	14.4	16.2	6.9	8.2	6.2	8.2	6.7	1.3	0.0	0.0	0.0	0.6	2.3	2.9	3.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	4.5	0.0	0.0	0.5	0.0	0.8	0.8	0.0	1.0	0.1	3.2	3.5	3.1	0.3	0.0	1.1	0.0	1.7	0.0	0.0	1.8	0.7	0.0	2.8	0.5	1.1	0.0	1.0	0.2	0.2	4.1	0.2	0.0	1.6	0.2
SLC27A3	"ACSVL3, FATP3, MGC4365"	ENSG00000143554	"Solute carrier family 27 member 3"	Q5K4L6	1	153774354-153780157	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ito cells: 131.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 5.9;granulocytes: 13.7;monocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 35.6;HaCaT: 12.5;MCF7: 18.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA006935, HPA067508"	Enhanced		Enhanced	"Endoplasmic reticulum"		Yes	No			"Endoplasmic reticulum"		"HPA006935: AB_1080003, HPA067508: AB_2685857"	"unprognostic (1.88e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.39e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.08e-1)"	20.7	3.7	4.9	6.4	4.3	3.7	15.0	7.5	6.6	11.1	11.6	3.6	7.9	3.5	10.1	39.1	9.4	9.5	9.2	7.0	3.5	2.4	12.2	19.5	21.1	7.0	3.5	4.7	13.6	5.7	4.5	6.7	9.7	3.3	11.6	6.1	4.6	7.7	9.7	3.6	11.0	6.8	10.5	1.8	6.9	14.4	15.4	3.4	3.5	8.6	10.3	5.5	9.7	9.4	0.6	5.9	13.7	8.7	2.2	2.2	2.5	4.0	0.2	1.7	0.8	35.6	6.9	3.1	1.5	3.0	0.6	0.8	2.3	1.8	0.5	4.2	1.7	0.3	12.5	1.7	1.4	0.4	0.3	2.3	0.8	2.2	1.0	4.3	1.4	2.9	4.6	4.7	0.2	0.9	0.6	4.8	0.2	0.4	0.7	0.2	18.8	0.1	4.1	4.1	8.6	1.9	7.1	0.3	0.4	1.0	0.5	3.5	3.9	0.8	8.3	1.5	2.4	2.2	4.1	1.1	0.8	1.7	4.4	0.0	1.3	1.2	0.1	2.0	4.8	0.6	7.2	8.7	13.7	2.1	7.3	1.5	0.5	1.0	2.2	5.9	0.6	0.5	1.1	1.7	2.2	7.2	1.0	0.3	2.5	4.9	4.3	7.5	6.6	3.5	2.4	3.5	4.7	3.3	3.4	17.9	43.8	4.5	9.1	10.4	0.8	2.5	38.2	0.0	7.9	3.5	0.0	24.4	0.0	3.1	0.4	20.2	2.5	0.0	6.4	10.1	17.3	4.2	25.3	25.9	29.3	1.6	4.1	131.3	31.9	2.4	17.5	32.9	21.9	45.1	16.0	1.5	3.7	33.6	13.4	3.4	1.0	6.5	12.8	1.1	3.4	6.8	7.3	15.9	9.1	2.6
SLC39A7	"D6S2244E, H2-KE4, HKE4, KE4, RING5, ZIP7"	ENSG00000112473	"Solute carrier family 39 member 7"	Q92504	6	33200445-33204439	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053999	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA053999: AB_2682338"	"unprognostic (3.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.24e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (4.87e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.20e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	14.7	25.1	9.0	12.1	9.5	6.1	15.8	11.9	11.9	24.7	19.8	12.2	43.3	17.3	20.1	24.6	14.4	13.6	25.6	20.7	8.7	8.9	24.6	55.1	20.2	11.6	12.6	9.6	14.4	49.2	37.1	24.2	43.8	18.8	22.8	22.9	16.8	48.0	41.7	10.4	11.3	18.8	20.1	10.6	15.2	21.1	9.5	10.7	9.9	28.2	14.4	17.0	16.6	13.9	2.6	3.4	6.2	2.8	4.2	5.1	2.1	8.5	9.9	15.2	14.1	22.9	15.7	13.3	22.9	30.1	17.8	21.0	16.2	8.3	6.4	11.2	25.5	13.8	9.7	11.5	13.5	15.9	8.1	10.2	10.9	11.6	20.8	16.6	10.8	13.2	14.8	11.4	15.7	17.0	17.6	14.2	6.8	11.9	10.5	12.2	9.7	5.9	6.3	6.5	12.5	9.1	6.4	8.9	10.6	11.9	10.7	9.9	8.0	9.3	22.0	12.5	9.6	21.3	10.1	14.0	16.4	10.0	12.2	15.2	16.5	14.5	5.7	9.9	10.3	18.1	6.2	2.4	2.3	5.1	2.8	4.8	1.8	3.2	3.9	2.3	2.6	2.9	3.3	2.4	4.2	1.6	3.4	3.0	2.1	9.0	9.5	11.9	11.9	8.7	8.9	12.6	9.6	18.8	10.7	23.8	33.3	14.5	25.7	32.1	27.2	29.7	28.1	22.7	33.0	24.4	27.5	88.4	5.0	60.8	0.6	33.7	62.8	23.3	75.1	113.6	62.0	56.4	19.7	31.1	38.7	11.1	24.3	29.4	17.0	1.9	42.6	23.9	38.8	27.9	109.3	41.2	56.0	56.2	40.3	20.1	22.2	19.4	33.9	7.9	10.6	35.8	141.1	27.4	54.4	33.5
SLC39A9	FLJ11274	ENSG00000029364	"Solute carrier family 39 member 9"	Q9NUM3	14	69398015-69462388	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 62.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007921, HPA075390"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA007921: AB_1080007, HPA075390: AB_2686748"	"unprognostic (2.37e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	15.8	22.2	19.5	11.3	19.2	8.8	24.8	15.0	26.3	19.5	25.5	22.4	20.6	20.8	19.1	25.6	22.3	16.5	16.7	14.5	18.9	19.1	31.2	52.9	15.7	13.0	17.8	13.7	16.3	28.0	24.5	24.6	29.7	17.1	19.4	22.7	17.0	65.2	24.2	7.7	16.7	27.8	16.3	19.3	16.3	19.8	17.4	14.1	18.3	22.4	13.7	19.2	14.5	14.6	9.9	17.2	12.5	14.8	9.2	12.5	9.2	29.4	23.2	14.9	15.0	25.6	19.9	13.4	18.1	21.0	15.5	17.9	17.4	27.9	24.0	13.2	20.9	7.9	24.3	16.2	17.0	19.6	16.2	8.7	15.2	13.2	13.2	19.2	11.2	21.6	16.0	27.2	14.2	21.4	16.6	16.2	20.4	11.6	24.0	18.0	16.4	16.7	12.1	11.9	24.7	16.5	16.9	21.0	15.6	20.9	32.2	15.3	25.1	17.5	30.6	10.5	12.0	43.0	18.3	17.2	28.4	20.3	11.8	12.3	26.4	14.7	18.5	26.8	12.8	23.1	11.9	14.8	12.5	11.7	14.1	12.5	9.9	10.2	11.5	17.2	7.7	10.3	11.2	12.0	9.2	13.0	8.3	7.4	9.2	19.5	19.2	15.0	26.3	18.9	19.1	17.8	13.7	17.1	14.1	17.9	13.0	13.7	6.6	10.8	7.2	7.0	20.4	12.0	10.3	15.7	5.9	12.4	5.0	12.6	13.3	14.6	36.8	0.0	21.6	13.5	14.1	18.8	11.5	62.5	14.0	9.5	28.3	23.4	21.5	15.1	12.0	9.3	6.8	10.0	31.8	10.4	22.1	20.1	12.0	14.6	11.0	6.5	12.9	11.8	6.4	10.9	14.9	8.2	22.3	12.4
SLMAP	"KIAA1601, SLAP"	ENSG00000163681	"Sarcolemma associated protein"	Q14BN4	3	57755450-57929168	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 133.6;urinary bladder: 114.2"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 272.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002357, HPA002358"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA		12000	"Endoplasmic reticulum"		"HPA002357: AB_1080023, HPA002358: AB_1080021"	"unprognostic (3.70e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.82e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (7.98e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (1.58e-6)"	"unprognostic (8.18e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.08e-2)"	10.6	10.7	7.0	22.4	11.1	7.4	12.0	10.2	7.2	26.5	50.3	5.8	24.7	9.8	43.0	19.5	44.0	21.3	15.0	58.2	6.5	5.6	8.0	7.8	8.0	7.2	6.9	6.0	21.4	5.8	16.0	8.0	7.7	6.8	47.8	12.2	8.7	8.6	37.7	26.1	9.4	23.3	133.6	6.0	7.2	27.2	14.9	6.8	11.2	11.1	12.1	6.3	114.2	26.4	5.9	5.1	15.8	5.5	7.1	5.9	4.5	22.1	12.5	10.7	15.4	16.1	16.2	14.6	20.5	21.2	14.4	13.9	30.0	33.0	14.9	9.8	16.3	25.8	12.2	19.1	27.3	18.9	16.4	10.9	25.8	17.7	23.5	15.7	25.5	14.4	11.7	21.9	17.7	33.0	18.6	16.4	15.1	21.0	13.5	14.7	7.2	17.4	13.1	16.1	16.1	24.3	7.2	11.7	14.8	29.4	24.2	6.1	7.2	26.7	20.3	12.6	14.7	11.0	16.2	19.4	15.9	12.7	20.1	26.5	15.7	26.7	20.3	14.3	22.3	14.9	7.5	5.5	15.8	5.9	3.6	4.9	5.9	4.6	5.0	5.1	4.5	5.4	5.5	13.4	7.1	3.6	2.9	5.1	4.5	7.0	11.1	10.2	7.2	6.5	5.6	6.9	6.0	6.8	6.8	35.7	34.1	6.2	37.6	81.7	24.0	272.3	33.1	29.4	29.6	31.4	47.1	15.6	16.6	39.8	28.6	23.2	38.0	0.0	29.8	10.7	23.5	70.4	3.5	20.3	13.9	30.2	13.8	16.0	19.4	17.7	30.2	18.8	27.0	11.8	24.3	98.5	46.3	29.2	67.5	24.5	32.2	51.8	116.9	81.2	26.8	64.1	13.6	23.0	23.4	106.8
SMPD3	NSMASE2	ENSG00000103056	"Sphingomyelin phosphodiesterase 3"	Q9NY59	16	68358325-68448688	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Lipid metabolism, Sphingolipid metabolism"	"Developmental protein, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.5;intestine: 46.4;lymphoid tissue: 73.0"	"Cell type enriched"	"Detected in many"	6	"Horizontal cells: 284.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"plasmacytoid DC: 44.5"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 44.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 9.6;MOLT-4: 13.6;RPMI-8226: 11.3;SCLC-21H: 13.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 103.1"	"Low region specificity"	"Detected in all"			"CAB033885, HPA065535, HPA069383"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB033885: AB_1126788, HPA065535: , HPA069383: "	"unprognostic (1.21e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (5.61e-3)"	"prognostic favorable (3.86e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.85e-4)"	"unprognostic (7.87e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-3)"	3.5	2.3	6.0	3.1	18.3	1.8	1.6	9.4	15.4	1.0	9.6	2.5	0.0	46.4	1.7	0.7	1.8	2.7	17.2	1.2	8.7	3.6	0.9	3.8	2.1	3.5	2.5	5.0	2.7	1.9	0.7	10.7	0.8	3.9	2.2	5.8	4.3	2.2	0.9	1.8	8.1	42.7	1.2	1.4	3.0	18.6	4.2	4.4	73.0	1.3	1.3	4.3	1.6	1.2	0.6	44.5	6.1	0.0	0.0	0.7	0.3	0.3	0.7	0.3	0.1	0.0	0.0	5.3	0.4	0.0	0.4	0.1	2.9	0.9	0.4	0.5	0.2	0.2	1.1	0.0	0.0	0.1	0.3	0.7	0.1	2.1	0.3	0.0	0.0	9.6	0.0	0.0	0.0	0.2	0.5	0.0	0.9	0.8	0.3	0.3	0.2	13.6	2.6	0.6	4.6	0.1	0.6	0.2	11.3	0.0	0.1	13.1	2.6	0.4	1.5	0.6	0.3	1.0	0.9	0.0	0.4	0.8	1.4	0.1	2.2	1.1	0.2	0.2	0.9	0.2	1.0	0.0	6.1	0.7	0.0	0.1	0.6	0.0	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.0	44.5	0.5	0.3	6.0	18.3	9.4	15.4	8.7	3.6	2.5	5.0	3.9	4.4	3.0	0.6	0.0	1.4	0.1	39.5	2.5	5.1	16.0	1.2	0.0	0.0	0.0	0.0	0.9	6.0	0.0	51.1	0.0	0.8	0.2	0.3	3.7	0.0	5.0	0.2	284.4	24.8	0.0	0.6	13.0	14.1	0.0	0.0	0.0	25.6	0.8	1.2	43.0	43.2	0.0	3.3	0.0	0.0	5.4	0.3	0.9	0.0	5.0	18.7	4.7
SOAT1	"ACAT, SOAT, STAT"	ENSG00000057252	"Sterol O-acyltransferase 1"	P35610	1	179293714-179358680	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 87.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009533, HPA047171"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB009533: AB_633499, HPA047171: AB_2679967"	"unprognostic (3.29e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.81e-3)"	"unprognostic (7.81e-3)"	"unprognostic (3.29e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.45e-3)"	"unprognostic (7.02e-3)"	"unprognostic (4.67e-3)"	"unprognostic (9.64e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.82e-1)"	23.9	87.4	4.1	8.3	5.7	7.0	9.6	2.9	4.0	6.8	7.2	5.6	7.8	5.5	8.2	6.0	3.4	8.3	9.8	5.7	5.5	4.1	12.1	8.8	18.6	13.0	6.2	2.3	10.8	15.5	8.1	14.6	11.6	4.9	13.1	6.9	9.6	51.1	8.9	4.1	5.8	7.0	7.5	10.5	13.6	8.1	6.8	4.9	4.0	6.2	2.9	7.2	9.4	8.7	6.6	24.3	19.8	26.8	18.5	16.0	14.8	20.4	9.6	7.9	11.7	30.9	16.9	42.5	9.9	17.5	22.0	25.7	9.8	23.4	11.6	15.7	18.0	26.8	7.5	25.1	5.9	23.8	13.2	5.2	5.4	8.1	10.2	12.7	9.2	2.1	13.3	3.8	25.7	22.1	9.3	9.4	14.3	11.6	6.0	34.2	4.3	9.8	3.0	3.8	3.3	3.2	12.2	10.3	6.8	19.4	12.8	2.4	6.2	15.3	6.5	5.7	9.8	6.8	6.3	8.9	26.2	12.6	28.6	21.8	8.5	31.0	9.9	10.4	5.0	48.5	19.6	26.8	0.7	14.0	17.0	13.5	6.6	13.1	13.1	24.3	5.5	12.7	12.6	19.8	18.5	11.1	4.4	16.0	14.8	4.1	5.7	2.9	4.0	5.5	4.1	6.2	2.3	4.9	4.9	20.8	33.1	10.4	8.5	8.9	7.2	5.6	22.9	48.2	14.8	19.2	13.7	14.8	1.7	33.4	19.5	13.0	7.9	0.0	21.9	46.9	18.6	33.8	13.9	21.9	69.5	6.4	57.5	21.5	66.9	10.8	30.2	63.1	21.9	44.1	27.7	6.8	20.1	10.5	24.4	12.8	13.0	25.8	13.0	5.6	8.2	4.5	7.3	27.9	16.8	6.5
SOCS2	"CIS2, Cish2, SOCS-2, SSI-2, SSI2, STATI2"	ENSG00000120833	"Suppressor of cytokine signaling 2"	O14508	12	93569814-93583487	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 123.3;monocytes: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 45.5"	"Lineage enhanced"	"Detected in many"		"granulocytes: 45.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 39.4;K-562: 31.9;REH: 75.7;THP-1: 32.6"	"Low region specificity"	"Detected in all"							CAB010356	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB010356: AB_2239660"	"unprognostic (4.16e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.64e-2)"	"prognostic favorable (1.09e-6)"	"unprognostic (1.07e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.35e-3)"	"prognostic favorable (8.17e-7)"	"unprognostic (1.71e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.40e-2)"	"unprognostic (9.09e-2)"	25.2	14.3	2.6	5.1	4.1	3.6	39.6	2.3	4.3	37.9	14.2	2.4	23.1	4.3	38.8	21.4	7.7	15.0	15.5	12.4	4.9	3.1	14.6	28.2	22.7	12.3	3.3	1.4	14.1	7.1	18.7	26.7	21.9	11.0	33.5	6.9	7.0	4.9	32.5	12.0	3.7	10.7	36.9	3.3	4.3	12.3	10.3	2.9	12.7	12.7	7.1	4.3	15.6	21.3	0.8	0.6	45.5	0.1	8.2	11.5	5.1	0.8	1.0	4.0	3.5	2.3	4.1	4.5	4.9	17.9	3.5	1.6	39.4	1.8	0.2	0.1	4.5	1.0	9.1	20.7	1.4	4.1	15.8	0.5	3.2	0.1	0.5	3.3	1.0	6.8	6.7	1.2	4.1	5.5	0.3	0.5	2.0	31.9	0.6	0.5	0.4	0.2	1.4	11.2	0.7	1.6	75.7	0.0	0.8	1.0	1.6	6.8	8.1	1.6	2.7	12.6	4.0	0.0	32.6	0.5	10.6	0.2	0.0	2.7	0.4	0.2	0.2	0.2	2.4	6.7	45.5	0.0	2.2	8.4	0.1	11.5	0.1	10.5	7.7	0.0	0.8	10.7	6.3	0.3	8.2	0.1	0.6	6.0	5.1	2.6	4.1	2.3	4.3	4.9	3.1	3.3	1.4	11.0	2.9	8.9	64.9	0.0	42.5	16.0	3.8	4.4	0.0	4.0	31.8	21.0	3.9	28.9	53.0	10.2	7.0	46.6	15.5	0.0	32.8	4.5	32.4	113.6	23.1	9.7	11.0	65.2	7.9	123.3	11.9	14.7	84.8	9.2	16.9	188.4	14.6	1.3	9.3	17.5	95.1	17.2	0.7	77.6	40.1	2.6	7.9	9.3	29.3	13.8	15.6	25.7
SPTLC1	"hLCB1, HSAN1, HSN1, LCB1, SPTI"	ENSG00000090054	"Serine palmitoyltransferase long chain base subunit 1"	O15269	9	92000087-92115384	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 76.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010860, CAB018747, HPA063907"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB018747: AB_2195864, HPA010860: AB_1080086, HPA063907: AB_2685148"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.37e-2)"	"prognostic favorable (1.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.49e-1)"	16.4	17.7	13.3	11.4	17.1	9.9	16.8	19.9	17.6	20.3	17.2	20.9	18.1	14.0	17.3	15.1	30.5	19.2	15.5	11.4	13.9	15.3	19.0	13.5	14.8	10.6	18.0	12.2	35.3	15.8	23.6	23.1	28.3	20.5	14.5	18.8	12.0	18.5	13.3	9.4	20.1	17.8	15.1	20.8	10.7	16.0	19.8	14.1	9.7	26.2	16.0	16.5	17.4	20.9	9.3	21.0	21.1	22.1	10.2	15.2	16.0	18.4	16.8	11.6	9.7	28.4	22.2	20.1	19.4	24.9	16.8	18.3	10.5	38.7	10.2	12.4	24.6	20.4	48.5	12.5	16.5	19.6	11.8	7.3	9.4	9.5	10.2	21.4	15.5	12.7	19.9	20.0	17.4	18.9	16.0	15.3	11.0	21.9	12.7	19.1	19.9	9.7	3.8	15.6	20.9	12.2	10.8	14.1	7.8	16.7	11.3	9.4	8.8	26.2	20.1	11.8	14.5	10.3	9.2	19.4	16.4	12.7	18.8	13.5	9.2	12.6	5.7	19.6	7.7	19.6	14.6	22.1	11.9	11.5	21.6	11.0	8.9	11.6	11.6	21.0	9.3	14.2	10.7	21.1	10.2	19.2	10.8	15.2	16.0	13.3	17.1	19.9	17.6	13.9	15.3	18.0	12.2	20.5	14.1	35.7	41.3	10.3	9.6	9.4	8.1	3.7	2.5	40.2	35.2	34.9	13.7	10.9	8.3	46.0	76.8	8.7	7.7	0.0	49.5	11.1	12.2	7.8	23.2	4.4	9.7	6.4	2.4	6.7	6.5	22.6	5.8	22.2	11.8	28.9	6.2	11.3	47.8	4.0	5.6	22.6	7.9	12.9	10.3	33.1	25.8	8.0	18.2	11.4	6.0	13.2
SSR1	TRAPA	ENSG00000124783	"Signal sequence receptor subunit 1"	P43307	6	7268306-7347446	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011276, HPA017062"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA011276: AB_1857503, HPA017062: AB_1857505"	"unprognostic (2.27e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.98e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.79e-6)"	"unprognostic (3.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.19e-2)"	37.8	38.5	22.5	35.8	25.7	37.3	29.9	30.8	24.1	41.6	26.9	28.6	35.7	27.4	33.2	34.2	38.7	25.7	27.7	27.8	21.6	29.8	41.4	99.0	30.0	41.7	25.1	18.8	36.5	53.6	21.7	40.3	37.1	24.7	26.0	33.3	25.9	55.8	39.9	24.2	21.8	31.5	32.6	31.4	40.1	28.2	18.6	24.6	32.0	36.8	28.2	34.6	34.3	26.0	22.8	60.3	33.8	50.3	24.9	33.9	54.1	20.0	20.5	15.9	29.3	43.2	30.8	24.8	46.4	38.3	31.7	38.3	27.9	16.7	27.1	82.1	47.3	29.2	18.1	19.0	26.5	43.9	28.3	16.1	28.9	24.1	58.0	44.9	53.2	32.8	27.2	29.2	36.3	74.8	24.5	34.8	13.6	32.3	32.7	34.8	24.1	14.5	14.0	13.4	22.7	23.3	19.8	20.0	101.4	27.7	28.7	21.5	10.0	28.2	15.6	43.1	50.1	25.3	23.6	30.8	34.2	26.1	26.4	39.6	33.8	50.1	21.9	16.6	30.1	62.4	33.8	50.3	33.2	26.9	36.8	33.9	22.8	30.1	30.1	60.3	17.7	28.8	28.8	28.4	24.9	31.1	42.0	31.8	54.1	22.5	25.7	30.8	24.1	21.6	29.8	25.1	18.8	24.7	24.6	26.8	37.9	78.9	52.1	69.0	70.6	38.3	91.7	32.1	53.4	123.9	94.2	69.1	13.3	83.2	10.0	65.3	48.5	23.3	89.4	184.0	80.1	92.1	46.2	127.8	119.1	66.7	59.8	77.3	135.2	9.6	72.8	143.0	89.4	55.1	89.0	65.4	68.5	31.6	68.6	56.7	95.4	25.8	62.9	44.0	54.3	65.9	101.8	73.0	76.6	57.0
SSR4	TRAPD	ENSG00000180879	"Signal sequence receptor subunit 4"	P51571	X	153793516-153798505	"Disease related genes, Plasma proteins, Predicted membrane proteins"			"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 699.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045209	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		600000	"Endoplasmic reticulum"		"HPA045209: AB_10961407"	"unprognostic (3.56e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.00e-3)"	"prognostic favorable (1.76e-4)"	"unprognostic (8.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.04e-3)"	"unprognostic (5.74e-3)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (5.51e-6)"	"unprognostic (8.18e-2)"	"unprognostic (2.24e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.33e-2)"	17.4	30.0	13.2	29.5	22.6	37.5	46.0	12.2	20.6	30.4	31.7	9.0	152.0	30.7	19.1	81.4	21.4	18.3	30.2	40.7	23.0	17.7	21.8	48.0	42.1	136.9	14.5	11.6	18.4	699.0	7.2	67.7	30.3	26.0	24.0	24.0	11.7	83.7	192.6	12.1	16.9	24.1	19.5	26.3	37.9	43.6	19.6	8.2	15.3	22.6	21.0	29.4	27.7	20.0	67.1	171.0	50.7	58.6	62.0	78.7	108.1	34.3	44.2	15.0	84.3	81.0	43.1	31.4	29.4	43.6	30.6	41.8	54.9	30.5	49.0	77.9	44.5	27.6	34.1	26.1	27.3	11.2	19.9	22.4	13.8	41.5	43.1	70.1	37.9	36.8	53.7	38.0	26.3	35.9	27.0	32.8	24.5	15.1	104.1	23.7	61.5	21.5	56.5	9.1	93.4	72.1	24.3	19.5	90.7	38.6	41.0	29.3	24.2	17.5	30.2	31.8	17.1	19.5	81.8	27.2	18.0	20.0	34.7	38.1	154.6	75.5	57.4	38.3	64.8	30.1	50.7	58.6	26.1	63.6	44.4	78.7	67.1	65.5	62.9	58.5	56.6	57.0	58.4	9.3	62.0	35.5	171.0	47.9	108.1	13.2	22.6	12.2	20.6	23.0	17.7	14.5	11.6	26.0	8.2	154.9	288.1	268.7	274.5	228.5	46.7	258.0	412.7	216.8	227.5	301.8	53.0	273.1	142.6	480.5	402.2	256.1	483.1	163.5	550.9	548.3	330.2	594.2	342.0	631.0	408.8	33.4	718.3	247.4	326.6	1155.6	311.8	347.4	1354.7	339.0	538.4	117.5	526.9	501.2	232.3	335.7	57.8	116.4	210.1	119.2	239.9	281.7	472.2	373.9	490.6	402.8
ST8SIA6	SIAT8F	ENSG00000148488	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6"	P61647	10	17318383-17454330	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 17.5"	"Group enriched"	"Detected in some"	7	"Endothelial cells: 8.7;granulocytes: 10.3;Ito cells: 15.4;Melanocytes: 8.5"	"Cancer enhanced"	"Detected in some"		"breast cancer: 5.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"HMC-1: 108.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011635, HPA072708"	Uncertain		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA011635: AB_2194921, HPA072708: "	"unprognostic (4.86e-3)"	"unprognostic (7.01e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.23e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.26e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.07e-3)"	1.8	0.9	3.1	1.0	5.0	4.0	14.4	2.5	3.4	1.1	1.7	3.3	0.4	1.0	1.6	10.4	2.4	1.3	1.9	9.1	3.7	4.4	2.5	2.4	17.5	0.8	8.8	1.7	1.1	0.5	0.3	1.3	3.5	5.5	4.3	1.8	13.7	1.9	0.6	2.0	2.8	1.3	1.3	4.3	1.5	1.0	1.2	2.5	0.0	1.8	0.5	2.0	1.1	3.9	0.9	0.7	3.8	1.4	2.1	5.6	0.9	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.0	13.3	0.0	0.1	0.0	0.0	108.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	2.5	0.1	0.9	1.3	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.4	1.3	2.5	0.4	0.5	0.3	1.2	1.4	0.7	0.9	1.0	1.7	2.9	2.1	0.7	0.6	5.6	0.9	3.1	5.0	2.5	3.4	3.7	4.4	8.8	1.7	5.5	2.5	0.0	0.0	0.0	0.1	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	8.7	0.0	0.0	0.0	0.0	0.2	1.6	10.3	0.0	0.1	0.0	0.0	15.4	0.8	0.4	0.0	0.0	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	1.0	0.0	0.0
STBD1	"FLJ41801, GENX-3414"	ENSG00000118804	"Starch binding domain 1"	O95210	4	76306026-76311599	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 16.1;liver: 14.3;skeletal muscle: 34.5"	"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 12.0;Ductal cells: 5.3;Enterocytes: 4.9;Exocrine glandular cells: 3.5;Pancreatic endocrine cells: 3.5;Paneth cells: 3.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 15.0;Karpas-707: 31.5;U-266/70: 20.4"	"Low region specificity"	"Detected in many"							"HPA011952, HPA012849"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA011952: AB_1847461, HPA012849: AB_1847460"	"unprognostic (1.46e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.74e-2)"	16.1	1.2	0.1	0.7	0.0	1.9	3.7	0.0	0.5	1.2	2.7			1.2	2.3	0.0	1.6	1.2	1.0	7.1	0.0	0.5	0.7	14.3	2.6	0.0	0.3		1.3	1.9	0.4	0.2	1.2		2.1	1.6		1.2	1.1	34.5	0.0	3.9	2.4	0.6	0.0	2.3	0.5			0.1		0.0	3.4	1.4	0.2	3.2	5.9	3.6	3.7	3.6	1.4	3.8	1.8	0.2	2.4	5.3	1.4	3.3	4.2	2.5	1.6	1.9	1.8	4.5	0.0	3.4	2.7	3.7	2.4	0.7	0.9	0.6	15.0	1.0	0.2	2.3	2.2	0.7	2.1	2.8	0.8	2.7	1.3	0.7	4.1	0.0	0.0	0.1	31.5	2.8	2.5	0.2	1.8	0.4	2.7	2.0	0.0	0.9	2.6	0.9	1.9	0.8	4.4	3.3	4.2	0.0	0.4	1.1	0.7	0.7	3.2	2.0	7.5	2.3	20.4	3.7	0.0	4.4	1.4	1.0	0.3	3.6	5.9	2.7	3.3	1.7	0.2	3.6	3.4	3.2	0.0	0.6	1.1	0.7	3.7	1.6	0.2	0.6	1.4											0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.0	4.9	0.0	3.5	1.1	0.3	0.4	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.0	0.0	3.5	3.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	1.5	0.6
STC2	STC-2	ENSG00000113739	"Stanniocalcin 2"	O76061	5	173314713-173329503	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 68.5;pancreas: 51.8"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 33.9;Ductal cells: 28.6;Extravillous trophoblasts: 43.0;Leydig cells: 21.3"	"Cancer enriched"	"Detected in all"	6	"breast cancer: 91.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 115.7;T-47d: 109.8;U-138 MG: 45.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA045372	Uncertain		Approved	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		15000000	"Endoplasmic reticulum"		"HPA045372: AB_10961040"	"prognostic favorable (7.40e-5)"	"unprognostic (2.40e-2)"	"unprognostic (9.03e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.89e-3)"	"prognostic unfavorable (1.76e-6)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (5.28e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (4.17e-8)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (8.56e-2)"	"unprognostic (5.06e-2)"	"unprognostic (7.93e-3)"	3.6	0.7	0.3	1.4	0.8	0.2	68.5	0.4	2.4	6.5	2.4	0.1	1.4	0.5	1.6	2.4	3.1	1.3	5.8	17.4	0.9	0.4	1.7	0.6	17.3	0.7	2.4	0.0	2.0	51.8	1.5	1.2	12.1	2.8	3.0	0.6	0.1	0.6	5.7	10.8	7.4	1.7	8.8	7.1	14.8	2.2	0.8	1.0	0.0	4.5	0.7	0.4	9.5	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	1.8	0.3	1.5	5.6	2.4	15.4	26.4	26.3	6.7	13.0	8.4	4.3	0.0	4.0	15.6	34.7	2.4	3.9	8.2	11.8	0.0	2.2	0.0	2.8	5.6	35.2	1.8	0.5	5.1	13.2	15.6	1.1	31.3	1.8	5.5	0.2	0.0	115.7	4.7	0.0	0.0	0.9	2.5	8.9	0.0	3.9	3.0	0.0	0.4	4.2	1.1	1.1	0.1	4.6	1.2	109.8	1.8	16.8	45.4	0.1	26.4	5.5	5.1	2.7	1.2	8.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.4	2.4	0.9	0.4	2.4	0.0	2.8	1.0	0.0	0.0	0.0	0.2	4.4	10.0	12.1	0.0	0.0	0.0	0.0	0.0	33.9	0.0	28.6	0.5	10.5	0.0	0.0	11.2	43.0	20.0	0.3	0.0	0.0	4.5	0.0	6.9	3.1	0.0	1.1	21.3	0.2	10.1	0.0	0.0	1.1	12.1	0.0	0.4	4.1	2.2	0.0	2.7	0.9	1.0	5.5	18.3	0.0	0.0	0.0
STIM1	"D11S4896E, GOK"	ENSG00000167323	"Stromal interaction molecule 1"	Q13586	11	3854527-4093210	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA011088, HPA012123, CAB037128, CAB037288"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		4900000	"Endoplasmic reticulum"		"CAB037128: AB_1079007, CAB037288: AB_1079008, HPA011088: AB_1849884, HPA012123: AB_1849882"	"unprognostic (2.06e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.39e-2)"	20.8	9.9	15.5	28.9	19.9	23.1	53.1	14.1	16.8	20.5	21.2	8.5	16.5	9.2	20.6	20.3	35.1	19.8	35.6	14.3	10.3	10.5	13.2	29.0	21.6	34.0	7.7	10.3	21.7	21.2	27.7	9.4	18.1	9.0	18.2	13.7	23.5	46.9	17.0	49.4	22.1	16.0	22.5	8.7	23.2	15.6	20.1	6.0	39.7	34.2	26.6	23.4	19.5	21.7	11.1	8.5	17.1	20.6	17.6	18.2	13.3	14.9	19.4	6.1	10.6	29.0	25.2	8.4	13.5	13.7	9.6	11.9	8.7	5.0	15.9	14.0	18.6	20.1	27.4	7.7	7.9	8.0	13.0	11.6	25.6	7.4	13.1	23.6	20.6	14.9	28.6	19.7	14.0	34.4	13.1	12.5	21.7	15.5	30.3	9.9	3.4	19.4	7.5	2.4	8.3	6.9	4.9	8.7	14.9	15.2	8.8	1.2	5.6	19.2	12.3	7.2	10.3	4.6	11.7	12.8	17.7	5.9	17.2	9.2	32.8	24.7	8.1	14.7	8.7	10.1	12.4	9.5	17.1	17.3	13.0	13.9	7.3	12.6	18.2	8.5	11.1	14.3	12.8	15.2	17.6	20.6	7.5	12.8	13.3	15.5	19.9	14.1	16.7	10.3	10.5	7.7	10.3	9.0	6.0	14.9	8.0	10.3	6.0	14.5	4.9	3.9	12.7	9.4	5.7	5.2	13.7	20.7	1.7	12.2	3.6	14.7	8.6	0.0	12.5	11.0	12.4	10.5	28.9	28.0	13.7	15.9	8.7	20.3	19.4	4.9	25.3	12.4	16.9	5.4	12.9	16.9	10.2	3.5	10.6	3.5	3.6	25.8	18.1	20.9	8.1	19.4	14.5	22.0	7.5	10.3
STT3B	"FLJ90106, SIMP, STT3-B"	ENSG00000163527	"STT3B, catalytic subunit of the oligosaccharyltransferase complex"	Q8TCJ2	3	31532638-31637622	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036448, HPA036646"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		9300	"Endoplasmic reticulum"		"HPA036448: AB_2675129, HPA036646: AB_10673472"	"unprognostic (2.17e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (7.91e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.02e-1)"	23.0	30.3	16.0	27.5	16.7	21.7	27.4	15.4	19.4	28.4	25.0	16.9	37.0	18.6	28.4	37.9	28.8	22.4	29.0	27.5	15.1	15.6	28.2	64.1	30.1	36.9	16.5	15.5	62.3	39.4	36.2	20.3	85.9	16.5	26.3	25.1	22.3	25.2	26.3	31.2	19.2	29.2	23.2	19.7	29.4	22.9	36.7	13.6	60.2	44.3	23.4	30.3	27.5	27.7	3.6	7.7	8.4	5.3	8.4	8.5	3.0	16.6	28.0	25.8	27.0	32.5	32.8	56.4	31.3	27.5	23.4	27.2	25.5	36.2	29.0	15.4	28.3	19.3	14.1	23.8	27.1	30.8	81.6	15.7	24.8	28.5	27.1	25.1	53.5	29.7	25.1	29.1	33.3	42.2	36.2	23.6	37.2	13.3	46.5	31.8	9.4	52.3	33.1	20.8	27.9	15.8	54.7	14.0	42.0	27.2	24.1	11.0	13.4	31.0	46.1	18.1	23.0	20.7	28.6	45.9	31.7	20.3	31.3	27.5	29.3	35.1	24.3	28.7	36.8	26.0	2.3	4.6	8.4	4.7	5.3	7.5	3.4	8.5	6.5	4.0	3.6	8.2	6.5	1.7	8.4	3.7	7.7	4.1	3.0	16.0	16.7	15.4	19.4	15.1	15.6	16.5	15.5	16.5	13.6	80.4	51.9	42.7	51.5	60.6	48.3	64.1	56.0	40.2	88.7	41.8	64.8	58.7	11.6	32.8	125.1	35.0	40.6	0.0	38.9	84.1	47.2	61.2	31.1	58.2	50.2	42.9	43.4	38.6	46.8	186.1	33.6	58.1	49.0	9.0	50.8	36.3	38.5	49.1	30.8	26.4	33.6	25.8	38.9	61.2	52.7	54.1	79.8	62.1	51.2	55.9
TECR	"GPSN2, MRT14, SC2, TER"	ENSG00000099797	"Trans-2,3-enoyl-CoA reductase"	Q9NZ01	19	14517085-14565980	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Oxidoreductase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 750.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029780, HPA056488"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029780: AB_10603348, HPA056488: AB_2683149"	"unprognostic (9.73e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.53e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (2.60e-4)"	32.8	43.2	45.0	15.0	43.7	23.0	26.2	51.7	70.8	34.9	26.1	64.5	40.1	37.8	16.5	38.2	89.6	32.4	19.0	22.3	42.9	38.3	29.0	45.9	20.7	17.8	45.6	34.7	25.0	37.0	95.0	20.9	68.5	50.4	23.9	21.7	34.5	69.8	42.0	121.4	89.5	34.8	13.8	53.3	20.0	24.5	59.6	40.2	29.8	33.5	40.7	49.5	18.3	43.8	21.7	30.2	10.7	22.8	34.3	60.6	32.7	36.5	27.3	26.1	29.4	38.1	17.4	27.6	10.7	30.3	34.5	42.9	36.3	42.3	19.6	22.5	22.4	26.7	57.1	27.5	43.5	13.9	32.2	23.6	33.4	40.9	39.9	23.0	23.6	25.5	25.8	34.8	30.3	16.6	17.2	16.2	29.3	21.4	67.8	17.6	46.0	27.8	41.2	27.3	94.0	29.6	25.9	17.0	87.0	46.8	19.7	32.6	20.0	17.9	48.2	22.9	13.6	25.9	46.9	9.4	27.7	11.9	24.0	36.0	20.8	19.9	20.3	28.4	35.6	27.6	9.2	16.0	10.7	32.0	22.8	34.7	21.7	42.0	36.6	27.3	21.0	49.2	38.8	7.2	34.3	17.1	30.2	60.6	32.7	45.0	43.7	51.7	70.8	42.9	38.3	45.6	34.7	50.4	40.2	68.5	70.5	64.7	187.4	150.7	86.7	43.3	104.4	85.6	61.4	157.1	115.8	406.1	48.0	132.1	327.6	56.2	226.7	46.7	199.9	418.2	76.1	121.3	34.7	135.7	163.0	106.5	96.0	70.6	99.0	750.0	67.3	92.0	155.3	61.3	121.5	562.9	101.5	115.2	56.6	150.3	157.6	64.7	100.0	163.9	115.2	209.5	406.6	101.5	176.8	172.7
TLR6	CD286	ENSG00000174130	"Toll like receptor 6"	Q9Y2C9	4	38823715-38856817	"CD markers, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 14.2;brain: 16.0;lymphoid tissue: 16.2"	"Cell type enhanced"	"Detected in some"	12	"B-cells: 5.0;Hofbauer cells: 5.9;Kupffer cells: 11.8;Macrophages: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 14.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 12.5;GAMG: 12.9;RPMI-8226: 9.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062733			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA062733: AB_2684853"	"unprognostic (9.82e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.62e-7)"	"unprognostic (4.89e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.12e-2)"	2.9	2.7	6.1	10.7	7.9	6.4	2.1	2.0	3.9	1.8	1.6	2.6	0.2	1.7	1.4	2.0	1.8	1.9	3.9	1.5	4.5	1.7	1.7	2.1	5.0	11.2	10.6	1.9	1.6	1.2	0.7	1.9	2.8	7.2	1.6	2.4	0.9	4.3	0.5	0.9	1.7	7.8	2.1	16.0	16.2	2.1	0.8	6.8	1.8	1.5	1.1	14.8	5.8	1.9	1.8	1.8	14.2	2.6	0.3	0.4	0.6	1.4	5.7	0.2	0.1	0.3	6.7	0.0	1.6	6.9	0.7	2.3	0.0	12.5	6.9	2.7	0.3	12.9	0.6	0.1	1.2	1.1	0.0	0.5	3.2	6.9	0.2	0.4	3.5	5.2	2.8	1.3	2.8	1.5	0.2	1.4	1.1	3.5	2.2	3.1	0.0	0.0	6.1	0.2	0.0	0.9	3.4	3.1	9.8	0.4	0.1	0.0	0.1	0.2	0.0	0.9	0.3	0.3	1.8	1.9	2.2	7.5	0.9	2.4	0.1	0.0	5.8	5.1	4.1	1.6	0.0	2.6	0.7	0.2	2.4	0.0	1.8	0.1	0.1	1.8	1.2	0.3	0.2	14.2	0.3	1.2	1.3	0.4	0.6	6.1	7.9	2.0	3.9	4.5	1.7	10.6	1.9	7.2	6.8	0.0	0.0	5.0	1.1	0.6	0.7	1.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.2	0.2	0.8	0.8	2.3	0.0	5.9	0.0	0.0	0.6	11.8	0.0	0.6	9.5	0.0	1.8	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.4	0.2	0.0	0.6	0.2	0.0	0.0	0.9
TMCO1	"HP10122, TMCC4"	ENSG00000143183	"Transmembrane and coiled-coil domains 1"	Q9UM00	1	165724293-165827755	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation, Glaucoma, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054768, HPA078775"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA054768: AB_2682597, HPA078775: "	"unprognostic (1.22e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (5.17e-7)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (5.92e-2)"	"unprognostic (4.16e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.80e-2)"	28.8	48.5	28.1	18.7	29.8	17.2	34.1	21.5	28.7	30.2	47.4	26.9	37.6	43.0	28.4	43.3	34.3	24.9	30.6	25.9	23.8	26.8	62.6	89.8	24.9	23.6	27.2	21.0	30.6	37.3	32.6	50.1	47.0	31.1	30.7	48.8	29.9	43.5	38.5	20.2	20.9	70.9	23.7	31.4	29.4	29.9	34.4	22.4	36.3	53.7	24.1	31.1	29.4	25.2	46.0	76.6	52.5	57.6	45.1	61.7	78.0	28.0	31.7	24.3	14.6	44.8	21.2	23.7	48.2	34.2	28.4	29.6	45.2	42.5	17.9	50.1	34.9	12.5	40.0	31.5	25.3	31.0	45.4	29.2	22.6	36.9	27.9	36.2	38.4	29.8	28.9	29.5	33.0	26.6	26.2	20.6	22.1	58.6	35.1	39.8	21.7	30.4	29.2	31.0	92.2	36.0	22.4	27.2	45.2	34.4	37.0	25.0	43.8	36.9	39.3	29.3	37.4	51.5	48.9	22.6	26.2	21.8	22.9	44.6	67.2	90.9	63.0	21.0	25.1	34.7	52.5	55.6	51.2	53.0	50.8	55.6	46.0	56.5	56.5	41.8	39.8	46.0	53.2	43.1	45.1	57.6	76.6	61.7	78.0	28.1	29.8	21.5	28.7	23.8	26.8	27.2	21.0	31.1	22.4	89.3	64.3	79.5	78.2	75.3	77.8	52.9	242.0	129.8	92.1	202.4	64.8	116.6	36.5	176.6	62.6	87.0	250.8	46.7	166.4	124.7	115.1	88.8	73.0	298.8	125.0	71.5	85.0	87.8	100.9	101.4	114.5	87.4	94.5	55.9	105.0	214.5	177.4	168.4	121.6	108.8	60.1	122.9	83.4	191.2	73.2	81.2	93.1	105.4	127.3	85.0
TMCO4	DKFZp686C23231	ENSG00000162542	"Transmembrane and coiled-coil domains 4"	Q5TGY1	1	19682213-19799945	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA014601, HPA014620"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA014601: AB_2204302, HPA014620: AB_2669051"	"unprognostic (3.31e-3)"	"unprognostic (8.94e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (3.71e-4)"	"unprognostic (6.99e-3)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (9.21e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-2)"	"prognostic favorable (4.12e-11)"	"unprognostic (1.67e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.81e-2)"	"prognostic favorable (3.64e-4)"	10.6	8.8	2.4	9.0	3.3	2.5	11.3	0.9	2.3	9.1	6.1	2.8	15.2	11.8	16.9	15.1	8.0	7.3	7.4	4.9	1.6	1.3	9.5	7.9	5.2	12.6	2.6	1.2	8.6	15.3	17.3	10.5	7.3	3.3	12.1	3.9	8.8	25.8	19.0	2.0	5.2	6.4	11.2	2.0	9.1	8.7	3.3	2.4	3.5	10.8	7.6	9.5	11.6	10.0	7.2	9.3	2.7	8.1	4.6	6.7	4.4	5.8	3.6	0.0	0.2	5.0	3.6	4.1	4.4	13.4	8.6	4.8	2.9	27.5	10.2	6.5	12.5	3.8	4.5	1.1	4.4	1.7	8.6	1.1	3.9	4.3	1.4	4.1	0.0	5.4	3.7	4.9	2.9	1.6	3.1	4.1	0.2	0.7	6.9	3.7	4.9	0.0	2.2	0.4	7.8	5.1	1.9	11.5	6.2	7.4	4.6	0.0	0.5	5.8	8.0	9.1	0.6	7.0	6.6	2.5	6.7	3.1	4.6	3.0	0.8	0.3	2.9	7.6	8.8	4.1	0.1	4.8	2.7	6.3	8.1	6.2	5.6	6.7	6.6	9.3	7.2	5.2	4.3	0.3	4.6	4.9	0.2	4.9	4.4	2.4	3.3	0.9	2.3	1.6	1.3	2.6	1.2	3.3	2.4	11.9	8.3	8.2	10.2	2.5	0.1	5.6	2.5	24.1	7.9	10.4	0.0	8.0	8.3	9.0	0.3	4.3	6.7	0.0	14.6	16.0	4.5	12.2	3.5	4.4	8.2	0.0	5.8	5.5	6.3	0.0	5.8	5.7	10.1	12.6	10.8	2.8	10.4	5.8	5.3	6.0	0.6	0.0	7.5	0.2	2.0	2.3	6.1	8.2	12.1	6.5
TMEM185A	"CXorf13, FAM11A, FRAXF"	ENSG00000269556	"Transmembrane protein 185A"	Q8NFB2	X	149596556-149631912	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 45.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048295, HPA071744"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA048295: AB_2680345, HPA071744: AB_2686441"	"unprognostic (9.76e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.71e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.40e-1)"	4.3	5.0	6.8	4.8	6.2	1.7	4.1	7.2	8.2	5.1	3.8	3.1	7.3	2.3	6.2	7.4	5.8	5.8	5.3	12.0	4.4		4.4	3.1	3.4	3.3	3.0	3.3	13.8	5.4	7.3	4.8	10.8	6.0	5.5	3.5	6.3	4.8	7.2	4.5	6.2	3.3	6.6	3.7	7.8	2.7	12.3	4.0	3.8	3.8	4.5	4.3	4.6	5.8	5.3	7.7	12.2	5.0	13.5	10.4	6.3	11.1	11.3	13.1	7.7	17.8	12.1	5.2	11.0	13.5	11.2	16.9	6.9	19.3	13.7	24.7	12.2	15.0	14.2	15.1	10.4	12.2	8.8	11.3	7.9	13.2	7.4	12.9	11.5	8.1	11.5	17.7	11.5	7.2	13.0	9.6	10.4	3.3	8.9	8.0	18.3	7.9	7.9	9.8	5.7	12.7	7.8	19.9	7.8	12.9	14.7	4.5	6.5	8.4	14.5	14.4	12.5	7.7	6.6	11.5	8.5	7.8	15.6	13.5	8.4	7.4	20.1	15.1	13.5	11.7	2.2	5.0	12.2	10.1	3.0	9.0	5.3	7.3	10.4	7.7	5.0	10.3	9.2	7.1	13.5	2.5	5.7	9.0	6.3											6.0	1.6	3.9	10.3	9.8	13.3	9.3	2.5	9.4	2.3	14.0	5.9	23.0	3.3	4.1	0.2	10.2	5.5	0.0	8.1	9.7	19.0	9.2	5.7	6.6	9.5	17.5	12.6	23.4	12.5	1.9	21.0	6.9	13.5	19.0	6.9	12.9	8.9	8.7	22.3	4.8	8.1	45.3	14.0	6.9	15.8	17.6	14.4	8.6	5.0	14.1
TMEM185B	"FAM11B, FLJ20979"	ENSG00000226479	"Transmembrane protein 185B"	Q9H7F4	2	120221278-120223408	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048295, HPA071744"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA048295: AB_2680345, HPA071744: AB_2686441"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (5.44e-4)"	"prognostic unfavorable (4.96e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.55e-2)"	"prognostic unfavorable (5.71e-7)"	"unprognostic (3.09e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-1)"	16.9	14.2	10.4	12.7	14.2	14.4	15.7	8.3	15.2	14.4	12.7	24.7	9.9	9.8	17.7	10.6	16.3	17.1	12.4	18.3	13.2	9.7	12.3	19.1	14.5	18.4	15.3	9.2	14.6	20.2	46.3	12.2	13.8	13.1	16.1	10.4	15.1	16.2	12.6	16.5	11.9	12.6	16.8	14.5	12.6	13.4	19.4	13.4	16.3	19.1	15.5	13.2	15.9	12.9	1.4	2.6	5.8	3.4	4.6	2.4	0.6	24.7	10.4	7.1	11.5	12.3	17.3	18.4	17.9	17.1	17.5	15.4	31.3	24.4	0.0	17.7	15.6	17.8	16.0	7.2	15.0	19.7	10.7	14.2	11.0	7.2	7.1	17.6	0.0	19.8	14.7	18.5	18.7	22.8	11.7	12.3	10.4	12.7	12.8	15.2	17.0	9.4	11.0	10.7	10.0	22.1	7.4	0.0	8.2	13.9	16.7	10.8	9.0	16.2	19.8	14.5	9.0	11.4	12.4	14.7	7.8	21.2	13.9	6.7	8.9	11.0	10.2	9.3	10.9	18.2	0.0	1.9	2.3	1.6	3.4	1.9	0.8	2.0	1.0	2.6	1.4	1.6	2.4	5.8	4.6	2.2	0.8	1.9	0.6	10.4	14.2	8.3	15.2	13.2	9.7	15.3	9.2	13.1	13.4	14.9	1.6	6.4	26.6	7.4	2.1	7.9	5.1	6.7	2.3	7.0	5.9	9.2	1.7	14.8	8.4	7.7	4.9	0.0	10.8	25.8	8.4	11.0	6.9	3.4	13.2	1.6	1.2	5.5	5.1	5.1	4.4	5.6	6.8	5.4	3.7	8.8	9.8	3.5	2.1	3.3	3.6	0.0	8.0	17.3	11.5	3.9	12.1	5.1	4.7	15.8
TMEM189	Kua	ENSG00000240849	"Transmembrane protein 189"	A5PLL7	20	50118254-50153734	"Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 139.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059549	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA059549: AB_2684059"	"unprognostic (3.11e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.03e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.79e-2)"	"prognostic unfavorable (5.79e-11)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.42e-2)"	15.1	13.9	12.0	11.0	23.8	7.7	13.6	7.9	18.1	13.0	14.5	33.7	20.5	13.2	16.3	17.3	27.0	10.0	12.3	15.5	15.0	10.7	9.1	21.0	14.3	8.3	33.1	9.0	6.5	8.9	19.8	6.5	26.1	20.7	13.3	11.5	7.9	14.6	22.0	17.1	24.3	13.2	32.2	32.1	10.4	14.5	11.3	24.9	10.0	8.5	11.7	14.8	16.0	15.4	2.0	6.2	6.3	13.9	4.1	5.8	3.9	8.6	8.0	9.6	7.5	14.6	11.0	16.0	6.1	5.8	12.9	7.3	21.6	13.9	3.2	9.9	5.8	18.5	24.2	4.8	12.4	4.7	1.7	3.6	4.1	11.6	18.4	8.2	6.6	11.3	9.3	29.1	7.2	7.6	6.3	15.4	5.5	4.2	4.7	4.3	7.6	5.2	16.8	4.6	22.3	8.4	4.3	7.3	3.4	24.3	12.8	5.0	3.3	6.9	24.1	13.8	9.8	3.8	9.5	12.1	10.9	5.6	7.0	6.0	3.5	5.8	1.3	9.4	5.0	8.7	5.3	5.7	6.3	3.7	10.8	2.9	2.0	4.1	3.1	6.2	1.9	3.5	4.1	2.3	4.1	13.9	3.9	5.8	3.9	12.0	23.8	7.9	18.1	15.0	10.7	33.1	9.0	20.7	24.9	35.7	20.7	7.5	38.4	43.6	5.5	13.7	0.0	5.3	9.1	19.2	0.0	74.8	1.7	32.6	43.7	16.1	18.8	0.0	31.5	139.1	23.8	25.4	6.9	10.6	34.3	7.9	11.5	18.4	14.6	86.5	16.4	21.1	8.5	30.7	10.2	4.1	47.3	13.3	17.0	3.8	3.6	19.4	15.1	6.0	11.5	36.9	41.9	13.8	12.7	45.7
TMEM230	"C20orf30, HSPC274"	ENSG00000089063	"Transmembrane protein 230"	Q96A57	20	5068232-5113103	"Predicted membrane proteins, Transporters"			"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA009078, HPA061421"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA009078: AB_1078345, HPA061421: AB_2684513"	"unprognostic (1.39e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.67e-3)"	"unprognostic (5.85e-3)"	"unprognostic (4.34e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.55e-2)"	40.0	40.4	34.3	17.1	27.9	15.6	80.9	20.2	44.8	35.7	29.9	23.2	33.3	18.7	30.2	39.0	26.0	27.4	31.4	49.7	32.7	36.1	44.6	81.0	32.9	49.2	41.1	23.1	31.5	53.5	22.4	31.5	21.8	25.8	33.8	27.9	27.4	26.8	31.0	32.4	10.6	29.4	28.1	44.3	20.6	25.8	24.0	16.4	18.8	42.5	24.9	22.2	31.5	18.9	45.6	44.7	30.5	49.2	39.1	48.2	78.3	33.3	23.5	30.9	23.2	70.0	62.5	23.6	27.1	40.8	26.8	29.7	18.5	33.4	16.0	22.3	39.1	30.6	27.8	22.9	40.4	38.9	17.8	26.3	28.3	7.3	56.8	44.8	32.7	11.8	43.1	45.2	20.5	41.3	37.5	35.2	35.8	26.4	44.4	43.8	9.5	32.9	30.6	23.5	64.2	33.6	21.4	20.7	34.3	40.2	17.2	26.1	31.7	16.3	34.3	56.3	34.8	27.4	31.3	29.5	34.9	20.4	33.4	29.0	29.7	58.9	31.3	14.0	28.3	36.5	28.4	48.1	30.5	39.3	49.2	48.2	45.6	43.1	41.9	44.7	37.9	45.0	44.3	15.6	39.1	46.1	43.8	38.6	78.3	34.3	27.9	20.2	44.8	32.7	36.1	41.1	23.1	25.8	16.4	53.6	61.3	129.3	107.8	62.5	93.4	47.8	94.3	64.3	48.9	146.5	60.9	146.0	426.1	129.1	144.0	103.4	53.5	46.7	97.3	172.4	154.3	157.7	111.9	118.4	189.6	58.8	91.9	120.3	153.8	67.6	196.5	153.1	189.0	263.3	96.8	65.8	86.4	119.7	207.2	284.9	89.9	84.1	143.4	110.9	90.6	52.9	123.8	145.1	112.1	128.5
TMEM97	MAC30	ENSG00000109084	"Transmembrane protein 97"	Q5BJF2	17	28319095-28328685	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"pancreas: 228.7"	"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 94.3;Exocrine glandular cells: 170.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044795, HPA076689"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044795: AB_10959306, HPA076689: "	"unprognostic (1.35e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.20e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.01e-2)"	2.0	11.5	3.1	2.8	3.3	1.7	3.4	2.9	4.9	2.6	4.2	2.2	1.2	4.7	2.9	1.9	3.1	4.0	8.1	1.6	2.4	3.0	2.2	33.7	12.5	3.4	2.4	2.7	8.2	228.7	1.7	0.6	2.0	7.7	6.9	3.8	3.2	1.5	2.8	5.7	3.6	3.2	3.4	4.0	1.7	13.2	31.5	1.3	4.6	1.3	3.9	2.5	12.5	6.0	9.0	13.8	1.7	2.3	8.2	10.0	4.6	9.9	25.0	48.1	23.7	6.4	9.2	15.8	9.6	6.2	15.3	20.5	70.9	7.6	27.2	10.5	3.7	31.7	10.7	30.5	16.4	12.1	12.8	21.4	10.2	13.1	30.2	5.8	16.2	8.2	18.7	2.1	14.9	6.2	1.8	4.6	17.6	21.3	20.5	5.1	16.8	25.3	15.3	21.1	40.1	6.5	20.4	52.8	24.6	18.8	45.4	34.7	15.2	15.4	12.2	7.8	28.1	21.6	7.5	3.0	16.5	13.0	14.1	17.6	16.6	32.7	24.9	3.3	11.7	9.7	0.4	2.0	1.7	7.3	2.3	8.5	9.0	6.2	8.8	13.8	5.1	10.0	9.3	0.9	8.2	0.8	8.0	5.8	4.6	3.1	3.3	2.9	4.2	2.4	3.0	2.4	2.7	7.7	1.3	8.9	43.3	13.7	5.6	12.9	11.4	6.8	94.3	16.0	17.0	14.0	15.7	19.3	13.3	16.0	18.3	4.7	3.4	23.3	170.2	63.4	9.1	12.3	1.1	86.2	17.6	3.2	37.2	8.0	6.2	38.1	12.4	8.5	15.1	18.0	13.5	7.8	60.6	0.0	10.6	4.3	8.4	6.5	6.1	87.2	53.0	9.8	8.9	7.1	27.0	7.0
TOR1AIP2	"IFRG15, LULL1, NET9"	ENSG00000169905	"Torsin 1A interacting protein 2"	"Q8NFQ8, Q9H496"	1	179839967-179877803	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051849, HPA058348, HPA070542"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA051849: AB_2681637, HPA058348: AB_2683687, HPA070542: AB_2686278"	"unprognostic (1.22e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.17e-2)"	"unprognostic (7.64e-3)"	"unprognostic (3.06e-1)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.99e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.36e-1)"	13.3	16.4	11.2	7.3	13.1	30.4	17.5	12.1	11.6	9.1	19.8	10.0	26.9	15.2	11.4	18.7	15.9	8.5	10.1	11.2	11.1	10.0	11.7	37.9	13.2	9.5	9.7	10.4	13.5	16.4	17.4	19.3	41.3	11.0	9.3	8.3	10.0	9.9	16.9	23.0	12.0	30.7	11.6	12.0	9.0	12.2	8.8	11.2	6.7	17.4	10.5	9.5	10.4	13.4	6.9	9.2	17.7	8.7	4.9	7.4	2.5	12.8	12.9	10.3	21.1	25.4	14.2	40.5	17.0	20.9	13.9	14.2	19.1	22.4	10.4	21.7	18.5	7.7	19.4	17.7	17.7	18.8	11.7	9.6	12.7	21.1	15.8	18.6	13.4	14.7	22.3	13.8	18.7	20.4	12.3	19.5	10.0	24.4	11.2	16.7	7.5	9.6	9.3	24.4	14.4	3.2	10.7	14.4	14.8	10.7	22.3	8.6	21.8	19.3	21.6	16.6	20.8	21.5	9.8	25.1	20.2	18.6	11.2	13.4	17.8	25.3	20.9	11.1	9.8	19.0	17.7	6.6	7.7	7.1	8.7	6.8	6.9	6.8	6.1	4.4	6.9	7.4	7.2	13.4	4.9	7.9	9.2	5.7	2.5	11.2	13.1	12.1	11.2	11.1	10.0	9.7	10.4	11.0	11.2	142.9	48.3	19.0	58.0	222.7	27.1	30.5	122.3	32.1	64.8	73.3	35.3	86.6	21.6	52.0	23.9	50.1	79.9	46.7	55.0	166.0	51.6	49.3	18.5	210.0	37.5	30.2	21.1	42.4	43.5	15.3	54.1	35.3	45.5	47.7	44.5	44.6	76.2	32.8	80.2	38.5	31.3	51.8	41.2	27.2	29.1	218.2	150.8	44.9	38.5	99.9
TRAPPC6B		ENSG00000182400	"Trafficking protein particle complex 6B"	Q86SZ2	14	39147811-39170532	"Predicted intracellular proteins"	Neurogenesis		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047928	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA047928: AB_2680214"	"unprognostic (3.89e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.18e-2)"	"prognostic favorable (1.76e-4)"	"unprognostic (2.98e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.90e-1)"	13.7	19.0	23.9	12.3	26.0	5.0	17.4	38.9	33.5	14.3	11.5	11.0	12.5	12.7	14.3	14.9	15.2	8.7	11.3	15.6	23.7	20.5	16.5	27.9	12.0	12.7	17.5	23.7	11.9	10.4	17.5	19.7	14.7	21.6	15.7	12.5	13.1	10.8	16.4	15.7	13.1	10.0	13.9	14.8	14.0	10.5	14.3	14.9	14.0	18.7	9.7	13.7	14.2	11.2	5.0	7.2	8.9	9.8	11.2	6.3	3.5	10.8	4.7	8.4	8.1	12.1	13.7	6.7	14.2	12.3	12.8	12.7	8.0	20.9	6.8	10.0	12.9	6.4	8.5	12.4	8.9	15.8	12.7	6.1	9.2	6.9	23.3	17.3	12.9	12.7	13.0	15.3	10.9	14.8	20.5	11.1	12.6	10.3	14.5	13.3	13.4	9.7	9.4	7.1	8.4	19.2	7.5	15.7	6.5	14.1	21.7	8.3	6.7	16.9	10.3	14.9	9.3	19.5	8.3	15.9	11.8	6.1	10.0	7.6	13.9	19.2	10.4	5.8	7.6	11.3	8.9	4.9	7.6	4.5	9.8	4.0	5.0	6.3	5.1	7.0	3.0	5.3	5.3	4.9	11.2	9.6	7.2	5.3	3.5	23.9	26.0	38.9	30.8	23.7	20.5	17.5	23.7	21.6	14.9	20.8	14.2	7.7	15.1	20.0	23.9	22.2	15.3	6.7	11.4	17.4	33.4	11.7	46.4	12.2	22.3	17.6	8.4	23.3	15.1	11.1	16.0	15.6	28.8	19.7	13.8	22.3	16.0	25.2	10.8	10.6	15.0	19.0	16.9	10.0	11.4	14.7	17.3	11.8	16.6	16.2	39.0	25.8	20.8	67.4	27.7	22.0	18.9	17.5	8.8	25.8
TTC39B	"C9orf52, FLJ33868"	ENSG00000155158	"Tetratricopeptide repeat domain 39B"	Q5VTQ0	9	15163622-15307360	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 2.0;gdT-cell: 4.1;MAIT T-cell: 5.4;memory CD4 T-cell: 5.6;memory CD8 T-cell: 6.3;naive CD4 T-cell: 6.7;naive CD8 T-cell: 4.1;NK-cell: 7.6;T-reg: 4.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.0;NK-cells: 7.6;T-cells: 6.7"	"Cell line enhanced"	"Detected in many"		"HEL: 27.2;RT4: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063162			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA063162: AB_2684952"	"unprognostic (1.64e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.47e-2)"	"unprognostic (7.89e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.12e-2)"	"prognostic favorable (9.64e-6)"	"unprognostic (5.99e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.89e-2)"	"prognostic favorable (4.08e-7)"	"unprognostic (3.31e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.48e-1)"	7.3	4.9	3.6	7.2	7.9	2.3	7.7	35.9	12.9	8.2	10.5	1.7	1.8	9.0	10.0	4.4	14.2	6.1	11.2	3.0	3.6	5.6	14.6	8.5	8.6	8.9	5.3	6.4	6.6	6.3	3.7	13.5	2.2	20.8	4.6	9.3	3.8	6.3	3.4	3.7	15.1	15.2	6.9	5.9	6.8	8.8	8.5	2.9	1.3	4.7	4.7	9.3	6.2	8.1	1.0	0.6	2.0	0.9	7.6	6.7	3.4	2.6	0.5	0.8	3.9	3.8	7.0	0.8	3.4	6.2	2.7	6.5	0.5	1.1	0.0	0.4	4.2	3.2	2.3	0.6	4.2	2.3	2.9	0.5	27.2	1.2	4.9	6.2	0.0	0.6	6.8	3.3	5.6	6.3	1.9	3.8	2.3	0.1	6.2	6.8	0.8	1.4	0.1	1.0	8.2	0.8	0.3	2.1	1.2	5.8	15.5	2.0	0.4	0.8	2.0	0.6	1.3	8.7	1.7	2.8	1.5	1.3	2.1	0.9	0.1	0.0	0.0	1.4	0.3	0.7	2.0	0.9	1.2	4.1	0.7	5.4	0.3	5.6	6.3	0.6	1.0	6.7	4.1	0.7	7.6	0.9	0.1	4.9	3.4	3.6	7.9	35.9	12.9	3.6	5.6	5.3	6.4	20.8	2.9	11.9	17.5	2.7	6.0	15.3	23.4	2.7	7.6	16.0	9.1	7.0	0.0	2.7	14.9	5.3	30.6	6.3	28.8	0.0	19.0	0.9	8.9	7.4	27.8	10.4	4.2	12.7	12.2	6.2	3.7	25.3	6.6	5.6	6.8	2.8	14.3	16.0	10.1	44.2	12.0	32.1	3.9	0.0	10.3	2.3	1.9	18.7	3.4	20.1	12.6	13.2
TXNDC5	"EndoPDI, ERp46, FLJ21353, FLJ90810, Hcc-2, MGC3178, PDIA15"	ENSG00000239264	"Thioredoxin domain containing 5"	Q8NBS9	6	7881517-7910814	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Erythroid cells: 23.3;Mucus-secreting cells: 19.0;Pancreatic endocrine cells: 10.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.6;plasmacytoid DC: 17.5"	"Group enriched"	"Detected in many"	21	"B-cells: 9.6;dendritic cells: 17.5"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 162.2;U-266/84: 344.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034677, HPA034678"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		14000000	"Endoplasmic reticulum"		"HPA034677: AB_2674275, HPA034678: AB_2674276"	"unprognostic (3.15e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.20e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.05e-1)"	"unprognostic (7.98e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	20.2	15.7	3.7	42.1	6.3	6.0	61.9	4.6	6.8	28.8	69.8	7.5	18.3	35.0	28.3	20.9	25.3	21.5	30.2	28.6	4.4	5.2	23.2	96.2	24.5	117.9	5.9	4.3	26.1	63.3	7.9	10.6	22.4	7.2	17.6	29.0	10.9	71.5	29.1	10.1	9.9	33.6	16.3	7.5	84.2	36.8	12.3	5.2	6.4	18.0	19.8	48.2	35.8	21.7	9.6	17.5	0.0	0.5	0.0	0.6	0.3	9.5	9.4	6.5	22.0	56.8	24.3	10.7	21.5	21.0	15.0	16.3	14.0	7.1	10.1	38.0	33.0	16.6	7.6	11.6	10.6	17.1	8.6	9.9	15.5	8.2	25.2	16.6	17.5	15.5	16.6	15.6	14.3	15.8	33.2	80.3	6.4	9.6	73.9	10.2	8.5	4.1	10.6	8.6	15.1	20.5	7.3	9.5	162.2	12.1	8.7	10.2	5.5	27.7	16.9	12.1	32.5	8.6	7.7	22.0	17.2	12.0	14.7	22.7	86.2	344.1	17.9	8.8	11.1	23.5	0.0	0.2	0.0	0.6	0.5	0.5	9.6	0.1	0.4	0.7	3.3	0.1	0.3	0.0	0.0	0.0	17.5	0.5	0.3	3.7	6.3	4.6	6.8	4.4	5.2	5.9	4.3	7.2	5.2	0.0	4.5	0.0	0.0	0.8	0.0	0.2	0.0	2.7	3.4	0.0	0.0	0.8	0.0	8.2	0.1	0.7	1.0	23.3	9.2	1.2	1.7	0.4	1.1	2.4	1.3	0.0	4.7	5.5	1.5	0.0	0.0	0.3	3.3	1.0	19.0	0.0	10.3	0.0	0.4	0.2	0.2	6.5	0.4	0.0	0.1	0.1	1.0	0.0	7.0	0.1
UBXN4	"KIAA0242, UBXD2, UBXDC1"	ENSG00000144224	"UBX domain protein 4"	Q92575	2	135741619-135785055	"Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036325	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA036325: AB_10669788"	"unprognostic (1.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.14e-3)"	32.5	37.8	24.3	27.0	28.4	24.5	29.5	28.6	27.6	35.5	29.2	26.6	35.0	31.7	32.7	33.2	29.4	26.5	27.7	25.5	25.7	21.2	34.3	64.7	27.8	24.1	30.0	28.8	34.7	38.8	42.1	39.7	33.5	33.0	30.5	27.6	23.0	38.0	38.2	52.0	29.7	33.8	26.2	38.3	25.4	29.7	32.1	29.8	47.3	39.9	25.0	25.1	35.5	36.3	24.8	27.3	33.6	23.4	27.2	24.8	16.7	40.6	11.9	24.2	19.8	32.1	35.5	27.1	35.1	35.2	30.2	27.1	19.9	30.3	26.2	45.7	30.9	14.2	29.2	14.8	20.8	32.0	32.6	18.1	23.6	17.6	26.4	29.5	26.2	23.0	27.0	17.8	28.5	26.4	33.1	35.5	19.0	22.4	37.6	27.2	20.2	31.0	13.9	18.9	18.3	20.7	26.2	33.1	44.0	29.0	30.4	23.7	14.5	31.5	19.6	18.9	20.8	22.3	21.6	33.1	26.4	12.7	26.4	17.6	33.0	19.7	22.5	33.1	17.5	24.6	26.0	18.5	27.1	23.7	20.3	22.8	24.8	22.6	22.9	17.7	22.2	23.2	22.1	33.6	27.2	23.4	27.3	24.8	16.7	24.3	28.4	28.6	27.6	25.7	21.2	30.0	28.8	33.0	29.8	193.5	142.1	145.9	214.6	155.6	174.0	125.9	124.9	278.4	224.1	120.4	210.1	200.1	76.3	215.2	577.7	126.2	161.9	23.3	170.5	181.5	166.3	295.4	166.9	183.2	124.1	92.2	178.9	103.7	85.0	224.8	159.9	131.8	87.7	162.3	136.0	168.8	182.9	133.3	135.1	127.3	321.9	103.5	125.7	404.1	239.3	160.5	317.3	126.7	136.2	247.3
UCKL1	"FLJ20517, URKL1"	ENSG00000198276	"Uridine-cytidine kinase 1 like 1"	Q9NWZ5	20	63939829-63956415	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 78.5;Rod photoreceptor cells: 130.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004722, HPA004769"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA004722: AB_1080455, HPA004769: AB_1080453"	"unprognostic (1.03e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (5.87e-2)"	"unprognostic (3.18e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.26e-3)"	17.4	18.1	16.5	16.0	18.3	21.1	19.8	50.4	20.7	18.5	21.9	21.6	17.3	32.0	18.0	17.7	19.7	17.9	12.0	21.0	17.1	9.4	21.3	20.6	15.6	18.3	20.3	11.5	31.7	22.6	14.1	22.1	17.5	15.7	19.4	9.1	31.0	28.9	24.4	52.3	27.9	29.8	18.1	11.8	26.7	20.1	11.5	19.7	16.7	24.1	33.1	20.1	16.2	21.2	22.2	8.9	6.3	14.0	5.3	14.8	7.9	11.5	12.3	10.6	14.1	7.8	6.7	17.1	9.3	6.4	19.3	9.7	29.3	9.0	11.7	15.7	6.0	13.2	19.0	8.2	12.8	3.8	4.9	13.8	8.9	24.6	42.8	8.6	15.1	17.0	9.3	11.5	7.7	6.4	7.7	8.9	11.6	12.5	12.5	6.0	14.9	17.7	26.4	7.8	9.2	28.8	18.1	8.0	20.1	7.9	16.8	25.2	14.7	13.4	13.2	14.2	5.5	13.8	13.7	9.8	20.5	7.7	13.3	12.0	13.1	7.0	5.4	10.5	10.8	7.7	4.2	7.7	6.3	13.2	12.9	14.8	22.2	12.8	11.2	8.9	12.7	7.5	9.0	1.2	5.3	14.0	5.1	13.5	7.9	16.5	18.3	50.4	20.7	17.1	9.4	20.3	11.5	15.7	19.7	23.8	8.8	20.2	17.9	16.8	27.5	18.2	22.9	8.1	11.4	8.7	78.5	27.3	19.9	17.0	1.9	16.5	26.3	0.0	9.6	20.5	15.0	11.6	12.7	10.5	16.0	19.1	20.6	10.4	9.1	2.2	16.4	13.4	10.1	22.6	20.8	17.1	16.9	23.0	19.4	12.3	130.6	25.8	18.7	10.7	14.0	16.7	27.9	9.6	21.7	17.1
UCN	"UI, UROC"	ENSG00000163794	Urocortin	P55089	2	27307400-27308445	"Predicted secreted proteins"	Hearing	Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 8.5"	"Cell type enhanced"	"Detected in some"	5	"Exocrine glandular cells: 3.2;Rod photoreceptor cells: 3.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"NK-cell: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/70: 20.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			CAB010911	Approved		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	133000		"Endoplasmic reticulum"		"CAB010911: AB_261834"	"unprognostic (7.35e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.42e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (1.84e-7)"	"unprognostic (4.84e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.11e-1)"	1.1	2.8	4.6	1.3	5.5	2.4	1.0	3.1	4.5	0.9	0.7			0.8	1.9	1.4	0.6	1.9	2.0	4.2	4.7	3.8	0.7	3.2	1.6	1.6	3.1		2.3	1.8	0.0	2.2	2.4		1.2	0.0		1.3	0.9	8.5	0.8	1.2	1.0	2.8	3.0	0.5	1.5			1.5		0.4	0.5	0.4	0.0	0.0	0.0	0.7	2.9	0.9	0.2	1.2	2.7	0.4	0.8	1.2	1.1	5.3	0.4	1.1	0.4	0.4	0.2	2.1	1.0	0.6	0.4	1.2	0.4	0.5	0.3	0.0	3.3	4.5	2.4	1.7	2.1	3.1	0.2	2.7	1.6	2.1	0.2	2.5	2.7	0.0	2.0	2.3	1.9	0.1	2.0	1.3	7.1	4.5	0.1	2.9	3.4	2.4	1.5	0.1	0.5	0.8	2.3	1.1	0.1	5.8	0.3	1.1	3.2	0.2	0.9	5.0	1.5	1.9	20.1	2.1	0.7	3.9	5.7	1.4	0.0	0.7	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	2.9	0.4	0.0	0.6	0.2											0.0	0.3	0.0	0.2	0.5	2.7	0.4	2.5	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.5	0.1	0.5	0.0	3.2	0.6	0.5	0.7	0.0	0.8	0.7	1.6	0.0	1.3	1.9	0.0	1.4	1.3	0.0	0.0	0.2	2.0	0.9	0.0	0.7	0.3	3.3	0.0	0.1	0.9	0.6	0.0	0.7	1.0	0.6	0.1
UFL1	"KIAA0776, Maxer, NLBP, RCAD"	ENSG00000014123	"UFM1 specific ligase 1"	O94874	6	96521595-96555276	"Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030558, HPA030559, HPA030560"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		6900	"Endoplasmic reticulum"		"HPA030558: AB_10600663, HPA030559: AB_10600537, HPA030560: AB_10602000"	"unprognostic (5.40e-2)"	"unprognostic (7.48e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.92e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.46e-1)"	20.2	26.3	19.8	21.9	24.0	14.6	20.9	16.4	23.6	22.1	17.9	19.4	32.1	21.5	20.5	28.5	23.6	18.6	20.2	22.1	21.6	17.8	21.6	32.7	15.8	21.5	31.1	20.0	24.8	35.7	28.8	32.4	25.6	28.0	24.6	19.2	14.2	23.9	30.7	33.0	19.3	28.4	18.5	33.0	18.8	20.6	13.4	27.3	29.2	27.6	23.1	20.1	24.0	18.8	11.2	12.6	10.1	11.7	14.7	14.7	7.9	8.9	4.7	10.1	16.9	14.6	22.4	15.1	12.6	12.9	8.1	7.6	5.9	10.5	21.7	16.1	12.6	9.0	17.5	8.2	11.9	11.9	11.6	7.4	9.5	7.5	10.8	19.5	17.8	14.2	16.0	11.2	9.6	26.8	15.1	13.2	14.0	12.6	24.1	15.3	8.6	6.5	11.1	3.6	7.7	5.4	8.3	11.9	17.1	14.6	16.4	7.1	7.0	10.4	12.3	11.7	9.4	29.9	15.3	12.9	11.4	6.2	11.5	13.2	14.3	7.3	16.7	17.5	12.0	10.4	7.8	9.2	10.1	10.9	11.7	12.5	11.2	11.5	11.6	11.8	11.0	14.7	11.5	2.0	14.7	11.2	12.6	12.7	7.9	19.8	24.0	16.4	23.6	21.6	17.8	31.1	20.0	28.0	27.3	53.6	39.1	26.8	27.8	17.3	47.7	56.2	30.6	76.3	54.6	43.6	43.2	53.5	16.6	35.6	46.2	28.1	32.8	0.0	44.3	29.6	25.7	28.2	29.0	62.7	31.5	41.3	19.0	33.7	30.2	36.5	46.3	26.2	13.5	31.5	45.7	31.7	33.7	37.9	47.4	28.0	67.4	19.4	28.6	88.5	29.6	16.8	76.1	30.9	32.0	23.0
VAPA	"hVAP-33, VAP-A"	ENSG00000101558	"VAMP associated protein A"	Q9P0L0	18	9914002-9960021	"Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009174	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA		5300000	"Endoplasmic reticulum"		"HPA009174: AB_1080549"	"unprognostic (4.03e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.36e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.99e-2)"	"unprognostic (8.11e-2)"	"prognostic favorable (5.72e-7)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.77e-2)"	27.5	64.8	28.8	21.0	35.5	73.5	27.4	32.9	39.4	24.9	34.3	30.7	19.3	27.8	30.8	23.8	42.3	27.9	29.4	39.9	28.0	30.2	32.7	33.2	35.1	24.6	33.4	28.8	40.6	36.5	25.0	19.4	35.2	48.1	25.2	32.7	18.0	27.9	21.8	55.4	27.6	32.3	28.5	39.1	27.7	34.0	25.2	28.8	36.3	36.4	28.3	22.9	36.0	30.2	24.5	30.6	62.5	37.3	22.2	24.6	39.7	17.3	10.5	12.7	8.3	15.0	16.3	17.8	21.5	17.9	19.6	21.6	14.1	17.3	17.1	20.1	18.8	17.0	12.2	12.3	20.5	22.5	10.6	15.4	27.8	11.2	21.7	35.7	37.5	53.4	15.3	20.8	18.5	22.1	15.4	19.8	14.0	28.0	17.9	17.1	9.3	28.8	21.8	8.2	59.8	16.8	15.1	17.3	23.1	19.1	17.5	18.0	9.8	24.9	15.2	15.4	12.2	14.2	19.4	21.1	32.0	23.8	33.1	26.1	32.1	26.0	20.4	18.1	16.2	21.9	26.1	37.3	62.5	19.3	32.4	22.7	24.5	20.3	20.7	30.6	22.7	22.2	20.4	59.2	22.2	26.4	21.8	24.6	39.7	28.8	35.5	32.9	39.4	28.0	30.2	33.4	28.8	48.1	28.8	119.1	156.9	129.2	289.0	598.2	103.5	201.2	160.5	211.5	124.0	197.1	58.9	238.9	388.0	249.4	7.6	182.0	272.4	70.0	315.1	261.3	247.0	278.9	222.5	128.2	255.8	128.7	138.8	187.9	265.3	9.5	168.5	232.2	264.9	418.4	154.5	119.8	283.7	174.6	203.3	294.2	76.5	187.5	270.9	168.9	212.6	544.1	378.5	153.4	155.5	360.2
VAPB	"ALS8, VAP-B, VAP-C"	ENSG00000124164	"VAMP associated protein B and C"	O95292	20	58389122-58451101	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Unfolded protein response"		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013144, CAB013722"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA		220000	"Endoplasmic reticulum"		"CAB013722: , HPA013144: AB_1858717"	"unprognostic (3.28e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (1.08e-8)"	"unprognostic (1.05e-1)"	"unprognostic (5.31e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.99e-2)"	17.4	31.1	21.8	12.6	24.3	4.8	13.2	16.5	31.8	11.7	16.1	17.0	13.3	22.5	13.0	13.1	14.8	13.7	12.7	24.5	21.4	22.1	21.8	23.5	13.6	10.4	23.2	25.1	17.7	15.5	28.5	16.3	11.1	31.6	15.0	12.1	11.4	17.9	15.7	46.8	15.3	20.6	15.2	24.9	11.4	14.7	9.4	15.8	6.7	26.7	18.8	9.4	11.6	18.5	5.6	4.3	6.8	5.2	6.6	9.5	4.6	10.9	11.0	12.4	6.6	11.4	4.8	11.0	9.8	4.1	15.2	7.5	44.3	10.6	9.7	14.1	6.6	12.1	21.0	9.8	14.1	9.1	4.5	7.4	5.8	12.2	13.9	11.5	5.4	7.4	10.9	16.4	8.4	7.0	7.4	7.5	9.7	13.7	5.5	7.3	34.4	8.5	10.8	6.5	21.5	14.6	8.6	11.5	6.3	11.6	14.7	17.5	12.1	16.2	43.2	16.9	7.1	17.7	8.3	10.3	24.6	12.0	12.3	13.1	7.4	7.9	11.1	20.8	6.0	12.4	3.9	4.4	5.2	7.8	4.4	9.1	5.6	9.0	6.2	4.3	4.7	6.7	9.5	6.8	6.6	5.2	4.3	5.0	4.6	21.8	24.3	16.5	31.8	21.4	22.1	23.2	25.1	31.6	15.8	41.7	23.2	11.7	12.1	10.4	26.4	43.1	25.5	18.7	13.6	29.6	27.5	28.5	29.9	29.7	4.2	20.4	30.7	0.0	26.6	42.2	18.8	15.2	9.2	32.1	14.0	33.4	20.8	14.7	14.0	5.1	17.3	13.9	13.5	24.4	22.3	34.0	29.0	19.2	23.7	31.6	29.2	12.9	20.5	20.4	28.3	9.3	37.2	18.7	24.2	13.6
VIP		ENSG00000146469	"Vasoactive intestinal peptide"	P01282	6	152750798-152759765	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.5;lymphoid tissue: 64.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 7.7;Melanocytes: 27.0"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 3.7;pancreatic cancer: 4.3;stomach cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HeLa: 2.2;SH-SY5Y: 7.0;TIME: 4.9;U-2 OS: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA017324, CAB018649, HPA072701, CAB079780"	Supported	Supported	Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	122000		"Endoplasmic reticulum"		"CAB018649: AB_2304501, CAB079780: , HPA017324: AB_1858754, HPA072701: AB_2686550"	"unprognostic (9.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.47e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.90e-2)"	1.2	5.7	9.7	64.7	8.3	0.3	0.9	1.5	20.1	0.6	31.5	0.5	0.3	7.5	0.7	0.4	13.1	0.5	4.2	1.1	12.4	7.7	0.9	0.6	1.7	0.4	2.7	8.3	0.4	3.8	0.5	0.4	0.5	1.6	6.3	28.3	3.2	0.4	6.9	0.8	0.4	32.5	18.0	0.4	5.2	13.2	0.5	0.1	0.0	1.3	0.5	0.4	9.1	4.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.4	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	7.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	2.0	0.2	0.2	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	9.7	8.3	1.5	20.1	12.4	7.7	2.7	8.3	1.6	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	7.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.3	4.2	0.0	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
VKORC1	VKCFD2	ENSG00000167397	"Vitamin K epoxide reductase complex subunit 1"	Q9BQB6	16	31090842-31095980	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 173.3"	"Cell type enhanced"	"Detected in all"	8	"Hepatocytes: 682.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 98.9"					"Low region specificity"	"Detected in all"			HPA042720	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA042720: AB_10961864"	"unprognostic (5.99e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.11e-3)"	"unprognostic (7.68e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.09e-10)"	"unprognostic (1.11e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.66e-2)"	21.3	23.0	9.3	11.5	11.0	12.9	28.1	9.4	14.5	24.3	19.3	17.1	16.5	12.6	24.0	27.4	18.5	17.8	22.6	20.1	9.8	10.2	29.9	173.3	16.4	17.5	13.7	9.1	25.5	55.5	14.0	25.0	22.5	13.3	22.3	12.6	20.8	34.8	21.4	11.4	15.9	26.8	27.7	12.5	15.4	17.5	18.2	10.6	15.8	25.6	13.8	14.6	28.4	18.7	32.3	49.9	59.6	40.6	24.7	43.7	33.6	10.5	27.1	8.9	25.5	98.9	58.9	9.9	39.1	34.0	19.3	32.8	11.2	12.1	8.3	21.2	48.9	13.6	9.8	12.3	15.3	22.0	11.7	29.9	7.5	37.5	53.9	15.6	14.6	11.3	34.0	8.2	26.6	22.9	52.3	20.8	11.8	9.8	19.8	37.6	38.2	10.7	30.0	16.1	14.6	26.1	19.4	23.7	41.2	19.0	9.2	18.2	22.1	17.1	12.5	19.0	15.0	20.6	17.8	18.1	25.9	9.3	23.7	14.7	12.0	11.1	7.3	67.4	25.3	13.3	21.5	40.6	59.6	40.3	28.1	39.7	29.9	40.5	40.7	39.6	32.3	36.4	35.4	34.2	24.7	28.3	49.9	43.7	33.6	9.3	11.0	9.4	14.5	9.8	10.2	13.7	9.1	13.3	10.6	53.6	38.2	37.9	58.4	75.2	11.2	20.0	119.8	32.1	40.9	102.9	7.9	64.0	53.0	183.3	4.8	87.9	36.0	46.7	112.2	211.1	138.5	58.9	55.3	682.4	166.1	9.5	64.4	119.7	79.0	8.3	146.4	85.1	109.6	129.8	41.2	64.7	107.2	24.6	161.9	160.1	16.9	58.2	95.7	23.7	24.7	97.9	33.1	47.3	51.3	46.5
VKORC1L1		ENSG00000196715	"Vitamin K epoxide reductase complex subunit 1 like 1"	Q8N0U8	7	65873267-65959563	"Enzymes, FDA approved drug targets, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA053954	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA053954: AB_2682319"	"unprognostic (3.01e-1)"	"unprognostic (1.76e-3)"	"unprognostic (4.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-3)"	"unprognostic (7.15e-3)"	"unprognostic (1.30e-3)"	"unprognostic (8.84e-3)"	"unprognostic (5.12e-2)"	"unprognostic (5.59e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.30e-1)"	"unprognostic (5.06e-2)"	38.2	9.2	10.5	8.3	16.7	3.0	23.7	9.0	19.7	10.4	11.1	14.2	9.2	8.6	10.1	8.8	10.0	8.8	8.0	9.3	10.3	11.4	8.2	17.8	14.3	6.2	12.0	12.1	14.4	11.7	28.5	8.0	9.7	14.1	9.9	10.0	8.0	9.0	10.5	14.9	11.4	9.7	9.3	13.2	5.7	9.9	9.4	7.6	9.1	11.1	4.5	6.6	9.7	9.3	2.8	7.5	5.6	4.2	6.5	3.4	1.8	22.4	14.5	11.7	14.7	37.4	14.9	21.3	24.4	15.8	14.6	14.8	14.0	22.2	19.6	19.8	17.5	22.2	15.5	16.7	9.9	24.5	12.2	16.5	13.3	13.3	11.9	18.3	18.4	10.3	11.9	12.8	14.8	20.7	11.4	14.5	11.2	28.0	15.0	17.4	8.8	15.1	21.5	28.1	21.3	10.9	16.6	17.1	24.4	14.1	9.0	14.1	20.2	18.9	34.3	10.7	17.4	17.2	14.3	16.4	23.7	16.2	14.8	24.7	13.6	22.1	22.5	14.5	21.0	20.6	3.8	2.7	5.6	2.9	2.5	2.4	2.8	3.4	3.2	2.8	2.5	2.3	2.3	3.1	6.5	4.2	7.5	3.1	1.8	10.5	16.7	9.0	19.7	10.3	11.4	12.0	12.1	14.1	7.6	68.5	29.5	0.8	14.6	22.0	20.5	21.3	30.6	8.1	26.1	15.7	11.8	10.0	5.0	15.9	28.9	15.9	16.9	23.3	21.7	18.4	16.7	23.4	4.7	44.5	14.4	28.6	13.3	8.6	7.0	5.5	16.4	9.0	6.8	4.6	23.5	8.5	24.2	2.9	17.3	10.2	17.4	6.5	13.4	17.9	6.6	28.0	7.3	5.2	18.7	16.9
VRK2		ENSG00000028116	"Vaccinia related kinase 2"	Q86Y07	2	57907651-58159920	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046459, HPA047503"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB046459: AB_1858773, HPA047503: AB_2680071"	"unprognostic (1.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (3.90e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.56e-1)"	18.7	17.7	10.9	21.9	28.3	14.9	16.1	2.4	15.1	15.6	13.5	27.3	16.3	9.9	18.4	16.7	26.8	13.2	10.9	21.6	14.4	8.9	12.4	15.2	15.6	19.5	29.2	13.5	14.2	20.0	16.1	18.7	16.1	18.7	15.7	15.6	9.3	20.5	17.6	21.5	12.8	12.9	20.1	19.0	20.1	13.5	12.5	31.2	13.6	17.4	16.7	23.0	18.1	19.4	19.7	17.0	21.6	21.3	11.3	12.2	9.2	14.2	9.5	1.1	6.3	7.1	13.1	19.7	13.2	13.2	9.1	9.3	19.4	15.1	17.4	17.4	11.6	15.0	10.9	13.8	14.4	13.7	31.2	9.3	19.6	7.7	13.8	11.3	16.6	11.7	7.2	17.2	14.6	21.1	10.9	26.2	2.4	19.2	11.2	15.2	8.2	0.1	12.7	12.0	22.6	4.8	19.0	4.8	11.8	15.1	11.7	3.8	0.1	20.9	12.5	10.5	10.9	8.8	10.2	14.6	0.2	30.3	8.2	0.2	16.5	13.0	9.3	7.4	20.6	15.0	13.7	16.8	21.6	10.1	21.3	12.2	19.7	9.8	11.8	16.6	19.0	7.4	9.5	6.0	11.3	20.6	17.0	11.5	9.2	10.9	28.3	2.4	15.1	14.4	8.9	29.2	13.5	18.7	31.2	20.8	9.1	14.1	11.3	8.8	1.0	17.1	10.2	30.8	15.9	17.4	0.0	19.7	13.3	22.0	16.8	15.0	2.9	46.7	22.8	18.5	8.5	8.1	16.3	6.8	17.1	0.0	6.3	4.9	17.7	6.5	5.5	21.4	10.1	49.5	4.3	4.6	21.8	7.8	5.6	7.1	3.6	6.5	13.7	8.3	12.6	7.3	16.2	12.7	7.1	12.2
VSTM5	"C11orf90, LOC387804"	ENSG00000214376	"V-set and transmembrane domain containing 5"	A8MXK1	11	93818232-93850531	"Predicted membrane proteins"		"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"brain: 9.9;placenta: 10.7"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 16.9;Syncytiotrophoblasts: 4.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.3;OE19: 6.8;PC-3: 10.0;SH-SY5Y: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029525, HPA063591"	Uncertain		Uncertain	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029525: AB_10600789, HPA063591: AB_2732704"	"unprognostic (1.26e-1)"	"unprognostic (4.48e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.54e-4)"	"unprognostic (2.45e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.26e-1)"	0.5	0.6	3.1	0.4	2.9	0.1	1.1	2.2	8.2	2.8	3.0	0.4	0.6	0.5	0.9	3.2	0.5	0.5	1.5	0.8	3.2	9.9	2.1	0.1	0.3	0.2	4.7	3.5	0.3	1.3	0.1	1.2	10.7	4.9	1.6	4.4	0.3	1.4	1.3	0.2	0.3	1.3	1.9	1.3	0.1	4.9	0.4	0.0	0.0	0.4	0.0	0.3	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.9	0.2	1.0	0.0	0.0	0.2	0.0	2.3	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	10.0	0.0	0.0	0.3	0.0	0.3	0.2	4.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	2.9	2.2	8.2	3.2	9.9	4.7	3.5	4.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.3	0.0	0.0	0.5	0.0	2.7	0.3	0.2	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.8	2.5	0.4	1.0	0.3	0.0	0.0	0.0	0.0	0.1	4.9	0.0	1.6	0.0
WDR83OS	"C19orf56, PTD008"	ENSG00000105583	"WD repeat domain 83 opposite strand"	Q9Y284	19	12668071-12671356	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA065685	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA065685: AB_2685531"	"unprognostic (1.73e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.47e-2)"	"prognostic favorable (2.09e-4)"	"unprognostic (1.71e-1)"	"prognostic favorable (8.84e-4)"	"unprognostic (4.17e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.34e-2)"	43.7	59.8	39.3	29.4	39.4	48.7	64.6	25.3	42.7	51.2	52.0	37.1	53.0	29.7	43.3	84.9	60.6	68.2	66.6	53.2	35.1	35.9	54.2	70.2	49.5	47.7	38.6	29.1	69.6	104.0	33.0	45.8	64.6	27.4	60.0	45.4	35.4	69.7	55.7	56.3	46.7	53.3	51.3	42.2	40.9	41.2	43.3	30.1	30.7	84.8	60.3	49.0	45.1	61.8	87.0	94.2	99.3	101.3	84.2	77.9	107.6	29.6	28.6	36.1	40.7	47.1	38.9	15.6	22.0	28.2	25.9	22.5	24.7	25.9	11.8	51.5	50.3	23.4	23.7	32.8	33.9	22.2	27.8	48.0	15.4	28.3	39.8	36.6	26.8	24.9	39.5	43.9	28.0	33.3	49.8	33.7	25.5	27.3	30.7	33.0	95.1	20.1	64.9	30.2	39.0	83.6	17.1	18.1	47.0	31.7	33.6	29.4	46.1	24.3	26.1	30.5	24.8	32.0	47.8	23.6	46.8	13.1	51.2	32.1	55.4	62.6	18.5	40.3	46.4	30.2	98.0	101.3	96.1	70.3	92.3	65.9	87.0	67.4	71.9	94.2	79.1	62.0	68.8	99.3	84.2	95.4	64.6	77.9	107.6	39.3	39.4	25.3	42.7	35.1	35.9	38.6	29.1	27.4	30.1	74.5	37.5	152.6	167.3	152.5	39.0	119.0	183.4	42.8	61.4	324.5	25.5	375.2	339.8	234.8	5.0	170.5	280.3	46.7	221.1	281.1	204.6	188.6	147.4	250.1	254.1	47.7	187.6	164.5	230.9	14.5	157.9	197.6	281.7	241.7	209.3	164.9	220.3	245.4	136.2	435.1	44.1	97.0	189.6	99.3	110.7	193.5	338.8	153.0	222.7	198.5
ZFYVE1	"DFCP1, KIAA1589, PPP1R172, TAFF1, ZNFN2A1"	ENSG00000165861	"Zinc finger FYVE-type containing 1"	Q9HBF4	14	72969451-73027212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 37.8;Late spermatids: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002898	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA002898: AB_1080653"	"unprognostic (2.19e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (5.07e-12)"	"unprognostic (4.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.48e-2)"	19.0	24.3	16.6	12.8	17.3	19.0	15.7	18.2	20.5	15.0	17.1	17.1	7.9	16.4	16.5	13.0	23.7	13.4	14.8	16.1	15.0	13.7	22.0	18.2	14.8	11.2	17.7	14.7	18.1	13.5	20.4	16.6	18.1	17.9	14.1	12.3	16.4	14.4	16.4	26.0	21.2	16.8	17.0	16.4	15.9	13.2	25.6	17.5	20.2	22.5	10.5	14.2	19.2	22.4	4.0	7.6	13.5	8.5	4.2	8.6	5.9	5.3	7.6	7.2	7.1	19.4	13.2	4.9	7.8	12.3	8.7	13.5	5.3	4.7	2.6	5.8	10.0	10.1	3.8	5.1	4.8	9.0	10.4	2.8	3.4	3.5	3.8	16.2	1.2	13.2	17.1	12.9	8.3	7.2	13.1	13.5	7.2	3.1	7.4	11.2	6.3	5.4	3.8	3.4	4.2	7.0	7.3	4.9	3.4	7.9	5.6	3.9	6.7	7.0	7.3	8.1	10.7	9.8	4.8	14.8	16.0	6.4	4.4	2.5	10.6	10.3	3.9	8.9	2.7	7.3	2.8	8.5	10.8	8.6	7.6	6.0	3.8	4.4	5.9	7.6	4.0	4.8	5.8	13.5	4.2	7.0	4.4	6.8	5.9	16.6	17.3	18.2	20.5	15.0	13.7	17.7	14.7	17.9	17.5	11.9	5.6	2.7	1.9	5.8	6.9	7.6	0.0	1.4	2.3	8.7	3.9	2.8	1.7	6.8	37.8	4.5	9.7	0.0	4.5	4.0	4.2	3.0	8.1	8.1	4.6	15.9	6.9	5.5	6.7	82.5	8.1	3.3	11.8	6.4	6.2	5.8	5.4	6.8	8.5	6.4	5.1	0.0	5.1	3.9	2.7	4.6	7.8	5.0	3.2	2.6
ZNF501	"MGC21738, ZNF52"	ENSG00000186446	"Zinc finger protein 501"	Q96CX3	3	44729596-44737083	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 9.5;Spermatogonia: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 6.7"					"Low region specificity"	"Detected in all"			HPA044161	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044161: AB_2678841"	"unprognostic (8.89e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.24e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.25e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.81e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.48e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.02e-2)"	5.6	2.8	6.8	3.6	8.3	1.3	8.5	11.7	8.0	7.0	6.2	7.5	4.7	2.6	7.5	4.0	4.7	7.3	4.5	5.6	7.3	4.8	5.0	2.3	4.7	6.8	5.9	6.7	10.0	5.3	2.7	5.7	5.9	4.9	8.1	4.1	3.6	4.9	7.3	5.3	4.4	3.6	8.0	6.3	4.9	4.4	6.7	9.8	4.2	6.6	3.4	4.3	7.2	7.2	3.4	1.1	2.9	1.1	2.7	3.5	1.2	0.0	0.0	2.1	0.0	3.9	6.7	0.8	2.4	2.2	2.6	3.0	0.9	0.9	1.8	0.0	1.1	1.9	0.7	0.0	0.9	2.5	0.0	1.2	0.0	0.2	1.7	5.4	0.0	0.0	3.9	2.5	2.9	0.2	0.8	1.6	0.0	0.0	0.0	0.8	0.0	0.8	0.1	4.9	1.1	0.0	1.3	0.0	1.0	2.2	1.4	2.6	1.7	1.4	1.5	1.0	4.1	0.1	0.1	1.0	0.1	2.3	2.4	1.9	4.2	2.6	0.0	0.1	0.0	3.1	2.0	0.7	2.9	2.4	0.9	3.3	2.9	2.3	2.6	1.1	3.4	3.5	2.4	1.1	2.7	1.1	1.0	2.3	1.2	6.8	8.3	11.7	8.0	7.3	4.8	5.9	6.7	4.9	9.8	0.0	0.3	0.0	1.7	0.8	2.9	2.0	0.0	1.4	2.3	3.5	2.0	1.5	0.0	2.1	0.6	2.1	0.5	0.0	1.7	1.5	2.5	0.9	0.0	0.8	1.4	9.5	1.2	1.8	1.8	1.3	1.4	0.8	0.0	1.0	0.7	7.0	1.7	0.0	1.4	1.0	3.2	6.5	1.9	4.8	10.2	1.4	0.2	1.7	0.9	0.7
ZNF804A	C2orf10	ENSG00000170396	"Zinc finger protein 804A"	Q7Z570	2	184598366-184939492	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 31.6;lymphoid tissue: 9.6"	"Cell type enriched"	"Detected in some"	5	"Bipolar cells: 31.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Region enriched"	"Detected in many"	4	"cerebellum: 31.6"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 20.8;RH-30: 14.3;THP-1: 10.5;U-698: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029195	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029195: AB_10603011"	"unprognostic (1.10e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.45e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.98e-4)"	"unprognostic (6.21e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.45e-2)"	"unprognostic (4.93e-2)"	0.4	1.0	4.3	9.6	7.2	1.8	0.4	31.6	10.7	0.6	0.8	0.1	0.8	1.5	0.4	0.3	0.6	0.4	4.8	0.3	5.2	7.3	1.8	0.6	1.2	2.7	2.2	3.0	0.8	0.3	0.2	0.4	0.5	5.4	4.1	1.1	2.4	1.1	4.4	0.3	0.3	3.3	0.5	1.5	1.8	1.2	0.9	0.4	0.0	4.4	0.0	2.9	1.8	2.1	2.0	1.2	1.0	1.7	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.1	4.9	1.6	1.5	0.0	0.0	20.8	0.0	0.0	2.1	0.0	0.3	0.0	3.7	0.1	0.0	5.5	0.8	0.1	8.2	5.2	0.0	2.5	0.0	0.0	1.3	2.5	3.9	0.0	0.0	0.9	0.0	0.0	0.0	4.9	0.0	0.0	3.3	0.0	14.3	0.8	0.0	0.0	0.3	2.4	0.0	0.0	0.0	0.1	0.0	10.5	0.0	5.3	0.1	0.2	2.1	2.2	0.0	15.5	6.1	1.5	1.7	0.0	1.1	0.0	0.0	1.7	0.0	2.0	0.0	0.0	1.2	0.3	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.3	4.3	7.2	31.6	7.5	5.2	7.3	2.2	3.0	5.4	0.4	0.0	1.1	3.4	0.0	0.0	31.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.2	0.0	0.0	2.7	0.4	0.3	3.2	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.0	2.6	6.5	0.2	0.5	1.4	0.0	0.0	0.0	0.0	0.0
ZSCAN21	"DKFZp434L134, NY-REN-21, Zipro1, ZNF38"	ENSG00000166529	"Zinc finger and SCAN domain containing 21"	Q9Y5A6	7	100049774-100065038	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA016948, HPA023591"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA016948: , HPA023591: AB_1859037"	"unprognostic (2.44e-3)"	"unprognostic (3.77e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.42e-3)"	"unprognostic (8.59e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (6.09e-2)"	10.6	12.2	10.9	10.8	11.1	8.1	12.5	15.2	14.8	13.6	12.3	16.3	10.7	7.3	15.9	14.9	10.9	13.9	12.7	8.3	10.8	9.9	14.9	14.8	9.4	8.5	12.0	15.5	13.7	20.3	12.1	10.7	12.0	11.1	13.1	8.4	14.9	16.3	11.9	16.1	9.7	9.6	12.2	11.5	9.1	10.6	26.0	13.3	10.5	12.6	5.7	7.3	11.2	9.7	7.7	6.5	13.5	6.4	10.2	12.0	5.1	4.5	7.6	12.6	14.5	11.8	7.7	10.3	5.2	7.9	10.2	10.3	6.0	5.1	4.8	6.5	6.1	17.4	4.1	11.1	7.4	10.2	6.4	9.2	4.4	6.1	5.5	12.8	6.1	1.8	9.0	13.1	9.9	16.7	8.5	8.1	10.0	10.3	4.3	7.5	11.3	10.4	10.3	15.5	6.2	5.7	7.2	10.1	5.8	8.5	7.0	6.5	16.4	7.0	15.3	9.9	18.6	6.1	5.4	3.8	9.3	11.5	8.1	7.1	8.4	7.8	10.8	4.4	4.0	12.4	13.5	6.4	12.7	11.1	6.3	12.0	7.7	6.9	10.2	6.5	7.1	7.6	8.6	0.8	10.2	3.9	6.2	7.5	5.1	10.9	11.1	15.2	14.8	10.8	9.9	12.0	15.5	11.1	13.3	3.0	3.2	3.7	2.9	1.3	5.2	1.2	5.1	2.7	5.7	3.5	2.0	14.7	6.6	6.1	1.7	4.2	2.6	0.0	3.5	5.4	4.3	3.4	2.3	4.7	4.4	9.5	1.7	1.8	2.6	0.0	5.5	2.2	3.3	3.6	2.5	15.4	4.2	3.4	9.2	8.4	5.3	0.0	4.1	10.4	17.7	3.3	14.8	1.8	2.9	1.4
